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 Summary  
 
Aquaporins (AQPs) are transmembrane proteins that facilitate the movement of 
water molecules across biological membrane by osmosis.  
 
Green fluorescent protein-tagged aquaporin 4 relocalized to the plasma 
membrane of HEK293 cells in response to reduced tonicity and this phenomenon 
was reproduced for endogenous AQP4 in primary astrocyte cultures. The 
mechanism was dependent on phosphorylation at serine-276 by PKA and 
required activation of CaM. AQP4 knockout animals are protected from brain 
edema so pharmacologically modulating the subcellular localization of AQP4 
may provide a platform for an alternative or complementary approach to 
hyperosmotic solution based edema therapies. Using the same methodology, we 
also describe some of the factors controlling AQP5 plasma membrane 
abundance. 
 
AQPs have a signature aromatic/arginine (ar/R) motif that is thought to aid in 
solute selectivity. Mutants of AQP4 in this region permitted the passage of small 
solutes differently to AQP1, questioning the validity of a generalized model of 
AQP solute exclusion. Furthermore, the relative selectivity for glycerol and urea 
of AQPs could be modulated independently of the physical size of the Ar/R 
region, suggesting that lack of solute exclusion and solute selectivity are not the 
same thing. 
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 AQPs retain homotetrameric quaternary structures, but the structural basis and 
functional relevance of this assembly is not known. Mutants of an intracellular 
loop of AQP4 had reduced ability to form tetramers and, despite no change in 
constitutive levels of membrane localization or water permeability, had reduced 
capacity to relocalize in response to hypotonicity.
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1 Introduction 
The aquaporin (AQP) protein family is comprised of integral membrane proteins, 
found in all phylogenetic kingdoms, which facilitate the bidirectional movement 
of water across biological membranes by osmosis. There are up to 13 
mammalian AQPs (depending on the mammal in question), which are found in 
most tissues (see Figure 1-1), with physiological functions ranging from the 
regulation of renal water balance and reabsorption [1], brain fluid homeostasis 
[2], triglyceride cycling between adipocytes and the liver [3] and structural 
integrity of the eye lens [4]. Because of this, understanding AQP function is 
crucial for the study of healthy ageing as well as the onset of many disease states 
such as brain swelling following stroke or head injury [5], nephrogenic diabetes 
insipidus [6, 7], cataracts [8], obesity [9], cancer cell proliferation and migration 
[10] and tumour angiogenesis [11].  
 
For many years it was assumed that biological membranes are freely permeable 
to the osmotic movement of water. However, biophysical measurements of the 
water permeabilities of erythrocyte (red blood cell) and kidney tubule 
membranes demonstrated that different cell types can have very different 
membrane permeabilities [12]. Since the unequivocal determination of the 
structure of biological membranes in the 1970s by Engelman’s X-ray diffraction 
experiments [13], culminating in the fluid-mosaic model of Singer and Nicholson 
[14], it was clear that osmotic movement of water across lipid bilayers could not 
explain the differences in membrane permeabilities between different cell types. 
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Figure 1-1 Distribution of AQP expression throughout the human body. Letters 
denote: a) Retina; b) Olfactory epithelium; c) Inner ear; d) Brain; e) Spinal cord; 
f) Blood vessels; g) Heart; h) Kidney; i) Salivary glands; j) Gastrointestinal tract; 
k) Liver; l) Pancreas; m) Lungs; n) Fat, Skin; o) Female reproductive tract; p) 
Male reproductive system [15]. 
 
AQP 0 
AQP 11 AQP 11 
AQP 12 
AQP 11 
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The concept of a membrane water pore was developed to explain these 
permeability differences: if some cells contained molecules that spanned the 
membrane and allowed water to pass through unimpeded by interactions with 
membrane lipids, this might explain the different rates of water passage across 
different cellular membranes [16]. Additionally, if the level of expression of 
these molecules could vary, the permeabilities of different membranes could 
form a continuous spectrum, depending on the density of pores in the membrane. 
The existence of a water channel protein was first demonstrated conclusively by 
Gheorghe Benga’s work using NMR to measure the water permeability of red 
blood cell membranes [17] and the molecular identity of this water channel 
protein was elucidated in 1992 by Preston and Agre [18], for which Peter Agre 
was jointly awarded the 2003 Nobel Prize in Chemistry. This protein was 
subsequently named aquaporin 1 (AQP1).  
 
Thirteen mammalian AQPs have been discovered to date (AQPs 0-12); they 
range in size (before post-translational modification) from 27 kDa (AQP8) to 37 
kDa (AQP7) and, for those proteins for which single channel water permeability 
has been quantified, have a 100-fold range in water permeability. A sub-set of 
the AQPs also function as channels for glycerol (and other small neutral solutes) 
and are referred to as (aqua)glyceroporins (GLPs). In humans, these are AQPs 3, 
7, 9 and 10. The permeability properties of the mammalian AQPs are 
summarized in Table 1-1, and a sequence alignment is presented inFigure 1-2.  
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Table 1-1 – Water, glycerol, urea and ammonia (NH3) permeabilities of known 
mammalian AQPs. Quantitative water permeability is per AQP channel i.e. after 
subtraction of the basal permeability of the expression membrane and normalized to the 
number of AQP molecules. Expression systems: X – Xenopus oocytes, PL – 
proteoliposomes, M – mammalian cells, V – vesicles derived from membrane 
fragmentation of AQP-expressing mammalian cells, Y – ammonia transport deficient 
yeast. . *estimated from membrane fragment vesicle water permeability relative to 
AQP1-containing vesicles and relative expression level. **These data have not been 
independently replicated. 
 
AQP 
Single channel 
water 
permeability (×10-
14 cm3s-1) 
 
Glycerol 
permeability 
 
Urea 
permeability 
 
Ammonia 
permeability 
AQP0 0.25 [19]; 
gated by CaM 
[20]; X, PL  
No [19]; 
X 
No [21]; 
X 
No [22]; 
X 
AQP1 6.0 [19]; 
X 
No [19]; 
X 
No [23]; 
X 
No [23]; 
X 
AQP2 3.3 [19]; 
X 
No [19]; 
X 
No [21]; 
X 
No [22]; 
X 
AQP3 2.1 [19]; 
X 
Yes [19]; 
X 
Controversial 
[21, 23-25]; 
X 
Yes [22, 23]; 
X 
AQP4 24 [19]; 
X 
No [19]; 
X 
No [26]; 
X 
No [22]; 
X 
AQP5 5.0 [19]; 
X 
No [19]; 
X 
No [27]; 
X 
No [22]; 
X 
 
 
AQP6 
Low pH and Hg2+ 
induce water 
permeability [28, 
29]. Basal 
permeability either 
is very low [29, 
30] or zero [31, 
32]; 
X 
 
 
Yes** [32]; 
X 
 
 
Yes** [32]; 
X 
 
 
Yes [22]; 
X 
  
AQP7 
Permeable [33]; no 
quantitative data; 
X 
 
Yes [33]; 
X 
 
Yes [33]; 
X 
 
Yes [22]; 
X 
 
AQP8 
Permeable [34, 
35]; no 
quantitative data; 
X, PL 
 
No [34, 35]; 
X, PL 
Controversial 
[34-36]; 
X, PL 
 
Yes [23, 37]; 
X, Y 
 
AQP9 
Permeable [38]; no 
quantitative data; 
PL 
 
Yes [23, 38]; 
X, PL 
 
Yes [23, 38]; 
X, PL 
 
Yes [23]; 
X 
 
AQP10 
Permeable [39]; no 
quantitative data; 
X 
 
Yes [39]; 
X 
 
Yes [39]; 
X 
 
Unknown 
AQP11 Permeable [40],~2 
[41]*; 
M, V 
Yes** [42]; 
M 
Unknown Unknown 
AQP12 Unknown Unknown Unknown Unknown 
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Figure 1-2 Sequence alignment of human AQPs, and bacterial and plant AQPs 
for comparison. NPA motifs are green, selectivity filter residues blue, and 
deviations from conservation red. 
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1.1 Structural biology of the AQP family 
There is a large amount of medium-to-high-resolution structural data available 
for the AQP family (43 structures deposited in the Protein Data Bank for 11 
different AQPs). These structures suggest that the AQPs share many common 
structural features. The AQP monomer is composed of six tilted transmembrane 
(TM) helices that surround a central cavity containing two helix-forming loops 
that enter and exit from the same side of the membrane (labelled as HH1 and 
HH2 in Figure 1-3 A). This central cavity is the pathway for water and solute 
transport. The two helical loops contain highly conserved asparagine-proline-
alanine (NPA) motifs. Crystallography and molecular dynamics (MD) 
simulations suggest that the asparagine residues act, in concert with surrounding 
backbone carbonyl groups, to enable water transport by providing hydrogen 
bonds to water molecules [43], thereby lowering the free energy penalty (caused 
by breaking of water-water hydrogen bonds) of removing a water molecule from 
bulk solution. Recent biophysical experiments comparing AQPs with gramicidin 
and the potassium channel KcsA [44] suggest that the number of pore-lining 
hydrogen-bonding sites for water determines the channel water permeability. In 
addition to providing hydrogen-bonding sites, the asparagine residues help to 
orient the water molecules such that the hydrogen atoms point ‘outwards’ from 
the pore, creating a barrier to proton transport [45]. A recent sub-angstrom 
crystal structure of the Pichia pastoris AQY1 found overlapping water densities 
in the pore that, supported by MD simulations, suggested a correlated pairwise 
movement of water molecules through the extracellular end of the pore. This 
correlated motion may help to minimise water-water hydrogen bonds in this  
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Figure 1-3 Structural biology of the AQP family. (A) Primary sequence and 
secondary structural motifs of the AQP family, exemplified by human AQP4 
with NPA motifs (blue) and selectivity filter residues (red) highlighted; (B) 
Structural alignment of the soluble loops of human AQP1 (dark blue), human 
AQP4 (red), bovine AQP0 (pink) and E. coli GlpF (green) from x-ray crystal 
structures; (C) Structural alignment of the TM regions of human AQPs 1 and 4, 
bovine AQP0 and E. coli GlpF. Colours as in (B); (D) Structural alignment of 
amino acid residues of the Ar/R selectivity filter; (E) Crystal structure of human 
AQP2 with the C-terminal helix (red) in four different conformations.  
F48 
F56 
F77 
W48 
R187 
R195 
R216 
R206 
H172 
H180 
H201 
G191 
A181 
C189 
A210 
F200 
TM4 
TM3 
Loop C 
Loop A 
TM1 TM2 TM2 
TM1 
TM4 
TM3 
TM6 TM6 
HH2 
HH2 
Loop E 
Loop D 
TM5 TM4 TM5 
TM4 
Loop B 
TM3 TM3 
HH1 
HH1 
TM1 
TM2 
HH1 
TM5 
TM6 HH2 
TM3 
TM4 
Loop A 
Loop B 
Loop C 
Loop D 
Loop E 
(A) 
(B) 
(C) 
(D) 
(E) 
 27 
region, providing a further barrier to proton permeation, without compromising 
water transport [43]. Crystallographic analysis of the E. coli GlpF (a GLP), 
suggested that the same asparagine residues also form hydrogen bonds with 
glycerol [46]. This is likely to be also true of other polar solutes that permeate 
GLPs. 
 
AQPs have intracellular amino (N-) and carboxyl (C-) termini of varying lengths; 
AQP8 has a short C-terminus of 10-15 residues, whereas AQP4 has a large C-
terminus consisting of ~70 residues. AQP11 has a large N-terminal tail of ~40 
residues, whereas AQPs 1,2 and 5 have short N-termini of <10 residues. In 
contrast to the structural conservation of the TM domains of AQPs (see Figure 
1-3 C), much less is known about the structure of the termini. This is because the 
majority of AQP crystal structures are obtained using constructs in which the N- 
and C-terminal tails of the protein have been truncated due to the difficulty of 
obtaining well-diffracting crystals using full-length AQP molecules [47]. This 
suggests an inherent structural flexibility in these regions of AQP molecules and 
indeed a recent X-ray structure of AQP2, which included ~20 residues of the 
(truncated) C-terminal tail, found this fragment of the C-terminus in four 
strikingly different conformations in each of the four AQP2 monomers within the 
tetrameric unit cell [48] (see Figure 1-3 E). 
 
AQPs retain a homotetrameric quaternary structure despite wide variety in the 
permeability properties, subcellular localization and trafficking responses 
between different members of the AQP family. Early biochemical work, using 
carboxyl-amine fusion dimers consisting of one wild-type unit and one unit 
 28 
missing the cysteine residue required for mercurial inhibition, showed that the 
functional units of AQPs are the monomers [49] and numerous molecular 
dynamics simulation studies support this [50]. Recent work on GlpF 
reconstituted into liposomes at low density has suggested that isolated AQP 
monomers may be equally capable of facilitating water transport as those 
incorporated into a tetramer [44]. Therefore it is not clear why AQPs retain this 
oligomeric structure. Data presented in chapter 5 shows a correlation between 
AQP4 tetramerization and a regulatory subcellular relocalization response. 
Regulation of AQP permeability and subcellular localization by the formation of 
heterotetramers has been demonstrated for some plant AQPs [51]. A fifth, central 
pore is formed at the fourfold axis of the tetramer. Several functional roles have 
been suggested for this pore, including carbon dioxide [52] and cation 
permeation [53]. Some biochemical studies have suggested that tetramers formed 
by GLPs have reduced stability compared to tetramers formed by AQPs with 
strict water selectivity [54, 55], although it is not clear whether there is any 
functional relevance to this correlation. Furthermore, data presented in chapter 5 
suggests that the human GLPs AQP9 and AQP10 are fully tetrameric, so this 
correlation may not hold for the entire GLP subfamily. 
1.2 The principles of AQP solute selectivity remain to be 
established 
All AQPs (with the possible exception of AQP12, which has yet to be 
characterized) transport water (Table 1), whilst some also transport glycerol. The 
glycerol permeable GLPs (e.g. human AQPs 3, 7, 9 and 10) are also permeable 
to urea. The urea permeability of AQP3 is controversial, with some studies 
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reporting urea transport and others no transport [21, 23-25]. This may be due to 
methodological differences, and is discussed in detail in section 3.2.1. 
 
Of the mammalian GLPs AQP3, AQP7, and AQP9 are also permeable to 
ammonia. AQP8 is the only glycerol impermeable mammalian AQP that is 
permeable to ammonia. The ammonia permeability of the most recently 
discovered member of the GLP group, AQP10, is still unknown. 
 
AQP11 and AQP12 are the most recently discovered members of the AQP 
family [56, 57]; due to this and their localisation to intracellular membranes, 
there have been minimal functional studies reported for AQP11 and AQP12. 
There is one report that AQP11 increased the glycerol permeability of an 
adipocyte cell line [42], but this permeability of AQP11 has yet to be replicated. 
 
The size exclusion model of AQP selectivity posits a correlation between these 
different permeabilities and the channel cross-sectional area at its narrowest 
point, known as the selectivity filter. This model is based primarily on in silico 
experiments using MD simulations and analysis of X-ray crystal structures, but 
only one in vitro set of experiments, using site-directed mutagenesis (SDM) to 
alter the selectivity of AQP1 [58]; it is therefore unclear whether this model is 
broadly applicable to the AQP family as a whole. A conserved arginine residue 
(in the second helical loop directly after the NPA motif) forms part of the 
channel constriction known as the aromatic/arginine (ar/R) selectivity filter (see 
Figure 1-3). In silico and crystallographic analyses of AQP1 [59], AQP4 [60] 
and AQPZ [61] have suggested that fluctuations of this arginine residue could 
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modulate channel water permeability, and in vitro evidence of this for human 
AQP4 is presented in chapter 4. In water-selective AQPs, the other components 
of this filter are a phenylalanine in the top half of the pore-facing side of TM 
helix 2 (TM2) and a histidine in a similar position in TM5 (see Figure 1-3D). In 
glycerol and urea permeable AQPs, this histidine is replaced by a small amino 
acid residue such as glycine (AQP3, -7, -10) or alanine (AQP9), although if the 
histidine is mutated to alanine in AQP1 it does not become a glycerol channel. In 
chapter 4, data is presented which suggests that the same mutation to AQP4 
renders it glycerol permeable, suggesting that the details of solute exclusion may 
differ between family members. 
 If both aromatic members of the filter (histidine and phenylalanine) are mutated 
to alanine, AQP1 functions as a urea channel and to a lesser extent as a glycerol 
channel [58]. Based on this observation and molecular simulations of AQP1 and 
the E. coli GLP, GlpF [58, 62], it has been suggested that the cross-sectional area 
of the pore at the ar/R region determines AQP selectivity for neutral polar 
solutes. Additionally, based on crystallographic analysis of GlpF and the 
bacterial water-selective AQP, AQPZ, it has been suggested that the positioning 
of the ar/R residues by the surrounding unstructured loops has a role in 
determining the channel size [63]. In AQP8, the only glycerol-impermeable, 
ammonia-permeable mammalian AQP, the third member of the filter is likely an 
isoleucine residue (based on sequence alignment), which is considerably larger 
than alanine or glycine. Overall, current thinking on solute selectivity suggests 
that the aromatic residues of the ar/R filter are important for solute exclusion in 
the water selective AQPs, but further molecular factors may be involved in 
mediating solute selectivity. 
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1.3 Physiological water transport by AQPs 
AQP-mediated water transport around the body is important for a variety of 
physiological processes in several different organs. 
1.3.1 Central nervous system (CNS) 
The predominant AQPs found in the central nervous system are AQP4 in glial 
cells, particularly those in direct contact with capillaries and the pia mater [64], 
AQP1 in the choroid plexus epithelium (which is thought to be responsible for 
the secretion of cerebrospinal fluid, CSF) [65], and AQP9 in glial cells and 
catecholaminergic (adrenergic, noradrenergic and dopaminergic) neurons [66]. 
Localization of AQP4 in astrocytes is polarized to the foot processes that make 
contact with endothelial cells, forming the blood-brain barrier, and areas of 
astrocyte membranes that encapsulate neuronal synapses [2] (see Figure 1-4). 
The localization to foot processes is mediated by a physical interaction with the 
dystrophin complex via the protein α-syntrophin, which binds to the three C-
terminal residues (SSV) of AQP4 [67]. The density of AQP4 in these regions is 
very high, with AQP4 molecules occupying up to 50% of the total surface area of 
these membranes [64]. 
AQP4 knockout animals have provided some indication of the physiological 
roles and pathophysiological complications of AQP4 in the CNS. 
AQP4 -/- mice had a 28% increase in brain extracellular volume [68] and 
increased brain water content by ~1% [69], and glial-conditional deletion of 
AQP4 in mice caused a 31% reduction in brain water uptake after hypo-osmotic 
stress [70], suggesting that the astrocytic layer ensheathing the brain vasculature 
is rate-limiting for water movement and that AQP4 is important either directly or 
indirectly for the control of brain water content and extracellular volume.  
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Figure 1-4 Localization of AQP4 in the central nervous system in support of 
brain water homeostasis, waste clearance and potassium handling. Blue cylinders 
represent AQP4. Purple cylinders represent potassium channels and yellow 
circles potassium ions. Dystrophin-associated protein complex schematic 
adapted from Fairclough et al [71] 
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Recent work has suggested that there is a paravascular network of spaces that 
allow the recycling of CSF along spaces around arteries, into the brain 
parenchyma and to spaces surrounding veins and that this bulk flow impacts on 
water and waste clearance from the brain. AQP4 -/- mice had reduced fluorescent 
tracer flow along these routes and increased build-up of injected amyloid-β 
(build-up and plaques of which are thought to responsible for the development of 
Alzheimer’s disease) [72], suggesting that AQP4-mediated transcellular water 
flow across astrocyte membranes is crucial for brain homeostasis. 
 
AQP4 appears to have an indirect role in potassium homeostasis of the brain 
extracellular fluid during and following synaptic activity. Neuronal 
depolarization involves the movement of K+ ions from the inside to the outside 
of neurons, and any increase of extracellular K+ concentration ( [K+]o ) can cause 
hyperexcitability and reduce the efficacy of synaptic transmission. To prevent 
this, astrocytes perform a regulatory function whereby excess K+ is taken up, 
correlated with a reduction of the extracellular volume by up to 30% and 
swelling of the astrocyte [73], which is impaired in AQP4 -/- mice [74]. This 
swelling suggests coupled movement of K+ and water. AQP4 -/- mouse brain 
slices had smaller stimulus-induced [K+]o increases but slower [K+]o clearance 
kinetics compared to wild-type mice [75]. Mathematical modelling explicitly 
accounting for intracellular K+ diffusion  suggested that water permeability of the 
perisynaptic astrocyte membrane can control the rate of K+ uptake by allowing 
volume changes that modulate [K+] on either side of the astrocyte membrane 
[76]. A link between K+ uptake and AQP4 is further suggested by the 
observation that the AQP4-mediated water permeability of primary rat astrocytes 
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was increased by 46% upon increase of [K+]o from 2.5 mM to 10 mM for 1 
minute and by 55% after 5 minutes [77]. Data presented in chapter 3 suggests 
that this response may be mediated by relocalization of AQP4 to the plasma 
membrane rather than the gating response suggested in this study. Furthermore, 
the inward rectifying potassium channel, Kir4.1, forms part of the same 
dystrophin-associated protein complex as AQP4 in glial cells [78]. Elevated 
[K+]o is associated with the pathophysiology of epilepsy [79]. In excised sclerotic 
hippocampal tissue from temporal lobe epilepsy (TLE) patients, AQP4 
expression was elevated at the transcript and protein levels, but decreased 
dystrophin expression suggested that AQP4 could have lost its polarized 
expression [80]. In a rat model of epilepsy, loss of AQP4 polarization, and a mild 
increase in AQP4 expression, preceded the onset of seizures [81]. Furthermore, 
three single nucleotide polymorphisms (SNPs) in non-coding regions of the 
AQP4 gene were found to be associated with temporal lobe epilepsy in humans 
[82]. The localization of AQP4 in the CNS is shown schematically in Figure 1-4. 
 
Although the data discussed here demonstrate a key requirement for AQP4 in 
brain homeostatic mechanisms, there also appears to be a disadvantage to AQP4 
expression in the brain: reduction of AQP4 expression was protective against 
cytotoxic edema formation in various models of pathology including water 
intoxication and middle cerebral artery occlusion (a stroke model) in AQP4 -/- 
mice [83], carotid artery ligation and hypoxia in AQP4 siRNA-treated piglets 
[84], transient retinal ischemia in AQP4 -/- mice [85] and traumatic brain injury 
(TBI) in rats treated with intravenous anti-AQP4 antibodies [86, 87]. 
Furthermore, glial specific overexpression of AQP4 in transgenic mice  
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accelerated cytotoxic swelling and intracranial pressure (ICP) elevation after 
water intoxication compared to wild-type and AQP4 -/- controls [88]. Disruption 
of AQP4 localization to perivascular endfeet by deletion of the dystrophin [89] 
or α-syntrophin [90, 91] genes in mice had the same protective effect. Taken 
together these data identify AQP4 as a clear molecular target for intervention 
into the various devastating pathologies, including stroke and traumatic brain 
injury, which involve cytotoxic cerebral edema. AQP4 could be modulated in 
several ways: direct inhibition of the water channel, protein expression levels or 
subcellular relocalization. In chapter 3, data is presented suggesting AQP4 
subcellular localization is dynamically regulated in response to changes in 
extracellular tonicity, which is a key driver of cytotoxic edema via misregulation 
of Na+, K+ and Cl- homeostasis [92]. 
 
The role of AQP1 in the choroid plexus appears to be to provide the high water 
permeability required for secretion of CSF, and water permeability may be rate 
limiting in this process as AQP1 knockout mice had a 25% reduction in CSF 
secretion and 56% reduction in intracranial pressure [65]. There is some 
controversial evidence that AQP1 may act as a cGMP-gated cation channel (see 
section 1.4.6). The secretion of CSF primarily involves active transport of Na+, 
K+, Cl- and HCO3- across the choroid plexus epithelium driving the osmotic 
movement of water [93], so it is possible that AQP1 could be performing a dual 
role in CSF secretion. Recent evidence using magnetic resonance imaging to 
measure influx of spin-labelled H2O into the CSF of live AQP1 -/- and AQP4 -/- 
mice suggests that AQP4 is more important for CSF secretion than AQP1 [94]. 
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1.3.2 Kidneys 
AQPs 1, 2, 3, 4, 6, 7, 8 and 11 are expressed in the mammalian kidney [1]. AQPs 
1 and 7 are thought to contribute to the renal water absorption mechanism by 
providing high water permeability to the descending limb of the loop of Henlé in 
order to return water to the blood and set up the osmotic gradient that forms the 
counter current multiplier mechanism [95]. AQP2-mediated water permeability 
is rate limiting for water reabsorption in the collecting duct, and dynamic 
regulation of the subcellular localization of AQP2 is used to modulate water 
reabsorption via arg8-vasopressin (AVP) signalling stimulated by hypovolaemia 
(low blood volume) and hypernateraemia (high blood sodium) [96]. AQPs 3 and 
4 are thought to provide a route back to the blood for water reabsorbed in the 
collecting duct via AQP2.  
1.4 Solute transport by AQPs 
1.4.1 Glycerol transport 
The movement of glycerol around the body is predominantly thought to include 
glycerol release from fat tissue through AQPs 7 and 10, entry into the liver 
through AQP9, reabsorption in the kidney through AQP7 and movement in the 
skin through AQP3. The contributions of AQPs to mammalian glycerol 
homeostasis are summarized in Figure 1-5. 
1.4.1.1 AQP7 glycerol transport 
AQP7 is expressed in adipose tissue in adipocytes [97] and capillary endothelia 
[98]. Upon hypoglycaemia, triglycerides are broken down within adipocytes to 
glycerol and free fatty acids [99]. Adrenaline [97] and noradrenaline [100],   
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Figure 1-5 Glycerol permeable AQPs contribute to mammalian glycerol 
physiology and homeostasis. 
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which are involved in activation of lipolysis, were reported to cause subcellular 
relocalization of AQP7 to the plasma membrane and lipid droplets of adipocytes. 
Glycerol liberated from triglyceride storage is released from adipocytes [101] 
into the blood and this was reduced threefold in AQP7 -/- mice [102]. Plasma 
glycerol levels in AQP7 -/- mice before and after adrenergic agonist stimulation 
were reduced and adrenaline-induced glycerol secretion by cultured mouse 
adipocytes was reduced approximately two-fold [103]. These results suggest that 
the major pathway for glycerol efflux from adipocytes after lipolysis is via 
AQP7.   
 
AQP7 -/- mice have enlarged adipocytes and obesity in adulthood [102]. A loss 
of function mutation in the human AQP7 gene has been discovered (G264V) but 
was not correlated with obesity [104]. This may be due to the presence of AQP10 
in human adipocyte membranes, which was found to contribute ~50% of the 
water and glycerol permeability of human adipocyte plasma membrane vesicles 
[105]. Mouse AQP10 is a pseudogene [106] which probably explains the 
differential effects of loss of AQP7 function between mice and humans. 
 
Glycerol is almost completely reabsorbed by the kidneys [107] (unless it is raised 
above ~0.3 mM[108]), suggesting the existence of a glycerol reabsorption 
pathway. AQP7 is expressed in the proximal tubule of the kidney. AQP7 -/- mice 
showed marked glyceroluria in comparison to wild type (~400-fold increase in 
urine glycerol) [109]. Human children homozygous for the AQP7 G264V mutant 
were found to have hyperglyceroluria, with a ~1000-fold increase in urine 
glycerol compared to heterozygous familial controls [110]. The G264V mutant 
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has been shown to have no activity as a glycerol or water channel in Xenopus 
oocytes [104], although plasma membrane expression was not verified in this 
study so that it could not differentiate between a non-functional channel and an 
incorrectly localised channel. The mutation disrupts a conserved GxxxG motif in 
TM6. These motifs are important for TM helix-helix packing interactions, 
allowing close contact between backbone atoms of two helices of an interacting 
pair [111]. Regardless of the loss of function mechanism of G264V, these data 
strongly suggest that AQP7 is the TM glycerol reabsorption pathway in the renal 
proximal tubule. 
1.4.1.2 AQP9 glycerol transport 
AQP9 is expressed in the liver [112], primarily in hepatocytes [113]. Upon 
fasting, glycerol released into the plasma from adipocytes is taken up by 
hepatocytes and used as a substrate for gluconeogenesis [114]. 
 
In rats, AQP9 protein expression was increased up to 20-fold after 24-96 hours 
fasting [38]. In mice, AQP9 expression measured in purified hepatocyte plasma 
membrane vesicles increased 10-fold after 18 hours fasting. This increase was 
accompanied by a two-fold increase in hepatocyte plasma membrane glycerol 
permeability, which was reversed by addition of phloretin (an apple polyphenol 
that inhibits AQP9). The increase was abolished in AQP9 -/- mice [115]. Fasted 
AQP9 -/- mice had elevated plasma glycerol compared to wild-type [115, 116]. 
In addition, plasma glucose concentration was decreased [116], indicating a 
gluconeogenetic deficiency. This data suggests a role for AQP9-mediated 
glycerol uptake by hepatocytes during fasting-induced hypoglycaemia.  
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CD8+ (cytotoxic) T cells are white blood cells that facilitate the destruction of 
infected or otherwise damaged cells. In mouse T-cells, AQP9 expression was 
upregulated post-infection, allowing cells to import glycerol for triglyceride 
synthesis. AQP9 -/- cells had reduced long-term survival compared to +/+ cells 
and the long-term survival of the +/+ cells could be inhibited by phloretin [117]. 
This suggests that AQP9 expression can act as a metabolic switch, enabling long-
term survival of T cells by enabling glycerol import for triglyceride synthesis to 
build up an energetic reserve, allowing cell survival in nutrient poor conditions. 
1.4.1.3 AQP3 glycerol transport 
AQP3 is expressed in the skin in keratinocytes below the stratum corneum (SC) 
[118]. The ability of the epidermis to maintain hydration is impaired in AQP3 -/- 
mice. In dry conditions, AQP3 -/- mice showed comparable (reduced) levels of 
SC hydration to wild-type mice, whereas at normal humidity, SC hydration was 
lower in the AQP3 -/- mice [119]. Elevated humidity (which prevents water loss 
via evaporation) did not correct the deficiency, which suggests that the primary 
role of AQP3 in skin hydration is not to provide water to replace that lost by 
evaporation.  
SC glycerol concentration in AQP3 -/- mice was reduced to ~40% of that of 
wild-type, with no significant difference in the levels of other osmolytes (ions, 
glucose, urea, lactate and free amino acids) [120]. Glycerol acts as a humectant 
(a ‘water-retaining’ osmolyte), which may be the mechanism by which it 
maintains skin hydration. It has also been suggested that glycerol may prevent 
SC water loss by inhibiting the phase transition of intercellular lipids from the 
liquid crystalline to the solid phase [121]. The rate of transport of glycerol from 
blood to the SC was reduced in AQP3 -/- mice resulting in reduced lipid 
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biosynthesis [122]. This suggests a further role for glycerol in maintaining skin 
hydration by allowing the maintenance of the SC lipid barrier. Furthermore, 
topical or systemic administration of glycerol was found to correct the skin 
deficiencies in AQP3 -/- mice [122].  
1.4.2 Urea transport 
Urea is produced in the liver (as a non-toxic carrier of waste nitrogen) from 
ammonia, which is a neurotoxic product of protein degradation. Ammonia causes 
cell death of astrocytes by stimulating the mitochondrial permeability transition 
[123]. An adult human excretes about 25 g/day of urea in the urine, and urea 
transport in the kidney is vital for the urinary concentrating mechanism [124]. 
The physiological roles of urea transport by AQPs are less clear than those of 
water and glycerol transport.  
1.4.2.1 Which mammalian AQPs are urea channels? 
AQPs 7 [33], 9 [125] and 10 [39] have been shown to be urea permeable and 
there is a consensus in the literature on the urea permeability of these AQPs. 
There is conflicting evidence in the literature on whether AQPs 3 and 8 are urea 
channels. 
 
Early work on AQP3 suggested that rat AQP3 was urea permeable, with 
expression of AQP3 in Xenopus oocytes increasing urea uptake twofold after 30 
minute incubations of oocytes with radiolabelled urea [126] or threefold in 
oocyte swelling assays [24]. Further studies on rat AQP3 found no urea transport 
using similar oocyte volumetric techniques [21, 23]. These studies differed in 
that the former used 165 mM urea whereas the latter two used 20 mM urea. It 
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may be that AQP3 urea transport is so slow that at 20 mM it does not induce 
large enough volume changes to be measured on the timescale of an oocyte 
swelling experiment (~1 min), or that the transport is non-linear, although this 
seems unlikely given the linear nature of water and glycerol transport by AQP3 
[127]. In one study, human AQP3 was used a positive control for AQP urea 
permeability. 1 mM of urea was added to AQP3-expressing oocytes and after a 
10 minute incubation, the oocytes had an intracellular urea concentration of ~75 
µM (assuming an oocyte volume of 1 µL) [25]. This is ~10% of the expected 
equilibrium value, and the fact that it is still so far from equilibrium even after 10 
minutes suggests that urea transport through AQP3, whilst non-zero, is very 
slow. This may explain the different results between short (typically ~1 min) 
volumetric experiments and the longer timescale radiolabelled solute uptake 
experiments.  
 
Early work on mouse AQP8 suggested that it was urea permeable [36], whereas 
rat AQP8 was not [35], both using radiolabelled solute uptake measurements in 
Xenopus oocytes. Work on purified rat, mouse and human APQ8 in 
proteoliposomes suggested that neither rat nor human AQP8 were urea 
permeable [34]. This study did not report mouse urea permeability due to 
liposome swelling discrepancies, probably caused by the ionic detergent required 
to solubilize mouse AQP8. There is considerable interspecies amino acid 
sequence variability for AQP8 (e.g. 74% identity between human and mouse 
AQP8, c.f. 94% for AQP1 and 93% for AQP4). Interestingly, one difference 
between human and mouse AQP8 is a residue that is predicted to be pore-lining 
(based on a homology model to bovine AQP0 [34]) and situated at the ar/R filter, 
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G207 (in human; A205 in mouse). The idea of species-specific differences in 
permeability of AQP8 is intriguing, but studies performed in parallel in the same 
experimental system are required to validate this. 
1.4.2.2 Urea transport by AQP9 
AQP9 is a urea channel in the liver expressed in hepatocytes at the sinusoidal 
surface. Urea permeability measurements (using stopped-flow light scattering to 
measure vesicle volume) performed on mouse hepatocyte plasma membrane 
vesicles of AQP9 -/- and urea transporter type A1/3 (UT-A1/3) -/- mice showed 
that AQP9 contributes ~30% to mouse hepatocyte membrane permeability and a 
member(s) of the UT-A family contributes ~40% [128]. However, AQP9 -/- 
mice did not demonstrate any deficiency in urea clearance from hepatocytes in a 
state that promotes elevated hepatic urea production (high protein diet), 
suggesting that AQP9 and the UT proteins in concert form a urea transport 
system with built-in redundancy.  
1.4.3 Ammonia transport 
Ammonia is produced as a by-product of protein breakdown and quickly 
converted to urea via the hepatic urea cycle to prevent ammonia neurotoxicity. It 
is important for control of acid-base balance in the kidney, where ammonia 
synthesis and excretion are tightly regulated and change in response to acidosis 
or alkalosis [129]. Members of the GLP subfamily, AQPs 3 [23], 7 [22] and 9 
[23], have been reported to be permeable to ammonia, as has AQP8 [23, 130]. 
There is also evidence of ammonia permeability of AQPs 1, 6 and 7 using 
microelectrode measurements of oocyte surface pH[22]. The physiological 
relevance of ammonia permeability of AQPs is unclear. 
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Figure 1-6 Predicted selectivity filter residues of AQP8 from homo sapiens (red) 
and mus musculus (blue) based on sequence alignment and homology modelling 
to bovine AQP0. 
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AQP8 -/- mice have only the very mild phenotypic abnormality of slight 
hypertriglyceridaemia after three weeks on a high (50%) fat diet [131]. AQP8 is 
expressed in the inner mitochondrial membrane of hepatocytes [132] and 
increased the transport of an ammonia analogue into AQP8-expressing S. 
cerevisiae and rat hepatocyte mitochondria by three-fold. However, AQP8 -/- 
mice do not show any impairment in ammonia clearance under physiological 
conditions or when chronically or acutely loaded with ammonia [133]. This 
suggests a secondary (non-AQP) pathway for ammonia, which either provides 
the majority of ammonia permeability in these tissues, or is upregulated in 
ammonia-permeable AQP knockouts. The proteins associated with the Rhesus 
(Rh) blood group system have been shown to function as ammonia channels 
[134]. Several of these are expressed in the liver [135] (RhB and RhC) and the 
kidneys (again RhB and RhC), where ammonia has an important role in acid-
base balance [136]. Rh -/- mice have been generated, however these studies have 
focused on the erythrocytic Rh proteins [137, 138]. Comprehensive phenotype 
analyses of RhB and RhC -/- organisms and double AQP/Rh knockouts could 
provide an answer. Knockdown of AQP8 in primary rat hepatocytes by ~80% 
reduced ammonium chloride-induced ureagenesis by 30% and abolished 
glucagon-stimulated increases in ureagenesis [139]. AQP8 knockdown in a 
human proximal tubule cell line decreased the rate of ammonia excretion by 31% 
at pH 7.4 and by 90% at pH 6.9 [140], suggesting that AQP8 ammonia 
permeability might be required for renal ammonia excretion and be involved in 
the renal adaptive response to acidosis. Furthermore, acid-induced 
downregulation of AQP8 by 30% in primary rat hepatocytes was correlated with 
a 31% reduction in hepatocyte ureagenesis, and AQP8 downregulation was 
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correlated with reduced liver urea content in rats subjected to seven days of 
acidosis [141]. These data support the idea of a physiological role for AQP8 in 
either plasma membrane diffusion of ammonia, mitochondrial ammonia 
transport, or both in support of renal and hepatic ammonia handling.  
 
AQPs 7 and 10 are present in adipocytes. It has been shown in humans that 
during intense exercise, adipose tissue removes ammonia from the plasma and 
develops an increased glutamine/glutamate ratio [142]. This suggests 
incorporation of ammonia into glutamine through glutamine synthase (which 
catalyses the reaction: glutamate + ATP + NH3 → glutamine + ADP + 
phosphate) in adipocytes as a secondary detoxification pathway in support of the 
hepatic urea cycle at times of elevated plasma ammonia. Whether AQPs 7 or 10 
contribute to this ammonia uptake is yet to be investigated. 
1.4.4 Carbon dioxide transport 
The majority of carbon dioxide (CO2) produced by cellular metabolism (~70%) 
is transported to the lungs for expulsion from the body via the bicarbonate 
(HCO3-) system. Briefly, carbon dioxide diffuses out of the cells in which it is 
produced and into the plasma. It moves down its concentration gradient into 
erythrocytes, where carbonic anhydrase catalyses conversion into carbonic acid. 
Upon dissociation (H2CO3→H+ + HCO3-), the HCO3- is exchanged across the 
erythrocyte membrane for Cl- and the proton binds to haemoglobin [124]. There 
has been speculation that CO2 transport into erythrocytes might be aided by 
channel proteins, and that an AQP could contribute to this [143, 144]. AQP1 is 
expressed at the plasma membrane of erythrocytes [18]. Human AQP1 has been 
reported to increase the CO2 permeability of Xenopus oocytes four-fold in the 
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presence of carbonic anhydrase suggesting that AQP1 functions as a CO2 
channel [145, 146]. AQP1 -/- human erythrocytes had a 60% reduction in CO2 
permeability when compared to human erythrocytes expressing AQP1 [147]. 
However, the CO2 permeability of AQP1 -/- mouse erythrocytes from AQP1 
knockout mice was not different to wild-type [148]. Stopped flow experiments 
with AQP1 reconstituted into liposomes have also given conflicting results. 
AQP1 from human blood increased the CO2 permeability of liposomes four-
fold[149], whereas mouse AQP1 showed no increase[148]. This agrees 
qualitatively with the results from measurements on intact erythrocytes in that 
human AQP1 appears to increase CO2 permeability of the membrane, whereas 
mouse AQP1 does not. This may be due to methodological differences, but it 
also raises the intriguing possibility that human AQP1 is CO2 permeable whereas 
mouse AQP1 is not. A recent review dedicated to AQPs and CO2 permeability of 
biological membranes [52] concluded that “the debate about the mechanism of 
membrane CO2 diffusion continues and it is difficult to draw general 
conclusions”. This is still very much an open question. 
1.4.5  Hydrogen peroxide transport 
Superoxide (O2-) molecules are produced in the mitochondria as a by-product of 
ATP synthesis and by the NADPH oxidase (NOX) family of enzyme complexes, 
which couple intracellular oxidation of NADPH to extracellular production of 
superoxide molecules. Superoxide undergoes disproportionation to molecular 
oxygen and hydrogen peroxide (H2O2), which can be catalysed by the enzyme 
superoxide dismutase [150], and the highly reactive H2O2 can then go on to form 
a variety of further reactive oxygen species (ROS). High levels of ROS derived 
from these pathways are well known to cause cellular damage and even death 
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and mitochondrial ROS were long considered to be purely harmful by-products 
of an imperfect metabolic system. However, work in the last decade has shown 
that they are crucial for a variety of physiological processes including adaptation 
to hypoxia, immune function and regulation of autophagy [151], so clearly there 
is a need for tight regulation of ROS levels. H2O2 and H2O are very similar 
molecules with similar molecular sizes, dipole moments and hydrogen bonding 
capacities [152], therefore it would not be surprising to find that some AQPs 
could transport H2O2. The half-life for H2O2 in cells is very short (e.g. ~1 ms in 
lymphocytes [153]), making biophysical experiments of the kind used for e.g. 
glycerol or urea permeation very difficult. Growth assays using H2O2 transport-
deficient yeast are typically used, and reduced growth after expression of an 
AQP is interpreted as an AQP-mediated increase in membrane H2O2 
permeability causing cellular damage and/or metabolic disruption. Using this 
technique, human AQP8, rat (but not human) AQP1 and several mutants thereof 
were shown to be H2O2 permeable [154]. Based on this data, the authors 
suggested that all AQPs function as H2O2 channels. It is not clear whether this is 
a valid generalization, but clearly some mammalian AQPs are H2O2 channels. 
 
Imaging studies demonstrated H2O2 permeability for human AQP8 and AQP3 
(but not AQP1). Furthermore, AQP3 overexpression in HeLa cells allowed the 
cells to respond to serum starvation via ROS mediated activation of the AKT 
(protein kinase B) signalling pathway, whereas cells not expressing AQP3 could 
not. Knockdown of AQP3 in a colon cancer cell line inhibited the AKT response 
to epidermal growth factor (EGF) [155], which can initiate ROS signalling via 
activation of NOX complexes. This suggests that AQP3 is required for uptake of 
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NOX-generated H2O2 in EGF signalling. There is also evidence of involvement 
of AQP3 in ROS-mediated signalling in T cell migration [156], AQP8 in 
leukaemia cell proliferation and metabolism [157], and in minimizing oxidative 
stress in hepatic mitochondria [158] and AQP11 in minimizing oxidative stress 
to the endoplasmic reticulum in kidney proximal tubule cells [159, 160]. Taken 
together, these examples provide clear evidence for AQP-mediated H2O2 
membrane permeability and suggest physiological roles in redox signalling via 
uptake of NOX-derived H2O2 and in cellular mechanisms for minimizing 
oxidative stress. 
1.4.6 Ion permeability of AQPs: An unresolved controversy 
AQPs support bulk movements of fluid by giving high water permeability to 
membranes that secrete osmolytes. These osmolytes are often ions (e.g. Na+, K+ 
and Cl-) and this is reflected in the fact that several AQPs form macromolecular 
complexes with ion channels and transporters, e.g. AQP4 and the Kir4.1 
inwardly rectifying potassium channel [47]. Perhaps a more efficient way for 
nature to achieve this dual permeability would be to have both ions and water 
pass through the same channel. Indeed it has been observed that several ion 
channels can transport water [44], but it has also been suggested that some AQPs 
may function as ion channels [161].  
 
The pH-sensitive anion permeability of AQP6 is well established, and it is likely 
that the monomeric pore is the ion pathway given that a point mutation to a pore-
lining residue of AQP6 (T63I) abolished ion permeability [162] and AQP6-
mimicking mutations of a pore-lining amino acid residue of AQP5 (L51R) 
conferred anion permeability [163]. There is also some evidence that the plant 
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AQP nodulin-26 from soybean can act as a voltage-gated, anion-biased ion 
channel [164, 165]. 
More controversial is the idea that the fifth pore formed at the fourfold axis of 
the tetramer of AQP1 may function as a cation channel. In Xenopus oocytes, 
heterologous expression of human AQP1 led to a PKA-activated cation 
permeability probably mediated by phosphorylation of AQP1 [166] and a cGMP-
activated cation permeability via direct binding of cGMP to the C-terminus of 
AQP1 [167]. PKC activity was shown to increase the cation permeability of 
AQP1 in Xenopus oocytes via direct phosphorylation of AQP1 at residues T157 
and T239 [168]. Phosphorylation at these sites by PKC is required for trigger-
induced translocation of AQP1 to the plasma membrane [169], so this may 
represent more AQP1 molecules in the membrane rather than an increase in the 
cation permeability or open probability of a single channel. Phosphorylation of a 
tyrosine residue (Y253) in the C-terminal tail of AQP1 was recently shown to be 
required for activation by cGMP [170]. The cGMP-activated cation current was 
verified for purified AQP1 in planar artificial membranes and the AQP1 water 
permeability inhibitor pCMBS did not inhibit ion permeation, suggesting that the 
water and ion pathways through AQP1 are not the same [171]. Furthermore, 
point mutations to residues lining the tetrameric pore altered conductance 
properties [170]. The open probability was found to be very small (<10-6) in the 
planar bilayer system [171], which raises doubts over the physiological relevance 
of this cation conductance. Furthermore, human APQ1 expressed in HEK293 
cells did not induce an above-background cation conductance when cells were 
loaded with either cGMP or analogues thereof [172]. Additionally, several 
laboratories reported being unable to replicate this result in the same 
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experimental system (and in some cases, with exactly the same AQP1 construct) 
[173].  
However, rat choroid plexus cells, which strongly express AQP1, were found to 
have a cGMP-activated cation conductance that was abolished by treatment with 
AQP1 siRNA. Activation of the current by atrial natriuretic peptide (ANP), 
which signals through guanylate cyclase, inhibited basal-to-apical fluid transport. 
The contribution of AQP1 to this inhibition was not confirmed directly, although 
Cd2+, which was shown to inhibit cGMP-induced cation conduction of AQP1, 
reversed the inhibition of fluid transport [174]. ANP and a cGMP analogue were 
also shown to upregulate apical-to-basal fluid transport in cultured retinal 
pigment epithelial cells, but this was reversed by an inhibitor of AQP1 water 
permeability [175]. It seems that under the right set of circumstances, AQP1 can 
act as a cation channel, with the ion pathway probably residing in the central 
pore formed by tetrameric assembly (see Figure 1-7). Whether or not this ion 
conductance has physiological relevance remains an open question. However, 
coupled water and ion movement are vital for several pathophysiological 
processes including tumour angiogenesis and cell migration [176] and epilepsy 
[177], so it remains an intriguing possibility that AQPs can perform a dual 
function. 
 
1.5 AQPs and cell volume regulation 
Many cells have the ability to modulate their physical size. This is achieved by 
the import or export of osmolytes in order to move water into or out of the cell 
by osmosis. Regulatory cell volume decrease (RVD) is mediated by potassium 
chloride and taurine efflux and regulatory cell volume increase (RVI) by sodium  
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Figure 1-7 The central pore (red arrow) formed at the fourfold axis of the AQP1 
tetramer, rendered in two different representations to aid visualization. This pore 
has been proposed as a possible pathway for CO2 and cations through AQP1. 
Green arrows show the monomer water pore. Rendered using VMD from PDB 
entry 1J4N.  
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influx [178]. AQPs play a role in mediating the osmotic water movement in cell 
volume regulation [15], but there is evidence that their role may go beyond 
facilitation of osmosis. 
The stretch-activated transient receptor potential vanilloid type 4 (TRPV4) 
channel is a Ca2 +-biased non-selective cation channel (NSCC) that is activated 
by cell swelling [179] and has been implicated in cellular responses to osmotic 
stimuli [180]. In some cell types TRPV4 has been shown to provide a Ca2 + 
signal that is correlated with activation of the K+ and Cl− channels responsible 
for the decrease in cellular osmolality associated with RVD [180, 181]. In human 
and murine salivary gland cells, TRPV4 has a functional interaction with AQP5; 
in AQP5 knockout cells, the hypotonicity-induced calcium influx through 
TRPV4 was attenuated and subsequent RVD was abolished. Hypotonicity also 
increased cell surface expression of both TRPV4 and AQP5 and increased their 
co-localisation[182]. This suggests a role for AQP5 in the regulation of TRPV4 
surface expression or hypotonicity-induced activity. 
In another example, the RVD of sperm of AQP3 −/− mice was inhibited 
compared to wild-type mice and the mice displayed reduced fertility [183, 184]. 
Upon entry into the female reproductive tract, sperm normally encounter a 
decrease in extracellular osmolality, which is thought to be the signal that 
activates sperm motility [183]. However, this hypotonic stress also causes cell 
swelling which, if left uncorrected by RVD, leads to impaired fertilisation, likely 
due to excessive bending of the sperm tail inside the uterus [184]. If AQP3 was 
simply acting passively as a water channel, RVD would not be abolished in 
AQP3 −/− sperm but rather the timescale on which the cell reaches osmotic 
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equilibrium would be increased. A possible explanation for reduced fertility and 
altered RVD in AQP3 −/− mice is therefore that AQP3, either alone or as part of 
a macromolecular complex which is disrupted by AQP3 knockout, is involved in 
the signalling pathway that activates RVD in sperm. 
In a further example, when exposed to a hypotonic extracellular solution, 
cultured renal cortical collecting duct (CCD) cells, which do not endogenously 
express AQP2, swelled in proportion to the change in extracellular osmolality 
but did not exhibit RVD. When transfected with AQP2, these cells showed an 
RVD of approximately 40%. Shrinkage was mediated by Ca2 + influx through 
TRPV4, which activated Ca2 +-dependent K+ and Cl− channels and Ca2 +-
dependent Ca2 + release from intracellular stores. In renal CCD cells expressing 
AQP2, hypotonic stress caused translocation of TRPV4 to the plasma membrane. 
This response did not occur in AQP2-negative cells. When TRPV4 was pre-
translocated to the cell surface prior to hypotonic exposure, RVD was recovered 
in AQP2-null cells, showing that it is not simply the high water permeability of 
AQP2 that allows RVD. However, there did not appear to be any co-localisation 
between endogenous TRPV4 and overexpressed AQP2 in this system, either 
before or after hypotonic shock, indicating a functional rather than physical 
interaction [185]. These observations suggest that AQP2 forms part of a sensory 
and signalling pathway that results in TRPV4 translocation, possibly via sensing 
of extracellular osmolality. 
It has been suggested that AQPs could act as direct sensors of osmotic gradients 
by coupling conformational changes of the protein to a pressure gradient within 
the pore [186]. This argument relies on the idea of the hydrostatic pressure 
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within the pore and it is not clear that the application of classical fluid mechanics 
is applicable to a system typically consisting of <10 water molecules. 
Nonetheless it is an intriguing idea, and taken together, these examples clearly 
support the idea of a signalling or sensory role for AQPs in cell volume 
regulation beyond a passive water conduction mechanism. 
1.6 Regulation of AQPs 
Cells may often need to modulate their membrane water or solute permeability in 
response to external stimuli. There are three possible ways in which this could be 
achieved: by up- or downregulating AQPs at the transcript level via activation or 
inhibition of transcription factors or RNA interference, by changing the number 
of AQP molecules in the membrane via exo- or endocytosis, or by directly 
blocking the AQP molecule via a conformational change that opens or closes the 
pore or by binding of a molecule that blocks the pore. There are examples of 
each of these approaches to AQP regulation being taken in nature. 
1.6.1 Transcriptional regulation of AQPs 
There is evidence of regulation of AQP copy number by activation or repression 
of transcription; this includes upregulation of AQP2 in response to AVP [187], 
downregulation of AQP3 in response to insulin [188] and upregulation of AQP1 
in response to hypoxia [189]. 
1.6.2 Kinase-dependent subcellular relocalization of AQPs 
Protein kinases are a large and diverse family of proteins that modify the 
structure and function of proteins by addition of a phosphate group to specific 
amino acid sidechains. Two kinases in particular, the cAMP-dependent PKA and 
the calcium and diacylglycerol-dependent PKC, have been shown to be able to 
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control the subcellular localization of several AQPs by direct phosphorylation of 
serine and threonine residues in the intracellular loop D and the C-terminal tails 
of AQPs. 
1.6.2.1 AQP2 and arginine vasopressin 
The best-studied example of kinase-mediated subcellular relocalization of an 
AQP to modulate cellular water permeability is that of AQP2 in the mammalian 
kidney collecting duct in response to AVP. AVP is released by the pituitary 
gland in response to elevated plasma osmolality or hypernatraemia [124] and 
activates the cAMP-dependent protein kinase A (PKA) in collecting duct cells by 
signalling through the V2 vasopressin receptor and adenylyl cyclase. PKA 
directly phosphorylates AQP2 at a serine residue (S256) in the C-terminal tail, 
which causes translocation of AQP2-containing intracellular vesicles to the 
apical membrane of the cells [96]. This phosphorylation event is necessary and 
sufficient for the translocation response as an S256A mutant of AQP2 was 
unable to relocalize in response to cAMP and an S256D phosphomimetic mutant 
was constitutively localized to the apical membrane independently of cAMP 
signalling [190]. 
 
Endocytosis of AQP2 may also be regulated. Protein kinase C activation led to 
an increased rate of internalization of AQP2 independently of AQP2 
phosphorylation and independently of the phosphorylation state of S256. 
Inhibition of endocytosis caused a build-up of AQP2 in the plasma membrane 
and this was independent of the phosphorylation state of S256 [191]. This 
highlights the fact that there is a constant antagonism between membrane 
trafficking and internalization of AQP2 (i.e. recycling) and that the membrane 
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abundance is controlled by modulation of the relative rates of these two 
processes. 
1.6.2.2 AQP1 and hypotonicity 
Relocalization of AQP1 in response to reduced extracellular osmolality was 
mediated by PKC activation by calcium released from intracellular stores after 
extracellular calcium influx through the mechanosensitive cation channel 
TRPC1. PKC directly phosphorylated AQP1 at two threonine residues in loop D 
(T157) and the C-terminal tail (T239), which led to relocalization of AQP1 to the 
plasma membrane in a calmodulin (CaM) and microtubule dependent manner 
[169], although the role of CaM in this response was not clear. This signalling 
pathway and trafficking response is represented as a cartoon in Figure 1-8. In 
chapter 3, results are presented which suggest that AQP4 can also relocalize in 
response to hypotonicity, although mediated by a different signalling pathway. 
1.6.2.3 AQP5 
AQP5 is expressed in the lacrimal and salivary glands and lungs, where it is 
thought be important for generation of tears, saliva and pulmonary secretions 
[182, 192, 193]. AQP5 regulation has been shown to be mediated biphasically by 
cAMP in a PKA-dependent manner, with exposure to elevated intracellular 
cAMP levels causing a short-term (minutes) decrease in AQP5 membrane 
abundance, probably via regulated endocytosis, whereas long-term (8 hours) 
exposure increased total AQP5 protein [192]. There are two consensus PKA sites 
in AQP5: S156 in cytoplasmic loop D [27, 194] and T259 [195] in the C-
terminus; the latter corresponds to S256 in AQP2. AQP5 can be directly 
phosphorylated by PKA at S156 and T259 [196]. Notably, S156 was 
 58 
phosphorylated preferentially in certain tumours suggesting that cell proliferation 
can be modulated by phosphorylation of this site although the constitutive 
membrane abundance of an S156A mutant was not distinguishable from wild-
type AQP5 [197]. Based on the crystal structure of human AQP5 it was 
hypothesized that phosphorylation of S156 could cause structural changes in 
loop D that would break its interaction with the C-terminus, thereby flagging the 
protein for translocation to the plasma membrane [198]. An investigation of this 
suggestion is presented in chapter 3. 
1.6.3 AQP gating 
1.6.3.1 Structural gating 
Although there is no evidence of gating in the mammalian AQPs, it is a well-
established regulatory mechanism for some plant AQPs. The best-studied 
example of this is the spinach SoPIP2;1, which has been crystallized in both 
open and closed conformations (see Figure 1-8). In the closed confirmation the 
sidechain of a leucine (L197) residue from the C-terminal end of the intracellular 
loop D protruded into the pore, physically occluding the channel and forming a 
hydrophobic ‘gate’ reducing the channel diameter to 0.8 Å. A large-scale motion 
of loop D was proposed to occur upon dephosphorylation of two serine residues 
in loop D and the C-terminal tail, thereby unblocking the cytoplasmic channel 
entrance [199] in a regulated manner and coupling cell signalling 
(phosphorylation) to membrane water permeability. 
1.6.3.2 Gating by AQP-binding proteins 
Calmodulin (CaM) is a calcium-binding protein that mediates many of the 
downstream signalling elements that begin with the release or influx of calcium   
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Figure 1-8 Regulation of AQPs exemplified by: (A) hypotonicity-induced 
translocation of human AQP1 from intracellular vesicles to the plasma 
membrane and (B) structural gating of spinach SoPIP2;1, crystallized in open 
(green) and closed (red) states, with a large scale motion of the intracellular loop 
D between the two states. 
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as a second messenger [200]. Activated (i.e. calcium-bound) CaM has been 
shown to be able to bind directly to a motif in the C-terminal tail of AQP0 [201], 
with a binding stoichiometry of two CaM molecules per AQP homotetramer. The 
CaM binding affinity was reduced by phosphomimetic mutation of consensus 
PKA and PKC sites within the CaM binding site of the AQP0 C-terminus [202]. 
The binding of CaM reduced AQP0 water permeability by twofold, and MD 
simulations suggested that CaM binding favoured a closed state of the 
cytoplasmic end of the AQP0 channel [201]. In this way, phosphorylation of the 
AQP is indirectly coupled to changes in the channel permeability (c.f. the direct 
coupling of SoPIP2). 
1.6.3.3 Gating by small molecule inhibitors 
Due to their involvement in a variety of pathophysiological processes and 
availability at the cell surface, AQPs are appealing drug targets. Since the 
discovery of the AQP family, it has been known that mercurial compounds and 
Hg2+ ions can act as inhibitors of most APQs by interacting with cysteine 
residues within the aqueous pore [203]. Mercurial compounds are not ideal as 
drugs due to the toxicity of mercury, but several organometallic compounds of 
gold, silver and copper have been shown to be inhibitory against AQPs 1 and 3 
[204]. Several drugs already licensed for other uses such as loop diuretics, 
antiepileptics and carbonic anhydrase inhibitors have been suggested to have 
inhibitory action against AQPs, but there are conflicting data in the literature 
where different expression systems have been used to study the action of the 
same drug on the same AQP, e.g. acetazolamide was reported to inhibit AQP4 in 
Xenopus oocytes [205], but not in AQP4-expressing glial cells [206]. Drug 
development for AQPs is still in its infancy, but is hampered by the challenges 
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associated with scaling up biophysical measurements of water permeability to 
high-throughput systems [207]. 
1.7 Open questios and outline of the thesis 
1. in vivo and ex vivo experiments with AQP4 -/- animals clearly show a role for 
AQP4 in brain volume homeostasis, but the molecular mechanisms underlying 
this are poorly understood. Given that astrocytes can rapidly modulate their 
membrane water permeability and that AQP1 has been shown to rapidly 
relocalize to the plasma membrane in response to hypotonictiy and/or cell 
volume changes, is there a similar mechanism underlying AQP4-mediated brain 
volume homeostasis, and is the hypotonicity-induced relocalization of AQP1 a 
mechanism employed more generally to regulate other AQPs? 
 
To address this question, chapter 3 describes the subcellular relocalization of 
GFP-tagged AQP4 and AQP5 constructs in HEK293 cells and endogenous 
AQP4 in rat primary cortical astrocytes as well as an investigation of the cell 
signalling pathways controlling these responses.  
 
2. Is the generalized model of size-based exclusion of neutral solutes in the 
water-selective AQPs really valid, given that it is based on detailed analysis of 
only one member of the AQP family (AQP1)? 
In chapter 4, mutants of the ar/R region of AQP4 and AQP3 are used to 
investigate the role of this region in solute exclusion, selectivity and water 
permeability and this is compared and contrasted with published data on similar 
mutants of AQP1. 
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3.  Structural data and in vitro analysis consistently demonstrates that AQPs are 
assembled into homotetramers, but it is not clear how or why this happens. 
Which regions of the proteins are important for homotetramerization and are 
there structural/functional consequences to the tetramerization? 
Chapter 5 describes the use of various biophysical techniques to study AQP4 
oligomerization, identifies the intracellular loop D as a key region for monomer-
monomer interactions in AQP4, and suggests that loop D interactions may be 
important for oligomerization across the AQP family. 
 
Finally, chapter 6 concludes the thesis with a summary of the key results and 
their implications, as well as suggestions for possible future extensions of this 
work. 
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2 Materials and Methods 
2.1 DNA constructs 
2.1.1 pDEST47 expression constructs 
Human AQPs 1, 3, 4, 5, 9 and 10 cDNA cloned into the mammalian expression 
vector pDEST47 (Invitrogen) were kind gifts of Dr. Matthew Conner (Sheffield 
Hallam University). This vector contains the following elements (Figure 2-1): 1. 
CMV promoter for high protein expression in mammalian cells. 2.T7 
promoter/priming site for insert sequencing and in vitro transcription. 3. attR1 
and attR2 sites for gene insertion using the Gateway system. 4. BGH 
polyadenylation sequence for transcription termination and reverse sequencing 
through the insert. 5. Neomycin resistance gene for selection of stable 
mammalian transfectants. 6. pUC origin of replication for high copy number 
replication in E. coli. 7. Ampicillin resistance gene for selection of transformed 
E. coli. 8. Green fluorescent protein (GFP) gene for transcription of GFP fusion 
proteins. Sequences of the wild-type inserts used and their translations are shown 
in Figure 2-2, Figure 2-3 and Figure 2-4. 
2.1.2 QuikChange site-directed mutagenesis 
100 ng of plasmid DNA was used as template with sense and antisense 
mutagenic oligonucleotides at a final concentration of 300 nM in a reaction 
volume of 50 µL. Final concentrations of 800 µM dNTPs (200 µM of each), 3 
units of Pfu polymerase (Promega) and 1X polymerase buffer were added. The  
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Figure 2-1 Vector map of the DEST47 vector used to transfect mammalian cells 
with AQP constructs. GFP – green fluorescent protein; PCMV – cytomegalovirus 
promoter; BGH pA – bovine growth hormone polyadenylation site; SV40 ori – 
simian virus 40 origin of replication; pUC – orgin of replication (UC = 
University of California).  
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Figure 2-2 DNA and amino acid sequences of the human AQP4 construct used 
in this work. 
  
gcaggctccaccatgtctgacagacccacagcaaggcggtggggtaagtgtggacctttgtgtaccagagagaacatcatggtggctttcaaaggggtctggactcaagctttctggaaa!
             M  S  D  R  P  T  A  R  R  W  G  K  C  G  P  L  C  T  R  E  N  I  M  V  A  F  K  G  V  W  T  Q  A  F  W  K !
!
gcagtcacagcggaatttctggccatgcttatttttgttctcctcagcctgggatccaccatcaactggggtggaacagaaaagcctttaccggtcgacatggttctcatctccctttgc!
 A  V  T  A  E  F  L  A  M  L  I  F  V  L  L  S  L  G  S  T  I  N  W  G  G  T  E  K  P  L  P  V  D  M  V  L  I  S  L  C !
!
tttggactcagcattgcaaccatggtgcagtgctttggccatatcagcggtggccacatcaaccctgcagtgactgtggccatggtgtgcaccaggaagatcagcatcgccaagtctgtc!
 F  G  L  S  I  A  T  M  V  Q  C  F  G  H  I  S  G  G  H  I  N  P  A  V  T  V  A  M  V  C  T  R  K  I  S  I  A  K  S  V !
!
ttctacatcgcagcccagtgcctgggggccatcattggagcaggaatcctctatctggtcacacctcccagtgtggtgggaggcctgggagtcaccatggttcatggaaatcttaccgct!
 F  Y  I  A  A  Q  C  L  G  A  I  I  G  A  G  I  L  Y  L  V  T  P  P  S  V  V  G  G  L  G  V  T  M  V  H  G  N  L  T  A !
!
ggtcatggtctcctggttgagttgataatcacatttcaattggtgtttactatctttgccagctgtgattccaaacggactgatgtcactggctcaatagctttagcaattggattttct!
 G  H  G  L  L  V  E  L  I  I  T  F  Q  L  V  F  T  I  F  A  S  C  D  S  K  R  T  D  V  T  G  S  I  A  L  A  I  G  F  S !
!
gttgcaattggacatttatttgcaatcaattatactggtgccagcatgaatcccgcccgatcctttggacctgcagttatcatgggaaattgggaaaaccattggatatattgggttggg!
 V  A  I  G  H  L  F  A  I  N  Y  T  G  A  S  M  N  P  A  R  S  F  G  P  A  V  I  M  G  N  W  E  N  H  W  I  Y  W  V  G !
!
cccatcataggagctgtcctcgctggtggcctttatgagtatgtcttctgtccagatgttgaattcaaacgtcgttttaaagaagccttcagcaaagctgcccagcaaacaaaaggaagc!
 P  I  I  G  A  V  L  A  G  G  L  Y  E  Y  V  F  C  P  D  V  E  F  K  R  R  F  K  E  A  F  S  K  A  A  Q  Q  T  K  G  S !
!
tacatggaggtggaggacaacaggagtcaggtagagacggatgatcttatttctaaacctggagtggtgcatgtgattgacgttgaccggggagaggagaagaaggggaaagaccaatct!
 Y  M  E  V  E  D  N  R  S  Q  V  E  T  D  D  L  I  S  K  P  G  V  V  H  V  I  D  V  D  R  G  E  E  K  K  G  K  D  Q  S !
!
ggagaggtattgtcttcagtagacccagctttcttgtacaaagtggttcgatctagaatggctagcaaaggagaagaacttttcactggagttgtcccaattcttgttgaattagatggt!
 G  E  V  L  S  S  V  D  P  A  F  L  Y  K  V  V  R  S  R  M  A  S  K  G  E  E  L  F  T  G  V  V  P  I  L  V  E  L  D  G !
!
gatgttaatgggcacaaattttctgtcagtggagagggtgaaggtgatgctacatacggaaagcttacccttaaatttatttgcactactggaaaactacctgttccatggccaacactt!
 D  V  N  G  H  K  F  S  V  S  G  E  G  E  G  D  A  T  Y  G  K  L  T  L  K  F  I  C  T  T  G  K  L  P  V  P  W  P  T  L !
!
gtcactactttctcttatggtgttcaatgcttttcccgttatccggatcatatgaaacggcatgactttttcaagagtgccatgcccgaaggttatgtacaggaacgcactatatctttc!
 V  T  T  F  S  Y  G  V  Q  C  F  S  R  Y  P  D  H  M  K  R  H  D  F  F  K  S  A  M  P  E  G  Y  V  Q  E  R  T  I  S  F!
!
aaagatgacgggaactacaagacgcgtgctgaagtcaagtttgaaggtgatacccttgttaatcgtatcgagttaaaaggtattgattttaaagaagatggaaacattctcggacacaaa!
 K  D  D  G  N  Y  K  T  R  A  E  V  K  F  E  G  D  T  L  V  N  R  I  E  L  K  G  I  D  F  K  E  D  G  N  I  L  G  H  K !
!
ctcgagtacaactataactcacacaatgtatacatcacggcagacaaacaaaagaatggaatcaaagctaacttcaaaattcgccacaacattgaagatggatccgttcaactagcagac!
 L  E  Y  N  Y  N  S  H  N  V  Y  I  T  A  D  K  Q  K  N  G  I  K  A  N  F  K  I  R  H  N  I  E  D  G  S  V  Q  L  A  D !
!
cattatcaacaaaatactccaattggcgatggccctgtccttttaccagacaaccattacctgtcgacacaatctgccctttcgaaagatcccaacgaaaagcgtgaccacatggtcctt!
 H  Y  Q  Q  N  T  P  I  G  D  G  P  V  L  L  P  D  N  H  Y  L  S  T  Q  S  A  L  S  K  D  P  N  E  K  R  D  H  M  V  L !
!
cttgagtttgtaactgctgctgggattacacatggcatggatgagctctacaaataa!
 L  E  F  V  T  A  A  G  I  T  H  G  M  D  E  L  Y  K STOP !
!
!!
AQP4 C-terminus 
GFP N-terminus 
GFP C-terminus 
AQP4 N-terminus 
Linker peptide: 
DPAFLYKVVRSR 
 66 
 
Figure 2-3 DNA and amino acid sequences of the human AQP3 construct used 
in this work. 
  
                                                                                 cttgatcaaacaagtttgtacaaaaaagcaggctccacc!
!
atgggtcgacagaaggagctggtgtcccgctgcggggagatgctccacatccgctaccggctgctccgacaggcgctggccgagtgcctggggaccctcatcctggtgatgtttggctgt!
 M  G  R  Q  K  E  L  V  S  R  C  G  E  M  L  H  I  R  Y  R  L  L  R  Q  A  L  A  E  C  L  G  T  L  I  L  V  M  F  G  C !
ggctccgtggcccaggttgtgctcagccggggcacccacggtggtttcctcaccatcaacctggcctttggctttgctgtcactctgggcatcctcatcgctggccaggtctctggggcc!
 G  S  V  A  Q  V  V  L  S  R  G  T  H  G  G  F  L  T  I  N  L  A  F  G  F  A  V  T  L  G  I  L  I  A  G  Q  V  S  G  A!
cacctgaaccctgccgtgacctttgccatgtgcttcctggctcgtgagccctggatcaagctgcccatctacaccctggcacagacgctgggagccttcttgggtgctggaatagttttt!
 H  L  N  P  A  V  T  F  A  M  C  F  L  A  R  E  P  W  I  K  L  P  I  Y  T  L  A  Q  T  L  G  A  F  L  G  A  G  I  V  F!
gggctgtattatgatgcaatctggcacttcgccgacaaccagctttttgtttcgggccccaatggcacagccggcatctttgctacctacccctctggacacttggatatgatcaatggc!
 G  L  Y  Y  D  A  I  W  H  F  A  D  N  Q  L  F  V  S  G  P  N  G  T  A  G  I  F  A  T  Y  P  S  G  H  L  D  M  I  N  G !
ttctttgaccagttcataggcacagcctcccttatcgtgtgtgtgctggccattgttgacccctacaacaaccccgtcccccgaggcctggaggccttcaccgtgggcctggtggtcctg!
 F  F  D  Q  F  I  G  T  A  S  L  I  V  C  V  L  A  I  V  D  P  Y  N  N  P  V  P  R  G  L  E  A  F  T  V  G  L  V  V  L!
gtcattggcacctccatgggcttcaactccggctatgccgtcaaccctgcccgggactttggcccccgcctttttacagcccttgcgggctggggctctgcagtcttcacggccggccag!
 V  I  G  T  S  M  G  F  N  S  G  Y  A  V  N  P  A  R  D  F  G  P  R  L  F  T  A  L  A  G  W  G  S  A  V  F  T  A  G  Q!
cattggtggtgggtgcccatcgtgtcctcactcctgggctccattgcgggtgtcttcgtgtaccagctgatgatcggctgccacctggagcagcccccaccctccaacgaggaagagaat!
 H  W  W  W  V  P  I  V  S  S  L  L  G  S  I  A  G  V  F  V  Y  Q  L  M  I  G  C  H  L  E  Q  P  P  P  S  N  E  E  E  N!
gtgaagctggcccatgtgaagcacaaggagcagatcgacccagctttcttgtacaaagtggttcgatctagaatggctagcaaaggagaagaacttttcactggagttgtcccaattctt!
 V  K  L  A  H  V  K  H  K  E  Q  I  D  P  A  F  L  Y  K  V  V  R  S  R  M  A  S  K  G  E  E  L  F  T  G  V  V  P  I  L !
gttgaattagatggtgatgttaatgggcacaaattttctgtcagtggagagggtgaaggtgatgctacatacggaaagcttacccttaaatttatttgcactactggaaaactacctgtt!
 V  E  L  D  G  D  V  N  G  H  K  F  S  V  S  G  E  G  E  G  D  A  T  Y  G  K  L  T  L  K  F  I  C  T  T  G  K  L  P  V !
ccatggccaacacttgtcactactttctcttatggtgttcaatgcttttcccgttatccggatcatatgaaacggcatgactttttcaagagtgccatgcccgaaggttatgtacaggaa!
 P  W  P  T  L  V  T  T  F  S  Y  G  V  Q  C  F  S  R  Y  P  D  H  M  K  R  H  D  F  F  K  S  A  M  P  E  G  Y  V  Q  E !
cgcactatatctttcaaagatgacgggaactacaagacgcgtgctgaagtcaagtttgaaggtgatacccttgttaatcgtatcgagttaaaaggtattgattttaaagaagatggaaac!
 R  T  I  S  F  K  D  D  G  N  Y  K  T  R  A  E  V  K  F  E  G  D  T  L  V  N  R  I  E  L  K  G  I  D  F  K  E  D  G  N !
attctcggacacaaactcgagtacaactataactcacacaatgtatacatcacggcagacaaacaaaagaatggaatcaaagctaacttcaaaattcgccacaacattgaagatggatcc!
 I  L  G  H  K  L  E  Y  N  Y  N  S  H  N  V  Y  I  T  A  D  K  Q  K  N  G  I  K  A  N  F  K  I  R  H  N  I  E  D  G  S !
gttcaactagcagaccattatcaacaaaatactccaattggcgatggccctgtccttttaccagacaaccattacctgtcgacacaatctgccctttcgaaagatcccaacgaaaagcgt !
 V  Q  L  A  D  H  Y  Q  Q  N  T  P  I  G  D  G  P  V  L  L  P  D  N  H  Y  L  S  T  Q  S  A  L  S  K  D  P  N  E  K  R !
gaccacatggtccttcttgagtttgtaactgctgctgggattacacatggcatggatgagctctacaaataa!
 D  H  M  V  L  L  E  F  V  T  A  A  G  I  T  H  G  M  D  E  L  Y  K STOP!
!
AQP3 C-term 
GFP N-term 
GFP C-term 
AQP3 N-term 
Linker peptide 
DPAFLYKVVRSR 
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Figure 2-4 DNA and amino acid sequences of the human AQP1 construct used 
in this work. 
  
                                                                                           agtttgtacaaaaaaagcaggctccacca!
!
atggctagcgagttcaagaagaagttattctggagggcagtggtggccgagttcctggccacgaccctctttgtcttcatcagcatcggttctgccctgggcttcaaatacccggtgggg!
 M  A  S  E  F  K  K  K  L  F  W  R  A  V  V  A  E  F  L  A  T  T  L  F  V  F  I  S  I  G  S  A  L  G  F  K  Y  P  V  G 
aacaaccagacggcggtccaggacaacgtgaaggtgtcgctggccttcgggctgagcatcgccacgctggcgcagagtgtgggccacatcagcggcgcccacctcaacccggctgtcaca!
 N  N  Q  T  A  V  Q  D  N  V  K  V  S  L  A  F  G  L  S  I  A  T  L  A  Q  S  V  G  H  I  S  G  A  H  L  N  P  A  V  T 
ctggggctgctgctcagctgccagatcagcatcttccgtgccctcatgtacatcatcgcccagtgcgtgggggccatcgtcgccaccgccatcctctcaggcatcacctcctccctgact!
 L  G  L  L  L  S  C  Q  I  S  I  F  R  A  L  M  Y  I  I  A  Q  C  V  G  A  I  V  A  T  A  I  L  S  G  I  T  S  S  L  T 
gggaactcgcttggccgcaatgacctggctgatggtgtgaactcgggccagggcctgggcatcgagatcatcgggaccctccagctggtgctatgcgtgctggctactaccgaccggagg!
 G  N  S  L  G  R  N  D  L  A  D  G  V  N  S  G  Q  G  L  G  I  E  I  I  G  T  L  Q  L  V  L  C  V  L  A  T  T  D  R  R 
cgccgtgaccttggtggctcagccccccttgccatcggcctctctgtagcccttggacacctcctggctattgactacactggctgtgggattaaccctgctcggtcctttggctccgcg!
 R  R  D  L  G  G  S  A  P  L  A  I  G  L  S  V  A  L  G  H  L  L  A  I  D  Y  T  G  C  G  I  N  P  A  R  S  F  G  S  A 
gtgatcacacacaacttcagcaaccactggattttctgggtggggccattcatcgggggagccctggctgtactcatctacgacttcatcctggccccacgcagcagtgacctcacagac!
 V  I  T  H  N  F  S  N  H  W  I  F  W  V  G  P  F  I  G  G  A  L  A  V  L  I  Y  D  F  I  L  A  P  R  S  S  D  L  T  D 
cgcgtgaaggtgtggaccagcggccaggtggaggagtatgacctggatgccgacgacatcaactccagggtggagatgaagcccaaagacccagctttcttgtacaaagtggttcgatct!
 R  V  K  V  W  T  S  G  Q  V  E  E  Y  D  L  D  A  D  D  I  N  S  R  V  E  M  K  P  K  D  P  A  F  L  Y  K  V  V  R  S !
agaatggccagcaaaggagaagaacttttcactggagttgtcccaattcttgttgaattagatggtgatgttaatgggcacaaattttctgtcagtggagagggtgaaggtgatgctaca !
 R  M  A  S  K  G  E  E  L  F  T  G  V  V  P  I  L  V  E  L  D  G  D  V  N  G  H  K  F  S  V  S  G  E  G  E  G  D  A  T !
tacggaaagcttacccttaaatttatttgcactactggaaaactacctgttccatggccaacacttgtcactactttctcttatggtgttcaatgcttttcccgttatccggatcatatg!
 Y  G  K  L  T  L  K  F  I  C  T  T  G  K  L  P  V  P  W  P  T  L  V  T  T  F  S  Y  G  V  Q  C  F  S  R  Y  P  D  H  M !
aaacggcatgactttttcaagagtgccatgcccgaaggttatgtacaggaacgcactatatctttcaaagatgacgggaactacaagacgcgtgctgaagtcaagtttgaaggtgatacc !
 K  R  H  D  F  F  K  S  A  M  P  E  G  Y  V  Q  E  R  T  I  S  F  K  D  D  G  N  Y  K  T  R  A  E  V  K  F  E  G  D  T !
cttgttaatcgtatcgagttaaaaggtattgattttaaagaagatggaaacattctcggacacaaactcgagtacaactataactcacacaatgtatacatcacggcagacaaacaaaag !
 L  V  N  R  I  E  L  K  G  I  D  F  K  E  D  G  N  I  L  G  H  K  L  E  Y  N  Y  N  S  H  N  V  Y  I  T  A  D  K  Q  K !
aatggaatcaaagctaacttcaaaattcgccacaacattgaagatggatccgttcaactagcagaccattatcaacaaaatactccaattggcgatggccctgtccttttaccagacaac!
 N  G  I  K  A  N  F  K  I  R  H  N  I  E  D  G  S  V  Q  L  A  D  H  Y  Q  Q  N  T  P  I  G  D  G  P  V  L  L  P  D  N !
cattacctgtcgycacaatctgccctttcgaaagatcccaacgaaaamtgcgaccatatggtccttcttgagtttgtaactgctgctgggattacacatggcatggatgagctctacaaa!
 H  Y  L  S  X  Q  S  A  L  S  K  D  P  N  E  X  C  D  H  M  V  L  L  E  F  V  T  A  A  G  I  T  H  G  M  D  E  L  Y  K !
taa!
STOP!
AQP1 C-term 
GFP N-term 
GFP C-term 
AQP1 N-term 
Linker peptide 
DPAFLYKVVRSR 
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reaction mix was thermocycled between 95 °C (denaturation) for 1 min, 55 °C 
(primer annealing) for 1 min and 72 °C (extension) for 16 min (2 min/kbase + 2 
min) for a total of 16 cycles. 5 µL was removed from the mix and 20 units of 
dpn1 were added to the remaining 45 µL and incubated at 37 °C for at least 2 
hours. 5 µL was taken from the resulting mix and pre- and post-dpn1 samples 
were compared by agarose gel electrophoresis. A representative gel is shown in 
Figure 2-5. 
2.1.3 Agarose gel electrophoresis 
DNA was separated on 1% w/v agarose gels loaded with the GelRed (Biotium) 
nucleic acid dye. Gels were visualized on a UV transilluminator and imaged 
using a GelDoc system (BioRad).  
2.1.4 Mutagenic oligonucleotide primers 
Complementary sense and antisense primers were designed to introduce the 
desired codon change with flanking sequences of 12-18 bp either side. Where 
possible primers included a guanine or cytosine at both the 3’ and 5’ ends to 
enable stronger binding to the template DNA. Primers were custom synthesized 
by Sigma (Dorset, UK). Lyophilized primers were resuspended in an appropriate 
amount of sterile molecular grade water to give a 100 µM stock and these were 
diluted to a 1 µM working stock.  
2.1.5 Preparation of competent cells 
LB agar plates (without antibiotic) were streaked with Top 10 E. coli cells and 
incubated overnight at 37°C. Single colonies were picked, inoculated into 5 ml 
LB medium and incubated overnight at 37°C with shaking. The 5ml cultures 
were inoculated into 400 ml LB medium in a 2 L flask and grown at 37°C with   
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Figure 2-5 Representative agarose gel of site-directed mutagenesis product, with 
and without digestion of methylated template by dpn1.   
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shaking until an OD590 of 0.35-0.4 was reached (rapid growth phase, ~ 3-5 hrs). 
50 mL cultures were incubated on ice in pre-chilled sterile plastic tubes. Cells 
were centrifuged at 4000 rcf at 4°C for 15 minutes, gently resuspended in 10 ml 
ice cold CaCl2 solution (60 mM CaCl2, 15% (v/v) glycerol, 10 mM PIPES, pH 
7.0), centrifuged again at 4000 rcf at 4°C for 15 minutes, gently resuspended in 
10 ml ice cold CaCl2 solution and incubated on ice for 30 minutes. Cells were 
centrifuged at 4000 rcf at 4°C for 15 minutes, resuspended in 2 mL ice cold 
CaCl2 solution, aliquoted 32 x 250 µl into pre-chilled sterile microcentrifuge 
tubes and frozen immediately at -80°C. 
2.1.6 Transformations 
Competent cells were thawed on ice. Cells were transferred into pre-chilled 1.5 
mL microcentrifuge tubes. For nicked, linear SDM products, 20 µL of the SDM 
reaction was added to 200 µL of competent cells. For supercoiled plasmids, 200 
ng was added to 20 µL of competent cells. Cells were subjected to heat shock at 
42 °C for 30 seconds in a water bath and incubated on ice for 5 minutes. Cells 
were recovered by addition of 1 mL lysogeny broth (LB) without antibiotic and 
shaking incubation at 37 °C for 1 hour. Cells were pelleted by centrifugation at 
4,000 rcf for 5 mins. Pellets were resuspended in 100 µL LB, plated onto 10 cm 
LB agar plates containing either 100 µg/mL ampicillin or 50 µg/mL kanamycin 
and incubated for 16 hours at 37 °C. 
2.1.7 Growth and isolation of plasmids 
Single colonies of transformed competent cells were picked using sterile 200 µL 
pipette tips. Colonies were grown for 16 hours in either 5 (for minipreps) or 200 
(for maxipreps) mL LB containing either 100 µg/mL ampicillin or 50 µg/mL 
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kanamycin according the plasmid being grown. DNA isolation was performed 
using Wizard plasmid miniprep kits (Promega) or PureLink HiPure plasmid 
maxiprep kits (Invitrogen) following the manufacturer’s instructions. 
2.1.8 Sequencing  
Plasmid inserts were sequenced in both forward and reverse direction using T7 
and BGH sequencing primers. Reads were typically 800 – 1000 bp and most 
forward and reverse sequence pairs overlapped. Where there was not an overlap, 
a second reverse primer targeted to bp 200-219 of the GFP gene was used to 
complete the sequence. Sequencing was done by GATC Biotech (Nottingham) or 
Functional Genomics (University of Birmingham). Putative mutant sequences 
were aligned to their respective wild-type sequences using Clustal Omega 
(European Bioinformatics Institute). Where mutations were successful, 
chromatograms were inspected at the mutated codon to exclude the possibility of 
mixed mutant/wild-type DNA (from e.g. accidentally picking two colonies). 
2.2 Mammalian cell culture 
2.2.1 HEK293 
Human embryonic kidney cells clone 293 (HEK293), grown for four passages 
(P4) after purchase from the supplier were a gift of Jasmeet Reyat and Dr. 
Michael Tomlinson (both School of Biosciences, University of Birmingham). 
These cells were grown to P5 and frozen in liquid nitrogen. These P5 cells were 
used as stocks for this work. Cells used in experiments were between P7 and 
P20. 
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2.2.2 MDCK 
Madin-Darby canine kidney cells at P6 after purchase from the supplier were a 
gift from Dr. Matthew Conner. These cells were grown to P7 and frozen in liquid 
nitrogen and these P7 cells were used as stock for this work. Cells used in 
experiments were between P8 and P20. 
2.2.3 U-251 MG 
U-373 MG (U373) human glioblastoma cells at P8 were a gift from Dr. Eric Hill 
(Aston University). These cells were grown to P9 and frozen in liquid nitrogen 
and these P9 cells were used as stock for this work. Cells used in experiments 
were between P10 and P12. 
2.2.4 Rat primary cortical astrocytes 
Rat primary cortical astrocytes (RPCAs) were purchased from Invitrogen. The 
supplied vial of cells was defined as P0. These cells were grown to confluence in 
a T75 flask, subcultured 1:5, and when confluent these P1 cells were frozen in 
liquid nitrogen. All experiments were performed with cells at P2 or P3. 
2.2.5 Cell culture 
Unless otherwise stated, all work with live cells was done in a class II biological 
safety cabinet. All cell culture reagants were purchased from Sigma-Aldrich 
(UK). Cells were cultured in a humidified 37 °C incubator with 5% CO2. All 
cells were routinely cultured in Dulbecco’s modified Eagle’s medium (DMEM), 
supplemented with either 10% (HEK, MDCK, U251) or 15% (RPCA) fetal 
bovine serum (FBS). RPCA media was supplemented with penicillin (100 
units/mL) and streptomycin (100 µg/mL). All media was pre-warmed to 37 °C 
before use. Cells were grown in a total volume of 1 mL/5 cm3 growth area. Cells 
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were subcultured at ~90% confluence by washing twice with pre-warmed 
calcium-free phosphate buffered saline (PBS) followed by incubation with 1 
mL/cm3 of either 0.25% trypsin – 0.53 mM EDTA (HEK, MDCK, U251) or 
accutase (RPCA) at 37 °C until cells became visibly rounded under a phase 
contrast microscope and were detachable by gentle rocking. 
HEK293 cells are very weakly adherent; as a result of this it is common practice 
to detach them by banging the culture vessel or using a pipette gun to squirt 
culture media onto the cells. Both of these methods increased the propensity of 
the cells to form dense clumps after seeding when compared to trypsin, 
especially when seeding into circular plates. Therefore HEK293 cells were 
routinely trypsinized. 
2.2.6 Frozen cell stocks 
Cells were grown to ~90% confluence in T75 flasks, detached and centrifuged 
for 5 mins at 1,000 rcf. Cell pellets were resuspended in 2 mL culture media 
containing 5% v/v dimethylsulfoxide (DMSO) and transferred to sterile freezer 
vials (1 mL / vial). Vials were frozen at -80 °C in a Mr Frosty (Nalgene) 
container filled with isopropanol to reduce freezing speed. After 48 hours at -80 
°C, vials were transferred to the liquid phase of a liquid nitrogen dewar. Cells 
were recovered by defrosting vials in a 37 °C water bath and adding the cell 
suspension to 14 mL of pre-warmed culture media in a T75 flask. Culture media 
was changed as early as possible on the following day to remove dead cells and 
cellular debris. 
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2.3 Transfections 
2.3.1 Transient 
Transient transfections were performed using polyethyleneimine (PEI). For 35 
mm dishes, the optimal amount of DNA for the cell type (HEK293, U251 - 2 µg, 
MDCK – 4 µg, RPCA – 1 µg) was added to 100 µL of serum-free DMEM, 
followed by the optimal amount of 1 mg/mL PEI in dH2O, pH 7.4 (HEK293 – 12 
µL, U251 - 12 µL, RPCA – 4 µL, MDCK – 18 µL). The mixture was vortexed 
for 10 seconds, incubated at room temperature for 10 mins, then added to 600 µL 
DMEM with serum. Cell culture medium was aspirated from cells and the 
transfection mix was added, squirting down the side of the plate to avoid 
agitation of the cells. Cells were incubated at 37 °C for 2 hours then 2 mL of 
culture media was added (leaving on the transfection mix). After a further 22 
hours, cells were either used in experiments or the transfection media was 
removed and replaced with 2 mL culture media. This mix was scaled up or 
down, keeping all concentrations the same for different sized culture vessels. 
2.3.2 Stable 
Stable transfections of MDCK cells were performed using the neomycin 
resistance gene on pDEST47. Cells were transiently transfected as described 
above. After 24 hours, cells were trypsinized, resuspended in culture media 
containing 700 µg/mL G418 and reseeded at varying dilutions, 1:2, 1:5, 1:10 and 
1:20 in 4 wells of a 6 well plate. Transient transfection and reseeding was done 
in triplicate. G418-supplemented media was refreshed every 3 days. After 14 
days, resistant colonies were inspected on a widefield fluorescence microscope 
for GFP expression. GFP-positive colonies were picked using 150 µL cloning 
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cylinders (Corning). Colonies from the lowest dilution were preferentially 
isolated (e.g. colonies from a 1:10 plate were preferred to those from a 1:5 plate). 
Marker pen was used to label the plates at the positions of the desired colonies. 
For each stable transfection, a total of 3 clones were isolated. Plates were washed 
with calcium-free PBS. Cloning cylinders were placed over the pen-marked 
positions on the plate(s) and pressed down firmly to seal. 50 µL trypsin-EDTA 
was added to cylinders and incubated until cells were removable by gentle 
pipetting. Cells were removed, serially diluted by a factor of 2 (to give 1:2, 1:4, 
etc.) up to 1:32, and seeded into wells of a 96 well plate. Culture media was 
added to a total volume of 100 µL/well. The lowest dilution that grew to 
confluence was trypsinized and transferred to a well of a 24 well plate, grown to 
confluence and transferred to a T25 flask. Upon reaching confluence, 2/3 of 
these cells were transferred to a T75 flask to grow for frozen stocks, and the 
remaining cells were seeded in 3 wells of a 24 well plate to be harvested for 
western blotting for AQP expression. All steps were performed with 700 µg/mL 
G418 in culture media. For routine culture after establishment of the stable 
transfection, 200 µg/mL was used to maintain light selection pressure. 
2.4 Confocal Microscopy 
Live cells in 35 mm Fluorodishes (World Precision Instruments) transfected with 
fluorescent constructs or with added fluorophores were imaged on either a Leica 
SP5 with a 63× 1.4 NA oil-immersion objective lens or a Zeiss 780 with a 63× 
1.2 NA water-immersion objective. Both microscopes were in temperature-
controlled environmental chambers that were warmed to 37 °C. Before imaging, 
culture media was replaced with 1 mL pre-warmed HEPES-buffered DMEM 
(Sigma) to maintain pH outside of a CO2-controlled environment. Fluorophore 
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excitation was achieved using either 405, 458, 488 514, or 564 nm laser lines. 
Cellular compartments were visualised using the following fluorophores: plasma 
membrane – FM4-64 (Life Technologies); nucleus – Hoechst (Sigma Aldrich); 
endoplasmic reticulum – CellLight ER tracker (Life Technologies); F-actin – 
CellLight LifeAct-RFP plasmid DNA transfected at 1 µg/35 mm plate (Ibidi).  
2.4.1 Tonicity-mediated translocation 
Live cells were exposed to tonicity changes whilst on the stage of the microscope 
to allow imaging of the same cells before and after tonicity changes. This was 
done by adding treatment solutions designed to give the desired final ion 
concentrations and osmolality to 1 mL of culture media already on the cells. 
Images were analysed by extraction of fluorescence line profiles covering the 
membrane and avoiding the nucleus using ImageJ. The profiles were processed 
using homemade software in Matlab. Background was subtracted using the 
extracellular regions of the profile. Average membrane expression was 
calculated as the mean of the maximal intensity at the two membrane peaks and 
cytosol expression was calculated as the mean intensity in the region between the 
membrane peaks starting 10 pixels in. Relative membrane expression (RME) was 
then calculated as (Im - Ic)/Im, where Im and Ic are the average membrane and 
cytosol intensities respectively as described by Conner et al [169]. This gives an 
RME of 1 if the entire signal is at the membrane and an RME of 0 if there are 
equal average intensities in membrane and cytosol pixels.  Five profiles from 
different regions were used for each cell and the resulting RME values were 
averaged to give an estimate of the RME for that cell. One experimental repeat 
consisted of analysis of 5 profiles each from at least three different cells in the 
same image. Results from this software were validated by comparison to results 
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using the non-automated procedure previously described [169]. Figure 2-6 shows 
a schematic of this analysis method. 
2.4.2 Fluorescence recovery after photobleaching (FRAP) 
FRAP was performed using a circular bleaching area of radius 1 µm. Bleaching 
was performed at 100% laser power, which was maintained until the 
fluorescence in the bleach region was reduced to <10% of the pre-bleach 
fluorescence. After bleaching, fluorescence from the bleached area was measured 
every 5 seconds and recovery curves were fitted to a single phase exponential 
recovery function. Diffusion coefficients were calculated using the approach and 
equation of Kang et. al. [208]: 
! = !! + !!8!!/!  
Where D is the diffusion constant, rn is the bleaching radius (set by the 
experimenter, 1 m in our experiments), !!/! is the half-time of recovery from 
the exponential fit and re is an effective bleaching radius, measured from a post-
bleach image. This effective radius corrects for the fact that bleaching is not 
instantaneous and therefore during bleaching some bleached fluorophores will 
diffuse out of the bleaching region and some unbleached fluorophores will 
diffuse into the bleaching region, tending to make the actual bleached area larger 
than that set by the experimenter. Recovery curves were collected from 5 
different cells on the same plate per experiment in 6 experimental repeats. 
2.4.3 Forster resonant energy transfer (FRET) 
AQP4-Turquoise2 and AQP4-Venus constructs were generated by site-directed 
mutagenesis of the AQP4-GFP construct described in section 2.1.1. Turquoise2  
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Figure 2-6 Calculation of the relative membrane expression of GFP fusion 
proteins from confocal fluorescence micrographs. 
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is a cyan fluorescent protein (CFP) derivative [209] and Venus is a yellow 
fluorescent protein (YFP) derivative [210]. 
CFP has an excitation maximum at ~425 nm and an emission maximum at 474. 
Venus has an excitation maximum at 515 nm and emission maximum at 528 nm. 
The microscope system used for this work had a 405 nm diode laser and 458 nm 
Argon laser line which could both be used to excite CFP.  Both lasers gave 
similar fluorescence intensity for CFP at the same laser power, however the 405 
nm laser excited Venus much less efficiently, so was chosen to minimize direct 
excitation of Venus in the FRET experiments.  
FRET experiments were performed using the sensitized emission methodology 
with the FRET signal corrected for donor emission in the acceptor channel and 
direct excitation of the acceptor, following van Rheenen et al [211] and 
normalised to the acceptor emission to give a normalized apparent FRET 
efficiency: 
! = !!" − !!! − (! − !")!!1− !" !!  
where FIA is the measured indirect (i.e. with donor excitation) acceptor 
fluorescence (the FRET signal), FD is the direct donor emission, FA is the direct 
acceptor emission and the greek letters are correction factors for acceptor 
fluorescence excited by the donor laser and detected at through the donor filters 
(α), donor fluorescence detected through the acceptor filters (β), excitation of the 
acceptor excited by the donor laser and measured through the acceptor filters (γ), 
and FRET signal measured through the donor filters (δ). The correction factors 
were obtained by imaging samples containing donor only or acceptor only before 
performing full FRET experiments. 
 80 
2.6 Lance cAMP assay 
The Lance cAMP kit (Perkin Elmer) was used to measure intracellular cAMP 
according to the manufacturer’s instructions. Because relatively small increases 
in cAMP were measured (~10-fold), the number of cells used in the assay was 
optimized to give a basal signal between 25% and 50% of the maximal assay 
response according to the produced cAMP standard curves. This was 10,000 
cells/well for HEK293 cells and 20,000 cells/well for rat primary astrocytes. 10 
µM forskolin (Sigma-Aldrich) was used as a positive control for adenylyl cyclase 
activity. Forskolin was prepared as a 10 mM stock in DMSO and stored at -20 
°C. 0.5 mM 3-isobutyl-1-methylxanthine (IBMX, Sigma-Aldrich) was used as a 
phosphodiesterase inhibitor. IBMX was prepared as a 1 M stock in DMSO and 
stored at -20 °C. All treatments were performed on cells adhered to tissue culture 
plates in DMEM. After treatments, cells were trypsinized and resuspended in 
stimulation buffer. The stimulation buffer used in the assay was Ca2+/Mg2+-free 
PBS, 0.1% w/v BSA, 0.5 mM IBMX. Stimulation buffer was heated to 37 °C 
and vortexed to thoroughly dissolve IBMX and BSA and filtered through a 0.22 
µm filter to remove any undissolved material. The FRET signal was read on a 
Pherastar FS plate reader (BMG Labtech). 
2.7 PKA activity assay 
An ELISA-based assay kit (Abcam) was used to measure PKA activity in cell 
lysates according to the manufacturer’s instructions. Cells were lysed in a non-
denaturing, phosphatase inhibiting lysis buffer for 45 mins, centrifuged at 21,000 
rcf for 10 minutes to remove insoluble material and protein was quantified using 
detergent-insensitive Bradford assay (Expedeon). Lysates were diluted in lysis 
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buffer as required to load 200 ng of total cellular protein in 30 µL (i.e. 6.66 ng/ 
µL) per well of the assay plate. 
2.8 Calcein fluorescence quenching 
Calcein is a fluorescent molecule that is quenched by protein in a concentration-
dependent manner. If the volume of a cell changes, so too does the intracellular 
protein concentration. Therefore, on short timescales where the number of 
protein molecules in a cell can be taken as constant, calcein fluorescence can be 
used as probe of cell volume. By applying an osmotic gradient to AQP-
expressing cells and measuring the rate of change of fluorescence (and thereby 
volume), the membrane water permeability can be quantified. This methodology 
was originally developed using fluorescence microscopy [212], and has since 
been adapted for fluorescence plate readers [213, 214]. We followed the protocol 
designed by Fenton et al [213] to measure membrane water permeability, and 
adapted it to measure membrane solute permeabilty. 
 
Cells were plated in cell culture-treated black-walled clear-bottomed 96 well 
plates (Corning) either the day before an experiment or two days before if 
transient transfections were required. 90 mins before the start of experiments, 
cells were loaded with calcein using 5 µM calcein-AM (Life Technologies) and 1 
mM probenecid (Sigma-Aldrich) in culture media (probenecid is an organic 
anion transporter antagonist used to prevent calcein leakage). Calcein-AM was 
prepared as a 5 mM stock in DMSO and stored at -20 °C in foil. Probenecid was 
prepared as a 175 mM stock in 200 mM NaOH and stored at -20 °C. After 90 
minutes at 37 °C, cells were washed twice in HEPES buffered DMEM with 1 
mM probenecid. HEPES buffering was to allow the cells to remain buffered in 
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the CO2-free environment of the plate reader. Cells were incubated for 10 mins at 
37 °C to equilibrate with the new media (in a 75 µL volume). A BioTek Synergy 
HT plate reader was used for all experiments. The plate reader temperature 
control was set to 37 °C 1 hour before the experiment. The plate reader injection 
system was not temperature-controlled, so all solutions that were used in the 
injection system were pre-warmed to 37 °C in a water bath. During the 
experiment, injected solutions were stored in 15 mL tubes (Greiner) and kept at 
37 °C using a heating block. Tubes were covered in parafilm to minimize 
evaporation. Error! Reference source not found.is a photograph of this set-up. 
Background was corrected for by including three wells of calcein-free cells on 
each plate and subtracting the average fluorescence of these wells from all 
readings with calcein. Fluorescence data was then normalized to the average of 
the first 5 readings for each well and single phase exponential decay functions 
were fitted by a least squares algorithm using the Solver tool in Microsoft Excel. 
2.8.1 Water permeability 
For water permeability measurements, 75 µL of 600 mM mannitol in HEPES-
buffered DMEM (media osmolality 300 mOsm; total osmolality 900 mOsm) was 
injected to give a final osmolality of 600 mOsm and an osmotic gradient of 300 
mOsm to induce cell shrinkage following Fenton et al. [213]. Fluorescence was 
measured every 50 ms. After 5 s of baseline readings, 75 L of the mannitol–
containing DMEM was injected. Relative fluorescence was converted to relative 
volume using a standard curve generated by measuring the relative change in 
fluorescence for cells subjected to varying extracellular osmolality and 
measuring the volume of cells from the same passage subjected to the same 
osmolality using a Coulter counter. 
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Figure 2-7 Plate reader setup for calcein fluorescence quenching. 
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2.8.2 Solute permeability 
To measure solute permeability, isotonic solutions of the desired solute are added 
to AQP-expressing cells. If the cell membrane is permeable to the solute, it will 
enter the cell down the solute concentration gradient. This will make the inside 
of the cell hypertonic compared to the outside, and therefore water will follow 
the solute by osmosis to maintain osmotic equilibrium, causing cell swelling. 
This methodology has been used to quantify the permeability of AQPs expressed 
in Xenopus oocytes using video microscopy [204], but to our knowledge, the 
calcein fluorescence quenching methodology has never been used to quantify 
AQP solute permeability. 
For neutral solute permeability measurements, fluorescence was measured every 
50 ms. After 5 s of baseline readings, 75 µL of an isotonic (300 mM) solution of 
the relevant solute, in dH2O, was injected to give a final concentration of 150 
mM. Relative fluorescence was converted to relative volume using a standard 
curve generated by measuring the relative change in fluorescence for cells 
subjected to varying (0-150 mM) concentrations of isotonic glycerol and 
measuring the volume of cells from the same passage subjected to the same 
glycerol concentrations, using a Coulter counter (Figure 2-8). This method has 
not previously been used to quantify solute permeability; therefore to check that 
it gives comparable results to other methods, we quantified the inhibitory effect 
(IC50) of a known AQP9 inhibitor, phloretin, on AQP9 glycerol permeability 
when transiently expressed in HEK293 cells. Phloretin has a published IC50 of 10 
µM [215]. We found an IC50 of 12 µM, in good agreement with this (Figure 2-9). 
Interestingly, we found a better fit to the data using a dose-response curve in 
which the Hill coefficient was allowed to vary. The Hill coefficient controls the  
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Figure 2-8 Calibration curve for conversion of relative calcein fluorescence to 
relative volume, measured using a Coulter counter, for intracellular glycerol 
concentrations of 0, 25, 50, 75, 100, 125 and 150 mM. 
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Figure 2-9 (A) Dose-response curves fitted to inhibition of AQP9 glycerol 
permeability by phloretin, with the Hill coefficient fixed to 1 (red), or allowed to 
vary (green). AQP9 activity was calculated by fitting the raw data to curves of 
the form C – Ae-kt, and normalizing the rate constant to that for a vehicle-only 
(0.1% MeOH) control. (B) Representative single fluorescence traces for 
phloretin concentrations at the extreme ends of the dose-response curve (10 nM, 
blue; 1 mM, red).  
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steepness of the slope at the midpoint (IC50), and a Hill coefficient different to 1 
is indicative of cooperative binding or multiple binding sites with different 
affinities [216], which might suggest that phloretin binding to AQP9 is not a 
simple 1:1 reaction. 
Cell-surface biotinylation 
Cells were plated in 24-well plates 2 days before experiments for transient 
transfections and 1 day before otherwise. Transient transfections were done as 
described in section 2.3.1. Cell surface amines were biotinylated using a cell 
impermeable amine-reactive biotinylation reagent (EZ-Link Sulfo-NHS-SS-
Biotin, Thermo Scientific). Cells were exposed to reductions in extracellular 
tonicity by diluting culture medium with dH2O. After treatment, cell culture 
media was washed out with ice cold PBS (with Ca2+/Mg2+) adjusted to the 
appropriate tonicity with dH2O, to remove amino acids and serum proteins that 
can compete for the NHS reaction whilst avoiding completely drying the cells.  
This was done by removing 375 µL of the 500 µL on the cells, keeping the plate 
flat, replacing it with an equal volume of PBS and repeating 5 times 
(corresponding to a dilution of culture media components by a factor of 45 = 
1024). Cells were incubated in 600 µL of 0.5 mg/mL biotinylation reagent in 
PBS diluted with dH2O to the tonicity matching the cell treatment, on ice for 30 
mins. For constitutive surface expression measurements, cells were washed twice 
in ice cold PBS instead of hypotonic treatment. Unreacted reagent was quenched 
3 times in 25 mM glycine in PBS for 5 mins. Cells were lysed in 350 µL tris-
triton lysis buffer (1% v/v triton X-100, 100 mM NaCl, 2 mM MgCl2, 25 mM 
tris pH 7.4) for 45 minutes on ice. The lysate was centrifuged at 21,000 g at 4 °C 
for 10 minutes to remove insoluble material. Biotinylated proteins in the 
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supernatants were precipitated by incubation in Neutravidin-coated 96-well 
plates (Pierce) for 2 hours at 4 °C. 100 µL of each lysate was loaded in triplicate 
with the same amount of total cellular protein (measured by BCA assay) per 
lysate. Plates were washed three times with 0.05% PBS-tween and blocked with 
3% w/v BSA in PBS for 1 hour at RT on an orbital shaker. After washing once 
with PBS-tween plates were incubated overnight on an orbital shaker at 4 °C 
with an AQP4 antibody (Abcam, ab128906) diluted 1:2,000 in 0.05% PBS-
tween. Plates were washed with 3 times with 0.05% PBS-tween and incubated 
with HRP-conjugated secondary antibody (Santa Cruz, sc-2313) diluted 1:5,000 
on an orbital shaker at RT for 1 hour. Plates were washed three times with 0.05% 
PBS-tween and incubated with o-phenylenediamine dihydrochloride (Sigma-
Aldrich) HRP substrate for 30 minutes on an orbital shaker, wrapped in foil. A 
volume of 100 µL of each solution (block, antibodies, washes and substrate) was 
used. Absorbance was measured at 450 nm using a BioTek Synergy HT plate 
reader. Figure 2-10 is a schematic of the workflow of these experiments. 
Linearity of the assay was confirmed by measuring the surface expression signal 
of HEK293 cells transfected with varying amounts (0-1 µg) of AQP4 DNA / 15 
mm cell culture well (Figure 2-11). 0.5 µg (equivalent to 2 µg / 35 mm plate) was 
used for routine experiments with transfected HEK293 cells. Specificity for 
surface localized protein was confirmed by measuring the surface expression 
signal from HEK293 cells transfected with either AQP4-GFP or GFP alone, 
using an anti-GFP primary antibody. GFP alone should reside in the cytoplasm 
and give no surface signal, whereas GFP should be detected in the AQP4-GFP 
sample due to being covalently bound to the surface AQP4 (Figure 2-11). 
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Figure 2-10 Schematic representation of cell surface biotinylation protocol. B – 
biotinylation reagent. HRP – horseradish peroxidase. Rectangles represent 
transmembrane proteins and circles represent cytoplasmic proteins. 
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Figure 2-11  (A) Linearity of surface expression signal of AQP4-GFP 
transfected into HEK293 cells as a function of the amount transfected DNA. (B) 
Surface expression signal, detected using an anti-GFP antibody, from HEK293 
cells transfected with either AQP4-GFP or GFP alone, demonstrating specificity 
for surface-localized protein. Data is represented as mean ± SEM, n=3. 
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2.9 SDS-PAGE 
SDS-PAGE was performed following a standard protocol. 0.75 mm thick 8% 
acrylamide gels were handcast using standard handcasting equipment (Bio-Rad).  
Stacking gels were 4% acrylamide. Samples were prepared by lysing a confluent 
35 mm dish of cells in 250 µL of ice cold RIPA buffer (1% v/v triton X-100, 
0.5% w/v sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 50 mM tris, pH 8) 
supplemented with a protease inhibitor cocktail (2 mM AEBSF, 0.3 µM 
aprotinin, 16 µM bestatin, 14 µM E-64, 1 µM leupeptin, 1 mM EDTA, Sigma). 
Lysates were centrifuged at 21,000 g for 10 mins at 4 °C to remove insoluble 
material. Protein concentration was determined using a detergent-insensitive 
Bradford assay (Bradford MX, Expedeon) according to the manufacturer’s 
instructions. 8 concentrations (0.1-2 mg/mL) of bovine serum albumin dissolved 
in RIPA buffer were used to make a standard curve. For transiently transfected 
HEK293 cells, 200 ng of total protein per well was loaded on the polyacrylamide 
gel. For stably transfected MDCK cells 1 µg was loaded. Lysates were mixed 
with an equal volume of 2x Laemlli buffer (4% w/v SDS, 20% v/v glycerol, 
0.02% w/v bromophenol blue, 4% v/v β-mercaptoethanol, 120 mM tris, pH 6.8) 
and incubated for 10 mins at room temperature before loadingonto the gel. High 
temperature (commonly 70 or 95 °C) incubation steps are commonly used at this 
point to facilitate protein denaturation. This was not done because high 
temperature was found to cause AQPs to aggregate (Figure 2-12). 
Electrophoresis was done at 200 V for 45 mins. Molecular weights were 
estimated using a commercial pre-stained protein marker (New England 
Biolabs). 
 92 
2.10 Blue native (BN)-PAGE 
Blue native PAGE was performed following the protocol of Fiala et al. [217] 
with the following modifications. 8% acrylamide gels were used instead of 
gradient gels. 1% triton X-100 was used in the lysis buffer. BSA was used as a 
molecular weight marker to give bands at 66 and 132 kDa (corresponding to 
monomeric and dimeric BSA). Lysates were not dialyzed as this was found to 
have no effect on protein migration (Figure 2-12). Gels were destained using 
10% v/v acetic acid, 40% v/v methanol. Proteins were denatured before Western 
blotting by soaking in 1% w/v SDS in tris-buffered saline (150 mM NaCl, 50 
mM tris, pH 7.5). 
2.11 Western blotting 
Proteins separated on polyacrylamide gels were transferred to methanol-activated 
PVDF membranes using a wet electroblotting system (Bio-Rad). Electrophoresis 
was done at 100 V for 1 hour. Membranes were blocked using 25 mL 20% w/v 
powdered skimmed milk (Marvel) in 0.1% PBS-tween for 1 hour on an orbital 
shaker. This was done in upside-down micropipette tip box lids. After blocking, 
membranes were washed 3 times for 5 mins in PBS-tween. Membranes were 
incubated in 5 mL of primary antibody diluted in PBS-tween at the appropriate 
optimized dilution (see section 2.12) overnight on a roller mixer in a 4 °C 
refrigerated room. This procedure was identical for SDS- and BN-PAGE. 
2.12  Antibodies 
2.12.1 Primary antibodies 
Boster PA1220 rabbit polyclonal antibody to AQP4 and Abcam ab11026 mouse 
polyclonal antibody to AQP4 were tested and did not detect AQP4 transfected   
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Figure 2-12 (A) Aggregation of AQP4 construct in SDS-PAGE when subjected 
to denaturation above room temperature. (B) Dialysis of lysates for BN-PAGE 
had no effect on protein migration. 
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into HEK293 cells or produced interfering non-specific bands. Abcam ab128906 
rabbit monoclonal antibody to AQP4 and Abcam ab6556 rabbit monoclonal 
antibody to GFP both detected AQP4-GFP fusion proteins and gave no 
background for untransfected control lysates, so these were used routinely for 
cell surface biotinylation and SDS/BN-PAGE. Abcam ab46182 rabbit polyclonal 
antibody to AQP4 was raised against an extracellular loop of AQP4 so was tested 
in cell surface expression ELISA. Although this antibody clearly detected AQP4 
in Western blots, there was no difference in cell surface ELISA signal between 
AQP4-transfected cells and control cells. This may represent partial occlusion of 
the epitope by the cell membrane in the native environment. 
2.12.2 Secondary antibodies 
Donkey anti-rabbit and donkey anti-mouse antibodies conjugated to horseradish 
peroxidase (Santa Cruz Biotechnology, sc-2313 & sc-2318) were used at the 
manufacturer recommended dilution (1:5,000). 
2.13 Inhibitors and agonists 
Compound Target Concentration 
W-7 CaM inhibitor 500 µM 
Trifluoperazine CaM inhibitor 127 µM 
CALP-3 CaM agonist 114 µM 
Hypericin Broad spectrum protein kinase 
inhibitor 
100 µM 
H-89 Non-specific kinase inhibitor 
(including PKA) 
5 µM 
Myristoylated PKI amide Protein kinase A inhibitor 3.6 µM 
Myristoylated PKC 
peptide inhibitor 
Protein kinase C inhibitor 200 µM 
Demecolchine Microtubule depolymerizing agent 24 µM 
Cytochalisin D Actin polymerization inhibitor 100 µM 
IBMX Phosphodiesterase inhibitor 500 µM 
Forskolin Adenylyl cyclase agonist 10 µM 
Probenecid Organic anion transporter inhibitor 1,000 µM 
Table 2-1 Inhibitors and agonists used for elucidation of cell signalling pathways 
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Where possible, inhibitors or agonists were used at 100× the IC50 or EC50 stated 
on the manufacturer’s datasheet. CALP-3 was used at 3× EC50 due to cost and 
limited solubility. 
2.14 Molecular dynamics simulations 
Simulations were done using Gromacs software, version 4.5.5 [218]. The 
GROMOS53A6 [219, 220] forcefield was used and modified to include lipid 
parameters [221]. An AQP4 tetramer was generated according to the biological 
assembly entry in the AQP4 PDB file 3GD8 [222]. N- and C-termini of the 
protein were truncated in the structure so proteins were simulated with neutral 
termini. The AQP4 tetramer was embedded into pre-equilibrated POPC bilayers 
using inflateGRO [223] and hydrated using Gromacs. Na+ and Cl- were added to 
a final concentration of 100 mM. Equilibration was achieved by steepest gradient 
energy minimization, 100 ps NVT simulation with 1000 kJmol-1nm-1 restraints 
on protein heavy atoms followed by three 1 ns NPT simulations with 1000, 100 
and 10 kJmol-1nm-1 restraints on protein heavy atoms followed by 30 ns 
unrestrained simulation. A Nosé-Hoover thermostat [224] (0.5 ps, 310 K) was 
used to maintain constant temperature and 2 Parinello-Rahmann barostats [225]  
(2 ps, 1 atm) were used to maintain constant pressure with zero surface tension. 
1.4 nm cut-offs were applied for dispersion and short-range electrostatic 
interactions. Long-range electrostatics were treated using the particle mesh 
Ewald method [226]. Hydrogen bonds were identified using the Hbonds plugin 
of VMD [227] using 3Å and 20° cut-offs. Hydrogen bond occupancy was 
calculated according to these cut-offs at 100 ps intervals along the trajectories 
and averaged over the 4 monomers. All analysis was done either with tools built 
into Gromacs or using VMD software [227]. 
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3 Results – Hypotonicity-induced relocalization of 
AQP4 
3.1 Aims 
The aims of the work presented in this chapter were: 
1. To determine whether AQP4-GFP fusion proteins can relocalize to the 
plasma membrane of HEK293 cells in response to hypotonicity in a 
similar manner that reported for AQP1-GFP. 
2. To investigate the cell signalling pathway(s) underlying this 
relocalization. 
3. To develop a complementary method of measuring AQP surface 
expression that does not require the protein to be tagged. 
4. To apply this complementary method to cells that are more 
physiologically relevant for AQP4 than HEK293 cells. 
5. To apply the methods used at the beginning of the chapter to study 
relocalization of human AQP5 to support X-ray crystallography 
experiments. 
3.2 Background 
AQP4 is highly expressed in the glial cells of the CNS and facilitates the 
osmotically driven pathological brain swelling associated with stroke and 
traumatic brain injury. Human AQP4 is a relatively-recently discovered member 
of the 13-strong family of mammalian AQPs [26]. AQP4 is found in a number of 
tissues including the kidney and GI tract but is notable for its high levels in 
astrocytes and its role in water homeostasis in the brain [228]. 
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AQP4 has been shown to be important for brain oedema formation following 
traumatic brain injury (TBI), stroke and meningitis [229]. AQP4 knock-out mice 
were protected from the formation of cytotoxic oedema in a stroke model [83], 
providing an explicit molecular target for managing this condition. Despite 
extensive research that has built on the well-understood structural biology of the 
AQP family, there are no drugs available to block water movement through 
AQP4 and in general, known AQP inhibitors are either cytotoxic (mercurial 
compounds) or are non-specific, leading to undesirable off-target effects [230-
232]. Understanding the regulation of AQP4 subcellular localization could 
provide a novel therapeutic platform for the treatment and/or prevention of 
cytotoxic oedema. 
The most well studied system in which cellular water flow is regulated is the 
translocation of AQP2 in response to AVP in the cells of the collecting duct of 
the mammalian kidney [233]. AQP2 is shuttled between the apical cell surface 
and intracellular vesicles in order to regulate water reabsorption. The mechanism 
involves AVP-mediated production of cAMP resulting in the activation of PKA 
and direct phosphorylation of the AQP2 C-terminal tail at serine 256 [234]. 
Specific SNARE proteins that facilitate the exocytosis of AQP2-containing 
vesicles have been identified [235]. Other AQPs have been shown to be 
translocated in response to environmental stimuli; a recent review suggested an 
emerging consensus on sub-cellular relocalization as a regulatory mechanism for 
the AQP family [236] following the discovery of the PKC-mediated 
translocation of threonine-phosphorylated AQP1 in response to changes of 
tonicity [169, 237]. 
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There is a requirement for rapid, physiological regulation of AQP4, which could 
be achieved at the transcriptional level or by short-term sub-cellular 
relocalization. There is contradictory evidence of transcriptional regulation of 
AQP4 in animal stroke models, with some studies reporting increased expression 
and others decreased expression [238], but whether AQP4 relocalization could be 
involved in the short or long term has yet to be investigated. AQP4 localization 
may be regulated by numerous intracellular mechanisms including PKA [239], 
PKC [240] and actin reorganization [241]. It is not clear if there are common 
mechanisms either within the AQP family or even for AQP4 in different cell 
types; this indicates a general lack of mechanistic awareness of AQP regulation. 
In this chapter, evidence is presented which suggests that AQP4 cell surface 
expression can be rapidly and reversibly regulated in response to changes of 
tonicity in primary cortical rat astrocytes and in transfected HEK293 cells. The 
translocation mechanism involves influx of extracellular calcium, activation of 
CaM and PKA activation, probably via activation of a Ca2+/CaM dependent 
adenylyl cyclase. Five putative PKA phosphorylation sites were identified and 
site-directed mutagenesis used to show that only phosphorylation at one of these 
sites, S276, was necessary for the translocation response in HEK293 cells. This 
site was phosphorylated in vivo in rats [242] and mice [243] and the mechanism 
also required PKA activity in primary cortical astrocytes. This data represents a 
novel mechanism that could suggest targets for therapeutic discovery in the 
treatment of cytotoxic brain oedema. 
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3.3 Results 
3.3.1 AQP4-GFP undergoes a rapid and reversible sub-cellular 
relocalization in HEK293 cells in response to changes in the 
tonicity of the extracellular environment 
HEK293 cells were used to investigate AQP4 sub-cellular relocalization as they 
are tractable for screening cellular inhibitors and protein mutants, as previously 
demonstrated by the discovery of the mechanism of tonicity-induced 
relocalization of human AQP1 using GFP-tagged proteins in our laboratory [169, 
237]. The distribution of AQP4-GFP fusion proteins transfected into HEK293 
cells was altered by changes in tonicity of the external environment, achieved by 
dilution of the culture media with dH2O. Live-cell confocal microscopy (Figure 
3-1 A-D) showed a rapid translocation of AQP4 to the cell surface in response to 
hypotonicity (following a 30s exposure from 340 mOsm/kg H2O to 85 mOsm/kg 
H2O). This effect was fully reversible. Surface expression of AQP4-GFP in 
fluorescence micrographs was quantified by calculating the relative membrane 
expression (RME) as described in section 2.4.1. Briefly, the difference between 
the average membrane fluorescence and the average intracellular fluorescence 
was calculated and this was normalized to the maximum fluorescence intensity 
(cells with protein evenly distributed between membrane and intracellular 
compartments have an RME of 0 and cells with 100% of the protein at the 
membrane have an RME of 100). Figure 3-1 shows that AQP4-GFP RME 
changed from 27.86±3.52 to 67.11±4.47, n=3, p=0.001. The change in AQP4-
GFP localization upon changing the extracellular tonicity from 340 mOsm/kg   
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Figure 3-1 Representative fluorescence micrographs of AQP4-GFP in HEK293 
cells following exposure to: (A) control medium (340 mOsm/kg H2O); (B), 30-s 
exposure to hypotonic medium (85 mOsm); and (C) return to isotonic medium 
with fluorescence intensity profiles across the yellow lines and cross-sectional 
areas calculated using ImageJ. (D) RME in the three conditions. n=3. p values 
from paired t-tests with Bonferroni's correction following ANOVA. (E) RME 
timeseries of AQP4-GFP (black) and AQP3-GFP (red) in HEK293 cells. (F) 
[K+]o reduction (left pair of bars) and hypotonicity (central pair) were applied 
independently and [K+]o was increased to 10 mM in isotonic conditions (right 
pair). All data are presented as mean ± S.E. 
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H2O to 85 mOsm/kg H2O happened on a timescale of 30 seconds. The change in 
RME was probably not due to a dilution effect or an artefact of the GFP tag as 
AQP3-GFP fusion proteins showed a similar distribution between membrane and 
cytoplasm, but no significant change in RME in response to reduced tonicity 
(Figure 3-1 E). 
Increased [K+]o has been reported to increase plasma membrane water 
permeability of cultured astrocytes, via phosphorylation of AQP4 at S111 [77]. It 
was not clear whether this effect was mediated by AQP4 translocation to the 
membrane or changes in single channel water permeability (or even an AQP4-
independent effect). However, it does suggest that the translocation measured in 
our system could be a response to reduced [K+]o, rather than a response to 
reduced extracellular osmolality per se. To investigate this, reduced osmolality 
and reduced [K+]o were applied independently (Figure 3-1 F). The translocation 
response was not due to a reduction in extracellular potassium concentration as 
isotonic reduction of [K+]o had no effect on RME, whereas hypotonicity in the 
presence of constant [K+]o had the same effect as hypotonicity induced by 
dilution of all solutes (Figure 3-1 F). Cells swelled leading to a 45 ± 1% increase 
of cross-sectional area after 1 minute compared to a 5 ± 1% increase for non-
transfected cells in the same images, visualized using the fluorescent membrane 
marker FM4-64 (Figure 3-2).  
AQP4 translocation was observed following a reduction of the extracellular 
tonicity to 85 mOsm/kg H2O (from 340). Reduction to 170 mOsm/kg H2O had 
no effect (Figure 3-3). RME was 25.98 ± 5.32 in control medium, 33.07 ± 5.24 in 
170 mOsm hypotonic medium (not significantly different from control) and  
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Figure 3-2 Representative cross-sectional areas of (A) AQP4-GFP transfected 
and (B) non-transfected HEK293 cells on the same plate before and after 
hypotonic challenge. Cells were visualized using the fluorescent membrane 
marker FM4-64 and AQP4 expression was determined by presence or absence of 
GFP signal. Areas were calculated using a particle detection algorithm built into 
ImageJ. The post-hypotonic challenge area as a percentage of the pre-challenge 
area is shown between each pair of images.  
  
293.4 µm2  
352.6 µm2 
232.0 µm2 
152.6 % 
 
151.7 % 
 
310.6 µm2 
211.7 µm2 
 
104.8 % 
 
104.6 % 
 
324.9 µm2 
221.9 µm2 
340 mOsm 85 mOsm 
192.7 µm2 
310.6 µm2 
 
(A) 
(B) 
 103 
 
Figure 3-3 A–C, AQP4-GFP-transfected HEK293 cells were imaged by confocal 
microscopy in solutions of: (A) 340 mOsm/kg H2O (B) 170 mOsm and (C) 85 
mOsm. Capture of each image was started 30 s after the change in tonicity. For 
170 mOsm, cells were allowed to equilibrate for 10 min to check for a slower 
translocation response. No difference was observed between 30 s and 10 min 
images. (D) Representative fluorescence profiles along the yellow lines in (A-C). 
(E) Mean RME for the three tonicities, averaged over at least three 
cells/experimental repeat, n = 3. p values are from paired t tests with Bonferroni's 
correction following ANOVA. All data are presented as mean ± S.E. n.s., not 
significant. 
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63.61 ± 6.16 in 85 mOsm hypotonic medium, p=0.0007 compared to 340 mOsm, 
after Bonferroni correction, n=3.  
3.3.2 Both AQP4 isoforms relocalized equally in HEK293 cells 
Human AQP4 exists in two isoforms: a long M1 form and a shorter M23 form 
that lacks the initial 22 amino acids of M1 (and there is evidence of further 
isoforms in rat [244]). Both proteins can be translated from the same full-length 
transcript by a ‘leaky scanning’ mechanism and different cell types express 
different M1/M23 ratios [245] via an unknown regulatory mechanism. To 
determine whether both or a single isoform was expressed from the wild-type 
AQP4 gene in our HEK293 system, we created constructs lacking either the M1 
or M23 translation initiation sites and compared the molecular weights of the 
resulting proteins with that translated from the wild-type gene, using SDS-
PAGE. Figure 3-4 shows that only the M1 isoform was present in HEK293 cells 
transfected with the wild-type AQP4 gene. M1 and M23 constructs had basal 
surface expression (i.e. at 340 mOsm) equivalent to the wild-type, measured 
using cell surface biotinylation. The confocal microscopy experiments described 
in section 3.3.1 were repeated using the M1 and M23 constructs. M23 formed the 
punctate orthogonal arrays of particles (OAPs) that have been previously 
described for this isoform [246]. RME for M23 changed from 24.58±4.85 at 340 
mOsm/kg H2O to 51.15±5.25 at 85 mOsm/kg H2O, n=3 p=0.004. The difference 
in hypotonic RME between M23, M1 and wild-type AQP4 were not significantly 
different (p=0.33). This suggested that both isoforms are equally translocated to 
the surface in response to hypotonic stimulus. 
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Figure 3-4 (A) Membrane organization of AQP4-GFP transfected into HEK293 
cells. The M1 isoform has a homogeneous membrane distribution, whereas M23 
clusters into orthogonal arrays of particles. (B) SDS-PAGE of protein transcribed 
in HEK293 cells from the AQP4 wild-type mRNA, AQP4 M1 construct, and 
AQP4 M23 construct. No M23 protein was detected in the wild-type sample. (C) 
There was no significant difference in constitutive surface expression between 
the three constructs. (D) Both isoforms of AQP4 are relocalized in response to 
reduction of the extracellular osmolality to 85 mOsm/kg H2O (M1: p=0.002, 
n=3; M23: p=0.004, n=3; WT: p=0.001, n=3.). All data are presented as mean ± 
S.E. 
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3.3.3 CaM, calcium and PKA regulate AQP4 relocalization 
AQP surface expression is known to be regulated by numerous cellular 
mechanisms. These include protein kinases, calcium channels and cytoskeletal 
reorganization [236]. AQP4 relocalization following hypotonic challenge was 
compared in the presence of a number of inhibitory compounds. These are 
described in Table 3-1. Inhibition of PKA by (in increasing order of specificity) 
hypericin, H-89 and myristoylated PKA substrate peptide (myrPKI) prevented 
AQP4 translocation, as did removal of calcium from the extracellular medium, 
and two inhibitors of CaM (a calcium-binding protein that mediates many of the 
downstream effects of calcium influx or release from intracellular stores). These 
data suggest that a combination of PKA kinase activity and calcium signalling 
mechanisms are required for AQP4 translocation. Prevention of the translocation 
response by inhibitors correlated with a reduction in cell swelling, suggesting a 
functional increase in membrane water permeability. 
3.3.4 Endogenous AQP4 in cultured primary rat astrocytes 
undergoes sub-cellular relocalization in response to 
hypotonicity 
AQP4 is expressed in the astrocytes of the CNS. To investigate AQP4 
relocalization in a more physiologically relevant system, surface expression of 
endogenous AQP4 in rat primary cortical astrocytes was measured using cell 
surface biotinylation followed by a neutravidin-based ELISA as described in 
section 0. Figure 3-5 shows that AQP4 surface localization increased 2.7-fold 
after 10 minutes of hypotonic challenge at 85 mOsm/kg H2O (n=3, p=0.006) but  
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Inhibitor/Control  
Media 
Isotonic 
RME 
(± SEM) 
Hypotonic 
RME 
(± SEM) 
 
Mean % area 
change (± SEM) 
 
Translocation 
Untreated control 28.77 (6.78) 78.84 (1.84)* 145.19 (1.11)* Yes 
Non-specific kinase 
inhibitor (hypericin) 
21.85 (6.80) 38.22 (5.58) 103.50 (2.05) No 
PKC (myrPKCi) 27.27 (4.73) 55.28 (3.97)* 141.00 (2.05)* Yes 
PKA (H-89) 23.11 (6.91) 29.81 (4.93) 107.31 (4.17) No 
PKA (myrPKI) 25.62 (5.16) 33.66 (6.62) 102.97 (5.21) No 
Actin inhibition 
(cytochalisin D) 
26.07 (6.10) 34.91 (5.48) 121.87 (4.81) No 
Microtubule 
inhibition 
(demecolcine) 
26.14 (5.89) 27.17 (8.14) 107.68 (7.13) No 
Calcium-free media 26.69 (6.03) 32.16 (4.48) 111.60 (1.92) No 
CaM inhibitor (W7) 16.86 (8.43) 22.11 (8.14) 110.31 (14.21) No 
CaM inhibitor 
(trifluoperazine) 
27.23 (7.11) 31.40 (5.91) 108.61 (5.47) No 
 
Table 3-1 Translocation of AQP4-GFP in HEK293 cells in the presence of 
various inhibitors, measured by confocal microscopy and subsequent image 
analysis. Cells were imaged before and after reduction of the extracellular 
osmolality to 85 mOsm/kg H2O. Each RME value is an average over three 
independent experiments, with each experiment analyzing at least 3 
cells/micrograph. p < 0.05 was considered statistically significant (*).  
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Figure 3-5 (A) Cell surface biotinylation of primary rat astrocytes subjected to 
hypotonicity and analysis of endogenous AQP4 surface expression. As a 
negative control for translocation, membrane expression of the glutamate 
transporter EAAT1 was measured under the same conditions, n=3. None of the 
variability in EAAT1 surface expression was statistically significant, p=0.37. (B) 
As above for AQP4 in the presence and absence of a PKA inhibitor (myrPKI). 
AQP4 surface expression increased 2.2-fold between 340 and 85 mOsm/kg H2O, 
n=3, p=0.008. In the presence of the inhibitor, AQP4 surface expression did not 
change significantly between 340 and 85 mOsm/kg of H2O, n=3, p=0.24. All 
data are presented as mean ± S.E. n.s., not significant.  
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did not change significantly after 10 minutes of hypotonic challenge at 140 
mOsm/kg H2O. It is important to confirm that this response is not due to a 
general effect of hypotonicity on vesicular membrane proteins or changes in 
protein availability for labelling due to membrane unfolding associated with 
cellular swelling. To discount these, we measured surface expression of the 
astrocytic excitatory amino acid transporter EAAT1. Surface expression of 
EAAT1 did not change significantly with either hypotonic treatment (n=3, 
p=0.37) and there was no significant effect on cell viability measured by tryptan 
blue exclusion (data not shown). 
3.3.5 PKA activity is required for endogenous AQP4 
relocalization in primary astrocytes 
 HEK293 cells provide a tractable model for studying the cell signalling 
components required for AQP4 translocation. However, it is possible that, 
despite sharing the translocation response, HEK293 cells and primary astrocytes 
translocate AQP4 by different mechanisms. To validate the mechanistic 
information obtained in HEK293 cells, we repeated the primary astrocyte cell 
surface biotinylation experiments in the presence of a PKA inhibitor. Figure 3-5 
shows that a 30 minute pre-incubation with myrPKI prevented the hypotonicity-
induced relocalization of endogenous AQP4 in rat primary cortical astrocytes. 
This suggests that the mechanistic details elucidated using HEK293 cells are 
probably comparable to the translocation of endogenous AQP4 in primary 
astrocytes. 
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3.3.6 Hypotonicity induces intracellular cAMP production and 
PKA activity in primary rat astrocytes 
Influx of extracellular calcium through several members of the TRP family of 
cation channels is a well-established cellular response to extracellular 
hypotonicity [247], although it is still unclear whether these channels open 
directly in response to swelling-associated changes in membrane tension or are 
activated downstream of some other mechanosensory or osmosensory system 
[248]. Previous work in our laboratory showed that this calcium response 
happens in HEK293 cells, is required for the hypotonicity-induced translocation 
of AQP1 and that the TRPC antagonist SKF96365 blocks the calcium response 
and the AQP1 relocalization [169]. In the case of AQP1, PKC was found to 
phosphorylate AQP1 to mediate the translocation. Some isoforms of PKC can be 
directly activated by calcium alone, suggesting a direct link between the TRP-
mediated calcium influx and AQP1 phosphorylation.  
Unlike AQP1 , the relocalization of AQP4 required PKA (and not PKC) for the 
translocation response. To investigate how PKA might be activated by calcium 
influx, measurement of intracellular cAMP (the activator of PKA) accumulation 
in response to hypotonicity were made in the presence and absence of 
extracellular calcium and a CaM agonist and antagonist (Figure 3-6 A). 
Hypotonicity (85 mOsm) increased intracellular cAMP by 11-fold (n=3, 
p=0.01), whereas hypotonicity in the absence of extracellular calcium or in the 
presence of the CaM antagonist W-7 did not change intracellular cAMP 
significantly (both n=3, p=0.40 and p=0.22 respectively). The CaM agonist 
CALP-3 was able to elicit the same cAMP response in isotonic conditions (n=3, 
p=0.02 vs. basal; p=0.16 vs. hypotonicity). PKA activity in response to the same  
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Figure 3-6 (A) Intracellular cAMP accumulation in rat primary cortical 
astrocytes in response to forskolin (adenylyl cyclase agonist, positive control), 
hypotonicity with and without extracellular calcium and CaM antagonist W-7, 
and the CaM agonist CALP-3. (B) PKA activity in lysates made from rat 
astrocytes subjected to the same treatments. Activity is normalized to the basal 
control. 100% on this scale is equivalent to 2.3±0.1 ng active PKA / µg of total 
cellular protein. 
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set of stimuli was also measured, and the PKA activity followed the same pattern 
as the cAMP accumulation (Figure 3-6 B). 
3.3.7 S276 phosphorylation is required for relocalization 
The data in Table 3-1 suggest a key role for PKA (but not PKC) in mediating 
AQP4 translocation. Using kinase site prediction software (NetPhosK 1.0 [249]), 
five serine residues were identified as PKA consensus sites. These were S52, 
S111, S180, S188 and S276. The locations of these residues in the AQP4 
structure are shown in Figure 3-7.  
The PKA consensus sites were individually mutated to alanine (to block 
phosphorylation) and aspartate (to act as a phosphomimetic). The effects of these 
mutations on the tonicity-induced relocalization of AQP4 are tabulated in Table 
3-2. Only mutations to S276 had any effect on hypotonicity-induced 
translocation. Substitution of S276 with alanine (S276A) blocked hypotonicity-
induced translocation while substitution with aspartate (S276D) had no effect, 
suggesting that PKA phosphorylation at S276 is necessary but not sufficient for 
translocation to occur or that S276D is a poor phosphomimetic. To determine 
whether this single phosphorylation event was the only mechanistic effect of 
PKA, translocation of the S276D mutant was measured in the presence of a PKA 
inhibitor (myrPKI). Unlike the wild-type protein, for which the translocation was 
inhibited by myrPKI, S276D still translocated to the membrane in the presence 
of the PKA inhibitor. This shows that S276D is a phosphomimetic and that PKA 
phosphorylation of AQP4 at S276 is a key step in the AQP4 translocation 
signalling pathway. Although the S52A mutant behaved like wild-type AQP4, 
S52D did not translocate, but also had greatly reduced basal surface expression 
in comparison to wild-type AQP4 and other phosphomimetic mutants. Low   
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Figure 3-7 Locations within the AQP4 structure of identified putative PKA sites 
that were mutated (red) and the AQP family conserved NPA motifs (blue) are 
shown. Blue lines represent approximate positions of membrane lipid 
headgroups. 
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Table 3-2 Translocation of phosphomimetic and phospho-blocking mutants of 
AQP4-GFP in HEK293 cells, measured by confocal microscopy and subsequent 
image analysis. Cells were imaged before and after reduction of the extracellular 
osmolality to 85 mOsm/kg H2O. Each RME value is an average over three 
independent experiments, with each experiment analysing at least 3 
cells/micrograph. Constitutive surface expression was measured by cell surface 
biotinylation and normalised to wild-type expression. p < 0.05 was considered 
statistically significant (*). 
Mutant Isotonic 
RME  (± 
SEM) 
Hypotonic 
RME  (± 
SEM) 
Mean % CSA 
change (± 
SEM) 
 
Translocation 
Constitutive 
surface 
expression (% 
of wild-type) 
S52A 34.18 
(4.06) 
59.34 (5.53)* 127.03 (5.99)* Yes 98.1 (5.3) 
S52D N/A N/A N/A No 17.0 (6.3)* 
S111A 36.24 
(9.95) 
62.43 (5.42)* 130.69 (4.76)* Yes 94.8 (6.4) 
S111D 31.17 
(4.22) 
52.99 (5.41)* 120.62 (8.40)* Yes 91.4 (4.6) 
S180A 35.43 
(7.78) 
69.03 (6.94)* 142.65 (7.78)* Yes 109.8 (4.5) 
S180D 36.86 
(6.07) 
53.56 (4.96)* 148.16 
(16.74)* 
Yes 99.7 (5.0) 
S188A 34.17 
(7.21) 
63.31 (7.00)* 137.01 (9.17)* Yes 98.6 (3.2) 
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surface expression prevented calculation of the RME and measurement of cross-
sectional area in confocal micrographs. S52D appeared to be localized 
throughout the cytoplasm (rather than degraded or held as inclusion bodies) 
suggesting that the protein is not simply grossly mis-folded. This may reflect a 
functional relevance, possibly interrupting processing through the Golgi 
apparatus or post-Golgi trafficking to the cell surface, which may be worthy of 
further study. 
3.3.8 AQP5 surface localization is controlled by 
phosphorylation, PKA and hypotonicity 
AQP5 is a water-selective channel expressed in the lacrimal and salivary glands 
and lungs, where it is thought be important for generation of tears, saliva and 
pulmonary secretions [182, 192, 193]. Our data from this study on AQP4 
combined with the publications on AQP1 suggest the possibility of a common 
relocalization machinery for these channels. There are two consensus PKA sites 
in AQP5: S156 in cytoplasmic loop D [27, 194] and T259 [195] in the C-
terminus; the latter corresponds to S256 in AQP2. AQP5 can be directly 
phosphorylated by PKA at S156 and T259 [196]. Notably, S156 was 
phosphorylated preferentially in certain tumours suggesting that cell proliferation 
can be modulated by phosphorylation of this site although the constitutive 
membrane abundance of an S156A mutant was not distinguishable from wild-
type AQP5 [197]. Based on the crystal structure of human AQP5 it was 
hypothesized that phosphorylation of S156 could cause structural changes in 
loop D that would break its interaction with the C-terminus, thereby flagging the 
protein for translocation to the plasma membrane [198]. In order to test this 
hypothesis on the role of S156 in the membrane translocation of AQP5, we used 
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real time translocation studies in living HEK293 cells as described earlier in this 
chapter (section 3.3.1).  
The RME of AQP5-GFP was increased by the introduction of the S156E 
phosphomimetic mutation from 0.56 ± 0.02 to 0.67 ± 0.01 (n=3, p=0.01), 
whereas the RME of AQP5-S156A was not significantly different (n=3, p=0.36) 
to wild-type AQP5-GFP (Figure 3-8).  
The RME of AQP5-GFP (wild-type and the S156A and S156E mutants) was 
measured after a 30 minute incubation with PKA inhibitor (myrPKI) or vehicle 
control. PKA inhibition increased the RME of all AQP5 constructs (Figure 3-9) 
compared to non-inhibited controls, suggesting a role for PKA signalling in the 
internalization of AQP5 as previously suggested [192]. PKA inhibition further 
increased the membrane abundance of the S156E mutant, indicating that the 
PKA inhibition effect is independent of the phosphorylation status of S156. 
Reduction of the extracellular osmolality to 85 mOsm/kg H2O caused rapid 
relocalization of AQP5 from intracellular compartments to the plasma membrane 
in a manner comparable to AQP1 [237] and AQP4 (Figure 3-10). The initial 
AQP5-GFP distribution profile was restored on returning to normal physiological 
osmolality. The RME of AQP5-GFP increased from 0.56 ± 0.03 in control 
medium to 0.72 ± 0.01 in hypotonic medium. Similarly, the RME increased from 
0.55 ± 0.02 to 0.71 ± 0.02 for the S156A mutant and from 0.67 ± 0.02 to 0.81 ± 
0.01 for the S156E mutant. Despite an increased level of constitutive surface 
expression, the change in RME for the S156E mutant (ΔRME = 0.14 ± 0.01) was 
similar to that for AQP5 or the S156A mutant (ΔRME = 0.15 ± 0.03 and 0.13 ± 
0.02 respectively). Inhibition of PKA, despite increasing constitutive surface  
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Figure 3-8 (A-C) Representative fluorescence micrographs of AQP5-GFP and 
S156 mutants in HEK293 cells in isotonic medium with fluorescence intensity 
profiles across the yellow lines (D) RME of the three constructs, n=3. * 
represents p<0.05 and n.s. not significant (p>0.05) from unpaired t-tests with 
Bonferroni's correction following ANOVA. 
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Figure 3-9 Representative fluorescence micrographs of AQP5-GFP and S156 
mutants in HEK293 cells in isotonic medium, with and without 30 minute pre-
incubation with the PKA inhibitor myrPKI (D) RME of the three constructs and 
two conditions, n=3. * represents p<0.05 from unpaired t-tests with Bonferroni's 
correction following ANOVA. 
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Figure 3-10 ) RME of the three AQP5 constructs in HEK293 cells subjected to a 
reduction of the extracellular osmolality from 340 mOsm/kg H2O (isotonic, black 
bars) to 85 mOsm/kg H2O (hypotonic, white bars), with and without inhibition of 
PKA by a 30 minute pre-treatment with myrPKI, n=3. * represents p<0.05 from 
paired t-tests with Bonferroni's correction following ANOVA. 
 
  
0.5 
0.6 
0.7 
0.8 
0.9 
1 
AQP5 
WT 
AQP5 
S156A 
AQP5 
S156E 
AQP5 
WT 
AQP5 
S156A  
AQP5 
S156E 
R
el
at
iv
e 
m
em
br
an
e 
ex
pr
es
si
on
 
isotonic 
hypotonic 
Non-inhibited 
control 
PKA inhibition 
* * 
* 
* * 
* 
 120 
expression of all constructs, did not inhibit the hypotonicity-induced 
relocalization of AQP5. Taken together, these results suggest that hypotonicity-
induced relocalization of AQP5 is not mediated by either PKA activity or 
phosphorylation at S156. 
3.4 Discussion 
3.4.1 AQP4 
AQP4-GFP fusion proteins in HEK293 cells and endogenous AQP4 in primary 
rat astrocytes rapidly relocalize to the plasma membrane in response to a 
reduction in local tonicity. The relocalization response takes about 30 seconds in 
HEK293 cells and is completely reversible upon return of the local tonicity to 
340 mOsm/kg H2O. The concomitant cell swelling following AQP4 
relocalization (which was reduced by inhibitors that blocked the translocation 
response) suggests that there is an effective increase in cell membrane water 
permeability. The mechanisms involved in AQP4 relocalization require PKA 
activity and cytoskeletal elements. Extracellular calcium is required, presumably 
passing through TRP channels, which are known to mediate a calcium signalling 
response to osmotic cell swelling [250]. 
CaM inhibition using two different CaM inhibitors (W7 and trifluoperazine) also 
blocked AQP4 translocation in response to hypotonicity. CaM-mediated 
regulation of AQPs is well established. CaM has been shown to inhibit AQP0 
water permeability by binding directly to the C-terminal tail [251, 252] and this 
binding can be inhibited by AQP0 phosphorylation [202]. In rat parotid cells, 
AQP5 was rapidly translocated to the apical membrane via acetylcholine 
signalling and inhibition of signalling elements downstream of CaM (CaM 
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kinase II, myosin light chain kinase and nitric oxide synthase) blocked this 
translocation response [253]. AVP-induced translocation of AQP2 in collecting 
duct cells can be attenuated by extracellular calcium in a CaM-dependent manner 
[254]. CaM has also been shown to bind directly to the N-terminal tail of AQP6 
[255], although the functional relevance of this interaction is unknown. We 
showed previously that inhibition of CaM prevented hypotonicity-induced 
relocalization of AQP1 in HEK293 cells [169]. Our data showing Ca2+/CaM 
dependent accumulation of cAMP and activation of PKA suggests the 
involvement of a Ca2+/CaM dependent adenylyl cyclase. In mammals, two of 
these exist, AC1 and AC8 [256], both of which are expressed in the rat cerebral 
cortex [257] and are therefore both likely to be present in our cortical rat 
astrocytes. Microarray analysis of HEK293 cells suggested that they express 
AC1 but not AC8 [258]. Therefore, if the mechanism of AQP4 translocation is 
conserved between HEK293 cells and astrocytes, AC1 is the most likely target 
for CaM in this response. Interestingly, a CaM binding site prediction tool (CaM 
Target Database [259]) predicts that the most likely site for direct binding of 
CaM to AQP4 is the 20-residue peptide at positions 277–296, directly upstream 
of the S276 phosphorylation site we identified, suggesting that CaM could be 
performing a dual function, and that S276 phosphorylation could act as a switch 
for CaM binding or release.  
Kinase-dependent translocation of AQPs to the plasma membrane from 
intracellular vesicles is an established regulatory mechanism that has been 
demonstrated for AQP2 in response to AVP signalling via PKA [260], AQP1 in 
response to hypotonicity via PKC [237], and AQP5 in response to acetylcholine 
via PKG[253]. Treatment with the broad-range kinase inhibitor, hypericin, 
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suggested a similar mechanism for AQP4 relocalization. Using specific 
inhibitors identified PKA activity as a requirement for tonicity-mediated 
translocation of AQP4. There is some evidence that PKA reduced surface 
availability of AQP4 in human gastric cells [239]. In our systems, PKA seems to 
be doing the opposite. 
All potential PKA sites of AQP4 were mutated, suggesting a key requirement for 
S276 in the C-terminal tail of AQP4. Phosphorylation at this residue has been 
detected in vivo in murine AQP4 [243] and rat AQP4 [242]. It was recently 
reported that phosphomimetic (S276D) or phosphorylation-deficient (S276A) 
mutations at this residue have no effect on surface expression or water 
permeability leaving the mechanistic role of this phosphorylated residue unclear 
[261]. Our data provide evidence of a functional role for S276 phosphorylation. 
It has also been reported that phosphorylation at S276 can increase lysosomal 
targeting of AQP4 upon internalization [262]. This may explain the slight 
reduction in constitutive surface expression (to 83.5±5.7 %) that we measured for 
the S276D mutant. PKC phosphorylation of S180 in response to AVP has been 
reported to cause AQP4 internalization in Xenopus oocytes [263]; we did not 
observe any change in constitutive surface expression or translocation response 
for the S180D phosphomimetic mutant in our system. This may reflect the lack 
of an element of this internalization pathway in HEK293 cells or a species-
specific effect. Phosphorylation of AQP4 at S111 in response to elevated [K+]o 
has been reported to increase membrane water permeability in an astrocytic cell 
line [77], although the mechanism was not established. Our data suggests that 
elevated [K+]o caused translocation of AQP4 to the plasma membrane, which 
provides a mechanistic explanation for this observation. This is in line with MD 
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simulations and Xenopus oocyte swelling assays using S111A and S111D 
mutants that showed that phosphorylation at S111 does not change the single 
channel water permeability of AQP4 [264]. S111A and S111D mutations had no 
effect on tonicity-induced translocation or constitutive surface expression in our 
system. 
The S276D phosphomimetic mutant translocated in the presence of a PKA 
inhibitor, suggesting that the only role of PKA in our system is to phosphorylate 
S276. Although it is probable that S276 is phosphorylated in our primary 
astrocyte experiments, we cannot rule out a difference in phosphorylation sites 
between different cells or a synergistic effect of several kinase sites in the 
primary cells as observed for the two threonine residues that are phosphorlyated 
by PKC to faciliatate translocation of AQP1 [169]. 
Interestingly, we found that transfected AQP4 (with and without GFP) did not 
relocalize in response to any tonicity change in the U373 glioblastoma cell line 
(Figure 3-11). There is some evidence that a dominant-negative splice variant of 
AQP4 lacking exon 4, which codes for the half-helix containing the second NPA 
motif, can inhibit surface expression of either the M1 or M23 isoforms of AQP4 
when co-expressed [265]. This was reported in muscle cells, but it may be 
possible that dysregulation of this isoform inhibits surface expression in U373 
cells. People with glioblastoma have a very poor prognosis. The cells are very 
invasive and oedema is a key problem (T. Belli, personal communication). This 
may be worthy of further investigation to determine whether this loss of the 
AQP4 translocation response is a peculiarity of the U373 cell line or 
representative of glioblastoma physiology.  
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Figure 3-11 (A) Representative confocal micrographs of an AQP4-GFP-
transfected U373 cell exposed to isotonic (340 mOsm/kg of H2O) media and 5-
min exposure to hypotonic (85 mOsm/kg of H2O) media. (B) and (C) Cell 
surface biotinylation of U373 cells transfected with AQP4 (C) and AQP4-GFP 
(D). No statistically significant change was observed between any of the 
treatment groups (340, 170, and 85 mOsm/kg of H2O), n = 3. Data are presented 
as mean ± S.E.  
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Finally, based on the data reported here, we propose the signalling pathway 
represented in Figure 3-12 as the most likely mechanism for the hypotonicity-
induced relocalization of AQP4. 
To conclude, the data reported here identify and provide a mechanistic 
explanation of the physiological subcellular relocalization of AQP4 in response 
to changes in local tonicity. A change in local tonicity is the key driver of glial 
cell swelling in stroke and contributes to the effects of cytotoxic oedema 
following traumatic brain injury. Modulating the surface expression of AQP4 
rather than trying to directly block its pore is a novel platform for developing 
therapies for these devastating conditions. 
3.4.2 AQP5 
Our data suggests that membrane expression of AQP5 in HEK293 cells is 
affected by phosphorylation of S156, either by increased membrane targeting or 
decreased internalization (or both). To our knowledge this is the first time that a 
specific phosphorylation site of AQP5 has been directly linked to a difference in 
membrane localization. The fact that the S156A mutant behaves like wild-type 
AQP5 indicates that phosphorylation of S156 may not occur under basal 
conditions. In this respect it is intriguing that S156 was preferentially 
phosphorylated in tumour cells [196]. It has been suggested that in tumours, 
PKA-dependent phosphorylation of S156 increased cell proliferation by 
activating the Ras pathway [266]. A number of studies have shown that 
upregulation of AQPs is common in a variety of cancers and that the AQP may 
promote cell proliferation and migration [11].   
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Figure 3-12 Schematic of the proposed signalling mechanisms involved in 
hypotonicity-induced relocalization of AQP4 based on the data in this chapter. 
CaM – CaM; PKA – protein kinase A. 
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Our data hint at a mechanism whereby phosphorylation of S156 of AQP5 
increases its membrane localization, thereby increasing the number of AQP5 
molecules able to participate in events on the plasma membrane and enhancing 
cancer cell proliferation. 
It was previously suggested that phosphorylation of S156 would break 
interactions between loop D and the C-terminus, thereby triggering a 
conformational change [198]. Significant conformational variability of the C-
terminus was seen in the structure of human AQP2, where the C-terminal helix 
of each monomer adopted a unique conformation that had not been observed in 
any previous mammalian AQP structure [48]. As the C-terminal region is known 
to be important for membrane translocation of both AQP2 [190], AQP5 [195, 
267], and AQP4 [268], such conformational changes may be recognized as a 
structural sorting signal by the cellular trafficking machinery. However, the 
structure of the AQP5 S156E mutant did not reveal any structural differences 
within loop D or the C-terminus (see Kitchen et al, PloS One, 2015, appendix 1). 
We therefore suggest that it is the presence of a phosphate group at S156 rather 
than a conformational change of the C-terminus that is recognized as a sorting 
signal, resulting in increased AQP5 membrane abundance.  
Our data further show that, independent of S156, basal levels of PKA activity 
(i.e. in the absence of a cAMP-stimulating agonist) decrease the membrane 
abundance of AQP5. This fits well with the short-term effect of cAMP and PKA 
that has been seen previously and for which PKA has been suggested to be 
involved in AQP5 internalization [192]. As PKA inhibition further increased 
membrane expression of the S156E mutant, the phosphorylation of S156 is 
probably not responsible for this short-term effect. Instead, we suggest that S156 
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phosphorylation may be involved in the long-term cAMP and PKA-dependent 
effect whereby an increase in AQP5 membrane abundance is seen after several 
hours. This is in agreement with the observation that the long-term effect of 
cAMP and PKA involves direct phosphorylation of AQP5 while the short-term 
effect does not [192].    
Finally, we show that AQP5-GFP is rapidly translocated to the plasma 
membrane of HEK293 cells in response to hypotonic conditions, but that this 
translocation is independent of S156 in loop D and also, unlike AQP4, 
independent of PKA activity. These three factors regulating AQP5 membrane 
localization are represented as a schematic in Figure 3-13.  
The hypotonicity-induced membrane translocation of AQP5 described here is 
consistent with that of AQP1 where the phosphorylation of Thr157 and/or 
Thr239 by PKC results in rapid accumulation in the cell-surface membrane 
[169]. Whether direct phosphorylation of AQP5 by PKC or another kinase 
mediates hypotonicity-induced membrane translocation in a similar manner 
remains to be shown. AQP5 is found in tissues that are subject to rapid changes 
in osmolarity and has an important role in cell volume regulation [182, 192, 
193]. Upon exposure to hypotonic conditions, cells undergo a rapid RVD to 
avoid rupture. This happens within a couple of minutes and involves the release 
of cellular water. RVD is often followed by RVI whereby the osmotically 
shrunken cell approaches its original volume [178]. The rapid response to  
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Figure 3-13 – A proposed model of the equilibrium between vesicular and 
surface-localized AQP5, regulated by three independent factors: phosphorylation 
of AQP5 at position S156 (panel B, shown by a phosphomimetic glutamate 
substitution (S156E) of AQP5); the effect of PKA (panel C) and the effect of 
decreasing the relative tonicity of the environment (panel D). Arrow sizes 
represent the relative rates of membrane trafficking and internalization. We 
speculate that these three pathways control the surface abundance of AQP5. 
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hypotonicity reported here supports the involvement of AQP5 in RVD as 
previously suggested [182]. On a longer time scale, hypotonic exposure has been 
shown to cause a decrease in AQP5 membrane abundance [193], most likely 
corresponding to the RVI response. Taken together, regulation of AQP5 
membrane abundance seems to be important for both the RVD and RVI 
components of cell volume regulation. Data from our laboratory previously 
showed that hypotonicity-induced calcium influx through TRPC1 was vital for 
translocation of AQP1 [169] and others have shown that calcium influx through 
TRPV4 mediates the AQP5-dependent regulatory volume decrease in acinar cells 
[182]. We therefore speculate that the sensor of extracellular osmolality that 
leads to AQP5 translocation is a member of the TRP family of gated cation 
channels.  
Due to its importance for fluid secretion in airway submucosal glands, AQP5 has 
been suggested to be a pharmacological target to treat the hyper-viscous and 
excessive gland secretions in cystic fibrosis and bronchitis/rhinitis respectively 
[269]. Our data provide the first link between a specific AQP5 phosphorylation 
site, S156, and changes in its subcellular localization. We further show that the 
S156-mediated change in localization does not require a substantial protein 
conformational change. We show that, independently of S156, PKA is further 
involved in basal recycling of AQP5 between the plasma membrane and 
intracellular compartments. Finally, we provide evidence of tonicity-induced 
changes in AQP5 localization that are not mediated by phosphorylation of S156 
or PKA. This provides a platform for elucidating the detailed mechanism(s) by 
which post-translational modifications govern translocation of AQP5 from 
intracellular storage vesicles to the target membrane in response to protein kinase 
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activity and osmotic triggers, potentially providing key information for drug 
design targeting AQP5. 
 
Finally, the data in this chapter showing tonicity-induced translocation of AQPs 
4 and 5 along with the published observation of AQP1 translocation, suggests 
that tonicity-induced translocation of AQPs to the plasma membrane is a 
conserved mechanism by which cells may control their membrane water 
permeability.   
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4 Results – A comparative analysis of AQP solute 
exclusion and selectivity 
4.1 Aims 
The aims of the work presented in this chapter were: 
1. To compare the neutral solute permeability of mutants of the AQP4 
selectivity filter to those published for AQP1 to discuss a general model 
of solute exclusion in the AQP family. 
2. To use homology modelling and mutagenesis of AQP3 to compare and 
contrast its solute permeability with AQP1/4 mutants. 
3. To quantitatively compare the glycerol and urea permeabilities of the 
wild-type human GLPs. 
4. To use water permeability measurements of AQP4 selectivity filter 
mutants to test a published prediction, based on MD simulations, about 
the role of this region in controlling water permeability. 
4.2 Background 
The AQPs can be split into two sub-families: the strictly water-selective AQPs 
and the aquaglyceroporins (GLPs), which facilitate the movement of small 
neutral polar solutes such as glycerol and urea in addition to water (to avoid 
confusion between the family as a whole and the water-selective sub-family, 
which are often interchangeably referred to as ‘AQPs’, in this chapter AQP will 
refer to the family as a whole and wAQP will be used to distinguish the strictly 
water-selective sub-family). 
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Two conserved structural features have been proposed to act as filters in the 
wAQPs to exclude the passage of neutral polar solutes and ions. The first of 
these is the constriction formed in the centre of the pore by two NPA motifs at 
the ends of two short alpha helices formed by the intracellular loop connecting 
the bottom (intracellular end) of TM2 to the bottom of TM3 and the extracellular 
loop connecting the top (extracellular end) of TM5 to the top of TM6. The 
asparagine residue is conserved in all known AQPs, whereas the proline and 
alanine residues, despite being highly conserved, can be substituted and still 
retain some AQP function (e.g. alanine to cysteine in AQP11 and proline to 
alanine in AQP7, both of which are functional water and glycerol channels). This 
structural feature is conserved across the whole AQP family and is not thought to 
contribute directly to the differences between the two sub-families, although 
subtle structural differences affecting this conserved motif could partially 
account for the differences in single channel water permeability between 
different members of the AQP family. 
 
The second structural feature is the ar/R region, located between the extracellular 
channel mouth and the NPA constriction site. It is formed by four amino acid 
residues from different locations in the primary sequence; two from several turns 
below the tops of TMs 2 and 5, one directly adjacent to the second NPA motif (at 
the C-terminal side) and one from the loop connecting the top of TM5 to the 
second NPA motif. The exact residues that form the ar/R arginine motif are 
thought to form the structural basis for differences in permeability between 
strictly wAQPs and the neutral solute permeable GLPs. In the wAQPs, the ar/R 
region is comprised of a histidine residue at the top of TM5, a phenylalanine 
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residue in TM2, a small residue (e.g., cysteine in AQP1 or alanine in AQP4) 
before the NPA motif and an arginine residue after the NPA motif. The arginine 
is highly conserved across the whole AQP family although not absolutely; it is 
replaced by a leucine in AQPs 11 and 12. Substitution of the arginine with valine 
in AQP1 caused H+ permeability [58]. Although functional studies have yet to 
show H+ permeability of AQPs 11 and 12, it is possible that the loss of this 
arginine residue may represent roles in H+ homeostasis for these proteins. 
The presence or absence of a histidine residue is the major difference at the ar/R 
region between wAQPs and GLPs. The histidine is conserved in the wAQPs and 
replaced by a smaller residue in the GLPs (glycine in AQPs 3,7 and 10, alanine 
in AQP9 and isoleucine in AQP8). Mutagenesis of AQP1 showed that 
replacement of the histidine with alanine, leucine or isoleucine (but not 
phenylalanine, glutamine, asparagine or methionine) converted AQP1 into an 
ammonia channel [270]. In the crystal structure of the bacterial GLP GlpF (the 
only GLP for which structural data has been reported), the glycine residue at the 
equivalent position to the histidine has a structural consequence, allowing a 
phenylalanine residue from the loop connecting the top of TM5 to the second 
NPA motif to pack in front of it. Based on sequence alignment (see Figure 4-1), 
in the mammalian GLPs, this member of the filter region is a tyrosine (AQPs 3 & 
7), cysteine (AQP9) or isoleucine residue (AQP10). 
 
The TM2 phenylalanine residue is also conserved in the wAQPs and is present in 
some of the GLPs (3, 7 and 9). Where this is not a phenylalanine residue it is 
usually replaced by another aromatic residue, such as a histidine residue in 
AQP8, a tyrosine residue in AQP11 or a tryptophan residue in GlpF.   
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Figure 4-1 Structure of the AQP ar/R region in a GLP and a water selective 
AQP, exemplified by (A) AQP3 (homology model to GlpF) and (B) AQP4 
(crystal structure [222]). Numbers in brackets refer to the positions defined in the 
sequence alignment below. (C) Sequence alignment of human AQPs in the four 
regions contributing to the ar/R channel constriction. GLPs are highlighted in 
green. The conserved residues are highlighted in blue; deviations from this are 
highlighted in red. 
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AQP0   AMAFGLA   ALGHLFG   YTGAGMN   NPARSFA!
GlpF   SVIWGLG   AVIGASM   LTGFAMN   NPARDFG!
AQPZ   ALAFGLT   TLIHLIS   VTNTSVN   NPARSTA!
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Simultaneous replacement of the phenylalanine and histidine residues with 
alanine converted rat AQP1 into a urea and glycerol channel, with a higher 
permeability for urea than glycerol [58]. AQP10 is the only mammalian AQP to 
not have a bulky residue in this position; it is replaced by a glycine. 
 
In silico experiments and an in vitro study of murine AQP, which created urea 
and glycerol permeable mutants [62][58] suggest that the ar/R region controls 
AQP solute selectivity and wAQP solute exclusion. However, a comparative 
study of GlpF and AQPZ failed to introduce glycerol permeability to AQPZ with 
GlpF-mimicking mutations to the selectivity filter [63]. Measurements of the 
electrostatic potential along the pore of two GLP and eight wAQP crystal 
structures suggested that a relatively flat potential profile is correlated with 
glycerol permeability [271], and solute hydrophobicity was also shown to be 
important for selectivity in silico [272].   
 
Here we report a set of mutants of the ar/R region of the water-selective human 
AQP4 and compare and contrast their solute permeabilities to those of the 
analogous AQP1 mutants previously reported. We report several mutants of 
AQP3 that alter the relative specificity for glycerol compared to urea, and block 
solute permeation respectively. We also make (to our knowledge) the first direct 
and quantitative comparison of the relative glycerol and urea permeabilities of 
members of the mammalian GLP family in live mammalian cells. Our data 
suggest that AQPs 1 and 4 have different solute exclusion mechanisms and that a 
general model of solute exclusion and selectivity may not be directly applicable 
to the AQP family as a whole. 
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4.3 Results 
4.3.1 AQP4 has a novel molecular mechanism for excluding 
glycerol and urea. 
AQP4 selectivity filter region substitution mutants F77A, H201A, H201G, 
H201E, H201F, R216A, F77A/H201A, F77A/H201G, F77A/R216A and 
H201A/R216A were generated using site-directed mutagenesis as described in 
2.1.2. These mutants were transiently transfected into HEK293 cells (chosen for 
their high transfection efficiency and low intrinsic glycerol/urea permeability) as 
described in 2.3.1 and cell swelling with iso-osmotic glycerol or urea solutions 
was measured using plate-reader based calcein fluorescence quenching as 
described in 0. Surface expression was measured using cell surface biotinylation 
as described in 0. Figure 4-2 shows that mutagenesis of the histidine at position 
201 in AQP4 to different amino acid residues can selectively create channels 
permeable to either urea or glycerol but not both. Substitution to alanine 
(H201A) conferred glycerol permeability, whereas glycine substitution (H201G) 
created a urea channel, both with permeability around tenfold lower than that of 
AQP3 for glycerol. The R216A substitution conferred both urea and glycerol 
permeability to AQP4. In AQP1, alanine substitution of the equivalent histidine 
and arginine residues (H180A, R195A) did not confer either glycerol or urea 
permeability to human AQP1, in agreement with a previous study on rat AQP1 
[58]. The H180G mutant of AQP1 was not urea permeable. The H201F mutant 
had reduced overall expression and minimal surface expression, possibly due to 
an interruption of protein folding by the introduction of steric clashes in the pore. 
Representative raw data is shown in Figure 4-3.   
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Figure 4-2 (A) Cell swelling rate constants of HEK293 cells transfected with 
AQP4 mutants, calculated from calcein fluorescence timeseries data. (B) Cell 
surface expression of AQP4 mutants in HEK293 cells measured by cell surface 
biotinylation and neutravidin ELISA. (C) Cell swelling rate constants normalized 
to surface expression and then normalized to AQP3 glycerol permeability. This 
gives a relative single channel permeability in units in which AQP3 glycerol 
permeability is 1. (D) Normalized permeabilities for the analogous mutants of 
AQP1 for comparison. 
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Figure 4-3 Representative calcein fluorescence timeseries for urea (red) and 
glycerol (blue) permeability of the AQP4 mutants described in Figure 4-2.  
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4.3.3 Water permeability of AQP4 mutants 
AQP4 and all selectivity filter mutants were stably transfected into MDCK cells 
(chosen for their low intrinsic water permeability and their previous use in the 
lierature for quantifying transfected AQP water permeability) as described in 
2.3.2 to measure water permeability using a plate-reader based calcein 
fluorescence quenching method as described in 2.8.1. Cell swelling rates were 
background-subtracted (using an untransfected MDCK control) and normalised 
to surface expression (measured using a cell surface biotinylation-based ELISA) 
to give relative single channel water permeability. None of the substitution 
mutants except H201E and R216A had significantly different water channel 
activity to wild-type AQP4. Figure 4-4 shows that the water permeability of 
H201E was reduced to 63±8% of wild-type (n=4, p=0.002) and the water 
permeability of R216A was increased to 147±3% of wild-type (n=4, p=0.005). 
Representative raw data is shown in Figure 4-5.   
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Figure 4-4 (A) Representative calcein fluorescence quenching curves of control 
MDCK cells and our stable MDCK-AQP4 cell line upon addition of 300 mM 
mannitol. (B) Cell shrinkage rates of MDCK cells stably transfected with AQP4 
mutants. Relative fluorescence data were converted to relative volume, and 
exponential decay functions were fitted. (C) Surface expression of AQP4 
mutants in stable MDCK clones, normalized to wild-type AQP4. (B) Normalized 
single-channel permeability calculated by subtracting the untransfected MDCK 
background and normalizing to surface expression. * represents p<0.01 in 
unpaired t-tests after ANOVA, with the p values subjected to Bonferroni’s 
correction. 
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Figure 4-5 Representative calcein fluorescence timeseries for water permeability 
of the AQP4 mutants described in Figure 4-4. 
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4.3.4 GLP-mimetic mutants of AQP4 are not solute permeable  
The pore layout of the GLPs is different to that of the water-selective AQPs. The 
aromatic histidine is a replaced by a small residue e.g. glycine or alanine. There 
is also a further aromatic residue (usually tyrosine or phenylalanine), the 
sidechain of which packs in front of this glycine residue (based on the GlpF 
crystal structure). Creating this structural landscape in AQP4 (H201G/A210Y, 
H201G/A210F, H201A/A210Y, H201A/A210F) did not create a solute-
permeable channel, despite robust surface expression determined by cell surface 
biotinylation, and despite the solute permeabilities of the H201A/G single 
mutants (Figure 4-6).  
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Figure 4-6 (A) Representative calcein fluorescence quenching curves for 
glycerol permeability of AQP4 GLP-mimetic double mutants. (B) Surface 
expression of AQP4 GLP-mimetic mutants measured by cell surface 
biotinylation.   
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4.3.5 AQP3 urea and glycerol permeability can be altered 
independently of each other 
Based on sequence alignment, the conserved histidine of the selectivity filter is 
replaced by a glycine in AQP3, but there is a tyrosine residue in position 3 (see 
Figure 4-1) that may pack in front of the glycine, and this is what we observed 
when we built a homology model of AQP3 based on a GlpF crystal structure [46] 
using MODELLER [273] (Figure 4-7 A). Substitution of this tyrosine residue in 
AQP3 with alanine (Y212A) conferred measurable urea permeability to AQP3 
(whereas the wild-type was not measurably permeable) whilst concomitantly 
reducing glycerol permeability to 47±6% of the wild-type. This swapping of 
selectivity suggests that the preference of AQP3 for glycerol over urea is not 
governed solely by the dimensions of the pore. Combining the Y212A mutation 
with G203H, to mimic the histidine residue present in wAQPs, produced a 
channel impermeable to both urea and glycerol (Figure 4-7). 
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Figure 4-7 (A) homology model of AQP3 to GlpF. Selectivity filter residues are 
coloured: F63 yellow, G203 green, Y212 orange, R218 blue. NPA motifs are 
coloured red. Y212, F63 and a glycerol molecule are shown in space-filling 
representation in the lower right panel, showing the packing of the glycerol 
backbone into a ‘hydrophobic corner’. (B) Solute permeabilities of wild-type 
AQP3 and the selectivity filter mutants Y212A and Y212A/G203H normalized 
to surface expression and then to AQP3 glycerol permeability. (C) 
Representative calcein fluorescence quenching curves of wild-type AQP3 and 
the Y212A mutant. 
  
0.99 
0.995 
1 
1.005 
1.01 
1.015 
1.02 
1.025 
1.03 
0 5 10 15 20 
N
or
m
al
iz
ed
  F
lu
or
es
ce
nc
e 
Time / seconds 
AQP3 Y212A 
AQP3 WT 
0.995 
1 
1.005 
1.01 
1.015 
1.02 
1.025 
1.03 
1.035 
0 5 10 15 20 
N
or
m
al
iz
ed
  F
lu
or
es
ce
nc
e 
Time / seconds 
AQP3 Y212A 
APQ3 WT 
urea glycerol 
0 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
AQ
P3
 
Y2
12
A 
G2
03
H/
Y2
12
A 
N
or
m
al
iz
ed
 p
er
m
ea
bi
lit
y 
glycerol 
urea 
(A) (B) 
(C) 
 147 
4.3.6 AQPs 3, 9 and 10 have different relative permeability for 
glycerol and urea 
In our experiments, the GLPs AQP3, 9 and 10 had different, biased selectivity 
for urea and glycerol. AQP10 had glycerol permeability of 0.94 ± 0.11 when 
normalised to AQP3 permeability, whereas the permeability of AQP9 to glycerol 
was almost two-fold higher at 1.81 ± 0.12. AQPs 9 and 10 had opposite biases 
towards glycerol and urea permeability, with Pu/Pg ratios of 0.84 ± 0.08 and 1.29 
± 0.09 respectively. These were both significantly different from 1 by one-
sample t-tests followed by Bonferroni correction for multiple comparison (p = 
0.02 and p=0.01 respectively). In our experimental setup, human AQP3 
expressed in HEK293 cells was a glycerol channel but was not measurably urea 
permeable, Figure 4-8.  
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Figure 4-8 (A) Representative calcein fluorescence quenching curves for human 
AQPs 3,9 and 10 for glycerol and urea permeability. (B) Average cell swelling 
rate constants from fits to calcein fluorescence timeseries data. (C) Surface 
expression of GFP-tagged AQPs 3,9 and 10 in HEK293 cells measured by cell 
surface biotinylation followed by ELISA with an anti-GFP antibody. (D) 
Relative single channel solute permeabilities of AQPs 3, 9 and 10 calculated by 
normalizing the cell swelling rate constant to surface expression and then to 
AQP3 glycerol permeability. (E) Ratio of urea permeability to glycerol 
permeability for AQPs 3, 9 and 10.  
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4.3.7 Molecular dynamics and in silico mutagenesis 
4.3.7.1 The role of R216 in AQP4 water permeability 
Hub et al. previously reported that, in MD simulations, fluctuations of the AQP4 
R216 sidechain between an ‘up’ state in which the sidechain packs against the 
pore wall and a ‘down’ state in which the sidechain points out into the pore (see 
Figure 4-9 A and B) could switch the channel between an open and a closed 
state, with an open probability of ∼0.45, measured using the OPLS force field 
[60] (with open defined as a distance of >0.57 nm between the arginine Cζ atom 
and the closest histidine heavy atom). We performed molecular dynamics 
simulations of an AQP4 tetramer embedded in a POPC bilayer using the 
GROMOS 53A6 force field, based on the AQP4 crystal structure [222], to 
attempt to qualitatively validate this result and to address the possibility of 
quantitative differences in the open probability between different protein force 
fields. We found that the arginine sidechain reoriented on the nanosecond 
timescale (Figure 4-9 D), which was characterized using the Cβ-Cγ-Cδ-N dihedral 
angle, following Wang et al [62]. We also found that a two-state model is 
appropriate for describing the simulation data, with the average R216 Cζ–H201 
distances of the open and closed states being 6.5 and 4.3 Å, respectively. Using 
the same definition of open, an open probability of 0.52 ± 0.12 was found (with 
the uncertainty estimated as the standard error over the four monomers). This is 
consistent with the work of Hub et al., suggesting that this probability is 
reasonably robust when measured using different force fields. Assuming this 
simple two-state model, our in vitro results allow us to estimate the open 
probability of the wild-type AQP4 channel, based on the idea that the R216A 
mutation forces the channel to permanently occupy the open state.   
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Figure 4-9 (A and B) Representative simulation snapshots of AQP4 showing the 
closed and open states of the channel with interrupted and continuous files of 
water molecules. R216 and H201 are shown in stick representation. (C) 
Histogram of the R216–H201 distance distribution in simulations, showing two 
clearly distinct states. Fitted Gaussians (red, sum in green) are centred at 0.43 
and 0.65 nm. (D) Fluctuation of the R216 sidechain dihedral angle between two 
states. (E) Channel radii in representative snapshots in which R216 was in the up 
or the down state, calculated using HOLE2 [274].  
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Previous molecular dynamics simulations suggested an approximately 40-fold 
difference in permeability between the open and closed states of AQP4 [60]. 
Using the following equation: 
!!!!"!!!" = ! !(!!!!,!!"#! + !!! 1 − !!,!!"#! )!(!!!!,!" + !!! 1 − !!,!" )  
where PR216A and PWT are the permeabilities measured in experiments, Po and Pc 
are the permeabilities of the open and closed states, respectively, and po is the 
channel open probability. Setting po,R216A equal to 1 and Po equal to 40Pc gives a 
wild-type open probability of 0.67 ± 0.02 (which is slightly higher than the value 
of 0.52 ± 0.12 that we estimated from simulations, but in reasonable agreement). 
4.3.7.2 In silico mutagenesis of selectivity filter mutants 
We generated models of all of our AQP4 and AQP3 mutants by in silico 
mutagenesis of the AQP4 crystal structure and the AQP3 homology model using 
Swiss PDBviewer [275] and compared the channel cross-sectional radii (Figure 
4-10) and areas (Figure 4-11) using the program HOLE. As a way of roughly 
quantifying the channel shape at the selectivity filter, we also fit ellipses to the 
protein surface at the selectivity filter and calculated the ellipticity (which can be 
thought of as a measure of the deviation from circularity: a circle has ellipticity e 
= 0, and e tends to one as the ratio of semi-minor to semi-major axes tends to 
zero). We looked for correlation between these physical parameters of the 
channel and the solute permeability. Aside from the H201A/R216A mutant, 
above a cross-sectional area of ~14 Å2, the area was reasonably well correlated 
with urea permeability for the AQP4 mutants (R2 = 0.83). We made a linear fit to 
the data in this region (excluding H201A/R216A; black line in Figure 4-12, panel 
A). We then used this fit to predict urea permeabilities of AQPs 3, 9, 10 and the  
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Figure 4-10 Channel radius profiles at the selectivity filter of  (A) AQP4 mutants 
and (B) AQP3 mutants, calculated using HOLE. 
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Figure 4-11 Pore-lining residues of AQP4 mutants at the selectivity filter and 
cross-sectional areas (bold) calculated using HOLE. 
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Figure 4-12 Correlation between selectivity filter (SF) cross-sectional area and: 
(A) urea permeability of AQP4 mutants, (B) urea permeability of AQP4 mutants 
and GLPs. The black line in (A) and (B) is a linear fit to all AQP4 mutants with 
non-zero urea permeability. (C) glycerol permeability of AQP4 mutants, (D) 
glycerol permeability of AQP4 mutants and GLPs.  
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Figure 4-13 (A,B,C) Correlation between selectivity filter (SF) geometric 
properties and glycerol permeability of AQP4 mutants. (D) Correlation between 
ellipticity and glycerol permeability of AQP4 mutants and GLPs. 
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AQP3 mutants (Figure 4-12 panel B). In contrast, glycerol permeability could 
not be explained by any of the geometric properties (Figure 4-13). 
4.3.7.3 Molecular dynamics of AQP4 H201A and H201G mutants 
In the in vitro experiments comparing urea/glycerol permeability of AQP4 
mutants, we obtained the curious result that the mutation H201A created a 
glycerol channel, whilst the mutation H201G created a urea channel. We 
hypothesized that the ‘hydrophobic corner’ formed by F77 and H201A (see 
Figure 4-11), analogous to the one proposed in GlpF, may be disrupted by the 
H201G mutation and that the loss of the alanine sidechain may make the V187 
sidechain carbonyl group solvent accessible and therefore be available for 
hydrogen bonding with water or solute molecules in the pore. We used 50 ns MD 
trajectories of the H201A, H201G and wild-type AQP4 tetramers to test this 
hypothesis. In wild-type AQP4 and the H201A mutant, no hydrogen bonds were 
observed between the V187 backbone and water molecules in the pore, using the 
Hbonds plugin for VMD with a 3 Å and 20° hydrogen bond cut-off. In contrast, 
in the H201G mutant, we found hydrogen bonds between V187 and water 
molecules in all four monomers, with occupancy of 24.7 ± 5.4 % (using the same 
3 Å and 20° cut-off), with the error estimated as the standard deviation over the 
four monomers (Figure 4-14 B). For comparison, we measured the hydrogen 
bond occupancy of water molecules with the two asparagine residues forming the 
NPA motifs. These were 55.7±7.0 % for N97 and 58.2±10.2 % for N213. A 
representative simulation snapshot in which this bo//nd is occupied is shown in 
Figure 4-14 A. 
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Figure 4-14 (A) Representative simulation snapshot of the AQP4 H201G 
mutant, showing the exposure of the V187 backbone to pore water molecules. 
Black lines represent hydrogen bonds. (B) Occupancy of the V187-water 
hydrogen bond, in comparison to the occupancy of the asparagine residues at the 
NPA motifs.  
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4.4 Discussion 
Our data show that in human AQP4, both the histidine and arginine residues of 
the ar/R region are crucial for neutral solute exclusion. The AQP4 substitution 
mutant H201A formed a glycerol permeable channel, AQP4 H201G was a urea 
permeable channel and AQP4 R216A was permeable to both glycerol and urea. 
This contrasts with AQP1, in which it has previously been reported that neither 
the H180A nor R195V substitution mutants of rat AQP1 were glycerol or urea 
permeable [58]. In addition, our data show that in human AQP1 R195A was also 
not permeable to glycerol or urea. The AQP4 double mutant F77A/H201A was 
permeable to both urea and glycerol, with a preference for urea and a Pu/Pg ratio 
of 4.6 ± 1.1. This is qualitatively similar to the equivalent human AQP1 mutant 
(F56A/H180A), which in our hands had a Pu/Pg ratio of 3.6 ± 1.4; this is 
somewhat higher than the 1.7 ± 0.6 previously reported for rat AQP1 [58], 
although these values are just compatible with one another within the 
experimental uncertainties. For the F77A/H201G double mutant, although the 
absolute glycerol and urea permeabilities were threefold higher than 
F77A/H201A, the Pu/Pg ratio stayed similar at 3.7 ± 0.4; similarly the Pu/Pg ratio 
for F77A/R216A was 3.3 ± 0.6. 
The H201A/R216A double mutant did not have measurable permeability for 
either glycerol or urea despite being highly expressed at the plasma membrane 
(125±5% of wild-type) and despite the glycerol permeability conferred by the 
individual H201A and R216A mutations. It is not clear whether this is due to the 
physicochemical properties of the H201A/R216A pore layout, or whether the 
mutation has a larger knock-on structural effect. Water permeability data for this 
mutant would help with interpretation of this result. 
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In the case of both AQP4 and AQP1, alanine substitution of the ar/R 
phenylalanine (F77A and F56A respectively) alone had no effect on either 
glycerol or urea permeation. Taken together, our data on the solute permeability 
of AQP4 mutants and the published literature on the permeability of AQP1 
mutants, suggest that there are differences in the molecular details of how 
different wAQPs exclude neutral solutes and that care must be taken to compare 
several family members when developing a generalized model of how wAQPs 
exclude molecules other than water. 
Of particular interest is the surprising result that mutating AQP4 H201 to alanine 
or glycine formed neutral solute channels with opposite glycerol and urea 
permeability behaviour: H201A was glycerol permeable but urea impermeable, 
H201G was urea permeable but glycerol impermeable. In the crystal structure of 
the bacterial glycerol facilitator GlpF, a co-crystallised glycerol molecule had its 
carbon backbone packed into a corner created by two hydrophobic residues 
(W48 and F200). It has been suggested that this hydrophobic corner facilitates 
preference of GlpF for glycerol over urea because glycerol has a hydrophobic 
face that can pack into the corner, whereas urea does not [46]. The H201A 
mutant, in combination with F77, could mimic this hydrophobic effect, whereas 
the glycine mutant, being less hydrophobic, does not. In addition, MD 
simulations suggested that this hydrophobic corner is further disrupted by the 
exposure of the V187 sidechain carbonyl group to the pore. This extra hydrogen-
bonding site may provide an extra free energy penalty disfavouring the packing 
of the glycerol backbone (which cannot satisfy the bond) into this region of the 
selectivity filter. 
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Alternatively it is possible that knock-on structural effects of the mutations, 
leading to two proteins with considerably different channel size and/or shape to 
the in silico mutants, cause the difference. To settle this conclusively would 
require structural analysis of the mutant proteins in vitro (e.g. x-ray 
crystallography). In either case, the difference in solute preference of the two 
mutants (for glycerol and urea) cannot be explained by pore size alone. 
Water permeability experiments showed a 47±3% increase in permeability for 
the AQP4 R216A mutant. Crystallographic analysis [276] and simulations [61] 
of AQPZ  have suggested that the selectivity filter arginine residue may undergo 
fluctuations between ‘up’ and ‘down’ conformations, with the down 
conformation associated with a closed state of the channel and reduced channel 
permeability. Similar results were reported for fluctuations of the selectivity filter 
histidine residue in human AQP5 [277]. We found that R216 of AQP4 
underwent the same fluctuations in molecular dynamics simulations. In situations 
such as these, the permeability measured in experiments would be an average of 
the permeabilities of the two states, weighted by their relative probabilities. In 
silico mutation of the AQPZ arginine to serine (R189S) increased the average 
water permeability by 26% [61], which agrees qualitatively with our in vitro 
result for AQP4 R216A. This suggests that R216 conformational fluctuations 
may switch AQP4 between high and low permeability states and that the alanine 
substitution forces the channel to permanently occupy the high permeability 
state. Water permeability of the H201E mutant was reduced to 63±8% of wild-
type AQP4. Replacement of the histidine residue with a negatively charged 
glutamate residue may favour the closed state of the channel by interaction with 
the positively charged R216 sidechain. Taken together, these results suggest that 
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the dynamics of R216 are important for AQP4 water permeability. Control of the 
open/closed probabilities by e.g. protein post-translational modification or 
protein-protein interactions may represent an unexplored mechanism by which 
AQP4 water permeability could be regulated by physiological stimuli. 
 
In our homology model of AQP3, a tyrosine residue, Y212, occupied a similar 
position to a phenylalanine (F200) in GlpF, producing a similar hydrophobic 
corner to that in the GlpF crystal structure. As this corner was previously 
suggested to facilitate glycerol selectivity in GlpF [46], we mutated the AQP3 
tyrosine residue to alanine. This mutation reduced the glycerol permeability of 
AQP3 to 51 ± 5 % of the wild-type permeability. In contrast, the urea 
permeability of the channel was increased from zero (or at least undetectably 
low) to 47 ± 7 % of the wild-type glycerol permeability, giving a Pu/Pg ratio of 
0.93 ± 0.16. The GlpF F200 equivalent in AQP9 is a cysteine residue (C213). 
This is similar in size to alanine and AQP9 had a similar Pu/Pg ratio of 0.84 ± 
0.08, although the individual urea and glycerol permeabilities of AQP9 were 
about threefold higher.  
 
Further mutations to AQP4 were made to mimic the pore layouts of GLPs. We 
replaced the histidine (H201) with both glycine and alanine in combination with 
replacement of the alanine (A210, analogous to AQP3 Y212) to either tyrosine or 
phenylalanine to give the following set of double mutations: H201G/A210F, 
H201G/A210Y, H201A/A210F and H201A/A210Y. None of these mutants were 
glycerol or urea permeable despite having surface expression that was 
comparable to wild-type AQP4 and despite the solute permeabilities of the single 
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H201A/G mutants. This suggests that the exact residues of the ar/R region are 
not the only molecular determinant of solute permeability, but that the structural 
context is also important. This is in agreement with a study in which mutation of 
the AQPZ selectivity filter residues to those of GlpF, alone and in combination, 
failed to introduce glycerol permeability to AQPZ. Crystallographic analyses of 
the AQPZ mutants and GlpF that suggested that the positioning of selectivity 
filter residues by the extracellular loop C and the unstructured loop connecting 
the top of TM5 to the second NPA half-helix may contribute to AQP solute 
permeability/exclusion [63]. 
 
We compared the glycerol and urea permeabilities of human AQPs 3, 9 and 10. 
To our knowledge, this is the first time this kind of comparison has been made in 
the same experimental system whilst controlling for relative surface expression. 
There are conflicting reports in the literature on whether AQP3 functions as a 
urea channel [126, 278] and it is not clear under what circumstances, if any, urea 
may permeate AQP3 (a detailed discussion of this is presented in Kitchen et al, 
Biochimica et biophysica acta, 2015, appendix 1). In our hands, human AQP3 
was glycerol permeable, but was not measurably urea permeable when 
transiently expressed in HEK293 cells, either with or without a C-terminal GFP 
tag. AQP10 had similar glycerol permeability to AQP3, whereas the permeability 
of AQP9 to glycerol was almost two-fold higher. AQPs 9 and 10 had opposite 
biases towards glycerol and urea permeability with both having a Pu/Pg ratio 
significantly different to 1. It may be that these differences in the Pu/Pg ratio 
represent a physiological mechanism by which the different solute permeabilities 
of a membrane can be fine-tuned by altering the relative expression of different 
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GLPs. Regardless of the physiological implications, this data suggests that 
channel cross-sectional size is not the only molecular feature governing solute 
permeation and that there is a still-to-be-discovered molecular mechanism 
governing polar solute selectivity (rather than simply lack of exclusion). For our 
AQP4 mutants, we found that, above ~14 Å2, channel cross-sectional area was 
reasonably correlated with urea permeability (R2 = 0.83). We made a linear fit of 
this data and found that this model predicted AQP3, AQP3 Y212A, AQP3 
G203H/Y212A and AQP10 urea permeability. In contrast, the geometric 
properties of the selectivity filter that we measured did not appear to correlate 
with glycerol permeability. 
 
As a whole, our data show that the details of solute permeability of mammalian 
GLPs and solute exclusion by wAQPs depend on a complex interplay between 
the exact residues that form the ar/R region and the structural context in which 
they are situated. We also show that the residues of the ar/R region can have a 
direct effect on channel water permeability (for AQP4 at least), probably by 
dynamic transitions between high and low permeability states of the channel, 
providing the first in vitro evidence for an effect observed in molecular dynamics 
simulations. Finally, our data imply that care must be taken when attempting to 
generalize results of mutagenic experiments on just one or two representative 
members of the AQP family; in order to develop a detailed understanding of 
AQP solute and water permeation, data on as many members of the family as 
possible should be compared and contrasted.  
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5 Results – Molecular determinants and functional 
consequences of AQP4 tetramerization 
5.1 Aims 
1. To use the published crystal structure of AQP4 as a guide for directed 
mutagenesis aimed at disrupting the tetrameric quaternary structure of 
AQP4. 
2. To use non-tetrameric mutants of AQP4 to investigate which aspects of 
AQP4 function require tetramerization. 
3. To investigate whether the region identified as important for AQP4 
tetramerization in aim 1 is important for other members of the AQP 
family.   
5.2 Background 
There is a wide variety in permeability properties, subcellular localization and 
trafficking responses between different members of the AQP family. Despite 
this, a wealth of medium to high resolution structural data for various members 
of the family (48 structures of 13 different AQPs deposited in the protein 
databank) all suggest that the AQP homotetrameric quaternary structure is highly 
conserved. Early biochemical work, using carboxyl-amine fusion dimers 
(consisting of one wild-type unit and one unit lacking the cysteine residue 
required for mercurial inhibition), showed that monomers are the functional AQP 
units [49]; numerous molecular dynamics simulation studies support this [50]. 
Recent work has suggested that isolated AQP monomers are equally capable of 
facilitating water transport as those incorporated into a tetramer [44]. Therefore it 
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is not clear why AQPs retain this tetrameric structure. Regulation of AQP 
function by the formation of heterotetramers with other AQPs has been 
suggested for some plant AQPs [51]. The fifth, central pore formed at the 
fourfold axis of the tetramer has also been suggested to transport carbon dioxide 
[52] and cations [53], at least in mammalian AQP1. Trigger-induced 
relocalization of AQP-containing vesicles to the plasma membrane is a well-
established regulatory mechanism for AQPs; the best-studied example of this is 
relocalization of AQP2 to the apical membrane of the collecting duct in the 
mammalian kidney in response to AVP, but there is also evidence for similar 
mechanisms for various other AQPs including AQP5 [279], AQP7 [97] and 
AQP1 [169]. Given the ubiquity of these regulatory responses across the AQP 
family and the conservation of the tetrameric quaternary structure, it may be that 
these trigger-induced relocalization responses involve interaction with proteins 
that only recognize the tetrameric form of AQPs. A naturally occurring AQP2 
mutant (R187C) has been reported which is unable to relocalize in response to 
AVP and is also unable to form tetramers [280], although it is not clear whether 
there is a direct link between these two observations. 
 
In this chapter, evidence is presented that suggests that intracellular loop D of 
AQP4 forms homomeric interactions between AQP subunits that stabilize the 
tetrameric quaternary structure. We also show that loss of tetramerization does 
not affect single channel water permeability. Our data suggest that 
tetramerization is not required for AQP4 to be trafficked through the ER and 
Golgi to the plasma membrane, but that unlike wild-type AQP4, the non-
tetrameric mutants are unable to relocalize to the plasma membrane in response 
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to changes in local osmolality as described in chapter 3. Finally, based on loss 
and gain of oligomerization mutants of AQP1 and AQP3, we suggest that loop 
D-mediated inter-monomer interactions may be a conserved mechanism by 
which AQPs control their quaternary structure. 
5.3 Results 
5.3.1 Compound mutations of loop D of AQP4 reduce tetrameric 
assembly 
Using the crystal structure of AQP4 [222], residues likely to form the tetrameric 
interface were identified, based on the physical distance between residues on 
adjacent monomers. Any residue within 3 angstroms of an adjacent AQP4 
molecule in the tetrameric structure was taken as a potential site of interaction, 
shown in orange and green in Figure 5-1 A and B. Alanine substitution 
mutagenesis was used to investigate the contribution of these residues to 
oligomeric assembly. The identified residues were clustered into two regions: 
The first cluster comprises a patch of hydrophobic residues at the interfaces of 
TM1 and TM2 of one monomer with TM4 and TM5 of the adjacent monomer 
(Figure 5-1 A); the second cluster comprises twelve predominantly polar and 
charged residues forming the intracellular loop D and the bottom of TM2 (Figure 
5-1 B). 24 single point alanine-substitution mutants were made and six 
compound mutants were used to investigate the possibility of synergistic effects 
of several residues (Table 5-1). There are two protein kinase A/C consensus sites 
in loop D (S180 and S188) so we also made phosphomimetic mutations (S180D 
and S188D) of these residues. All mutants are listed in the left-hand column of 
Table 5-1. BN-PAGE followed by Western blotting (described in sections   
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Figure 5-1 Residues at the AQP4 tetrameric interface. (A) We identified 
hydrophobic residues (orange) in TMs 1, 2, 4 and 5 that formed inter-monomer 
contacts in the crystal structure and (B) polar residues (green) at the bottom of 
TM2 and in the intracellular loop D. (C) Ball diagram showing the position of 
the identified residues in the primary sequences and secondary structural motifs 
of AQP4. Two regions of loop D were selected for compound mutation, which 
we denote loop D1 (179-DSKRT-183) and loop D2 (184-DVTGS-188).  Blue 
lines represent approximate position of membrane lipid headgroups. All residues 
are listed in Table 5-1. 
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D2 
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Mutant Oligomerization 
state 
Surface 
expression (% 
of WT) 
I43A T 113.9±5.1 
I47A T 95.8±3.2 
L50A T 102.5±4.1 
L51A T 96.1±13.0 
I57A T 104.1±4.1 
TM1 
(I43A/I47A/L50A/L51A/I57A) 
T 86.9±3.1 
L72A T 121.1±25.6 
L79A T 88.9±13.3 
TM2 
(L72A/L79A) 
T 97.7±5.6 
L161A T 91.9±18.4 
I165A T 87.9±3.6 
TM4 
(L161A/I165A) 
T 85.4±11.2 
I189A T 97.7±5.9 
I199A T 96.2±8.5 
F203A T 112.4±13.3 
TM5 
(I189A/I199A/F203A) 
T 93.3±9.0 
Q86A T 118±4.4 
H90A T 113.5±4.1 
D179A T (95±2%) 
D (5±2%) 
87.6±19.4 
S180A T 109.8±4.5 
S180D T 99.7±4.9 
K181A T 103.2±4.5 
R182A T 96.1±22.1 
T183 T 105.6±3.6 
Loop D1 
(D179A/S180A/K181A/R182A/T183A) 
T (19±4%) 
D (27±5%) 
M (53±4%) 
 
88.5±6.1 
D184A T 97.7±8.8 
V185A T 102.2±5.4 
T186A T 95.1±7.5 
G187A T 106.7±5.1 
S188A T 98.6±3.2 
S188D T 104.1±4.2 
Loop D2 
(D184A/V185A/T186A/G187A/S188A) 
T (33±7%) 
D (67±7%) 
83.1±11.0 
Table 5-1 Oligomerization state and surface expression of AQP4 mutants. A 
solidus, e.g. L72A/L79A, represents compound mutations. T = tetramer, D = 
dimer, M = monomer. All data are reported as mean±S.E., n=3. 
 
 169 
2.10and 2.11) was used to assess the oligomeric state of all mutants expressed in 
HEK293 cells. Representative BN blots are shown in Figure 5-2 and the effect of 
all mutations on oligomeric assembly and surface expression is summarised in 
Table 5-1 and Figure 5-2.  
None of the hydrophobic residues in the hydrophobic patches had any effect on 
tetramer formation, either in isolation or as compound mutants. TM compound 
mutants consisted of simultaneous mutations of all residues identified within that 
transmembrane segment (e.g. TM1 denotes the simultaneous mutations I43A/ 
I47A/ L50A/ L51A/ I57A). 
Of the loop D single alanine mutants, only D179A had an effect on oligomeric 
assembly in isolation, and this effect was only slight, with 95±2% of the protein 
still assembled into tetramers. Unlike the hydrophobic cluster, the compound 
mutants of loop D had a clear effect on the ability of AQP4 to tetramerize. The 
two compound mutants loop D1 (D179A/ S180A/ K181A/ R182A/ T183A) and 
loop D2 (D184A/ V185A/ T186A/ G187A/ S188A) caused reductions in 
oligomeric assembly with only 19±4% of the loop D1 protein assembled into 
tetramers with both dimers (27%±5) and monomers (53±4%) present, whereas 
the loop D2 protein predominantly formed dimers (67±7%) with 33±7% 
assembled into tetramers. 
5.3.2 Surface expression of non-tetrameric mutants 
There was no significant difference in the surface expression of the loop D 
mutants compared with wild-type AQP4. Surface expression was assessed 
qualitatively by live cell confocal microscopy using GFP-tagged AQP4 mutant 
constructs and quantitatively by cell surface biotinylation. Figure 5-3 shows   
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Figure 5-2 BN-PAGE and Western blotting of AQP4 mutants. (A) 
Representative Western blots following BN-PAGE of Triton X-100 solubilized 
AQP4 mutants, showing the effect of the loop D1 and loop D2 compound 
mutations, and a lack of effect of mutations to the transmembrane hydrophobic 
patch. 66 and 132 denote the positions of BSA molecular weight marker bands. 
The AQP4-GFP construct, has a predicted molecular weight of 63.1 kDa. (B) 
Percentage of protein assembled into tetramers calculated using densitometry 
following BN-PAGE and Western blotting. Effective mutations are highlighted 
with white bars. Data is presented as mean ± S.E., n=3. 
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Figure 5-3 Plasma membrane localization of non-tetrameric mutants. (A) 
Representative fluorescence micrographs of HEK293 cells transfected with 
AQP4-GFP and loop D mutants. (B) Surface expression of AQP4 mutants in 
HEK 293 cells measured by cell surface biotinylation followed by neutravidin-
based ELISA. Loop D compound mutants are highlighted in red. The S52D 
mutant identified in chapter 3 was used as a negative control for surface 
expression. n.s., not significant. (C) Representative blots of AQP4 mutants 
subjected to BN-PAGE. WC = whole cell lysate; S = surface protein only, 
isolated by cell surface biotinylation. (D) Representative FRAP curves from 
photobleaching AQP4-GFP fusion proteins in HEK 293 cells. (E) Average half-
times of fluorescence recovery averaged over fits to 5 curves per experiment and 
6 experimental repeats. All data is presented as mean ± S.E.  
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representative confocal micrographs of HEK293 cells transfected with GFP 
fusion proteins of AQP4 wild-type, and the loop D1 and loop D2 mutants. 
Surface expression in transiently transfected HEK293 cells measured by cell 
surface biotinylation was not significantly different (p=0.53, one-way ANOVA) 
for either of the loop D compound mutants or the single alanine mutants. This 
suggests that the post-Golgi trafficking machinery is able to interact with non-
tetrameric AQPs. The cell surface biotinylation data is summarized for all 
mutants in the third column of Table 5-1. 
5.3.3 Mutants in the plasma membrane have reduced oligomeric 
state  
It was important to confirm the reduced oligomeric state of AQP4 molecules that 
had been trafficked to the cell surface, rule out intracellular retention of 
dimeric/monomeric species, and to rule out changes in detergent sensitivity 
caused by loop D substitutions. Several complementary biophysical techniques 
were used to do this. 
5.3.3.1 Fluorescence recovery after photobleaching (FRAP) 
Recovery curves were collected from five different AQP-transfected HEK293 
cells per experimental repeat (n = 6), as described in section 2.4.2. 
Representative fluorescence recovery curves are shown in Figure 5-3, along with 
the average recovery half-times. From these, diffusion coefficients were 
calculated: 5.2±0.3×10-3, µm2s-1 (AQP4 WT), 5.9±0.3×10-3 µm2s-1 (Loop D1) 
and 5.8±0.2×10-3 µm2s-1 (Loop D2). Both Loop D mutant diffusion coefficients 
were significantly different from the wild-type (Loop D1 p=0.01 and loop D2 
p=0.02 by Student’s t-test following ANOVA, with p values subjected to 
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Bonferroni correction). The FRAP data suggests a reduced oligomeric state for 
the surface-localized loop D mutants, although the increased diffusion coefficient 
could also be explained by the inability of these mutants to form a complex with 
a third party protein.  
5.3.3.2 BN-PAGE of biotinylated cell surface protein 
To complement the FRAP experiments, biotinylated cell surface proteins were 
isolated using neutravidin-coated plates, eluted by reducing the S-S bond 
incorporated into the biotinylation reagent using 1% β-mercaptoethanol in BN 
lysis buffer and subjected to BN-PAGE (representative blots are shown in Figure 
5-3). Surface-localized mutant AQP4 molecules subjected to BN-PAGE had the 
same loss of tetramerization seen in whole cell lysates.  
5.3.3.3 Forster resonant energy transfer (FRET) 
Finally, to complement the above analyses, AQP4 constructs tagged with Venus 
(a YFP derivative) and mTurquoise2 (a CFP derivative) were generated and co-
transfected into HEK293 cells to form a FRET biosensor for homo-
oligomerization in living cells as described in section 2.4.3. The wild-type AQP4 
constructs gave a robust FRET signal with an average apparent efficiency of 
44.2±3.6% (Figure 5-4). We were unable to measure any FRET in cells co-
transfected with AQP1-Venus and AQP4-Turquoise, suggesting that the FRET 
interactions occur primarily within the AQP4 tetramers and not between 
tetramers that are transiently close together in the plane of the membrane. The 
probability for a particular donor molecule to take part in FRET is dependent on 
the number of acceptors within the Forster radius and vice versa.  
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Figure 5-4 . A FRET biosensor for AQP4 oligomerization. Fluorescence 
confocal microscopy of live HEK293 cells transiently transfected with AQP4-
Venus alone, AQP4-mTurquoise2 alone and the two co-transfected. Excitation at 
405 nm is for Turquoise and 514 is for Venus. 
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For CFP-YFP, the Forster radius is ~5 nm [281]. Based on the AQP4 crystal 
structure, the monomer-monomer centre of mass separations are 2.8 nm 
(adjacent monomers) and 3.9 nm (diagonal monomers), so both would be 
expected to contribute to the FRET signal (assuming that the average separation 
of the C-terminal tails is similar). The average number of FRET pairings in a 
sample of co-transfected cells is therefore dependent on the level of AQP4 
oligomerization. Both loop D1 and D2 compound mutants had a slightly larger 
than twofold reduction in FRET efficiency (to 17±6% and 20±4% respectively) 
compared to the wild-type (Figure 5-5), suggesting that these constructs have a 
reduced propensity to oligomerize in live cells, further confirming that the 
changes seen in the BN-PAGE were not mediated by changes in detergent 
sensitivity. Furthermore, for the mutants, there was no difference in FRET 
efficiency between plasma membrane and intracellular membranes (Figure 5-5), 
suggesting that the oligomerization state of these mutants is the same in 
intracellular membranes as in the plasma membrane. Taken together, these data 
suggest a reduced oligomeric state for the AQP4 loop D mutants in the plasma 
membrane of living cells.  
5.3.4 Loop D mutants have wild-type water permeability 
Both loop D compound mutants and wild-type AQP4 were stably transfected into 
MDCK cells (described in section 2.3.2) to measure water channel function. 
Membrane water permeability of MDCK cells, measured by calcein fluorescence 
quenching, as described in sections 2.8 and 2.8.1, (Figure 5-6), was increased 
sevenfold by stable expression of AQP4. Water permeability due to the 
transfected AQP was calculated by subtracting the permeability of untransfected 
cells and the resulting permeability was normalized to the surface expression   
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Figure 5-5 Reduced FRET from AQP4 mutants (A) Average apparent FRET 
efficiencies for AQP4 wild-type and the loop D1 and D2 mutants, calculated by 
normalizing the corrected FRET intensity to YFP intensity for each pixel. Five 
different areas on each plate were imaged per experimental repeat, n=4. (B) 
Representative line scan across a cell, passing through membrane and cytoplasm 
and avoiding the nucleus. Whereas the YFP signal (red) shows clear peaks at the 
plasma membrane, the FRET efficiency (blue) does not. (C) Representative 
processed FRET efficiency images compared to unprocessed FRET and YFP. 
Whereas both YFP and the raw FRET show clear membrane signals, the FRET 
efficiency does not. 
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measured by cell surface biotinylation to allow for differences in cellular 
expression due to differences in the position of chromosomal integration of the 
stably transfected gene. After normalization to surface expression, no significant 
difference in permeability was observed between the loop D mutants and wild-
type AQP4, suggesting that tetramerization of AQP4 was not required for full 
water channel activity. 
5.3.5 Loop D mutants do not relocalize in response to 
hypotonicity 
We recently reported that AQP4 rapidly relocalizes to the plasma membrane 
from intracellular membranes in response to reduced extracellular tonicity [268] 
and this phenomenon is true for other mammalian AQPs [169]. Despite wild-
type water permeability and constitutive surface expression of the loop D 
mutants, this response to hypotonicity was blocked by both of the loop D 
compound mutations. Relative membrane expression of wild-type AQP4-GFP 
imaged in live HEK 293 cells increased from 27.9±3.5 to 67.1±4.5 (p=0.003) 
upon reduction of the extracellular tonicity to 85 mOsm, whereas the distribution 
of both the loop D1 and loop D2 mutants did not change significantly (p=0.29 
and p=0.34 respectively; Figure 5-7). 
5.3.6 Molecular dynamics simulations suggest a dynamic 
network of loop D interactions 
To investigate the contribution of loop D to AQP4 oligomerization we did five 
independent 100 ns molecular dynamics simulations of a hydrated AQP4 
tetramer embedded in a POPC bilayer. We found a dynamic network of 
hydrogen bonds between loop D residues on adjacent monomers and also   
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Figure 5-6 Water permeability of non-tetrameric mutants. (A) Representative 
calcein fluorescence quenching curves from stably transfected MDCK cells 
subjected to a 300 mOsm mannitol osmotic gradient. (B) Water permeability of 
MDCK cells normalized to AQP4 WT-transfected MDCK cells. (C) Normalized 
surface expression of AQP4 constructs in the stably expressing MDCK clones 
used for water permeability measurements, measured by cell surface 
biotinylation. (D) MDCK membrane water permeability normalized to surface 
expression, to give normalized single channel permeability. All data is presented 
as mean ± SEM, n=4. 
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Figure 5-7 Tonicity-induced translocation of non-tetrameric mutants (A) 
Representative fluorescence micrographs of HEK 293 cells transfected with 
AQP4-GFP fusion proteins, before and after 30 seconds of exposure to hypotonic 
(85 mOsm) medium. (B) Relative membrane expression of AQP4-GFP fusion 
proteins before and after exposure to hypotonic medium. At least four cells per 
image were analyzed for each experimental repeat. n = 3. Data are presented as 
mean ± S.E.M. p values are from paired t-tests, following ANOVA, with 
Bonferroni’s correction. 
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between loop D residues and a glutamine (Q86) and histidine (H90) residue at 
the bottom of TM2. On average, each monomer was involved in 3.8±1.4 (mean ± 
standard deviation) loop D hydrogen bonds with its two neighbouring molecules 
at any given time, which is equivalent to 7.6±2.8 loop D hydrogen bonds per 
tetramer. Every loop D residue apart from S180 was able to act as a hydrogen 
bond donor or acceptor with another loop D residue on one of the two adjacent 
monomers and seven residues (R182, T183, D184, V185, T186, G187 and S188) 
were found to have at least three different possible hydrogen bonding 
interactions. This network of interactions is represented as a heat map in Figure 
5-8A. Interactions involving V185 and G187 were backbone hydrogen bonds. 
Both of these residues were able to act as hydrogen bond donors from the 
backbone amine group (V185 to an adjacent V185, and G187 to D184, V185 and 
T186) and acceptors at the backbone carbonyl group (V185 from an adjacent 
V185 as well as T183, T186, G187 and S188, and G187 from T186, S188 and 
Q86). Loop D (as well as loop A) showed relatively large structural fluctuations 
(Figure 5-8) despite maintaining an average of 3.8±1.4 inter-monomer hydrogen 
bonding interactions. Representative snapshots showing the most highly 
occupied hydrogen bonds, H90-D179, S188-G187, S188-S188, Q86-D184, Q86-
S188 and T183-D184 are shown in Figure 5-9. Loop D could potentially stabilize 
the AQP4 tetramer in one of two ways: by preventing monomers from drifting 
apart during rapid association/dissociation of the inter-monomer TM interfaces, 
or by providing inter-monomer interactions that stabilize the tetramer in a more 
permanent way, preventing dissociation in the first place. In simulations we 
found that the average monomer-monomer centre of mass separation was stable   
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Figure 5-8 A dynamic network of loop D hydrogen bonds in simulations of 
AQP4. (A) Heat map showing percentage occupancy of loop D hydrogen bonds 
averaged over 4 monomers comprising a tetramer and over 5 independent 100 ns 
simulations. (B) Backbone heavy atom root mean-squared deviation (RMSD) of 
AQP4 residues, demonstrating the structural flexibility of loops A and D. 
RMSDs were calculated independently for each trajectory and averaged. (C) 
Zoomed view of loop D RMSD. 
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Figure 5-9 (A) Snapshots of molecular dynamics trajectories in which the six 
most highly occupied inter-monomer hydrogen bonds involving loop D residues 
are occupied. (B) Representative inter-monomer centre of mass distance for a 
single interface (red) and averaged over the four interfaces of a tetramer (blue). 
(E) Representative inter-monomer buried area for a single interface (red) and 
averaged over the four interfaces of a tetramer (blue). 
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with a root mean square fluctuation (RMSF) of only 0.53 Å (c.f. typical carbon-
carbon bond length of ~1.5 Å) about a mean of 28.67 Å, and the inter-monomer 
buried (solvent-inaccessible) area was also stable, with a RMSF of 230 Å2 about 
a mean of 2960 Å2. Representative timeseries data are shown in Figure 5-9. This 
suggests that there is no spontaneous dissociation/reassociation of the inter-
monomer interfaces, at least on the timescale of these simulations (100 ns). 
5.3.7 Loop D may represent a common motif for oligomeric 
assembly across the AQP family 
To investigate whether our AQP4 data could be more widely applicable to other 
members of the AQP family, we performed a sequence alignment of the loop in 
all human AQPs, as well as the E. coli AQPs as comparison (Figure 5-10) using 
the Clustal Omega software [282]. AQP1 contains a similar acidic-x-basic-basic 
motif to AQP4 in the first half of the loop (DRRRR vs. DSKRT), so we made the 
loop D1 mutant in AQP1 (D158A/K159A/K160A/K161A/K162A). This motif is 
lacking in AQP3, therefore we introduced it via 2 different mutations, 
P181S/Y182K/N183R and P181E/Y182K/N183R (to give DSKRN and DEKRN 
vs. the wild-type DPYNN). The loop D1 compound mutation to AQP1 caused a 
similar loss of oligomerization to that observed for AQP4, and both AQP3 
mutations caused the protein to migrate primarily as a band with a molecular 
weight consistent with a dimeric species, whereas wild-type AQP3 appeared to 
migrate primarily as a monomer (Figure 5-10). Both AQP1 and AQP3 migrated 
as diffuse bands, consistent with glycosylation. PNGase F treatment was used to 
attempt deglycosylation. This appeared to be incompatible with the BN-PAGE 
experiments, as 1 hour treatments with PNGase F at 37 °C caused AQP1 and 
AQP3 wild-type and mutants to form aggregates that did not migrate beyond the 
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interface between stacking and separating gels (data not shown). This may be 
due to increased temperature sensitivity of Triton X-100 solubilized AQPs. 
Finally, to investigate whether loss of AQP oligomerization is a general feature 
of the GLP subfamily, we transfected HEK293 cells with AQPs 9 and 10 and 
subjected Triton X-100 extracted protein to BN-PAGE. Unlike AQP3, we found 
that AQPs 9 and 10 migrated exclusively as tetramers (Figure 5-10). 
5.4 Discussion 
Our data show that the plasma membrane abundance of AQP4 in HEK293 cells 
is unaffected by loss of tetrameric assembly. This strongly suggests that 
tetrameric assembly is not required for AQP4 to be correctly trafficked through 
the ER and Golgi to the plasma membrane. It is possible that our mutants are 
trafficked as tetramers and then dissociate once inserted into the plasma 
membrane; the FRET data suggest that this is unlikely to be the case, although 
we cannot differentiate between particular intracellular compartments on the 
basis of this data, leaving open the possibility of differences in oligomerization 
state between different intracellular compartments. Our diffusion coefficients 
calculated from the FRAP data are comparable with other reports of diffusion of 
AQP-GFP constructs in mammalian cells (e.g. 5.7 x10-3 µm2s-1 for AQP2 [283], 
3.1 x10-3 µm2s-1 for AQP1 [284]). We found a small, but statistically significant 
increase in diffusion coefficient for the mutants that were non-tetrameric in BN-
PAGE. Although we have not estimated hydrodynamic radii for our constructs, 
the relationship D  ln(1/R) derived by Saffman and Delbruck [285] suggests a 
hydrodynamic radius of 1.2±1.0 nm for our non-tetrameric constructs (assuming 
R = 4 nm for a freely-diffusing AQP4 tetramer), which is at least consistent with 
a loss of tetrameric assembly. We found no difference in the mobile fraction   
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Figure 5-10 Comparison of loop D between different human AQPs. (A) All 13 
human AQPs as well as AQPZ and GlpF (both from E. coli) were aligned using 
Clustal Omega (EMBL-EBI). Acidic residues are coloured red, basic blue, and 
neutral residues able to form sidechain hydrogen bonds green. (B) BN-PAGE 
and Western blotting of wild-type and mutant AQPs 1 and 3 and wild-type AQPs 
9 and 10. 66 and 132 represent BSA molecular weight markers. 
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between the wild-type, D1 or D2 mutants  (90±6%, 89±4% and 92±7% 
respectively, n.s. p=0.28), suggesting that there is no difference in the proportion 
of the protein involved in membrane-anchoring interactions. Although we cannot 
rule out loss of an AQP4 binding partner as an alternative explanation of these 
data with absolute certainty, in combination with the cell surface BN-PAGE and 
FRET data it is highly suggestive of non-tetrameric mutant AQP4 molecules in 
the plasma membrane. Human AQP3 was reported to exist in all four possible 
oligomeric states (monomer, dimer, trimer and tetramer) in the plasma 
membrane of erythrocytes [55]. It may be that some or all members of the AQP 
family can be trafficked to the plasma membrane independently of their 
oligomerization state. 
 
Our MD simulations suggest a dynamic network of transient hydrogen bonds 
between the residues of loop D of adjacent monomers and also with two residues 
at the bottom of TM2. The fact that almost every residue involved in this 
network has several hydrogen bonding options may explain why none of the 
single alanine substitution mutations had an effect on tetrameric assembly. For 
example, the most highly occupied hydrogen bond that we found was H90-D179, 
which had 66.5% occupancy averaged over the four monomers and five 
trajectories. When this bond was not occupied, the D184 sidechain was able to 
act as a hydrogen bond acceptor from the histidine imidazole NH group, and the 
T186 sidechain hydroxyl group was able to act as a hydrogen bond donor to 
D179. These alternative interactions may be able to partially compensate for the 
loss of the D179-H90 interaction in the D179A and H90A single alanine 
substitutions. D179 had only one alternative interaction, whereas H90 had three. 
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This may explain why the D179A mutation had a slight effect on 
oligomerization, whereas the H90A mutant did not. 
 
S-nitrosylation of AQP11 at a cysteine residue in the extracellular loop E (C227) 
has been suggested to be required for AQP11 oligomeric assembly, with the 
C227S mutant showing reduced oligomeric assembly in mouse kidney [286]. 
This supports the idea of a role for post-translational modification in AQP 
oligomerization. Loop D of AQP4 contains two sites predicted to be targets for 
post-translational modification. These are protein kinase sites at S180 and S188. 
Phosphorylation at S180 was suggested to reduce AQP4 water permeability via a 
gating effect in LLC-PK1 cells [287], but this was not supported by MD 
simulations of AQP4-pS180 [288], and structural studies showed no difference 
between wild-type AQP4 and a phosphomimetic S180D mutant [289, 290]. We 
used phosphomimetic (S180D, S188D) and phospho-blocking (S180A, S188A) 
mutations to investigate a potential role for post-translational modification in 
AQP4 oligomeric assembly. We found that all four phosphorylation mutants 
were able to assemble into tetramers, suggesting that phosphorylation of loop D 
is not involved in tetrameric assembly of AQP4. 
 
We recently reported that AQP4 in primary rat astrocytes and HEK293 cells 
rapidly relocalized to the plasma membrane upon reduction of extracellular 
tonicity [268], and this may involve changes in interactions between AQP4-
containing vesicles and cytoskeletal elements as described by others [291, 292]. 
Interestingly, neither of the mutants with reduced ability to tetramerize were able 
to relocalize in response to a hypotonic extracellular stimulus. It is possible that a 
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binding partner of AQP4 involved in the translocation response recognizes an 
epitope formed by the interface of several AQP molecules within a tetramer, and 
that disrupting tetrameric assembly disrupts this epitope. Although the C-
terminal PKA phosphorylation site (S276) that controls this response is ~100 
residues away in the primary sequence, it may be that phosphorylation of this 
residue causes a conformational change in the large (~70 residue) C-terminal tail 
of AQP4, which allows an AQP4-binding protein to bind to the intracellular face 
of AQP4 including loop D. Structural data for AQPs are routinely collected after 
cleaving the C-terminus at the bottom of TM6 to aid crystallization and high-
resolution structure determination [47]. This is true for AQP4 and in the structure 
that we used to identify mutagenic targets and as input for our simulations, the 
protein was truncated at the bottom of TM6, at residue 254 of 323 [222]. This 
makes it difficult for us to make any concrete predictions about interactions of 
the AQP4 C-terminus, especially given its large size. 
 
Based on a sequence alignment of loop D, we made mutants of human AQPs 1 
and 3. Wild-type AQP1 was tetrameric when extracted from HEK293 
membranes using Triton X-100, whereas AQP3 was primarily as a monomeric, 
both of which are in agreement with previous reports [55, 293]. Mutating the first 
five residues of AQP1 loop D to alanine (which rendered AQP4 primarily 
monomeric) caused the protein to migrate primarily as a monomer in BN-PAGE. 
Introducing the conserved acid-x-base-base motif (present in loop D of both 
AQPs 1 and 4) into AQP3 caused it to migrate primarily as a dimer. It has been 
suggested that lack of oligomerization may have a role in controlling substrate 
selectivity of the GLP subfamily [294], which consists of AQPs 3, 7, 9 and 10 in 
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humans. However we find that, unlike AQP3, both AQPs 9 and 10 both exist 
exclusively as tetramers when extracted from HEK293 membranes using Triton 
X-100. This suggests that solute permeability of AQPs is not correlated with 
oligomeric state. 
 
Previous mutational analysis of AQP1 found an extracellular motif consisting of 
an aspartate residue (D185) at the top of TM5 that can interact with a lysine 
residue (K51) at the top of TM2 to increase tetramer stability in detergent [295]. 
Whether this had an effect on native protein in live cells was not clear. The 
S205D mutant of the insect aquaporin AQPcic was shown to exist in a primarily 
monomeric state when extracted from yeast and Xenopus oocyte membranes, 
whereas the wild type was tetrameric [296, 297]. This mutant had a complete 
loss of water channel function, and it not clear whether this was due to subtle 
changes in structure leading to a gating effect, gross misfolding, loss of surface 
expression or a direct result of the loss of oligomerization through loss of 
monomer-monomer interactions that stabilize the open state of the pore. This 
makes interpretation of this result very difficult.  
 
In summary, we show that loop D of AQP4 forms a hub for a dynamic network 
of interactions that stabilize the AQP4 tetramer, both when solubilized using 
nonionic detergent and in living mammalian cells. Tetrameric assembly was not 
required for either ER-to-Golgi-to-plasma membrane trafficking or water 
channel activity. Non-tetrameric mutants were unable to relocalize in response to 
tonicity changes, which may reflect a requirement for tetramerization in the 
regulation of AQP relocalization or key protein-protein interactions mediated by 
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loop D of AQP4. We conclude that loop D interactions may represent a 
conserved mechanism for controlling oligomerization across the AQP family. 
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6 Conclusions 
 
6.1 General discussion and future directions 
6.1.1 Hypotonicity-induced translocation of AQP4  
The data reported in chapter 3 identify and partially elucidate the molecular 
mechanism of the subcellular relocalization of AQP4 in response to changes in 
local tonicity. A change in local tonicity is the key driver of glial cell swelling in 
stroke and contributes to the effects of cytotoxic oedema following traumatic 
brain injury. Modulating the surface expression of AQP4 rather than trying to 
directly block its pore is a novel platform for developing therapies for these 
devastating conditions. One of the compounds that we identified as an inhibitor 
of the AQP4 translocation response, trifluoperazine, is already licensed for use in 
humans as an anti-psychotic medication, primarily used as a treatment for 
schizophrenia. Our data raises the possibility of repurposing this drug for use in 
slowing or limiting the development of cytotoxic edema. 
Intervention using trifluoperazine (and the other compounds identified) in a 
rodent model of stroke (such as middle cerebral artery occlusion) or head trauma 
could be used to investigate this possibility. 
 
CaM appeared to be responsible for the activation of PKA via AC1 to facilitate 
AQP4 translocation. However, a CaM binding site prediction algorithm 
suggested that there could be a site for direct binding of CaM to AQP4 directly 
adjacent to the phosphorylation site (S276) controlling the translocation 
response. This raises the possibility of a dual role for CaM. Co-
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immunoprecipitation (CoIP) could be used to investigate this, and the S276A/D 
mutants could be used to investigate whether S276 phosphorylation has any 
effect on a putative CaM interaction. 
 
6.1.2 Regulation of AQP5 localization 
Due to its importance for fluid secretion in airway submucosal glands, AQP5 has 
been suggested to be a pharmacological target to treat the hyper-viscous and 
excessive gland secretions in cystic fibrosis and bronchitis/rhinitis respectively. 
Our data provide the first link between a specific AQP5 phosphorylation site 
(S156) and changes in its subcellular localization. We further show that the 
S156-mediated change in localization does not require a substantial protein 
conformational change. We show that, independently of S156, PKA is further 
involved in basal recycling of AQP5 between the plasma membrane and 
intracellular compartments. Finally, we provide evidence for tonicity-induced 
changes in AQP5 localization that are not mediated by phosphorylation of S156 
or PKA. The protein kinase responsible for the tonicity-dependent translocation 
of AQP5 was not identified in this work, although PKA was ruled out. PKC 
phosphorlyation of AQP1 led to tonicity-induced relocalization so this would be 
the obvious next kinase to test. There is also a PKG phosphorylation site in the 
C-terminal tail of AQP5, corresponding to S276 of AQP4 and S256 of AQP2. 
Given the roles of these two sites in AQP4 and AQP2 translocation respectively, 
this would be another obvious target. 
Furthermore, the physiological relevance of the AQP5 localization mechanisms 
need to be validated in more physiologically relevant cells, e.g. acinar cells or 
airway epithelial cells. This could be done using a similar methodology to that 
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used in chapter 3 to investigate endogeneous AQP4 relocalization in primary 
astrocytes. 
6.1.3 AQP solute permeability 
The data presented in chapter 4 suggest that the details of solute permeability of 
mammalian GLPs and solute exclusion by water selective AQPs depend on a 
complex interplay between the exact residues that form the ar/R region and the 
structural context in which they are situated. The data imply that care must be 
taken when attempting to generalize results of mutagenic experiments on just one 
or two representative members of the AQP family; in order to develop a detailed 
understanding of AQP solute and water permeation, data on as many members of 
the family as possible should be compared and contrasted. An obvious extension 
of this work would be to make alanine substitution mutants to all of the water-
selective AQPs and to make protein hybrids (e.g. swapping TM segments) to try 
to account for differences that are not explained by residues at the selectivity 
filter e.g. the fact that the AQP1 H180A substitution mutant is not glycerol 
permeable, but the analogous AQP4 H201A substitution mutant is. 
Furthermore, we presented the first in vitro evidence that fluctuations of the 
selectivity filter arginine residue are important for the rate of water permeation 
through AQP4. It would be interesting to investigate whether or not this holds 
true for all members of the family and whether the size of the effect is conserved 
between different AQPs.  
6.1.4 AQP4 tetramerization 
The data reported in chapter 5 showed that loop D of AQP4 forms a hub for a 
dynamic network of interactions that stabilize the AQP4 tetramer, both when 
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solubilized using non-ionic detergent and in living HEK293 cells. Tetrameric 
assembly was not required for either ER-to-Golgi-to-plasma membrane 
trafficking or water channel activity. Non-tetrameric mutants were unable to 
relocalize in response to tonicity changes, which may reflect a requirement for 
tetramerization in the regulation of AQP relocalization or key protein-protein 
interactions mediated by loop D of AQP4. CoIP of wild-type, loop D1 and D2 
mutants, followed by identification of binding partners by mass spectrometry 
could be used to investigate this. The lack of relocalization of non-tetrameric 
mutants could also be used as the basis for a novel treatment approach similar to 
that described in chapter 3. For example, a cell-permeant AQP4 loop D peptide 
could be investigated as a potential competitive inhibitor of AQP4 
oligomerization, and therefore as an inhibitor of tonicitiy-induced AQP4 
relocalization. Finally, we concluded that loop D interactions may represent a 
conserved mechanism for controlling oligomerization across the AQP family, but 
we only obtained data confirming this for AQP1, AQP3 and AQP4. The loop D 
alanine substitution mutagenic approach should therefore be extended to other 
members of the AQP family to assess the hypothesis that loop D is important for 
oligomerization of all members of the family.  
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Appendix: Publications arising from the data presented 
in this thesis 
The discussion presented in the introduction (chapter 1) has been adapted for two 
review articles. These are appended on the following pages, followed by four 
original research articles, presented in the order in which the data appear in the 
thesis. 
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Background: Aquaporin (AQP) water channels are best known as passive transporters of water that are vital for
water homeostasis.
Scope of review:AQP knockout studies inwhole animals and cultured cells, alongwith naturally occurring human
mutations suggest that the transport of neutral solutes throughAQPs has important physiological roles. Emerging
biophysical evidence suggests that AQPsmay also facilitate gas (CO2) and cation transport. AQPsmay be involved
in cell signalling for volume regulation and controlling the subcellular localization of other proteins by forming
macromolecular complexes. This review examines the evidence for these diverse functions of AQPs as well
their physiological relevance.
Major conclusions: Aswell as being crucial for water homeostasis, AQPs are involved in physiologically important
transport ofmolecules other thanwater, regulation of surface expression of othermembrane proteins, cell adhe-
sion, and signalling in cell volume regulation.
General signiﬁcance: Elucidating the full range of functional roles of AQPs beyond the passive conduction ofwater
will improve our understanding of mammalian physiology in health and disease. The functional variety of AQPs
makes them an exciting drug target and could provide routes to a range of novel therapies.
© 2015 Elsevier B.V. All rights reserved.
1. Introduction
The aquaporin (AQP) protein family is comprised of many small
integral membrane proteins found in all phylogenetic kingdoms.
There are up to 13mammalian AQPs, which are found in most tissues
with functions ranging from the regulation of renal water balance
[1], brain-ﬂuid homeostasis [2], triglyceride cycling between adipo-
cytes and the liver [3] and structural integrity of the eye lens [4].
Because of this, understanding AQP function is crucial for the study
of healthy ageing as well as the onset of many disease states such
as brain swelling following stroke or head injury [5], nephrogenic
diabetes insipidus [6,7], cataracts [8], obesity [9], cancer cell prolifer-
ation and migration [10] and tumour angiogenesis [11]. Many of
these functions and diseases involve either permeability of molecules
other than water, or a function of the AQP other than facilitating mem-
brane permeability.
Thirteen human AQPs have been discovered to date; they range in
size (before post-translational modiﬁcation) from 27 kDa (AQP8) to
37 kDa (AQP7) and, for those proteins for which single channel perme-
ability has been quantiﬁed, have a 100-fold range inwater permeability.
A sub-set of these AQPs also function as channels for glycerol (and other
solutes) and are referred to as (aqua)glyceroporins (GLPs). In humans,
these are AQP3, -7, -9 and -10. AQP6 has also (controversially, see
Section 4) been shown to be permeable to glycerol, although phyloge-
netically it is a member of the water-selective AQP subfamily [12]. It
also is notable for its unusual permeability properties (activation by
low pH and anion permeability) and intracellular localization. The per-
meability properties of the mammalian AQPs are summarized in
Table 1.
This review discusses how AQPs select and regulate the passage of
solutes such as glycerol, urea and ammonia across cell membranes
and the physiological relevance of this solute ﬂow as well as putative
functions of AQPs beyond facilitation of membrane permeability.
2. The structural biology of the AQP family is established
There is a large amount of medium-to-high-resolution structural
data available for the AQP family (43 structures deposited in the Protein
Data Bank for 11 different AQPs). These structures suggest that the AQPs
Biochimica et Biophysica Acta 1850 (2015) 2410–2421
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share many common structural features. The AQP monomer is com-
posed of six tilted transmembrane (TM) helices that surround a central
cavity containing two helix-forming loops that enter and exit from the
same side of themembrane (see Fig. 1A). This central cavity is the path-
way for water and solute transport. The two helical loops contain highly
conserved asparagine–proline–alanine (NPA) motifs. Crystallography
and molecular dynamics (MD) simulations suggest that the asparagine
residues act, in concert with surrounding backbone carbonyl groups, to
enable water transport by providing hydrogen bonds to water mole-
cules [37], thereby lowering the free energy penalty (caused by break-
ing of water–water hydrogen bonds) of removing a water molecule
from bulk solution. Recent biophysical experiments comparing AQPs
with gramicidin and the potassium channel KcsA [38] suggest that the
number of pore-lining hydrogen-bonding sites for water determines
the channel water permeability. In addition to providing hydrogen-
bonding sites, the asparagine residues help to orient the water mole-
cules such that the hydrogen atoms point ‘outwards’ from the pore, cre-
ating a barrier to proton transport [39]. A recent sub-angstrom crystal
structure of the Pichia pastoris AQY1 found overlapping water densities
in the pore that, supported by MD simulations, suggested a correlated
pairwise movement of water molecules through the extracellular end
of the pore. This correlated motion may help to minimise water–water
hydrogen bonds in this region, providing a further barrier to proton per-
meation, without compromising water transport [37].
Crystallographic analysis of the Escherichia coli, GlpF (a GLP), sug-
gests that the same asparagine residues also form hydrogen bonds
with glycerol [40]. This is likely to be also true of other polar solutes
that permeate GLPs.
AQPs have intracellular amino (N-) and carboxyl (C-) termini of
varying lengths; AQP8 has a short C-terminus of 10–15 residues,where-
as AQP4 has a large C-terminus consisting of ~70 residues. AQP11 has a
large N-terminal tail of ~40 residues, whereas AQPs 1, 2 and 5 have
short N-termini of b10 residues. In contrast to the structural conserva-
tion of the TM region of AQPs, much less is known about the structure
of the termini. This is because the majority of AQP crystal structures
are obtained using constructs in which the N- and C-terminal tails of
Table 1
Water, glycerol, urea and ammonia (NH3) permeabilities of known human AQPs. Quantitative water permeability is per AQP channel i.e. after subtraction of the basal permeability of the
expressionmembrane and normalized to the number of AQPmolecules. Expression systems: X— Xenopus oocytes, PL— proteoliposomes,M—mammalian cells, V— vesicles derived from
membrane fragmentation of AQP-expressing mammalian cells, Y — ammonia transport deﬁcient yeast.
AQP Single channel water permeability (×10−14 cm3 s−1) Glycerol permeability Urea permeability Ammonia permeability
AQP0 0.25 [13]; gated by calmodulin [14]; X, PL No [13]; X No [15]; X No [16]; X
AQP1 6.0 [13]; X No [13]; X No [17]; X No [17]; X
AQP2 3.3 [13]; X No [13]; X No [15]; X No [16]; X
AQP3 2.1 [13]; X Yes [13]; X Controversial [15,17–19]; X Yes [16,17]; X
AQP4 24 [13]; X No [13]; X No [20]; X No [16]; X
AQP5 5.0 [13]; X No [13]; X No [21]; X No [16]; X
AQP6 Low pH and Hg2+ induce water permeability [22,23].
Basal permeability either is very low [23,24] or zero [25,26]; X
Yesb [26]; X Yesb [26]; X Yes [16]; X
AQP7 Permeable [27]; no quantitative data; X Yes [27]; X Yes [27]; X Yes [16]; X
AQP8 Permeable [28,29]; no quantitative data; X, PL No [28,29]; X, PL Controversial [28–30]; X, PL Yes [17,31]; X, Y
AQP9 Permeable [32]; no quantitative data; PL Yes [17,32]; X, PL Yes [17,32]; X, PL Yes [17]; X
AQP10 Permeable [33]; no quantitative data; X Yes [33]; X Yes [33]; X Unknown
AQP11 Permeable [34], ~2 [35]a; M, V Yesb [36]; M Unknown Unknown
AQP12 Unknown Unknown Unknown Unknown
a Estimated from membrane fragment vesicle water permeability relative to AQP1-containing vesicles and relative expression level.
b These data have not been independently replicated.
Fig. 1. Structure of AQPs exempliﬁed by human AQP4. (A) AQPs have six bilayer-spanning helices and two helix-forming loops. These loops contain the conserved NPAmotifs (coloured
blue). The residues forming the arginine/aromatic region thought to be important for solute selectivity are coloured yellow. (B) Simulation snapshot of AQP4 embedded in a POPC bilayer.
Phosphorus atoms in the lipid headgroups are coloured green and the fatty acid tails are yellow. Visualized using VMD [189].
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the protein have been truncated due the difﬁculty of obtaining well-
diffracting crystals using full-length AQP molecules [41]. This suggests
an inherent structural ﬂexibility in these regions of AQP molecules
and indeed a recent X-ray structure of AQP2, which included ~20 resi-
dues of the (truncated) C-terminal tail, found this fragment of the C-
terminus in four strikingly different conformations in each of the four
AQP2 monomers within the tetrameric unit cell [42].
AQPs are generally agreed to form tetramers [43–45] assembled
around a central axis perpendicular to the plane of the membrane
(see Fig. 1B). A ﬁfth, hydrophobic pore appears to form around this cen-
tral axis with each of the monomers contributing one of the four ‘walls’
of the pore. The function, if any, of this ﬁfth pore is not yet known, al-
though postulated functions will be discussed in later sections. Some
biochemical studies have suggested that tetramers formed by GLPs
have reduced stability compared to tetramers formed by AQPs with
strict water selectivity [46,47].
3. The principles of solute selectivity by AQPs remain to
be established
All AQPs (except AQP12, which has yet to be characterized) trans-
port water (Table 1), while some also transport glycerol. The glycerol
permeable GLPs (e.g. human AQPs 7, 9 and 10) are also permeable to
urea. The urea permeability of AQP3 is controversial, with some studies
reporting urea transport and others no transport [15,17–19]. This may
be due to methodological differences, and is discussed in detail in
Section 4.2.1.
Of the mammalian GLPs AQP3, -7, and -9 are also permeable to am-
monia. AQP8 is the only glycerol impermeable mammalian AQP that is
permeable to ammonia (excluding 11 and 12, whose glycerol and/or
ammonia permeabilities are currently unknown). The ammonia perme-
ability of the most recently discovered member of the GLP group,
AQP10, is still unknown.
AQP11 and -12 are the most recently discovered members of the
AQP family [48,49]; due to this and their localisation to intracellular
membranes, non-water permeability experiments and functional
studies have yet to be reported for AQP11 and AQP12 respectively.
There is one report that AQP11 increased the glycerol permeability of
an adipocyte cell line [36], but this permeability of AQP11 has yet to
be replicated.
The ‘size exclusion’ model of AQP selectivity posits a correlation be-
tween the size of channel entrance and the permeability of the channel
to different polarmolecules. Notably, thismodel is based on in silico and
crystallographic experiments, but minimal in vitro experiments; it is
therefore unclear whether this model is broadly applicable to the AQP
family as a whole. A conserved arginine residue (in the second helical
loop directly after the NPA motif) forms part of a channel constriction
known as the aromatic/arginine (ar/R) selectivity ﬁlter (see Fig. 1A).
In water-selective AQPs, the other components of this ﬁlter are a phe-
nylalanine in the top half of the pore-facing side of transmembrane
helix 2 (TM2) and a histidine in a similar position in TM5. In glycerol
and urea permeable AQPs, this histidine is replaced by a small amino
acid residue such as glycine (AQP3, -7, -10) or alanine (AQP9), although
if the histidine is mutated to alanine in AQP1 it does not become a glyc-
erol channel. If both aromaticmembers of theﬁlter (H and F) aremutat-
ed to alanine, AQP1 functions as a urea channel and to a lesser extent as
a glycerol channel [50]. Based on this observation and molecular simu-
lations of AQP1 and the E. coli GLP, GlpF [50,51], it has been suggested
that the cross-sectional area of the pore at the ar/R region determines
AQP selectivity for neutral polar solutes. Additionally, based on crystal-
lographic analysis of GlpF and the bacterial water-selective AQP, AQPZ,
it has been suggested that the positioning of the ar/R residues by
the surrounding unstructured loops has a role in determining the chan-
nel size [52]. In AQP8, the only glycerol-impermeable, ammonia-
permeable mammalian AQP, the third member of the ﬁlter is likely an
isoleucine residue (based on sequence alignment), which is slightly
larger than alanine or glycine. Overall, current thinking on solute selec-
tivity suggests that the aromatic residues of the ar/R ﬁlter are important
for solute exclusion in the water selective AQPs, but further molecular
factors may be involved in mediating solute selectivity.
4. Physiological solute transport by AQPs
4.1. Glycerol transport
The movement of glycerol around the body is predominantly
thought to include glycerol release from fat tissue through AQP7,
entry into the liver through AQP9 and movement in the skin and kid-
neys through AQP3.
4.1.1. AQP7
AQP7 is expressed in adipose tissue in adipocytes [53] and capillary
endothelia [54]. Upon hypoglycaemia, triglycerides are broken down
within adipocytes to glycerol and free fatty acids [55]. Adrenaline, the
plasma level of which is elevated upon hypoglycaemia, caused translo-
cation of AQP7 from intracellular membranes to the plasma membrane
[53]. Adrenaline signals through the β3-adrenergic receptor to initiate
adipocytic lipolysis [56]making this themost likely link between adren-
aline and AQP7 translocation although this has yet to be veriﬁed. Recent
work has also suggested that AQP7 can be relocalised to lipid droplets
by noradrenaline, possibly in a PKA dependent manner [57], raising
the possibility of differential effects of lipolysis-inducing hormones on
AQP7 localization.
The glycerol liberated from triglyceride storage is released from ad-
ipocytes [58] and plasmaglycerol becomes elevated. In AQP7−/−mice,
adipocyte plasma membrane glycerol permeability was reduced three-
fold [59]. Plasma glycerol levels in the fasting state and in response to
β3-adrenergic agonist were reduced and adrenaline-induced glycerol
secretion by cultured mouse adipocytes (differentiated 3T3-L1 cells)
was reduced approximately two-fold [60]. These results suggest that
the major pathway for glycerol efﬂux from adipocytes after lipolysis is
AQP7.
AQP7−/− mice develop adipocyte hypertrophy and subsequent
obesity in adulthood [59]. A loss of function mutation in the human
AQP7 gene has been discovered (G264→V) although this genotype
was not correlated with obesity in humans [61]. This may be due to
the presence of AQP10 in human adipocyte membranes, which was
found to contribute ~50% of the water and glycerol permeability of
healthy human adipocyte plasma membrane vesicles [62]. Mouse
AQP10 is a pseudogene [63] and therefore this secondary route for glyc-
erol efﬂux does not exist in mice.
The serum concentration of glycerol in humans under normal phys-
iological conditions is typically between 0.05 and 0.1 mM [64] and in-
creases several-fold upon fasting (due to glycerol and free fatty acid
liberation from adipose triglyceride storage) [65]. Glycerol is almost
completely reabsorbed by the kidneys [66] (unless it is raised above
~0.3mM [67]), suggesting the existence of a glycerol reabsorption path-
way. AQP7 is expressed in the proximal tubule of the kidney. AQP7−/−
mice showed marked glyceroluria in comparison to wild type (~400-
fold increase in urine glycerol) [68]. Human children homozygous for
the AQP7 G264V mutant were found to have hyperglyceroluria, with a
~1000-fold increase in urine glycerol when compared to heterozygous
familial controls [69]. The G264Vmutant has been shown to have no ac-
tivity as a glycerol or water channel in Xenopus oocytes [61], although
plasma membrane expression was not veriﬁed in this study so that it
could not differentiate between a non-functional channel and an incor-
rectly localised channel. The mutation disrupts a conserved GxxxG
motif. These are important motifs for transmembrane helix–helix inter-
actions because they allow close contact between the backbone atoms
of the two helices of an interacting pair [70]. It may be that the protein
is incorrectly trafﬁcked and localised in intracellular membranes due to
an inability to form tetramers or an interaction required for membrane
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trafﬁcking. Regardless of the loss of function mechanism, these data
strongly suggest that AQP7 is the TM glycerol reabsorption pathway in
the renal proximal tubule.
4.1.2. AQP9
AQP9 is expressed in the liver [71], primarily in the hepatocyteswith
the strongest expression at the sinusoidal surface [72] (the liver sinu-
soids are continuous with the hepatic artery and portal vein). Upon
fasting, glycerol released into the plasma from adipocytes is taken up
by hepatocytes and used as a substrate for gluconeogenesis [73].
In rats, AQP9 protein expression is increased up to 20-fold after 24–
96 hour fasting [32]. Inmice, AQP9 expression measured in puriﬁed he-
patocyte plasma membrane vesicles increased 10-fold after 18 hour
fasting. This 10-fold increase was accompanied by a two-fold increase
in hepatocyte plasma membrane glycerol permeability, which was re-
versed by addition of phloretin (an apple polyphenol that inhibits
AQP9, AQP3 and several non-AQP membrane channel proteins includ-
ing the SGLT1&2 glucose transporters and UT-A urea channels [74]).
The increase was abolished in AQP9−/−mice [75]. Fasted AQP9−/−
mice have elevated plasma glycerol compared to wild-type [75,76]. In
addition, plasma glucose concentration was decreased [76], indicating
a gluconeogenetic deﬁciency. This data supports a physiological role
for AQP9-mediated glycerol uptake by hepatocytes during fasting-
induced hypoglycaemia.
Although the AQP9-mediated diffusion of glycerol into hepatocytes
forms a sizeable proportion of the glycerol uptake in the fasting state
(~50% in fastingmice), the fact that themembrane permeability to glyc-
erol only doubles upon such a large increase in AQP9 expression sug-
gests that there is also an AQP9-independent route for glycerol
uptake. Whether this is directly across the lipid bilayer or through a
phloretin insensitive glycerol channel is not clear.
CD8+ (cytotoxic) T cells are white blood cells that facilitate the de-
struction of infected or otherwise damaged cells. During infection,
antigen-speciﬁc CD8+ cells proliferate and differentiate into effector
cells, which are involved in combatting infection. After pathogen clear-
ance, most of the effector cells die and a small population remains as
memory T cells, which can survive for decades [77]. In mouse memory
cells, AQP9 expression was upregulated post-infection via IL-7
signalling, allowing cells to import glycerol for triglyceride synthesis.
AQP9−/− T cells had reduced long-term survival compared to +/+
cells and the long-term survival of the +/+ cells could be inhibited by
phloretin [78]. This suggests that AQP9 expression can act as ametabolic
switch, enabling long-term survival of memory T cells by enabling tri-
glyceride synthesis to build up an energetic reserve, allowing cell sur-
vival in nutrient poor conditions.
Similarly to that seen in hepatocytes, intracellular glycerol in CD8+ T
cells was reduced by ~50% in the AQP9−/− cells, again suggesting a
secondary route for glycerol uptake.
4.1.3. AQP3
AQP3 is expressed in the skin in keratinocytes below the stratum
corneum (SC). It is most strongly expressed at the plasma membrane
in these cells with some intracellular labelling reported in cells of the
basal layer [79]. The ability of the epidermis tomaintain hydration is im-
paired in AQP3−/−mice. In dry conditions, AQP3−/−mice showed
comparable (reduced) levels of SC hydration to wild-type mice, where-
as at normal humidity, SC hydration was lower in the AQP3−/−mice
[80]. Elevated humidity (which prevents water loss via evaporation)
did not correct the deﬁciency, which suggests that the primary role of
AQP3 in skin hydration is not to provide water to replace that lost by
evaporation.
SC glycerol concentration in AQP3−/−mice is reduced to ~40% of
that of wild-type, with no signiﬁcant difference in the levels of other
osmolytes (ions, glucose, urea, lactate and free amino acids) [81]. Glyc-
erol acts as a humectant (a ‘water-retaining’ osmolyte), which may be
the mechanism by which it maintains skin hydration. It has also been
suggested that glycerol may prevent SC water loss by inhibiting the
phase transition of intercellular lipids from the liquid crystalline to the
solid phase [82] due to the fact that breaks in a solid crystal lattice in-
crease the water permeability in in vitro models of the SC intercellular
lipid barrier [83]. The rate of transport of glycerol from blood to the SC
was reduced in AQP3−/−mice resulting in reduced lipid biosynthesis
[84]. This suggests a further role for glycerol in maintaining skin hydra-
tion by allowing the maintenance of the SC lipid barrier.
Further evidence for the role of AQP3-mediated glycerol transport is
provided by the fact that topical or systemic administration of glycerol
was found to correct the skin deﬁciencies in AQP3−/−mice [84].
4.2. Urea transport
Urea is produced in the liver (as a non-toxic carrier of waste nitro-
gen) from ammonia, which is a neurotoxic product of protein degrada-
tion. Ammonia causes cell death of astrocytes by stimulating the
mitochondrial permeability transition [85] (opening of promiscuous
mitochondrial membrane channels that leads to apoptosis or necrosis,
depending on cellular ATP availability [86]), although the mechanism
by which this happens is not clear. An adult human excretes about
25 g/day of urea in the urine, and urea transport in the kidney is vital
for the urinary concentrating mechanism [87]. The physiological roles
of urea transport by AQPs are less clear than those of water and glycerol
transport.
4.2.1. Which mammalian AQPs are urea channels?
AQPs 7 [27], 9 [88] and 10 [33] have been shown to be urea perme-
able and there is a consensus in the literature on the urea permeability
of these AQPs. For example, AQP9 is a urea channel in the liver
expressed in hepatocytes at the sinusoidal surface. Urea permeability
measurements performed on mouse hepatocyte plasma membrane
vesicles of AQP9−/− and urea transporter type A1/3 (UT-A1/3)−/−
mice showed that AQP9 contributes ~30% to mouse hepatocyte mem-
brane permeability and a member(s) of the UT-A family contributes
~40% [91]. However, AQP9−/−mice did not demonstrate any deﬁcien-
cy in urea clearance from hepatocytes in a state that promotes elevated
hepatic urea production (high protein diet), suggesting that AQP9 and
UT-A provide redundant pathways for urea transport from hepatocytes
to the blood.
However, there is conﬂicting evidence in the literature on whether
AQPs 3 and 8 are urea channels. Early work on AQP3 suggested that
rat AQP3 was urea permeable, with expression of AQP3 in Xenopus oo-
cytes increasing urea uptake twofold after 30minute incubations of oo-
cytes with radiolabelled urea [89] or threefold in oocyte swelling assays
[18]. Further studies on rat AQP3 found no urea transport using similar
oocyte volumetric techniques [15,17]. These studies differed in that the
former used 165 mM urea whereas the latter two used 20 mM urea. It
may be that AQP3 urea transport is so slow that at 20mM it does not in-
duce large enough volume changes to be measured on the timescale of
an oocyte swelling experiment (~1 min), or that the transport is non-
linear, although this seems unlikely given the linear nature of water
and glycerol transport by AQP3 [90].
In one study, human AQP3 was used a positive control for AQP urea
permeability. 1 mM of urea was added to AQP3-expressing oocytes and
after a 10 minute incubation, the oocytes had an intracellular urea con-
centration of ~75 μM (assuming an oocyte volume of 1 μL) [19]. This is
~10% of the expected equilibrium value, and the fact that it is still so
far from equilibrium even after 10 min suggests that urea transport
through AQP3, whilst non-zero, is very slow. This may explain the dif-
ferent results between short (typically ~1min) volumetric experiments
and the longer timescale radiolabelled solute uptake experiments.
Early work on mouse AQP8 suggested that it was urea permeable
[30], whereas rat AQP8was not [29], both using radiolabelled solute up-
take measurements in Xenopus oocytes. Work on puriﬁed rat, mouse
and human APQ8 in proteoliposomes suggested that neither rat nor
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human AQP8 were urea permeable [28]. This study did not report
mouse urea permeability due to liposome swelling discrepancies, prob-
ably caused by the ionic detergent required to solubilize mouse AQP8.
There is considerable interspecies amino acid sequence variability
for AQP8 (e.g. 74% identity between human and mouse AQP8, c.f. 94%
for AQP1 and 93% for AQP4). Interestingly, one difference between
human and mouse AQP8 is a residue that is predicted to be pore-
lining (based on a homology model to bovine AQP0 [28]) and situated
at the ar/R ﬁlter, G207 (in human; A205 in mouse). The idea of
species-speciﬁc differences in permeability of AQP8 is intriguing, but
studies performed in parallel in the same experimental system are re-
quired to validate this.
4.3. Ammonia transport
Ammonia is produced as a by-product of protein breakdown and
quickly converted to urea via the hepatic urea cycle to prevent ammonia
neurotoxicity. It is important for control of acid–base balance in the kid-
ney, where ammonia synthesis and excretion are tightly regulated and
change in response to acid- or alkalosis [92].
Members of the GLP subfamily, AQPs 3 [17], 7 [16] and 9 [17], have
been reported to be permeable to ammonia, as has AQP8 [17,93].
There is also evidence of ammonia permeability of AQPs 1, 6 and 7
using microelectrode measurements of oocyte surface pH [16]. The
physiological relevance of ammonia permeability of AQPs is unclear.
AQP8−/−mice have only the very mild phenotypic abnormality of
slight hypertriglyceridaemia after three weeks on a high (50%) fat diet
[94]. AQP8 is expressed in the inner mitochondrial membrane of hepa-
tocytes [95] and increased the transport of an ammonia analogue into
AQP8-expressing Saccharomyces cerevisiae and rat hepatocyte mito-
chondria by three-fold. However, AQP8−/−mice do not show any im-
pairment in ammonia clearanceunder physiological conditions orwhen
chronically or acutely loaded with ammonia [96]. This suggests a sec-
ondary (non-AQP) pathway for ammonia, which either provides the
majority of ammonia permeability in these tissues, or is up-regulated
in ammonia-permeable AQP knockouts. The proteins associated with
the Rhesus (Rh) blood group system have been shown to function as
ammonia channels [97]. Several of these are expressed in the liver
[98] (RhB and RhC) and the kidneys (again RhB andRhC),where ammo-
nia has an important role in acid–base balance [99]. Rh−/−mice have
been generated, however these studies have focused on the erythrocytic
Rh proteins [100,101]. Phenotype analysis of RhB and RhC−/−
organisms and double AQP/Rh knockouts could provide an answer.
Knockdown of AQP8 in primary rat hepatocytes by ~80% reduced am-
monium chloride-induced ureagenesis by 30% and abolished
glucagon-stimulated increases in ureagenesis [102]. AQP8 knockdown
in a human proximal tubule cell line decreased the rate of ammonia ex-
cretion by 31% at pH 7.4 and by 90% at pH 6.9 [103], suggesting that
AQP8 ammonia permeability might be required for renal ammonia
excretion and be involved in the renal adaptive response to acidosis.
Furthermore, acid-induced downregulation of AQP8 by 30% in pri-
mary rat hepatocytes was correlated with a 31% reduction in hepato-
cyte ureagenesis, and AQP8 downregulation was correlated with
reduced liver urea content in rats subjected to seven days of acidosis
[104]. These data support the idea of a physiological role for AQP8 in
either plasma membrane diffusion of ammonia, mitochondrial am-
monia transport, or both in support of renal and hepatic ammonia
handling.
AQP3−/−mice have several physiological abnormalities including
reduced skin elasticity [80] and polyuria [105], but these can all be ex-
plained in terms of reduced glycerol and water permeability, so it is un-
clear whether AQP3 ammonia permeability has any physiological
function.
AQP7 is present in adipocytes. It has been shown in humans that
during intense exercise, adipose tissue removes ammonia from the
plasma and increases its glutamine/glutamate ratio [106], suggesting
incorporation of ammonia into glutamine through glutamine synthase
as a secondary detoxiﬁcation pathway in support of the hepatic urea
cycle at times of elevated plasma ammonia. Whether AQP7 contributes
to this ammonia uptake is yet to be investigated.
4.4. Carbon dioxide transport
The majority of carbon dioxide (CO2) produced by cellular metabo-
lism (~70%) is transported to the lungs for expulsion from the body
via the bicarbonate (HCO3−) system. Brieﬂy, carbon dioxide diffuses
out of the cells in which it is produced and into the plasma. It moves
down its concentration gradient into erythrocytes (red blood cells),
where carbonic anhydrase catalyses conversion into carbonic acid.
Upon dissociation (H2CO3→ H+ + HCO3−), the HCO3− ion is exchanged
across the erythrocyte membrane for a chloride ion and the proton
binds to haemoglobin [87].
There has been speculation that CO2 transport across the plasma
membrane of erythrocytes might be aided by channel proteins [107,
108]. There is conﬂicting data onwhether anAQP contributes to this po-
tential CO2 pathway. AQP1 is expressed at the plasma membrane of
erythrocytes [109]. Human AQP1 has been reported to increase the
CO2 permeability of Xenopus oocytes four-fold in the presence of car-
bonic anhydrase suggesting that AQP1 functions as a CO2 channel
[110]. Further work ruled out the possibility of AQP1 increasing the oo-
cyte membrane permeability by altering local lipid composition or
structure, interaction between AQP1 and carbonic anhydrase or up-
regulating a native CO2 channel by use of a mercurial AQP1 inhibitor
(pCMBS) and the AQP1 C189S mutant, which is insensitive to mercury
[111].
AQP1−/− human erythrocytes (Colton-null cells) retain HCO3− per-
meability, but have a 60% reduction in CO2 permeability when com-
pared to human erythrocytes expressing AQP1 (i.e. not Colton-null)
[112]. However, the CO2 permeability of AQP1−/−mouse erythrocytes
from AQP1 knockout mice was not different to wild-type [113].
Stopped ﬂow experiments with AQP1 reconstituted into liposomes
have also given conﬂicting results. AQP1 from human blood increased
the CO2 permeability of liposomes four-fold [114], whereas mouse
AQP1 showed no increase [113]. This agrees qualitatively with the re-
sults from measurements on intact erythrocytes in that human AQP1
appears to increase CO2 permeability of the membrane, whereas
mouse AQP1 does not. This may be due to methodological differences,
but it also raises the intriguing possibility that human AQP1 is CO2 per-
meable whereas mouse AQP1 is not.
It is possible that if CO2 permeates AQP1, it does so through the cen-
tral tetrameric pore rather than the monomeric water pore. Molecular
dynamics simulations using a variety of enhanced sampling methods
and unbiased simulation consistently suggest that the free energy
barrier to permeation of the central, hydrophobic pore of AQP1 is con-
siderably smaller than the barrier to permeation of the water pores
[115–117], probably due to the water–protein hydrogen bonds at the
selectivity ﬁlter and NPA sites that need to be disrupted in order for a
CO2 molecule to traverse the water pore. Simulation of model bilayers
suggest that the free energy barrier for passage of CO2 directly across
the membrane is much smaller than for permeation through AQP1,
and in this kind of system, AQP expression would probably serve to de-
crease the CO2 permeability by reducing the surface area available for
diffusion directly across the membrane [115,116]. However, it is not
clear how good of a model a single species phospholipid bilayer is for
a cellular membrane. It is possible that a simulated bilayer containing
a mixture of lipid species along with sterols would display different re-
sistance to CO2 passage, and biophysical measurements of CO2 diffusion
into artiﬁcial lipid vesicles showed that addition of cholesterol could re-
duce membrane CO2 permeability by up to 100-fold [118]. This agrees
qualitatively with MD simulations that include cholesterol [119]. In
addition to CO2, MD simulations have also suggested that the central
pore could be permeable to molecular oxygen [115] and there is some
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evidence that AQP1 overexpression could accelerate cellular hypoxia
[120], althoughwhether thiswas a direct or indirect effectwasnot clear.
It seems apparent that AQP1 can conduct CO2 (possibly along with
AQP 0, 5, 6 and 9 and theM23 isoform of AQP4 [16]), however the phys-
iological relevance (if any) of AQP CO2 permeability is yet to be demon-
strated. There is also a similar debate in the plant AQP ﬁeld on whether
AQPsmight contribute to regulatingCO2 levels for photosynthesis [121].
A recent review dedicated to AQPs and CO2 permeability of biological
membranes [122] concluded that “the debate about the mechanism of
membrane CO2 diffusion continues and it is difﬁcult to draw general
conclusions”. This is still very much an open question.
4.5. Hydrogen peroxide transport
Superoxide (O2−) molecules are produced in the mitochondria as a
by-product of ATP synthesis (particularly by complexes I and III in the
electron transport chain) and by the NADPH oxidase (NOX) family of
enzyme complexes, which couple intracellular oxidation of NADPH to
extracellular production of superoxide (O2−) molecules. High levels of
reactive oxygen species (ROS) derived from these pathways are well
known to cause cellular damage and even death and mitochondrial
ROS were long considered to be purely harmful by-products of an im-
perfect metabolic system. However, work in the last decade has
shown that they are crucial for a variety of physiological processes in-
cluding adaptation to hypoxia, immune function and regulation of au-
tophagy (probably mediated by redox modiﬁcation of cysteine
residues) [123], so clearly there is a need for tight regulation of ROS
levels. Superoxide undergoes disproportionation to molecular oxygen
and hydrogen peroxide (H2O2), which can be catalysed by the enzyme
superoxide dismutase [124], and the highly reactive H2O2 can then go
on to form a variety of further ROS.
H2O2 and H2O have similarmolecular sizes, dipolemoments and hy-
drogen bonding capacities [125], therefore it would not be surprising to
ﬁnd that some AQPs could transport H2O2. The half-life for H2O2 in cells
is very short (e.g. ~1 ms in lymphocytes [126]), making biophysical ex-
periments of the kind used for e.g. glycerol or urea permeation very dif-
ﬁcult. Growth assays using H2O2 transport-deﬁcient yeast are typically
used, and reduced growth after expression of an AQP is interpreted as
anAQP-mediated increase inmembraneH2O2 permeability causing cel-
lular damage and/or metabolic disruption. Using this technique, human
AQP8, rat (but not human) AQP1 and several mutants thereof were
shown to be H2O2 permeable [127]. Based on this data, the authors sug-
gested that all AQPs function as H2O2 channels. It is not clear whether
this is a valid generalization, but clearly some mammalian AQPs are
H2O2 channels.
Imaging studies using a novel H2O2 sensitive ﬂuorescent dye in tran-
siently transfected HEK293 cells demonstrated H2O2 permeability for
human AQP8 and AQP3 (but not AQP1). Furthermore, AQP3 overex-
pression in HeLa cells allowed the cells to respond to serum starvation
via ROS mediated activation of the AKT (protein kinase B) signalling
pathway, whereas cells not expressing AQP3 could not. Knockdown of
AQP3 in a colon cancer cell line inhibited the AKT response to epidermal
growth factor (EGF) [128], which can initiate ROS signalling via activa-
tion of NOX complexes. This suggests that AQP3 is required for uptake
of NOX-generated H2O2 in EGF signalling.
T cell migration along chemokine gradients is vital for correct im-
mune responses. T cells from AQP3−/−mice had 40–60% reductions
in migration distance in response to a variety of chemokines and had
a ~50% reduction in chemokine-induced transendothelial migration.
Activation of Cdc42, a small GTPase involved in cytoskeletal reorganiza-
tion associated with chemotaxis, was completely inhibited in the
AQP3−/− cells. Treatment with extracellular catalase, which catalyses
H2O2 breakdown to H2O and O2, prevented the Cdc42 response in
AQP3+/+ cells and treatmentwith high concentration (100 μM) of ex-
ogenous H2O2 recovered both the Cdc42 response and the T cell migra-
tion in AQP3−/− cells [129]. Together, these data suggest that AQP3 is
required for uptake of extracellular H2O2 (probably NOX-generated) in
the T cell chemotactic response.
Intracellular ROS levels can be elevated in leukaemia cells and NOX-
derived ROS can activate leukaemia cell survival pathways. In a leukae-
mia cell line, shRNA-mediated knockdown of AQP8 reduced and
overexpression increased intracellular H2O2 content aswell as H2O2 up-
take after 10 min in 100 μMH2O2. Furthermore, cellular glucose uptake
and proliferation were correlated with intracellular H2O2 and AQP8 ex-
pression [130], suggesting that AQP8 can facilitate increased metabo-
lism and proliferation in leukaemia.
AQP8 is also expressed in inner mitochondrial membranes (IMM) in
hepatocytes. Knockdown of AQP8 by 60% using siRNA in a hepatocyte
cell line caused a twofold increase in mitochondrial ROS concentration
and a 45% decrease in H2O2 output in isolated mitochondria. This was
correlated with an 80% depolarization of the mitochondrial membrane,
whichwas reversible by cyclosporin A (an inhibitor of themitochondri-
al permeability transition) or a mitochondrial antioxidant, and a ~30%
reduction in cell viability [131]. This suggests that AQP8-mediated
H2O2 release from hepatic mitochondria acts as a mechanism to mini-
mise mitochondrial oxidative stress.
AQP11 is localised to the ER in the renal proximal tubule. The C227S
mutation of AQP11 caused proximal tubule injury and eventual renal
failure in mice [132]. Mice heterozygous for the AQP11 C227S mutant
were predisposed to glucose-induced accumulation of ROS in the
proximal tubule and reduction of kidney function. Inhibition of glucose
uptake by thenon-speciﬁc inhibitor phlorizin or antioxidant (sulforaph-
ane) treatment was able to protect kidney function. This effect was
reproduced in a proximal tubule cell line, in which siRNA-mediated
knockdown of AQP11 increased intracellular ROS concentration twofold
in the absence of glucose and fourfold in the presence of glucose [133]. It
is not clearwhether AQP11was controlling intracellular ROS accumula-
tion by acting as an ER H2O2 channel, or whether this was an indirect
effect.
Taken together, these examples provide clear evidence for AQP-
mediated H2O2 membrane permeability and suggest physiological
roles in redox signalling via uptake of NOX-derived H2O2 and in cellular
mechanisms for minimizing oxidative stress.
A recent review of H2O2 permeability of AQPs suggested that rat
AQP1 may be permeable to H2O2 whereas human AQP1 is not [134].
The authors of the cited study [127] suggest that the difference is due
to differences in plasma membrane localization, although surface ex-
pressionwas notmeasured directly. This difference is particularly inter-
esting given the speculation that we made regarding differences in CO2
permeability between human andmouse AQP1 and the possible differ-
ences in AQP8 urea permeability between species and raises the impor-
tant point that despite high levels of conservation between AQPs from
different mammals, they are not exactly the same proteins (e.g. rAQP1
and hAQP1 differ by 18 residues), and direct comparison between
AQPs from different mammals in different experimental systems may
not always be appropriate.
5. The physiological role of AQP6: an unusual AQP
AQP6 is expressed primarily in kidney epithelia, where it is
expressed only in intracellular membranes. Immunostaining was ob-
served in podocyte intracellular vesicles, sub-apical vesicles in straight
proximal tubule cells, and in both sub-apical and sub-basolateral do-
mains within type A (acid-secreting) intercalated cells in the collecting
duct [135].
AQP6 has low intrinsic water permeability: The membrane water
permeability of Xenopus oocytes expressing AQP6 was increased less
than threefold [22,136], and in some experiments, not at all [25,26]. In
contrast to other members of the AQP family, mercury increases rather
than inhibits AQP6 water permeability, which is reversibly increased
approximately tenfold upon HgCl2 application. Low pH activated a re-
versible anion permeability of AQP6 [22] which was also shown to be
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~tenfoldmore permeable to nitrate than chloride [137]. In rat collecting
duct, intercalated cells, AQP6 co-localises with H+-ATPase in intracellu-
lar vesicles [22], and in the intercalated cells of alkali-loaded rats, AQP6
mRNA and protein levels increased after a week [138]. These results,
along with the pH-activation of AQP6 water and anion permeability
suggest involvement of AQP6 in acid–base balance in the renal
collecting duct. However the lack of in vivo experiments with AQP6
knockouts or naturally occurring mutations precludes any meaningful
conclusions about the physiological roles of AQP6.
6. Ion permeability of AQPs: an unresolved controversy
AQPs support bulk movements of ﬂuid by giving high water perme-
ability tomembranes that secrete osmolytes. These osmolytes are often
ions (e.g. Na+, K+ and Cl−) and this is reﬂected in the fact that several
AQPs form macromolecular complexes with ion channels and trans-
porters [41]. Perhaps a more efﬁcient way for nature to achieve this
dual permeability would be to have both ions and water pass through
the same channel. Indeed it has been observed that several ion channels
can transport water [38], but it has also been suggested that some AQPs
may function as ion channels.
The pH-sensitive ion permeability of AQP6 is well established, and it
is likely that the monomeric pore is the ion pathway given that a point
mutation to a pore-lining residue of AQP6 abolished ion permeability
[137] and AQP6-mimicking mutations of a pore-lining amino acid resi-
due of AQP5 conferred anion permeability [139]. There is also some ev-
idence that the plant AQP nodulin-26 from soybean can act as a voltage-
gated, anion-biased ion channel [140,141].
More controversial is the idea that the ﬁfth pore formed at the four-
fold axis of the tetramer of AQP1 may function as a cation channel. In
Xenopus oocytes, heterologous expression of human AQP1 led to a
PKA-activated cation permeability probably mediated by phosphoryla-
tion of AQP1 [142] and a cGMP-activated cation permeability via direct
binding of cGMP to the C-terminus of AQP1 [143]. PKC activity was
shown to increase the cation permeability of AQP1 in Xenopus oocytes
via direct phosphorylation of AQP1 at residues T157 and T239 [144].
We recently showed that phosphorylation at these sites by PKC is
required for trigger-induced translocation of AQP1 to the plasmamem-
brane [145], so this may represent more AQP1 molecules in the mem-
brane rather than an increase in the cation permeability or open
probability of a single channel. Phosphorylation of a tyrosine residue
(Y253) in the C-terminal tail of AQP1was recently shown to be required
for activation by cGMP [146]. The cGMP-activated cation current was
veriﬁed for puriﬁed AQP1 in planar artiﬁcial membranes and the AQP1
water permeability inhibitor pCMBS did not inhibit ion permeation,
suggesting that the water and ion pathways through AQP1 are not the
same [147]. Furthermore, point mutations to residues lining the tetra-
meric pore altered conductance properties [146]. The open probability
was found to be very small (b10−6) in the planar bilayer system
[147], which raises doubts over the physiological relevance of this cat-
ion conductance. This study suggested that this very low probability
could reﬂect a misfolding or protein degradation artefact rather than a
“real” function of AQP1. Furthermore, human APQ1 expressed in
HEK293 cells did not induce an above-background cation conductance
when cells were loaded with either cGMP or analogues thereof [148].
Additionally, after the initial report of AQP1 cation permeability by
Yool et al., several laboratories reported being unable to replicate this
result in the same experimental system (and in some cases,with exactly
the same AQP1 construct) [149]. High variability in oocyte response to
forskolin was also reported. It was suggested that the discrepancy
could be due the protocol for choosing ‘healthy’ oocytes on which to
perform experiments. A cut-off for oocyte membrane potential is
routinely used for this. Yool et al. choose oocytes with a potential
b−20mV, whereas others used a−35mV cut-off. If AQP1 does indeed
act as a cation channel it is plausible that it could cause a slight
depolarization, leading to oocytes in which AQP1 is acting as an ion
channel to be falsely excluded as unhealthy.
Rat choroid plexus cells, which strongly expressAQP1,were found to
have a cGMP-activated cation conductance that was abolished by treat-
ment with AQP1 siRNA. Activation of the current by atrial natriuretic
peptide (ANP), which signals through guanylate cyclase, inhibited
basal-to-apical ﬂuid transport. The contribution of AQP1 to this inhibi-
tionwas not conﬁrmed directly, although Cd2+,whichwas shown to in-
hibit cGMP-induced cation conduction of AQP1, reversed the inhibition
of ﬂuid transport [150]. ANP and a cGMP analogue were also shown to
upregulate apical-to-basal ﬂuid transport in cultured retinal pigment
epithelial cells, but this was reversed by an inhibitor of AQP1water per-
meability [151].
It is clear that, under the right set of circumstances, AQP1 can act as a
cation channel, with the ion pathway probably residing in the central
pore formed by tetrameric assembly. Whether or not this ion conduc-
tance has physiological relevance remains an open question. However,
coupled water and ion movement are vital for several pathophysiologi-
cal processes including tumour angiogenesis and cell migration [152]
and epilepsy [153], so it remains an intriguing possibility that AQPs
are performing a dual function.
7. Cell volume regulation by AQPs
Many cells have the ability to modulate their physical size. This is
achieved by the import or export of osmolytes in order to move water
into or out of the cell by osmosis. Regulatory cell volume decrease
(RVD) is mediated by potassium chloride and taurine efﬂux and regula-
tory cell volume increase (RVI) by sodium inﬂux [154]. AQPs play a role
in mediating the osmotic water movement in cell volume regulation
[155], but there is some evidence that their role may go beyond acting
as a passive water pore.
The stretch-activated transient receptor potential vanilloid type 4
(TRPV4) channel is a Ca2+-biased non-selective cation channel
(NSCC) that is activated by cell swelling [156] and has been implicated
in cellular responses to osmotic stimuli [157]. In some cell types
TRPV4 has been shown to provide a Ca2+ signal that is correlated
with activation of the K+ and Cl− channels responsible for the decrease
in cellular osmolality associatedwith RVD [157,158]. In human andmu-
rine salivary gland cells, TRPV4 has a functional interaction with AQP5;
in AQP5 knockout cells, the hypotonicity-induced calcium inﬂux
through TRPV4was attenuated and subsequent RVDwas abolished. Hy-
potonicity also increased cell surface expression of both TRPV4 and
AQP5 and increased their co-localisation [159]. This suggests a role for
AQP5 in the regulation of TRPV4 surface expression or hypotonicity-
induced activity.
In another example, the RVD of sperm of AQP3−/− mice was
inhibited compared to wild-type mice and the mice displayed reduced
fertility [160] [161]. Upon entry into the female reproductive tract,
sperm normally encounter a decrease in extracellular osmolality,
which is thought to be the signal that activates sperm motility [160].
However, this hypotonic stress also causes cell swellingwhich, if left un-
corrected by RVD, leads to impaired fertilisation, likely due to excessive
bending of the sperm tail inside the uterus [161]. If AQP3 was simply
acting passively as a water channel, RVD would not be abolished in
AQP3−/− sperm but rather the timescale onwhich the cell reaches os-
motic equilibrium would be increased. A possible explanation for re-
duced fertility and altered RVD in AQP3−/− mice is therefore that
AQP3, either alone or as part of a macromolecular complex which is
disrupted by AQP3 knockout, is involved in the signalling pathway
that activates RVD in sperm.
In a further example, when exposed to a hypotonic extracellular so-
lution, cultured renal cortical collecting duct (CCD) cells, which do not
endogenously express AQP2, swelled in proportion to the change in ex-
tracellular osmolality but did not exhibit RVD. However, when
transfected with AQP2, these cells showed an RVD of approximately
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40%. Shrinkage was mediated by Ca2+ inﬂux through TRPV4, which ac-
tivated Ca2+-dependent K+ and Cl− channels and Ca2+-dependent
Ca2+ release from intracellular stores. In renal CCD cells expressing
AQP2, hypotonic stress caused translocation of TRPV4 to the plasma
membrane. This response did not occur in AQP2-negative cells. When
TRPV4 was pre-translocated to the cell surface prior to hypotonic expo-
sure, RVD was recovered in AQP2-null cells, showing that it is not sim-
ply the high water permeability of AQP2 that allows RVD. However,
there did not appear to be any co-localisation between endogenous
TRPV4 and overexpressed AQP2 in this system, either before or after hy-
potonic shock, indicating a functional rather than physical interaction
[162]. These observations suggest that AQP2 forms part of a sensory
and signalling pathway that results in TRPV4 translocation, possibly
via sensing of extracellular osmolality.
In a nasopharyngeal cancer cell line, swelling-induced chloride
currents could be inhibited by siRNA-mediated knockdown of AQP3,
extracellular application of CuCl2 (a non-speciﬁc AQP3 inhibitor) or in-
jection of AQP3 antibodies via recording pipettes. AQP3 also co-
immunoprecipitated with the ClC3 chloride channel in this system
[163]. The effect of the current-inhibiting treatments on AQP3-ClC3 in-
teraction or ClC3 subcellular localization was not investigated, but this
data suggests a role for AQP3 in RVD chloride efﬂux in these cells, pos-
sibly mediated via activation or localization of the ClC3 chloride
channel.
It has been suggested that AQPs could act as direct sensors of osmot-
ic gradients by coupling conformational changes of the protein to a
pressure gradient within the pore [164]. This argument relies on the
idea of the hydrostatic pressure within the pore and it is not clear that
the application of classical ﬂuidmechanics is applicable to a system typ-
ically consisting of b10 water molecules. Nonetheless it is an intriguing
idea, and taken together, these examples clearly support the idea of a
signalling or sensory role for AQPs in cell volume regulation beyond a
passive water conduction mechanism.
8. Regulation of membrane protein localization by AQPs
There is some evidence that the expression of one AQP can regulate
the expression, localization or membrane trafﬁcking of other AQPs and
of other membrane proteins.
AQP3−/−mice have polyuria and a urinary concentrating defect. In
the cortical collecting ducts of knockout mice, apical AQP2 expression
was reduced compared to controls and basolateral AQP4 localization
was completely absent. In contrast, medullary collecting duct levels of
both AQP2 and AQP4 was not different between wild-type and
AQP3−/−mice [105]. This may reﬂect a requirement of AQP3 for ex-
pression or trafﬁcking of AQPs 2 and 4 in certain cell types, although
these observations could also be due to regulation of AQPs 2 and 4 in re-
sponse to the polyuria phenotype.
AQP11−/− mice develop polycystic kidney disease (PKD). In
AQP11−/−mice, polycystin 1 (PC1), a protein towhich loss of function
mutations are associated with autosomal dominant PKD, was upregu-
lated twofold. However, the plasma membrane localization of PC1 was
almost completely abolished and PC1 was differentially glycosylated
in the AQP11−/−mice compared to AQP11+/+ [165]. Glycosylation
of some membrane proteins is a crucial step in protein folding and pas-
sage through the ER quality control system [166]. Othermembrane pro-
teins (AQP1 and PC2) were correctly glycosylated, suggesting that this
was a PC1 speciﬁc effect. This data suggests that AQP11 can regulate
the surface expression of PC1, possibly by mediating an interaction
with a glycosyltransferase or part of the ER quality control system.
The interactions between the stretch-activated cation channel
TRPV4 and both AQP2 and AQP5 has been discussed in Section 6. Brieﬂy,
expression of these AQPs was required for the hypotonicity-induced
translocation of TRPV4 to the plasma membrane associated with RVD
[159,162]. It may be that in these systems, AQPs and TRPV4 are present
in the same vesicles, but the trafﬁcking machinery interacts only with
the AQP. We have recently described hypotonicity-induced transloca-
tion of AQP1 in HEK293 cells [145] and AQP4 in primary rat astrocytes
[167], so this may reﬂect a general regulatory mechanism by which
AQPs can mediate the subcellular localization of other membrane
proteins.
The histone methyltransferase Dot1a was shown to inhibit the ex-
pression of AQP5 in murine renal cells. Knocking out Dot1a led to
AQP5 expression in these cells. The total level of AQP2 expression was
unchanged in the presence of AQP5, but AQP2 membrane trafﬁcking
was impaired. In addition to this, co-transfection of AQP5 and AQP2
into IMCD3 cells reduced AQP2 surface expression compared to transfec-
tion of AQP2 alone, suggesting that AQP5 can regulate AQP2 localization.
Furthermore, AQP2 and AQP5 co-immunoprecipitatedwith one another,
suggesting a direct physical interaction [168]. The stoichiometry of the
AQP2/AQP5 complexes was not investigated, so it is not clear whether
the interactionwas betweenAQP2 andAQP5homotetramers, or through
the formation of AQP2/AQP5 heterotetramers (which is an established
regulatory mechanism employed by some plant AQPs [169]).
9. AQPs and cell–cell adhesion
Adhesion of cells to one another is a vital process that paved theway
for evolution of multicellular organisms, and allows for the formation of
the varied and complex structures thatmake up the anatomyofmodern
animals and plants.
There is evidence that some AQPs can perform a cell–cell adhesion
function by forming a direct interaction with a membrane component
on an adjacent cell (possibly another AQP molecule). This is well
established for AQP0 and there is controversial evidence that AQP4
may also be able to perform this function.
9.1. AQP0
AQP0 (also called MIP, for lens Membrane Intrinsic Protein) is
expressed primarily in lens ﬁbre cells, which are cells of the eye special-
ized to form a tightly-packed transparent layer that scatters a minimal
amount of incident light to support the function of the eye [8]. It is the
most highly expressed membrane protein in these cells (45% by molar-
ity of all lensﬁbremembrane protein inmice [170]). AQP0 tetramers as-
semble into large arrays in junctional microdomains [171], which
dynamically associate and dissociate at the array edges, with only an es-
timated 1% existing as free tetramers at a given time,measured by high-
speed atomic force microscopy of isolated sheep lens ﬁbre membranes
[172].
Knockout studies and a variety of naturally-occurring AQP0 muta-
tions in humans and mice [8] consistently show that loss of AQP0 func-
tion in the lens ﬁbre cells causes cataracts, likely via loss of the tight
packing of the cells required to minimise light scattering. It has also
been suggested, based on analysis of lenses of AQP0−/− and −/+
mice, that AQP0 is vital for creating the lens refractive index gradient re-
quired to minimise spherical aberration, via an unknown mechanism
[173].
A qualitative analysis of lens ﬁbre cell–cell adhesion in AQP0−/−
mice showed that transgenic expression of AQP1 in the AQP0−/−
model could not rescue ﬁbre adhesion [4], nor correct lens transparency
defects [174], supporting the idea that the role of AQP0 in lens physiol-
ogy is not related to membrane water permeability. Furthermore, ex-
pression of AQP0 in several in vitro model systems consistently shows
that it is able to mediate cell–cell adhesion [175].
Early biophysical work on AQP0 proteoliposomes showed that AQP0
is able to mediate interactions with membranes containing negatively
charged lipids [176]. It was suggested that this is due to the presence
of several positively charged (and no negatively charged) residues in
the extracellular loops A, C and E of AQP0. In humanAQP0 this positively
charged surface ismadeup of two arginine residues (R33 and R113) and
three histidine residues (H40, H122 and H201).
2417P. Kitchen et al. / Biochimica et Biophysica Acta 1850 (2015) 2410–2421
A naturally occurring AQP0 mutation, R33C, showed a reduction in
cell–cell adhesion of 18, 27 or 34% (depending on methodology) for
the mutant when compared to wild-type AQP0, despite no effect on
membrane localization [177]. This suggests that removal of the con-
served positive charge in loop A has a deleterious effect on AQP0-
mediated cell adhesion, supporting the idea of a positively charged
face of AQP0 that forms electrostatic interactions with negatively
charged molecules on an adjacent membrane. It is also possible that
addition of the cysteine sulfhydryl group facilitates a novel post-
translational modiﬁcation that inhibits adhesive interactions.
Crystallographic analyses of AQP0 suggest a differentmodel of AQP0
mediated cell–cell adhesion in which AQP0 molecules on adjacent cells
interact with one another directly. An electron crystal structure of
double-layered 2D AQP0 crystals suggested that two AQP0 molecules
on adjacent membranes might be able form an interaction via their ex-
tracellular loops, primarily mediated by proline residues [178]. Follow-
up work showed that the way in which the AQP0 extracellular domains
(ECDs) interact in these crystals is strongly dependent on the
headgroup of co-crystallized lipids [179]. It has been suggested, based
on comparison of the electron structure with a 3D X-ray structure of
full-length AQP0 [180], that a conformational change in loop A induced
by proteolytic truncation of the C-terminus (which is observed in vivo
[8]) could facilitate direct binding of AQP0 molecules to one another
[181]. However biochemical analysis showed that truncation of either
the N- or C-terminus has no effect on the adhesion properties of AQP0
[182].
Experiments with a fusion protein consisting of the sequences of the
three extracellular loops of AQP0 fused directly adjacent to one another
showed that this protein was able to competitively inhibit AQP0 medi-
ated cell–cell adhesion [183]. Given the relative location of the three
loops in the AQP0 fold and the lack of transmembrane anchoring in
the fusion protein, it is very unlikely that this protein is structurally sim-
ilar to the ECD of intact AQP0. The fact that, despite this, it functions as
an inhibitor of AQP0 mediated cell–cell adhesion does not support the
idea of the adhesion being mediated by direct AQP0–AQP0 binding,
whichwould depend on the structure of the ECD. It does, however, sup-
port the idea of mediation via an (structure independent) electrostatic
interaction between the positively charged AQP0 ECD and a negatively
charged membrane component on an adjacent cell.
9.2. AQP4
AQP4 is a water-selective AQP primarily expressed in glial cells (as-
trocytes and retinal Müller cells) of the central nervous system and the
basolateralmembranes of kidney collecting duct cells [155]. AQP4 exists
in two major isoforms (although there is emerging evidence of further
isoforms [184]). These are the long (323 amino acids) M1 isoform and
the shorter (301 amino acids) M23 isoform, named for the position of
the N-terminal methionine. Similarly to AQP0, the M23 isoform of
AQP4 is able to form large supramolecular arrays (termed OAPs for Or-
thogonal Array of Particles).
Electron crystallography of double-layered 2D AQP4-M23 crystals
suggested that AQP4 molecules on adjacent cells could interact via
their ECDs in a similar way to that suggested for AQP0, again mediated
by interaction between proline residues [185]. In the same study, AQP4-
M23 was shown to facilitate cell–cell interactions between adhesion-
deﬁcientmouseﬁbroblasts. This resultwas corroborated in a similar ex-
perimental system, and it was shown that the adhesion generated by
AQP4-M23 was considerably weaker than that by AQP0. Furthermore,
AQP4-M1 was shown not to facilitate adhesion [175]. Another study in
the same experimental system failed to reproduce these results and fur-
thermore failed to ﬁnd AQP4-mediated adhesion in primarymouse glia
or AQP4-transfected CHO cell membrane vesicles [186].
Transfection of AQP4-M23 into a glioblastoma cell line (D54, which
lacks endogenous AQP4 expression) increased adhesion of the cells to
collagen, ﬁbronectin, laminin, and vitronectin substrates [187]. Clearly
this is not due to any potential cell–cell adhesion properties of AQP4
and the lack of substrate speciﬁcity makes this a difﬁcult result to inter-
pret. However, AQP4-M23was shown to preferentially localise tomem-
brane–substrate adhesion sites [188], so it is possible that AQP4-M23
could facilitate aggregation or localization of adhesionmolecules, there-
by having an indirect effect on cellular adhesion, both to other cells and
to basement membrane components.
10. Conclusion
Mammalian AQPs are primarily known as facilitators of physiologi-
cal processes through bi-directional, passive water transport. We have
reviewed evidence demonstrating that this is far from all they do.
AQPs facilitate physiological processes by mediating the diffusion of
small, neutral solutes. This is best understood for AQP-mediated glycer-
ol transport that facilitates glycerol metabolism, triglyceride cycling and
skin hydration. AQPs also have a role in cell volume regulation and it is
becoming increasingly clear that this role can extend beyond simply
acting as a passive water pore and may involve AQP-mediated signal
transduction, although the mechanisms that may be involved in this
are notwell understood.Many cell types express several differentmem-
bers of the AQP family and there is emerging evidence that the different
members can interact with one another either physically or functional-
ly. The involvement of AQPs in human physiology and cellular homeo-
stasis goes far beyond their acting as simple water pores with
implications for a range of physiological processes and pathophysiolog-
ical conditions.
Transparency Document
The Transparency document associated with this article can be
found, in online version.
Acknowledgements
This work was supported by the Engineering and Physical Sciences
Research Council via a Molecular Organisation and Assembly in Cells
Doctoral Training Centre studentship to PK (grant no: EP/F500378/1).
RMB acknowledges funding from the Biotechnology and Biological Sci-
ences ResearchCouncil (BBSRC; via grants BB/I019960/1, BB/K013319/1
and BB/L502194/1) and the Innovative Medicines Joint Undertaking
under Grant Agreement no. 115583 to the ND4BB ENABLE Consortium.
References
[1] M.L. Kortenoeven, R.A. Fenton, Renal aquaporins and water balance disorders,
Biochim. Biophys. Acta 1840 (2014) 1533–1549.
[2] E.A. Nagelhus, O.P. Ottersen, Physiological roles of aquaporin-4 in brain, Physiol.
Rev. 93 (2013) 1543–1562.
[3] J. Lebeck, Metabolic impact of the glycerol channels AQP7 and AQP9 in adipose tis-
sue and liver, J. Mol. Endocrinol. 52 (2014) R165–R178.
[4] S.S. Kumari, S. Eswaramoorthy, R.T. Mathias, K. Varadaraj, Unique and analogous
functions of aquaporin 0 for ﬁber cell architecture and ocular lens transparency,
Biochim. Biophys. Acta 1812 (2011) 1089–1097.
[5] J. Badaut, A.M. Fukuda, A. Jullienne, K.G. Petry, Aquaporin and brain diseases,
Biochim. Biophys. Acta 1840 (2014) 1554–1565.
[6] L.S. King, M. Yasui, P. Agre, Aquaporins in health and disease, Mol. Med. Today 6
(2000) 60–65.
[7] D. Bockenhauer, D.G. Bichet, Pathophysiology, diagnosis and management of
nephrogenic diabetes insipidus, Nat. Rev. Nephrol. (2015).
[8] A.B. Chepelinsky, Structural function of MIP/aquaporin 0 in the eye lens; genetic
defects lead to congenital inherited cataracts, Handb. Exp. Pharmacol. (2009)
265–297.
[9] A. Madeira, T.F. Moura, G. Soveral, Aquaglyceroporins: implications in adipose biol-
ogy and obesity, Cell. Mol. Life Sci. 72 (2015) 759–771.
[10] J.Wang, L. Feng, Z. Zhu,M. Zheng, D.Wang, Z. Chen, H. Sun, Aquaporins as diagnos-
tic and therapeutic targets in cancer: how far we are? J. Transl. Med. 13 (2015) 96.
[11] D. Ribatti, G. Ranieri, T. Annese, B. Nico, Aquaporins in cancer, Biochim. Biophys.
Acta 1840 (2014) 1550–1553.
[12] F. Abascal, I. Irisarri, R. Zardoya, Diversity and evolution of membrane intrinsic pro-
teins, Biochim. Biophys. Acta 1840 (2014) 1468–1481.
2418 P. Kitchen et al. / Biochimica et Biophysica Acta 1850 (2015) 2410–2421
[13] B. Yang, A.S. Verkman, Water and glycerol permeabilities of aquaporins 1–5 and
MIP determined quantitatively by expression of epitope-tagged constructs in
Xenopus oocytes, J. Biol. Chem. 272 (1997) 16140–16146.
[14] K.L. Nemeth-Cahalan, K. Kalman, J.E. Hall, Molecular basis of pH and Ca2+ regula-
tion of aquaporin water permeability, J. Gen. Physiol. 123 (2004) 573–580.
[15] A.K. Meinild, D.A. Klaerke, T. Zeuthen, Bidirectional water ﬂuxes and speciﬁcity for
small hydrophilic molecules in aquaporins 0–5, J. Biol. Chem. 273 (1998)
32446–32451.
[16] R.R. Geyer, R. Musa-Aziz, X. Qin,W.F. Boron, Relative CO2/NH3 selectivities of mam-
malian aquaporins 0–9, Am. J. Physiol. Cell Physiol. 304 (2013) C985–C994.
[17] L.M. Holm, T.P. Jahn, A.L. Moller, J.K. Schjoerring, D. Ferri, D.A. Klaerke, T. Zeuthen,
NH3 and NH4+ permeability in aquaporin-expressing Xenopus oocytes, Pﬂugers
Arch. - Eur. J. Physiol. 450 (2005) 415–428.
[18] M. Echevarria, E.E. Windhager, S.S. Tate, G. Frindt, Cloning and expression of AQP3,
a water channel from the medullary collecting duct of rat kidney, Proc. Natl. Acad.
Sci. U. S. A. 91 (1994) 10997–11001.
[19] A. Herraiz, F. Chauvigne, J. Cerda, X. Belles, M.D. Piulachs, Identiﬁcation and func-
tional characterization of an ovarian aquaporin from the cockroach Blattella
germanica L. (Dictyoptera, Blattellidae), J. Exp. Biol. 214 (2011) 3630–3638.
[20] J.S. Jung, R.V. Bhat, G.M. Preston, W.B. Guggino, J.M. Baraban, P. Agre, Molecular
characterization of an aquaporin cDNA from brain: candidate osmoreceptor and
regulator of water balance, Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 13052–13056.
[21] S. Raina, G.M. Preston, W.B. Guggino, P. Agre, Molecular cloning and characteriza-
tion of an aquaporin cDNA from salivary, lacrimal, and respiratory tissues, J. Biol.
Chem. 270 (1995) 1908–1912.
[22] M. Yasui, A. Hazama, T.H. Kwon, S. Nielsen, W.B. Guggino, P. Agre, Rapid gating and
anion permeability of an intracellular aquaporin, Nature 402 (1999) 184–187.
[23] H. Nagase, J. Agren, A. Saito, K. Liu, P. Agre, A. Hazama,M. Yasui,Molecular cloning and
characterization of mouse aquaporin 6, Biochem. Biophys. Res. Commun. 352 (2007)
12–16.
[24] A. Hazama, D. Kozono, W.B. Guggino, P. Agre, M. Yasui, Ion permeation of AQP6
water channel protein. Single channel recordings after Hg2+ activation, J. Biol.
Chem. 277 (2002) 29224–29230.
[25] K. Liu, D. Kozono, Y. Kato, P. Agre, A. Hazama, M. Yasui, Conversion of aquaporin 6
from an anion channel to a water-selective channel by a single amino acid substi-
tution, Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2192–2197.
[26] L.M. Holm, D.A. Klaerke, T. Zeuthen, Aquaporin 6 is permeable to glycerol and urea,
Pﬂugers Arch. - Eur. J. Physiol. 448 (2004) 181–186.
[27] K. Ishibashi, M. Kuwahara, Y. Gu, Y. Kageyama, A. Tohsaka, F. Suzuki, F. Marumo, S.
Sasaki, Cloning and functional expression of a new water channel abundantly
expressed in the testis permeable to water, glycerol, and urea, J. Biol. Chem. 272
(1997) 20782–20786.
[28] K. Liu, H. Nagase, C.G. Huang, G. Calamita, P. Agre, Puriﬁcation and functional char-
acterization of aquaporin-8, Biol. Cell 98 (2006) 153–161.
[29] Y. Koyama, T. Yamamoto, D. Kondo, H. Funaki, E. Yaoita, K. Kawasaki, N. Sato, K.
Hatakeyama, I. Kihara, Molecular cloning of a new aquaporin from rat pancreas
and liver, J. Biol. Chem. 272 (1997) 30329–30333.
[30] T. Ma, B. Yang, A.S. Verkman, Cloning of a novel water and urea-permeable aqua-
porin frommouse expressed strongly in colon, placenta, liver, and heart, Biochem.
Biophys. Res. Commun. 240 (1997) 324–328.
[31] T.P. Jahn, A.L.B. Moller, T. Zeuthen, L.M. Holm, D.A. Klaerke, B. Mohsin, W.
Kuhlbrandt, J.K. Schjoerring, Aquaporin homologues in plants andmammals trans-
port ammonia, FEBS Lett. 574 (2004) 31–36.
[32] J.M. Carbrey, D.A. Gorelick-Feldman, D. Kozono, J. Praetorius, S. Nielsen, P. Agre,
Aquaglyceroporin AQP9: solute permeation and metabolic control of expression
in liver, Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2945–2950.
[33] K. Ishibashi, T. Morinaga, M. Kuwahara, S. Sasaki, M. Imai, Cloning and identiﬁca-
tion of a newmember of water channel (AQP10) as an aquaglyceroporin, Biochim.
Biophys. Acta 1576 (2002) 335–340.
[34] M. Ikeda, A. Andoo, M. Shimono, N. Takamatsu, A. Taki, K. Muta, W.
Matsushita, T. Uechi, T. Matsuzaki, N. Kenmochi, K. Takata, S. Sasaki, K. Ito,
K. Ishibashi, The NPC motif of aquaporin-11, unlike the NPA motif of known
aquaporins, is essential for full expression of molecular function, J. Biol.
Chem. 286 (2011) 3342–3350.
[35] K. Yakata, K. Tani, Y. Fujiyoshi, Water permeability and characterization of
aquaporin-11, J. Struct. Biol. 174 (2011) 315–320.
[36] A. Madeira, S. Fernandez-Veledo, M. Camps, A. Zorzano, T.F. Moura, V. Ceperuelo-
Mallafre, J. Vendrell, G. Soveral, Human aquaporin-11 is a water and glycerol chan-
nel and localizes in the vicinity of lipid droplets in human adipocytes, Obesity 22
(2014) 2010–2017.
[37] U. Kosinska Eriksson, G. Fischer, R. Friemann, G. Enkavi, E. Tajkhorshid, R. Neutze,
Subangstrom resolution X-ray structure details aquaporin–water interactions, Sci-
ence 340 (2013) 1346–1349.
[38] A. Horner, F. Zocher, J. Preiner, N. Ollinger, C. Siligan, S.A. Akimov, P. Pohl, The mo-
bility of single-ﬁle water molecules is governed by the number of H-bonds they
may form with channel-lining residues, Sci. Adv. 1 (2015), e1400083.
[39] E. Tajkhorshid, P. Nollert, M.O. Jensen, L.J. Miercke, J. O'Connell, R.M. Stroud, K.
Schulten, Control of the selectivity of the aquaporinwater channel family by global
orientational tuning, Science 296 (2002) 525–530.
[40] D. Fu, A. Libson, L.J. Miercke, C. Weitzman, P. Nollert, J. Krucinski, R.M. Stroud, Struc-
ture of a glycerol-conducting channel and the basis for its selectivity, Science 290
(2000) 481–486.
[41] J. Sjohamn, K. Hedfalk, Unraveling aquaporin interaction partners, Biochim.
Biophys. Acta 1840 (2014) 1614–1623.
[42] A. Frick, U.K. Eriksson, F. deMattia, F. Oberg, K. Hedfalk, R. Neutze,W.J. de Grip, P.M.
Deen, S. Tornroth-Horseﬁeld, X-ray structure of human aquaporin 2 and its
implications for nephrogenic diabetes insipidus and trafﬁcking, Proc. Natl. Acad.
Sci. U. S. A. 111 (2014) 6305–6310.
[43] J.D. Ho, R. Yeh, A. Sandstrom, I. Chorny,W.E. Harries, R.A. Robbins, L.J. Miercke, R.M.
Stroud, Crystal structure of human aquaporin 4 at 1.8 A and its mechanism of con-
ductance, Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 7437–7442.
[44] J. Jiang, B.V. Daniels, D. Fu, Crystal structure of AqpZ tetramer reveals two dis-
tinct Arg-189 conformations associated with water permeation through the
narrowest constriction of the water-conducting channel, J. Biol. Chem. 281
(2006) 454–460.
[45] T. Walz, T. Hirai, K. Murata, J.B. Heymann, K. Mitsuoka, Y. Fujiyoshi, B.L. Smith, P.
Agre, A. Engel, The three-dimensional structure of aquaporin-1, Nature 387
(1997) 624–627.
[46] M.J. Borgnia, P. Agre, Reconstitution and functional comparison of puriﬁed GlpF
and AqpZ, the glycerol and water channels from Escherichia coli, Proc. Natl. Acad.
Sci. U. S. A. 98 (2001) 2888–2893.
[47] N. Roudier, P. Bailly, P. Gane, N. Lucien, R. Gobin, J.P. Cartron, P. Ripoche, Erythroid
expression and oligomeric state of the AQP3 protein, J. Biol. Chem. 277 (2002)
7664–7669.
[48] T. Itoh, T. Rai, M. Kuwahara, S.B. Ko, S. Uchida, S. Sasaki, K. Ishibashi, Identiﬁcation
of a novel aquaporin, AQP12, expressed in pancreatic acinar cells, Biochem.
Biophys. Res. Commun. 330 (2005) 832–838.
[49] D.A. Gorelick, J. Praetorius, T. Tsunenari, S. Nielsen, P. Agre, Aquaporin-11: a chan-
nel protein lacking apparent transport function expressed in brain, BMC Biochem.
7 (2006) 14.
[50] E. Beitz, B. Wu, L.M. Holm, J.E. Schultz, T. Zeuthen, Point mutations in the aromatic/
arginine region in aquaporin 1 allow passage of urea, glycerol, ammonia, and pro-
tons, Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 269–274.
[51] Y.Wang, K. Schulten, E. Tajkhorshid,Whatmakes an aquaporin a glycerol channel?
A comparative study of AqpZ and GlpF, Structure 13 (2005) 1107–1118.
[52] D.F. Savage, J.D. O'Connell 3rd, L.J. Miercke, J. Finer-Moore, R.M. Stroud, Structural
context shapes the aquaporin selectivity ﬁlter, Proc. Natl. Acad. Sci. U. S. A. 107
(2010) 17164–17169.
[53] K. Kishida, H. Kuriyama, T. Funahashi, I. Shimomura, S. Kihara, N. Ouchi, M. Nishida,
H. Nishizawa, M. Matsuda, M. Takahashi, K. Hotta, T. Nakamura, S. Yamashita, Y.
Tochino, Y. Matsuzawa, Aquaporin adipose, a putative glycerol channel in adipo-
cytes, J. Biol. Chem. 275 (2000) 20896–20902.
[54] M.T. Skowronski, J. Lebeck, A. Rojek, J. Praetorius, E.M. Fuchtbauer, J. Frokiaer, S.
Nielsen, AQP7 is localized in capillaries of adipose tissue, cardiac and striated mus-
cle: implications in glycerol metabolism, Am. J. Physiol. Renal Physiol. 292 (2007)
F956–F965.
[55] R.E. Duncan, M. Ahmadian, K. Jaworski, E. Sarkadi-Nagy, H.S. Sul, Regulation of li-
polysis in adipocytes, Annu. Rev. Nutr. 27 (2007) 79–101.
[56] B.J. Lipworth, Clinical pharmacology of beta 3-adrenoceptors, Br. J. Clin. Pharmacol.
42 (1996) 291–300.
[57] T. Miyauchi, H. Yamamoto, Y. Abe, G.J. Yoshida, A. Rojek, E. Sohara, S. Uchida, S.
Nielsen, M. Yasui, Dynamic subcellular localization of aquaporin-7 in white adipo-
cytes, FEBS Lett. 589 (2015) 608–614.
[58] M. Vaughan, The production and release of glycerol by adipose tissue incubated
in vitro, J. Biol. Chem. 237 (1962) 3354–3358.
[59] M. Hara-Chikuma, E. Sohara, T. Rai, M. Ikawa, M. Okabe, S. Sasaki, S. Uchida, A.S.
Verkman, Progressive adipocyte hypertrophy in aquaporin-7-deﬁcient mice: adi-
pocyte glycerol permeability as a novel regulator of fat accumulation, J. Biol.
Chem. 280 (2005) 15493–15496.
[60] N. Maeda, T. Funahashi, T. Hibuse, A. Nagasawa, K. Kishida, H. Kuriyama, T.
Nakamura, S. Kihara, I. Shimomura, Y. Matsuzawa, Adaptation to fasting by glycer-
ol transport through aquaporin 7 in adipose tissue, Proc. Natl. Acad. Sci. U. S. A. 101
(2004) 17801–17806.
[61] H. Kondo, I. Shimomura, K. Kishida, H. Kuriyama, Y. Makino, H. Nishizawa, M.
Matsuda, N. Maeda, H. Nagaretani, S. Kihara, Y. Kurachi, T. Nakamura, T.
Funahashi, Y. Matsuzawa, Human aquaporin adipose (AQPap) gene. Genomic
structure, promoter analysis and functional mutation, Eur. J. Biochem. 269
(2002) 1814–1826.
[62] U. Laforenza, M.F. Scafﬁno, G. Gastaldi, Aquaporin-10 represents an alterna-
tive pathway for glycerol efﬂux from human adipocytes, PLoS One 8 (2013),
e54474.
[63] T. Morinaga, M. Nakakoshi, A. Hirao, M. Imai, K. Ishibashi, Mouse aquaporin 10
gene (AQP10) is a pseudogene, Biochem. Biophys. Res. Commun. 294 (2002)
630–634.
[64] E.C. Lin, Glycerol utilization and its regulation inmammals, Annu. Rev. Biochem. 46
(1977) 765–795.
[65] W.M. Bortz, P. Paul, A.C. Haff, W.L. Holmes, Glycerol turnover and oxidation inman,
J. Clin. Invest. 51 (1972) 1537–1546.
[66] C.F. Borchgrevink, R.J. Havel, Transport of glycerol in human blood, Proc. Soc. Exp.
Biol. Med., 113 (1963) 946–949.
[67] J.L. Nelson, M.E. Harmon, R.A. Robergs, Identifying plasma glycerol concentration as-
sociated with urinary glycerol excretion in trained humans, J. Anal. Toxicol. 35
(2011) 617–623.
[68] E. Sohara, T. Rai, J. Miyazaki, A.S. Verkman, S. Sasaki, S. Uchida, Defective water and
glycerol transport in the proximal tubules of AQP7 knockout mice, Am. J. Physiol.
Renal Physiol. 289 (2005) F1195–F1200.
[69] C. Goubau, J. Jaeken, E.N. Levtchenko, C. Thys, M. Di Michele, G.A. Martens, E. Gerlo,
R. De Vos, G.M. Buyse, N. Goemans, C. Van Geet, K. Freson, Homozygosity for aqua-
porin 7 G264V in three unrelated childrenwith hyperglyceroluria and amild plate-
let secretion defect, Genet. Med. 15 (2013) 55–63.
[70] W.P. Russ, D.M. Engelman, The GxxxG motif: a framework for transmembrane
helix–helix association, J. Mol. Biol. 296 (2000) 911–919.
2419P. Kitchen et al. / Biochimica et Biophysica Acta 1850 (2015) 2410–2421
[71] H. Tsukaguchi, C. Shayakul, U.V. Berger, B. Mackenzie, S. Devidas, W.B. Guggino,
A.N. van Hoek, M.A. Hediger, Molecular characterization of a broad selectivity neu-
tral solute channel, J. Biol. Chem. 273 (1998) 24737–24743.
[72] M. Elkjaer, Z. Vajda, L.N. Nejsum, T. Kwon, U.B. Jensen, M. Amiry-
Moghaddam, J. Frokiaer, S. Nielsen, Immunolocalization of AQP9 in liver, ep-
ididymis, testis, spleen, and brain, Biochem. Biophys. Res. Commun. 276
(2000) 1118–1128.
[73] S.J. Pilkis, D.K. Granner, Molecular physiology of the regulation of hepatic gluco-
neogenesis and glycolysis, Annu. Rev. Physiol. 54 (1992) 885–909.
[74] R.A. Fenton, C.L. Chou, G.S. Stewart, C.P. Smith, M.A. Knepper, Urinary concentrat-
ing defect in mice with selective deletion of phloretin-sensitive urea transporters
in the renal collecting duct, Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7469–7474.
[75] G. Calamita, P. Gena, D. Ferri, A. Rosito, A. Rojek, S. Nielsen, R.A. Marinelli, G. Fruhbeck,
M. Svelto, Biophysical assessment of aquaporin-9 as principal facilitative pathway in
mouse liver import of glucogenetic glycerol, Biol. Cell. 104 (2012) 342–351.
[76] A.M. Rojek, M.T. Skowronski, E.M. Fuchtbauer, A.C. Fuchtbauer, R.A. Fenton, P. Agre,
J. Frokiaer, S. Nielsen, Defective glycerol metabolism in aquaporin 9 (AQP9) knock-
out mice, Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 3609–3614.
[77] N. Zhang, M.J. Bevan, CD8(+) T cells: foot soldiers of the immune system, Immu-
nity 35 (2011) 161–168.
[78] G. Cui, M.M. Staron, S.M. Gray, P.C. Ho, R.A. Amezquita, J. Wu, S.M. Kaech, IL-7-in-
duced glycerol transport and TAG synthesis promotes memory CD8+ T cell lon-
gevity, Cell 161 (2015) 750–761.
[79] R. Sougrat, M. Morand, C. Gondran, P. Barre, R. Gobin, F. Bonte, M. Dumas, J.M.
Verbavatz, Functional expression of AQP3 in human skin epidermis and recon-
structed epidermis, J. Invest. Dermatol. 118 (2002) 678–685.
[80] T. Ma, M. Hara, R. Sougrat, J.M. Verbavatz, A.S. Verkman, Impaired stratum
corneum hydration in mice lacking epidermal water channel aquaporin-3, J. Biol.
Chem. 277 (2002) 17147–17153.
[81] M. Hara, T. Ma, A.S. Verkman, Selectively reduced glycerol in skin of aquaporin-3-
deﬁcient mice may account for impaired skin hydration, elasticity, and barrier re-
covery, J. Biol. Chem. 277 (2002) 46616–46621.
[82] C.L. Froebe, F.A. Simion, H. Ohlmeyer, L.D. Rhein, J. Mattai, R.H. Cagan, S.E. Friberg, Pre-
vention of stratum-corneum lipid phase-transitions invitro by glycerol — an alterna-
tive mechanism for skin moisturization, J. Soc. Cosmet. Chem. 41 (1990) 51–65.
[83] S.E. Friberg, I. Kayali, L. Rhein, Direct role of linoleic-acid in barrier function— effect
of linoleic-acid on the crystalline-structure of oleic-acid oleate model stratum-
corneum lipid, J. Dispers. Sci. Technol. 11 (1990) 31–47.
[84] M. Hara, A.S. Verkman, Glycerol replacement corrects defective skin hydration,
elasticity, and barrier function in aquaporin-3-deﬁcient mice, Proc. Natl. Acad.
Sci. U. S. A. 100 (2003) 7360–7365.
[85] M.D. Norenberg, K.V. Rama Rao, A.R. Jayakumar, Ammonia neurotoxicity and the
mitochondrial permeability transition, J. Bioenerg. Biomembr. 36 (2004) 303–307.
[86] J.S. Kim, L. He, J.J. Lemasters, Mitochondrial permeability transition: a common
pathway to necrosis and apoptosis, Biochem. Biophys. Res. Commun. 304 (2003)
463–470.
[87] F. Martini, J.L. Nath, Anatomy & Physiology, 2nd ed. Benjamin Cummings, San
Francisco, 2010.
[88] K. Ishibashi, M. Kuwahara, Y. Gu, Y. Tanaka, F. Marumo, S. Sasaki, Cloning and func-
tional expression of a new aquaporin (AQP9) abundantly expressed in the periph-
eral leukocytes permeable to water and urea, but not to glycerol, Biochem.
Biophys. Res. Commun. 244 (1998) 268–274.
[89] K. Ishibashi, S. Sasaki, K. Fushimi, S. Uchida, M. Kuwahara, H. Saito, T. Furukawa, K.
Nakajima, Y. Yamaguchi, T. Gojobori, et al., Molecular cloning and expression of a
member of the aquaporin family with permeability to glycerol and urea in addition
to water expressed at the basolateral membrane of kidney collecting duct cells,
Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 6269–6273.
[90] M. Echevarria, E.E. Windhager, G. Frindt, Selectivity of the renal collecting duct
water channel aquaporin-3, J. Biol. Chem. 271 (1996) 25079–25082.
[91] S. Jelen, P. Gena, J. Lebeck, A. Rojek, J. Praetorius, J. Frokiaer, R.A. Fenton, S. Nielsen,
G. Calamita, M. Rutzler, Aquaporin-9 and urea transporter-A gene deletions affect
urea transmembrane passage in murine hepatocytes, Am. J. Physiol. Gastrointest.
Liver Physiol. 303 (2012) G1279–G1287.
[92] I.D.Weiner, W.E. Mitch, J.M. Sands, Urea and ammoniametabolism and the control
of renal nitrogen excretion, Clin. J. Am. Soc. Nephrol. (2014).
[93] S.M. Saparov, K. Liu, P. Agre, P. Pohl, Fast and selective ammonia transport by
aquaporin-8, J. Biol. Chem. 282 (2007) 5296–5301.
[94] B. Yang, Y. Song, D. Zhao, A.S. Verkman, Phenotype analysis of aquaporin-8 null
mice, Am. J. Physiol. Cell Physiol. 288 (2005) C1161–C1170.
[95] G. Calamita, D. Ferri, P. Gena, G.E. Liquori, A. Cavalier, D. Thomas, M. Svelto,
The inner mitochondrial membrane has aquaporin-8 water channels and is
highly permeable to water, J. Biol. Chem. 280 (2005) 17149–17153.
[96] B. Yang, D. Zhao, E. Solenov, A.S. Verkman, Evidence from knockout mice against
physiologically signiﬁcant aquaporin 8-facilitated ammonia transport, Am. J. Phys-
iol. Cell Physiol. 291 (2006) C417–C423.
[97] A.M. Marini, G. Matassi, V. Raynal, B. Andre, J.P. Cartron, B. Cherif-Zahar, The
human Rhesus-associated RhAG protein and a kidney homologue promote ammo-
nium transport in yeast, Nat. Genet. 26 (2000) 341–344.
[98] I.D.Weiner, R.T. Miller, J.W. Verlander, Localization of the ammonium transporters,
Rh B glycoprotein and Rh C glycoprotein, in the mouse liver, Gastroenterology 124
(2003) 1432–1440.
[99] I.D. Weiner, J.W. Verlander, Role of NH3 and NH4+ transporters in renal acid–base
transport, Am. J. Physiol. Renal Physiol. 300 (2011) F11–F23.
[100] D. Goossens, M.M. Trinh-Trang-Tan, M. Debbia, P. Ripoche, C. Vilela-Lamego, F.
Louache, W. Vainchenker, Y. Colin, J.P. Cartron, Generation and characterisation
of Rhd and Rhag null mice, Br. J. Haematol. 148 (2010) 161–172.
[101] D. Goossens, V. Bony, P. Gane, Y. Colin, J.P. Cartron, Generation of mice with
inactivated Rh or Rhag genes, Transfus. Clin. Biol. 13 (2006) 164–166.
[102] L.R. Soria, J. Marrone, G. Calamita, R.A. Marinelli, Ammonia detoxiﬁcation via
ureagenesis in rat hepatocytes involves mitochondrial aquaporin-8 channels,
Hepatology 57 (2013) 2061–2071.
[103] S.M. Molinas, L. Trumper, R.A. Marinelli, Mitochondrial aquaporin-8 in renal prox-
imal tubule cells: evidence for a role in the response to metabolic acidosis, Am. J.
Physiol. Renal Physiol. 303 (2012) F458–F466.
[104] S.M. Molinas, L.R. Soria, J. Marrone, M. Danielli, L. Trumper, R.A. Marinelli, Acidosis-
induced downregulation of hepatocyte mitochondrial aquaporin-8 and
ureagenesis from ammonia, Biochem. Cell Biol. 93 (2015) 417–420.
[105] T. Ma, Y. Song, B. Yang, A. Gillespie, E.J. Carlson, C.J. Epstein, A.S. Verkman,
Nephrogenic diabetes insipidus in mice lacking aquaporin-3 water channels,
Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 4386–4391.
[106] M. Esbjornsson, J. Bulow, B. Norman, L. Simonsen, J. Nowak, O. Rooyackers, L.
Kaijser, E. Jansson, Adipose tissue extracts plasma ammonia after sprint exercise
in women and men, J. Appl. Physiol. 101 (2006) 1576–1580.
[107] V. Endeward, J.P. Cartron, P. Ripoche, G. Gros, RhAG protein of the Rhesus complex
is a CO2 channel in the human red cell membrane, FASEB J. 22 (2008) 64–73.
[108] M.E. Blank, H. Ehmke, Aquaporin-1 and HCO3−-Cl− transporter-mediated transport
of CO2 across the human erythrocyte membrane, J. Physiol. 550 (2003) 419–429.
[109] G.M. Preston, T.P. Carroll, W.B. Guggino, P. Agre, Appearance of water channels in
Xenopus oocytes expressing red cell CHIP28 protein, Science 256 (1992) 385–387.
[110] N.L. Nakhoul, B.A. Davis, M.F. Romero, W.F. Boron, Effect of expressing the water
channel aquaporin-1 on the CO2 permeability of Xenopus oocytes, Am. J. Physiol.
274 (1998) C543–C548.
[111] G.J. Cooper, W.F. Boron, Effect of PCMBS on CO2 permeability of Xenopus oocytes
expressing aquaporin 1 or its C189S mutant, Am. J. Physiol. 275 (1998)
C1481–C1486.
[112] V. Endeward, R. Musa-Aziz, G.J. Cooper, L.M. Chen, M.F. Pelletier, L.V. Virkki, C.T.
Supuran, L.S. King, W.F. Boron, G. Gros, Evidence that aquaporin 1 is a major
pathway for CO2 transport across the human erythrocyte membrane, FASEB J.
20 (2006) 1974–1981.
[113] B. Yang, N. Fukuda, A. van Hoek,M.A. Matthay, T. Ma, A.S. Verkman, Carbon dioxide
permeability of aquaporin-1 measured in erythrocytes and lung of aquaporin-1
null mice and in reconstituted proteoliposomes, J. Biol. Chem. 275 (2000)
2686–2692.
[114] G.V. Prasad, L.A. Coury, F. Finn, M.L. Zeidel, Reconstituted aquaporin 1 water chan-
nels transport CO2 across membranes, J. Biol. Chem. 273 (1998) 33123–33126.
[115] Y.Wang, J. Cohen,W.F. Boron, K. Schulten, E. Tajkhorshid, Exploring gas permeabil-
ity of cellular membranes and membrane channels with molecular dynamics, J.
Struct. Biol. 157 (2007) 534–544.
[116] J.S. Hub, B.L. de Groot, Does CO2 permeate through aquaporin-1? Biophys. J. 91
(2006) 842–848.
[117] Y. Wang, S.A. Shaikh, E. Tajkhorshid, Exploring transmembrane diffusion pathways
with molecular dynamics, Physiology 25 (2010) 142–154.
[118] F. Itel, S. Al-Samir, F. Oberg, M. Chami, M. Kumar, C.T. Supuran, P.M. Deen, W.
Meier, K. Hedfalk, G. Gros, V. Endeward, CO2 permeability of cell membranes is
regulated by membrane cholesterol and protein gas channels, FASEB J. 26 (2012)
5182–5191.
[119] J.S. Hub, F.K. Winkler, M. Merrick, B.L. de Groot, Potentials of mean force and per-
meabilities for carbon dioxide, ammonia, and water ﬂux across a Rhesus protein
channel and lipid membranes, J. Am. Chem. Soc. 132 (2010) 13251–13263.
[120] M. Echevarria, A.M. Munoz-Cabello, R. Sanchez-Silva, J.J. Toledo-Aral, J. Lopez-
Barneo, Development of cytosolic hypoxia and hypoxia-inducible factor stabiliza-
tion are facilitated by aquaporin-1 expression, J. Biol. Chem. 282 (2007)
30207–30215.
[121] G. Li, V. Santoni, C. Maurel, Plant aquaporins: roles in plant physiology, Biochim.
Biophys. Acta 1840 (2014) 1574–1582.
[122] R. Kaldenhoff, L. Kai, N. Uehlein, Aquaporins and membrane diffusion of CO2 in liv-
ing organisms, Biochim. Biophys. Acta 1840 (2014) 1592–1595.
[123] L.A. Sena, N.S. Chandel, Physiological roles of mitochondrial reactive oxygen spe-
cies, Mol. Cell 48 (2012) 158–167.
[124] Y. Sheng, I.A. Abreu, D.E. Cabelli, M.J. Maroney, A.F. Miller, M. Teixeira, J.S.
Valentine, Superoxide dismutases and superoxide reductases, Chem. Rev. 114
(2014) 3854–3918.
[125] G.P. Bienert, J.K. Schjoerring, T.P. Jahn, Membrane transport of hydrogen peroxide,
Biochim. Biophys. Acta 1758 (2006) 994–1003.
[126] M. Reth, Hydrogen peroxide as second messenger in lymphocyte activation, Nat.
Immunol. 3 (2002) 1129–1134.
[127] A. Almasalmeh, D. Krenc, B. Wu, E. Beitz, Structural determinants of the hydrogen
peroxide permeability of aquaporins, FEBS J. 281 (2014) 647–656.
[128] E.W. Miller, B.C. Dickinson, C.J. Chang, Aquaporin-3 mediates hydrogen peroxide
uptake to regulate downstream intracellular signaling, Proc. Natl. Acad. Sci. U. S.
A. 107 (2010) 15681–15686.
[129] M. Hara-Chikuma, S. Chikuma, Y. Sugiyama, K. Kabashima, A.S. Verkman, S. Inoue,
Y. Miyachi, Chemokine-dependent T cell migration requires aquaporin-3-mediated
hydrogen peroxide uptake, J. Exp. Med. 209 (2012) 1743–1752.
[130] F. Vieceli Dalla Sega, L. Zambonin, D. Fiorentini, B. Rizzo, C. Caliceti, L. Landi, S.
Hrelia, C. Prata, Speciﬁc aquaporins facilitate Nox-produced hydrogen peroxide
transport through plasma membrane in leukaemia cells, Biochim. Biophys. Acta
1843 (2014) 806–814.
[131] M.J. Marchissio, D.E. Frances, C.E. Carnovale, R.A. Marinelli, Mitochondrial
aquaporin-8 knockdown in human hepatoma HepG2 cells causes ROS-induced
mitochondrial depolarization and loss of viability, Toxicol. Appl. Pharmacol. 264
(2012) 246–254.
2420 P. Kitchen et al. / Biochimica et Biophysica Acta 1850 (2015) 2410–2421
[132] E.E. Tchekneva, Z. Khuchua, L.S. Davis, V. Kadkina, S.R. Dunn, S. Bachman, K.
Ishibashi, E.M. Rinchik, R.C. Harris, M.M. Dikov, M.D. Breyer, Single amino acid sub-
stitution in aquaporin 11 causes renal failure, J. Am. Soc. Nephrol. 19 (2008)
1955–1964.
[133] E.N. Atochina-Vasserman, A. Biktasova, E. Abramova, D.S. Cheng, V.V. Polosukhin,
H. Tanjore, S. Takahashi, H. Sonoda, L. Foye, C. Venkov, S.V. Ryzhov, S. Novitskiy,
N. Shlonimskaya, M. Ikeda, T.S. Blackwell, W.E. Lawson, A.J. Gow, R.C. Harris,
M.M. Dikov, E.E. Tchekneva, Aquaporin 11 insufﬁciency modulates kidney suscep-
tibility to oxidative stress, Am. J. Physiol. Renal Physiol. 304 (2013) F1295–F1307.
[134] G.P. Bienert, F. Chaumont, Aquaporin-facilitated transmembrane diffusion of hy-
drogen peroxide, Biochim. Biophys. Acta 1840 (2014) 1596–1604.
[135] M. Yasui, T.H. Kwon, M.A. Knepper, S. Nielsen, P. Agre, Aquaporin-6: an intracellular
vesicle water channel protein in renal epithelia, Proc. Natl. Acad. Sci. U. S. A. 96
(1999) 5808–5813.
[136] T. Ma, B. Yang, W.L. Kuo, A.S. Verkman, cDNA cloning and gene structure of a novel
water channel expressed exclusively in human kidney: evidence for a gene cluster
of aquaporins at chromosome locus 12q13, Genomics 35 (1996) 543–550.
[137] M. Ikeda, E. Beitz, D. Kozono, W.B. Guggino, P. Agre, M. Yasui, Characterization of
aquaporin-6 as a nitrate channel in mammalian cells. Requirement of pore-lining
residue threonine 63, J. Biol. Chem. 277 (2002) 39873–39879.
[138] D. Promeneur, T.H. Kwon, M. Yasui, G.H. Kim, J. Frokiaer, M.A. Knepper, P. Agre, S.
Nielsen, Regulation of AQP6 mRNA and protein expression in rats in response to
altered acid–base or water balance, Am. J. Physiol. Renal Physiol. 279 (2000)
F1014–F1026.
[139] X. Qin, W.F. Boron, Mutation of a single amino acid converts the human water
channel aquaporin 5 into an anion channel, Am. J. Physiol. Cell Physiol. 305
(2013) C663–C672.
[140] J.W. Lee, Y. Zhang, C.D. Weaver, N.H. Shomer, C.F. Louis, D.M. Roberts, Phosphory-
lation of nodulin 26 on serine 262 affects its voltage-sensitive channel activity in
planar lipid bilayers, J. Biol. Chem. 270 (1995) 27051–27057.
[141] C.D. Weaver, N.H. Shomer, C.F. Louis, D.M. Roberts, Nodulin 26, a nodule-speciﬁc
symbiosome membrane protein from soybean, is an ion channel, J. Biol. Chem.
269 (1994) 17858–17862.
[142] A.J. Yool, W.D. Stamer, J.W. Regan, Forskolin stimulation of water and cation per-
meability in aquaporin 1 water channels, Science 273 (1996) 1216–1218.
[143] T.L. Anthony, H.L. Brooks, D. Boassa, S. Leonov, G.M. Yanochko, J.W. Regan, A.J. Yool,
Cloned human aquaporin-1 is a cyclic GMP-gated ion channel, Mol. Pharmacol. 57
(2000) 576–588.
[144] W. Zhang, E. Zitron, M. Homme, L. Kihm, C. Morath, D. Scherer, S. Hegge, D.
Thomas, C.P. Schmitt, M. Zeier, H. Katus, C. Karle, V. Schwenger, Aquaporin-1 chan-
nel function is positively regulated by protein kinase C, J. Biol. Chem. 282 (2007)
20933–20940.
[145] M.T. Conner, A.C. Conner, C.E. Bland, L.H. Taylor, J.E. Brown, H.R. Parri, R.M. Bill,
Rapid aquaporin translocation regulates cellular water ﬂow: mechanism of
hypotonicity-induced subcellular localization of aquaporin 1 water channel, J.
Biol. Chem. 287 (2012) 11516–11525.
[146] E.M. Campbell, D.N. Birdsell, A.J. Yool, The activity of human aquaporin 1 as a
cGMP-gated cation channel is regulated by tyrosine phosphorylation in the
carboxyl-terminal domain, Mol. Pharmacol. 81 (2012) 97–105.
[147] S.M. Saparov, D. Kozono, U. Rothe, P. Agre, P. Pohl, Water and ion permeation of
aquaporin-1 in planar lipid bilayers. Major differences in structural determinants
and stoichiometry, J. Biol. Chem. 276 (2001) 31515–31520.
[148] S.P. Tsunoda, B. Wiesner, D. Lorenz, W. Rosenthal, P. Pohl, Aquaporin-1, nothing
but a water channel, J. Biol. Chem. 279 (2004) 11364–11367.
[149] P. Agre, M.D. Lee, S. Devidas, W.B. Guggino, Aquaporins and ion conductance, Sci-
ence 275 (1997) 1490 author reply 1492.
[150] D. Boassa, W.D. Stamer, A.J. Yool, Ion channel function of aquaporin-1 natively
expressed in choroid plexus, J. Neurosci. 26 (2006) 7811–7819.
[151] N.W. Baetz, W.D. Stamer, A.J. Yool, Stimulation of aquaporin-mediated ﬂuid trans-
port by cyclic GMP in human retinal pigment epithelium in vitro, Invest.
Ophthalmol. Vis. Sci. 53 (2012) 2127–2132.
[152] S. Saadoun, M.C. Papadopoulos, M. Hara-Chikuma, A.S. Verkman, Impairment of
angiogenesis and cell migration by targeted aquaporin-1 gene disruption, Nature
434 (2005) 786–792.
[153] D.K. Binder, E.A. Nagelhus, O.P. Ottersen, Aquaporin-4 and epilepsy, Glia 60 (2012)
1203–1214.
[154] E.K. Hoffmann, I.H. Lambert, S.F. Pedersen, Physiology of cell volume regulation in
vertebrates, Physiol. Rev. 89 (2009) 193–277.
[155] R.E. Day, P. Kitchen, D.S. Owen, C. Bland, L. Marshall, A.C. Conner, R.M. Bill, M.T.
Conner, Human aquaporins: regulators of transcellular water ﬂow, Biochim.
Biophys. Acta 1840 (2014) 1492–1506.
[156] B. Nilius, J. Vriens, J. Prenen, G. Droogmans, T. Voets, TRPV4 calcium entry channel:
a paradigm for gating diversity, Am. J. Physiol. Cell Physiol. 286 (2004) C195–C205.
[157] W. Liedtke, Transient receptor potential vanilloid channels functioning in trans-
duction of osmotic stimuli, J. Endocrinol. 191 (2006) 515–523.
[158] W. Liedtke, C. Kim, Functionality of the TRPV subfamily of TRP ion channels: add
mechano-TRP and osmo-TRP to the lexicon! Cell. Mol. Life Sci. 62 (2005)
2985–3001.
[159] X. Liu, B.C. Bandyopadhyay, T. Nakamoto, B. Singh, W. Liedtke, J.E. Melvin, I.
Ambudkar, A role for AQP5 in activation of TRPV4 by hypotonicity: concerted in-
volvement of AQP5 and TRPV4 in regulation of cell volume recovery, J. Biol.
Chem. 281 (2006) 15485–15495.
[160] Q. Chen, E.K. Duan, Aquaporins in sperm osmoadaptation: an emerging role for
volume regulation, Acta Pharmacol. Sin. 32 (2011) 721–724.
[161] Q. Chen, H. Peng, L. Lei, Y. Zhang, H. Kuang, Y. Cao, Q.X. Shi, T. Ma, E. Duan, Aqua-
porin3 is a sperm water channel essential for postcopulatory sperm
osmoadaptation and migration, Cell Res. 21 (2011) 922–933.
[162] L. Galizia, A. Pizzoni, J. Fernandez, V. Rivarola, C. Capurro, P. Ford, Functional inter-
action between AQP2 and TRPV4 in renal cells, J. Cell. Biochem. 113 (2012)
580–589.
[163] H. Zhang, H. Li, E. Liu, Y. Guang, L. Yang, J. Mao, L. Zhu, L. Chen, L. Wang, The AQP-3
water channel and the ClC-3 chloride channel coordinate the hypotonicity-
induced swelling volume in nasopharyngeal carcinoma cells, Int. J. Biochem. Cell
Biol. 57 (2014) 96–107.
[164] A.E. Hill, Y. Shachar-Hill, Are aquaporins the missing transmembrane
osmosensors? J. Membr. Biol. 248 (2015) 753–765.
[165] Y. Inoue, E. Sohara, K. Kobayashi, M. Chiga, T. Rai, K. Ishibashi, S. Horie, X. Su, J.
Zhou, S. Sasaki, S. Uchida, Aberrant glycosylation and localization of polycystin-1
cause polycystic kidney in an AQP11 knockout model, J. Am. Soc. Nephrol. 25
(2014) 2789–2799.
[166] S.P. Ferris, V.K. Kodali, R.J. Kaufman, Glycoprotein folding and quality-control
mechanisms in protein-folding diseases, Dis. Model. Mech. 7 (2014) 331–341.
[167] P. Kitchen, R.E. Day, L.H. Taylor, M.M. Salman, R.M. Bill, M.T. Conner, A.C. Conner,
Identiﬁcation and molecular mechanisms of the rapid tonicity-induced
relocalization of aquaporin 4, J. Biol. Chem. (2015).
[168] H.Wu, L. Chen, X. Zhang, Q. Zhou, J.M. Li, S. Berger, Z. Borok, B. Zhou, Z. Xiao, H. Yin,
M. Liu, Y. Wang, J. Jin, M.R. Blackburn, Y. Xia, W. Zhang, Aqp5 is a new transcrip-
tional target of Dot1a and a regulator of Aqp2, PLoS One 8 (2013), e53342.
[169] C. Hachez, A. Besserer, A.S. Chevalier, F. Chaumont, Insights into plant plasma
membrane aquaporin trafﬁcking, Trends Plant Sci. 18 (2013) 344–352.
[170] S. Bassnett, P.A. Wilmarth, L.L. David, The membrane proteome of the mouse lens
ﬁber cell, Mol. Vis. 15 (2009) 2448–2463.
[171] S. Scheuring, N. Buzhynskyy, S. Jaroslawski, R.P. Goncalves, R.K. Hite, T.Walz, Struc-
tural models of the supramolecular organization of AQP0 and connexons in junc-
tional microdomains, J. Struct. Biol. 160 (2007) 385–394.
[172] A. Colom, I. Casuso, T. Boudier, S. Scheuring, High-speed atomic force microscopy:
cooperative adhesion and dynamic equilibrium of junctional microdomain mem-
brane proteins, J. Mol. Biol. 423 (2012) 249–256.
[173] S.S. Kumari, K. Varadaraj, Aquaporin 0 plays a pivotal role in refractive index gradi-
ent development inmammalian eye lens to prevent spherical aberration, Biochem.
Biophys. Res. Commun. 452 (2014) 986–991.
[174] K. Varadaraj, S.S. Kumari, R.T. Mathias, Transgenic expression of AQP1 in the ﬁber
cells of AQP0 knockout mouse: effects on lens transparency, Exp. Eye Res. 91
(2010) 393–404.
[175] S.S. Kumari, K. Varadaraj, Intact AQP0 performs cell-to-cell adhesion, Biochem.
Biophys. Res. Commun. 390 (2009) 1034–1039.
[176] L.F. Michea, M. de la Fuente, N. Lagos, Lens major intrinsic protein (MIP) promotes
adhesion when reconstituted into large unilamellar liposomes, Biochemistry 33
(1994) 7663–7669.
[177] S.S. Kumari, J. Gandhi, M.H. Mustehsan, S. Eren, K. Varadaraj, Functional character-
ization of an AQP0 missense mutation, R33C, that causes dominant congenital lens
cataract, reveals impaired cell-to-cell adhesion, Exp. Eye Res. 116 (2013) 371–385.
[178] T. Gonen, P. Sliz, J. Kistler, Y. Cheng, T. Walz, Aquaporin-0 membrane junctions re-
veal the structure of a closed water pore, Nature 429 (2004) 193–197.
[179] R.K. Hite, P.L. Chiu, J.M. Schuller, T. Walz, Effect of lipid head groups on double-
layered two-dimensional crystals formed by aquaporin-0, PLoS One 10 (2015),
e0117371.
[180] W.E. Harries, D. Akhavan, L.J. Miercke, S. Khademi, R.M. Stroud, The channel archi-
tecture of aquaporin 0 at a 2.2-A resolution, Proc. Natl. Acad. Sci. U. S. A. 101 (2004)
14045–14050.
[181] A. Engel, Y. Fujiyoshi, T. Gonen, T. Walz, Junction-forming aquaporins, Curr. Opin.
Struct. Biol. 18 (2008) 229–235.
[182] S. Sindhu Kumari, K. Varadaraj, Intact and N- or C-terminal end truncated AQP0
function as openwater channels and cell-to-cell adhesion proteins: end truncation
could be a prelude for adjusting the refractive index of the lens to prevent spher-
ical aberration, Biochim. Biophys. Acta 1840 (2014) 2862–2877.
[183] J. Liu, J. Xu, S. Gu, B.J. Nicholson, J.X. Jiang, Aquaporin 0 enhances gap junction coupling
via its cell adhesion function and interaction with connexin 50, J. Cell Sci. 124 (2011)
198–206.
[184] M. De Bellis, F. Pisani, M.G. Mola, D. Basco, F. Catalano, G.P. Nicchia, M. Svelto, A.
Frigeri, A novel human aquaporin-4 splice variant exhibits a dominant-negative
activity: a new mechanism to regulate water permeability, Mol. Biol. Cell 25
(2014) 470–480.
[185] Y. Hiroaki, K. Tani, A. Kamegawa, N. Gyobu, K. Nishikawa, H. Suzuki, T. Walz, S.
Sasaki, K. Mitsuoka, K. Kimura, A. Mizoguchi, Y. Fujiyoshi, Implications of the
aquaporin-4 structure on array formation and cell adhesion, J. Mol. Biol. 355
(2006) 628–639.
[186] H. Zhang, A.S. Verkman, Evidence against involvement of aquaporin-4 in cell–cell
adhesion, J. Mol. Biol. 382 (2008) 1136–1143.
[187] E. McCoy, H. Sontheimer, Expression and function of water channels (aquaporins)
in migrating malignant astrocytes, Glia 55 (2007) 1034–1043.
[188] A.J. Smith, B.J. Jin, J. Ratelade, A.S. Verkman, Aggregation state determines the local-
ization and function of M1- and M23-aquaporin-4 in astrocytes, J. Cell Biol. 204
(2014) 559–573.
[189] W. Humphrey, A. Dalke, K. Schulten, VMD: visual molecular dynamics, J. Mol.
Graph. 14 (1996) 33–38 27-38.
2421P. Kitchen et al. / Biochimica et Biophysica Acta 1850 (2015) 2410–2421
Review
Human aquaporins: Regulators of transcellular water ﬂow☆☆
Rebecca E. Day a, Philip Kitchen b, David S. Owen a, Charlotte Bland d, Lindsay Marshall d, Alex C. Conner c,⁎,
Roslyn M. Bill d,⁎, Matthew T. Conner a,⁎
a Biomedical Research Centre, Shefﬁeld Hallam University, Howard Street, Shefﬁeld S1 1WB, UK
b Molecular Organisation and Assembly in Cells Doctoral Training Centre, University of Warwick, Coventry CV4 7AL, UK
c School of Clinical and Experimental Medicine, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
d School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham B4 7ET, UK
a b s t r a c ta r t i c l e i n f o
Article history:
Received 5 July 2013
Received in revised form 19 September 2013
Accepted 23 September 2013
Available online 30 September 2013
Keywords:
Aquaporin regulation
Transcellular water ﬂow
Homeostasis
Cell volume regulation
Regulatory volume increase
Regulatory volume decrease
Background: Emerging evidence supports the view that (AQP) aquaporin water channels are regulators of trans-
cellularwater ﬂow. Consistent with their expression inmost tissues, AQPs are associatedwith diverse physiolog-
ical and pathophysiological processes.
Scope of review: AQP knockout studies suggest that the regulatory role of AQPs, rather than their action as passive
channels, is their critical function. Transport through all AQPs occurs by a common passive mechanism, but their
regulation and cellular distribution varies signiﬁcantly depending on cell and tissue type; the role of AQPs in cell
volume regulation (CVR) is particularly notable. This reviewexamines the regulatory role of AQPs in transcellular
waterﬂow, especially in CVR.We focus on key systems of the human body, encompassing processes as diverse as
urine concentration in the kidney to clearance of brain oedema.
Major conclusions: AQPs are crucial for the regulation of water homeostasis, providing selective pores for the
rapidmovement ofwater across diverse cellmembranes and playing regulatory roles in CVR. Gatingmechanisms
have been proposed for human AQPs, but have only been reported for plant andmicrobial AQPs. Consequently, it
is likely that the distribution and abundance of AQPs in a particular membrane is the determinant of membrane
water permeability and a regulator of transcellular water ﬂow.
General signiﬁcance: Elucidating the mechanisms that regulate transcellular water ﬂow will improve our under-
standing of the human body in health and disease. The central role of speciﬁc AQPs in regulating water homeo-
stasis will provide routes to a range of novel therapies. This article is part of a Special Issue entitled Aquaporins.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY license.
1. Introduction: Transcellularwaterﬂow: a regulatory role for human
1.1. Aquaporins
A striking property of most human tissues is their capacity for
extremely rapid ﬂuid transport. This is exempliﬁed by urine concentra-
tion in the kidney [1], the rapid formation of aﬂuid-ﬁlled cavity adjacent
to the oocyte during ovarian folliculogenesis [2] and secretion of saliva
from salivary glands [3]. These processes are essential to human health
and rely on the highly-regulated transport of water through tissues
[4,5]. Such trans-tissue water ﬂow is possible by two routes: transcellu-
lar water ﬂow across both basal and apical membranes, which occurs in
response to the osmotic stimuli [4] created by salt transport [6]; or
paracellular ﬂow across cell–cell junctions into intercellular spaces,
driven by salt or solute gradients [6]. Paracellular water ﬂow plays an
important role in leaky epithelia such as the corneal endothelium [7].
In this review, we focus on the regulatory role of aquaporin (AQP)
water channels in mediating transcellular water ﬂow across cell
membranes in the major systems of the human body (Fig. 1). The
study of the mechanisms of human AQP regulation that mediate
transcellular water ﬂow is still in its infancy and therefore this
review will also discuss mammalian AQPs as potential models for the
regulation of human AQPs (Table 1).
Transcellular water ﬂow is dependent on the permeability of the
plasma membrane to water molecules. Water movement by osmosis
may be through the lipid bilayer, by passive co-transport with other
ions and solutes [8] or through AQP water channels [9]. Many AQP
channels are thought to have an exquisite speciﬁcity for water and are
capable of rapidly transporting it in response to changes in tonicity;
evidence suggests that they make a critical contribution to the regula-
tion of transcellular water ﬂow [10].
Since theﬁrst AQPwas identiﬁed by Peter Agre in 1988 [11], thirteen
human AQPs have been discovered. Structural results for several family
members [12–14] have established that AQP channels share a common
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Fig. 1. Aquaporin expression in humans. The ﬁgure shows the wide distribution of AQP water channels throughout the human body. Organs are highlighted, starting at top right; within
each organ, the major AQPs involved in transcellular water ﬂow are denoted; a) Retina— AQP4, b) Olfactory epithelium— AQP4, c) The inner ear— AQP4 and AQP1, d) Brain— AQP4 in
astrocytes and AQP1 in choroid plexus, e) Spinal cord— AQP1, AQP4 and AQP8; Nucleus pulposus cells of the intervertebral disc— AQP1 and AQP3; Osteoclasts— AQP9, f) Blood vessels—
AQP1 in endothelial cells, g) Heart— AQP4, h) Kidney (showing the nephron in detail)— AQP1, AQP2, AQP3, AQP4 and AQP7, i) Salivary glands— AQP5, j) Gastrointestinal tract— AQP3,
AQP4, AQP5 and AQP9, k) Liver—AQP1, AQP8 and AQP9, l) Pancreas—AQP1 and AQP8,m) Lungs—AQP3, AQP4, AQP5, n) Fat (adipocytes)—AQP7; Skin—AQP1, AQP3, AQP5 andAQP10,
o) Female reproductive tract — AQP7, AQP8 and AQP9 in ovaries, and p) Male reproductive system — AQP3 and AQP7 in sperm cells.
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Table 1
Tissue distribution and roles of AQPs in transcellular water ﬂow. AQPs discussed in this review are presented in terms of their localisation and regulatory roles in transcellular water ﬂow within organ tissues.
System AQP protein localisation Role of aquaporins in transcellular water ﬂow References
Nervous Retina — AQP4 Suggested role in Muller cell water balance. [64]
Olfactory epithelium — AQP4 Membrane permeability - link to olfaction. [65]
Inner ear — AQP4 (hensons, claudius and Inner Succlus cells), AQP1 (ﬁbrocytes) AQP4 mediated transcellular water ﬂow in to Henson cells exiting via AQP4 on basal membrane of Claudius cells [66]
Brain — AQP4 astrocytes, AQP1 (choroid plexus) AQP4 at astrocyte end feet for BBB water permeability. AQP1 secretion of CSF, AQP4 absorption of CSF [62,47]
Spinal cord — AQP1, AQP4, AQP8 Localisation of AQPs suggests transcellular water ﬂow from perivascular space to interstitium, into central canal [54]
Renal (kidney) Proximal tubule — AQP1 (apical and basolateral),
AQP7 (apical of convoluted and straight)
Water reabsorption, importance of AQP7 unknown [9,69]
Renal collecting duct cells — AQP2 (apical, sub apical vesicles),
AQP3 and AQP4 (basolateral)
Urine concentration by AQP2 AVP mediated water absorption - AQP3 and 4 exit pathways into blood [63,68]
Descending thin limb of henle — AQP1 Water reabsorption [9]
Descending vasa recta — AQP1 Water reabsorption [9]
Connecting tubule — AQP3 Water homeostasis [9]
Integumentary Skin — AQP1 (endothelia of dermis), AQP3+10 (keratinocytes of epidermis),
AQP5 (sweat glands)
Homeostasis, glycerol or water transport for skin hydration, sweat excretion [96–98]
Fat — AQP7 (adipocytes) Glycerol transport [102]
Cardiovascular Blood vessels — AQP1 strongly expressed in endothelia outside of brain i.e. Airspace-Capillary osmotic water permeability and heart vasculature [112]
Cardiomyocytes — AQP4 Absorption of excess water from interstitial space into to capillaries [113]
Respiratory Lung alveolar epithelium — AQP5 (apical membrane) Transcellular water ﬂow route for water absorption and secretion in airway, Role in airway hydration [117]
Airway epithelial lining — AQP3 and AQP4 Possibly provide route for water into capillaries of airway [87]
Airway sub-mucosal glands — AQP5 (apical membrane) Fluid secretions into lumen of submusosal glands for mucous production and hydration [119]
Reproductive Ovarian granulosa cells — AQP7, AQP8, AQP9 Transcellular water ﬂow in folliculogenesis [2]
Epididymis Transepithelial water transport and sperm concentration [129,135,137,138]
Sperm — AQP3, AQP7 CVR to prevent swelling and to aid mobility [41]
Digestive Salivary Glands — AQP5 (acinar cells, intercalated duct cells),
AQP8 (myoepithelial cells)
Transcellular water transfer in process of primary saliva secretion [87,147]
Oesophagus — AQP3 (stratiﬁed epithelia) Intracellular osmolarity and CVR to water deprived cells [143]
Stomach — AQP3 (stratiﬁed epithelia), AQP4 (BLM parietal cells),
AQP5 (pyloric gland)
Provide water to cells facing harsh conditions, AQP4 - gastric acid secretion,
AQP5 transcellular water secretion for mucous production
[141,143,144]
Small intestine — AQP4, AQP9 (goblet cells) Transcellular colonic ﬂuid transport, AQP9 aids in mucous secretion [149]
Colon — AQP3 (simple+ stratiﬁed epithelia of distal colon),
AQP4 (surface epithelia)
Water absorption from intestine and colonic ﬂuid transport [144,149]
Liver — AQP1 (cholangiocytes), AQP8 (hepatocytes),
AQP9 (sinusoidol membrane of hepatocyte)
AQP8 — osmotic driven water transfer and homeostasis, AQP9 — glycerol uptake from blood released by AQP7 [82,152]
Pancreas — AQP1 (inter/intralobular ducts), AQP8 (acinar cells) AQP1 — Transcellular water transfer and pancreatic juice secretion, AQP8 — Pancreatic juice secretion [146]
Musculoskeletal Muscle ﬁbres — AQP4 Contraction-induced muscle swelling
Articular cartilage — AQP1, AQP3 Involved in cell swelling during mechanistic load [160]
Intervertebral disc — AQP1, AQP3 (nucleus pulposus cells) AQP1 and 3 involved in NP cell swelling during mechanistic load [159]
Osteoclasts — AQP9 AQP9 osteoclast differentiation and cell fusion — increase in cell volume [154,156]
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structural architecture. Together with biochemical studies, these
structural data [15] have revealed that the functional AQP unit is a
homotetramer [15] and that each AQP monomer is composed of six
transmembrane (TM) α-helices connected by alternating intracellular
(ICL) and extracellular (ECL) loops. The TM domains form a right-
handed bundle around the central pore of each AQP monomer through
which water transport occurs [16]. The speciﬁcity of the pore for water
is a result of direct hydrogen bonding, in a pairwise manner, between a
single ﬁle of water molecules and the AQP family's signature Asn-Pro-
Ala motif at the narrowest part of the pore [16]. Water selectivity is
further aided by interactions with the aromatic/arginine constriction
site, which physically restricts the pore [16]. While the structural bio-
logy of the AQP family is therefore widely accepted, the mechanisms
that regulate the physiological function of AQPs are lesswell established
[17].
AQPs are expressed in a wide range of tissues (Fig. 1), often spatially
located within a certain region of the cell. This enables them to play a
central role in the ﬂow of water through those tissues, which typically
triggers cell volume regulation (CVR) mechanisms. Whilst transport
through all AQPs utilises a commonpassivemechanism, their regulation
and cellular distribution varies signiﬁcantly between systems, speciﬁ-
cally in constituent tissues and cells [17]. This review examines the
regulation of transcellular water ﬂow in the human body by AQP
channels with a particular focus on CVR.
2. Transcellular water ﬂow and cell volume regulation
CVR is a necessary mechanistic component of AQP-mediated trans-
cellular water ﬂow (Fig. 2). It comprises regulatory volume decrease
(RVD), usually in response to hypotonicity-induced cell swelling, and
regulatory volume increase (RVI), usually in response to hypertonicity-
induced cell shrinkage. The molecular mechanisms underlying these
responses are not yet fully understood, but it is unlikely that there is a
single common mechanism [18]. The signalling pathways associated
with CVR appear to be cell-type dependent [18]. Nonetheless, the end
results of these varied pathways are similar: RVD relies on osmolyte
(potassium chloride and taurine [19]) and water efﬂux from the cell to
reduce cell volume whereas RVI is achieved by osmolyte and associated
water inﬂux via import of sodium to the cell. Although the rapid RVI
process following cell shrinkage involves inorganic ions, after hours of
prolonged hypertonic exposure, animal cells often replace the ions
with non-perturbing organic osmolytes. Themechanisms for this include
external transport into the cell, down-regulation of organic degradation
and up-regulation of organic synthesis [20]. These mechanisms facilitate
the homeostasis of osmolality within the cell.
2.1. Regulatory volume decrease
In RVD (Fig. 2), the activation of K+ channels allows efﬂux of K+
from the cell and subsequent water loss by osmosis either through
AQPs or directly through the lipid bilayer; biophysical data show that
AQP expression can increase membrane water permeability by up to
~50 fold [21,22]. This K+ efﬂux can be either dependent on intracellular
calcium concentration [Ca2+] (e.g. in human cervical cancer cells [23])
or [Ca2+]i independent (e.g. in Ehrlich ascites tumour cells [24]). In
most cell types an intact actin cytoskeleton is necessary for
hypotonicity-induced K+ efﬂux. However, in trigeminal ganglion
neurons, cytochalasin D (an actin polymerisation inhibitor) treatment
stimulated swelling activation of a K+ current [25] demonstrating that
in these cells an intact actin network not only is unnecessary for RVD,
but also appears to be inhibitory. In some cells, protein kinase C (PKC)
activation has also been shown to induce an outward K+ current via
the same channels that are activated in RVD [26]. Movement of K+
out of the cell is favoured by the concentration gradient but to maintain
the electrostatic membrane potential, volume-regulated anion chan-
nel(s) (VRAC) simultaneously move anions (mainly Cl− during RVD)
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Fig. 2. Solute transport pathways mediating CVR (A) regulatory volume decrease and (B) regulatory volume increase. Water movement by osmosis may be through AQPs or directly
through the cell membrane depending on the cellular AQP isoforms and expression levels. KCC: potassium chlorine co-transporter; NKCC: sodium potassium chlorine co-transporter;
VRAC: volume regulated anion channel; NSCC: non-selective cation channel.
1495R.E. Day et al. / Biochimica et Biophysica Acta 1840 (2014) 1492–1506
out of the cell, probably activated by tyrosine kinases [27,28]. It is also
thought that four K+-Cl− co-transporters (KCCs), known to be activated
by cell swelling, may be involved [29,30].
2.2. Regulatory volume increase
In RVI (Fig. 2), the activation of Na+-H+ exchangers and Na+-K+-
2Cl− co-transporters (NKCCs) causes cellular inﬂux of Na+ and subse-
quent volume increase by osmotic movement of water [18]. The
Na+-H+ exchange pump, NHE1, is known to be activated by cell
shrinkage [31], which may be mediated by binding of calmodulin to its
carboxy-terminus [32]. The co-transporter, NKCC1, is known to be
activated by cell shrinkage, potentially through lysine-deﬁcient protein
kinase 1 (WNK1) and proline/alanine-rich protein kinase (SPAK) signal-
ling [33]. Amiloride-sensitive non-selective cation channels (NSCCs)
may also play a role [34].
2.3. The regulatory role of aquaporins
The water permeability of cell membranes may not be the rate-
limiting factor in CVR [35], but any rapid change in cell volume is likely
to involve AQPs. For example, the stretch-activated transient receptor
potential vanilloid type 4 (TRPV4) channel is a Ca2+-biased NSCC that
is activated by cell swelling [36] and has been implicated in osmosensing
[37]. In some cell types TRPV4 has been shown to provide a Ca2+ signal
that is correlated with activation of the K+ and Cl− channels responsible
for the decrease in cellular osmolality associated with RVD [38,39]. In
human and murine salivary gland cells, TRPV4 has a functional interac-
tion with AQP5: in AQP5 knockout cells, the hypotonicity-induced
calcium inﬂux through TRPV4 was attenuated and subsequent RVD
was abolished. Hypotonicity also increased cell surface expression of
both TRPV4 and AQP5 and increased their co-localisation [40].
In another example, the sperm of AQP3−/−mice did not undergo
their normal RVD process and the mice displayed reduced fertility
[41,42]. Upon entry into the female reproductive tract, sperms normally
encounter a decrease in extracellular osmolality, which is thought to be
the signal that activates sperm motility [41]. However, this hypotonic
stress also causes cell swelling which, if left uncorrected by RVD, leads
to impaired fertilisation caused by excessive bending of the sperm tail
inside the uterus [42]. If AQP3 was simply acting passively as a water
channel, RVD would not be abolished in AQP3 −/− mice but rather
the timescale on which the cell reaches osmotic equilibrium would be
increased. One explanation for reduced fertility and altered RVD in
AQP3 −/− mice is therefore that AQP3, either alone or as part of a
macromolecular complex, is involved in the signalling pathway that
activates RVD in sperm.
When exposed to a hypotonic extracellular solution, cultured renal
cortical collecting duct (renal CCD) cells, which do not endogenously
express AQP2, swell in proportion to the change in extracellular osmo-
lality but do not exhibit RVD. However, when they are transfected
with AQP2, these cells show an RVD of approximately 40%. Shrinkage
is mediated by Ca2+ inﬂux through TRPV4, which activates Ca2+-
dependent K+ and Cl− channels and Ca2+-dependent Ca2+ release
from intracellular stores. In renal CCD cells expressing AQP2, hypotonic
stress causes translocation of TRPV4 to the plasma membrane, which is
absent in AQP2-negative cells. When TRPV4 was translocated to the
cell surface prior to hypotonic exposure using 4α-phorbol 12,13-
didecanoate, RVD was recovered in AQP2-null cells, showing that it is
not simply the high water permeability of AQP2 that allows RVD. How-
ever, there does not appear to be any co-localisation between endoge-
nous TRPV4 and overexpressed AQP2 in this system, either before
or after hypotonic shock, indicating a functional rather than physical
interaction [43]. These observations suggest that AQP2 (and therefore
possibly other members of the AQP family) forms part of a sensory
and signalling pathway that results in TRPV4 translocation, possibly
via sensing of extracellular osmolality.
Taken together, these examples support the idea of a signalling or
sensory role for AQPs in RVD mechanisms. We have been unable to
ﬁnd any evidence of AQPs playing similar roles in RVI. However, given
that a variety of AQPs could be involved in the RVD mechanism and
that RVI and RVD share a common basic mechanism involving the
movement of osmolytes to elicit a volume change, it would not be
surprising to discover a link between RVI and AQPs that goes beyond a
passive water conduction mechanism.
3. Regulation of transcellular water ﬂow in the human body
3.1. The brain and nervous system
3.1.1. Localisation of AQPs
AQPs are widely expressed in the central nervous system (CNS);
indeed, more studies have been conducted on AQPs in the CNS than
on AQPs in the peripheral and enteric nervous systems (for a detailed
review on AQPs in the nervous system see Papadopoulos et al. [44]).
The major AQPs found in the CNS are (i) AQP4 in the glia [45] and
neurons [46], (ii) AQP1 in the epithelia of the choroid plexus (which
forms the cerebrospinal ﬂuid (CSF)–brain barrier) [47], dorsal root
ganglia [48] and oesophageal neurons [49] and (iii) AQP9 in the
substantia nigra [50]. Glial cells are not nerve cells but are essential for
regulation and homeostasis of the CNS and comprise approximately
90% of cells in the brain [51]. Astrocytes are the most abundant glial
cells within the brain [51] and high levels of AQP4 are expressed in
their plasma membranes. The distribution of AQP4 is highly polarised
to the astrocytic end feet, which contact the blood vessels associated
with the blood–brain and brain–ﬂuid interfaces [81]. The astrocytic
end feet therefore function as part of the blood–brain-barrier (BBB)
water exchange mechanism; this has been established to be AQP4
dependent since deletion of AQP4 in mice resulted in a 31% decrease
in brain water uptake measured using the wet/dry mass method to
determine brain water content [52].
3.1.2. Regulatory role of AQPs
As themain AQP of the CNS, AQP4 is expected to play amajor role in
the regulation of water ﬂow in the brain, spinal cord [53,54] and inter-
stitial ﬂuid surrounding neurons, thereby maintaining the K+ concen-
trations required for neuroexcitation [46,55]. In support of this, when
AQP4 was silenced in astrocytes by RNA interference, the apparent
diffusion coefﬁcient (which is a measure of water movement within
tissues, determined by magnetic resonance imaging) was decreased
by 50% in rat brain [56]. It is in this context that low AQP4 expression
levels have been associated with epileptic seizures [55].
There is evidence that AQP translocation occurs in astrocytes, which
may be responsible for the regulation of AQP abundance in the plasma
membrane [57]. Although AQP4 is primarily expressed at the plasma
membrane, its surface abundance is increased by AQP4-carrying vesi-
cles in response to hypotonic stimuli in cultured rat cortical astrocytes:
a positive correlation between vesicle mobility and AQP4 density at the
plasma membrane was observed [58]. As well as AQP4, the stretch-
activated TRPV4 channel is also strongly expressed in astrocytic end
feet [59]. It has been suggested that AQP4 and TRPV4 are co-expressed
and form a molecular complex, interacting at the plasma membrane
to control CVR in astrocytes. When mouse primary astrocytes were
put under hypotonic stress, an increase in intracellular Ca2+was follow-
ed by an RVD response; this mechanism failed in cells deﬁcient in AQP4
and in cells where RNA interference was used to silence TRPV4, even
if they were transfected with AQP1 [59,60]. This suggests that RVD in
astrocytes may be AQP4/TRPV4 speciﬁc, although the swelling of
AQP1-expressing cells in this study was not as marked as for AQP4-
expressing cells. Therefore, if total cell volume is the biophysical quanti-
ty being detected during the RVD response, it is possible that the loss of
RVD simply reﬂects the fact that a volume threshold has not beenmet. If
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there is an AQP4/TRPV4 interaction, it may be similar to the interaction
between AQP2 and TRPV4 in renal cells [43], discussed above.
AQP4 has been largely associated with the pathophysiology of brain
oedema [61] of which there are two major types: vasogenic oedema is
the accumulation of water in the extracellular space, usually due to
impaired function of the BBB; cytotoxic oedema is the swelling of
astrocytes whilst maintaining their cellular integrity [44]. Movement
of water from the blood across endothelia into astrocytes is mediated
by AQP4 channels; reduced cytotoxic oedema was seen in AQP4 −/−
mice [62]. AQP4 is also thought to mediate the reabsorption of excess
ﬂuid in vasogenic brain oedema by transcellular movement of ﬂuid
from the extracellular space at the astrocytic end feet to the vascular
and ventricular regions of the brain through the endothelial and epithe-
lial barriers. In support of this, AQP4 null mice show an increase in brain
water accumulation due to the reduction of transcellular water transfer
to blood or CSF [61].
AQP1 expression is restricted to the choroid plexus region of the
brain under normal conditions [47], but it is expressed in microvascular
endothelia and reactive astrocytes of brain tumours where it is thought
to play a role in the development of vasogenic oedema [63].
Osmotically-induced water transport was reduced 5-fold in AQP1 null
mice along with a decrease in intracranial pressure and a 25% decrease
in CSF production [47]. The same group also investigated the expression
and localisation of AQPs in mouse spinal cord, an area that has not been
the focus ofmany studies. Expression of AQP4was detected in the astro-
cytic end feet of the grey matter in contact with capillaries and the
ﬁbrous glial processes of the white matter, again surrounding the
blood vessels. The distribution of several other AQPs throughout the
spinal cord suggests a role inmaintenance ofwater balance via transcel-
lular water ﬂow; ﬂuid moves rapidly from the spinal subarachnoid
space into the perivascular space and across the interstitium into the
central canal. This rapid water movement may be mediated by AQP4
and AQP9 in the glia limitans and AQP8 across the ependymal layer
into the central canal [54].
In addition to its localisation in astrocytes, AQP4 is also expressed in
the retina [64], the olfactory epithelium [65] and within Claudius' and
Henson's cells of the inner ear [66]. Large K+ ﬂuxes trigger an AQP4-
mediated transcellular water inﬂux that exits via AQP4 channels local-
ised on the basal membrane of Claudius' cells [66]; AQP4 involvement
in CVR may be an important mechanistic component of acoustic signal
transduction since AQP4 null mice are completely deaf but have no
alterations to the morphology of the inner ear [66].
3.1.3. Conclusions
Transcellular water ﬂow within the brain is largely associated with
the formation and clearance of oedema; the highly-polarised distribu-
tion of AQP4 at the end feet of astrocytes is key in the absorption of
excess vasogenic ﬂuid for clearance by the capillaries into the blood-
stream. However, AQP4 may have an additive effect on water accumu-
lation in cytotoxic oedema as summarised in Fig. 3. The positioning of
AQP1 along the epithelial barrier of the CSF-containing choroid plexus
indicates a role in supplying water for CSF via a transcellular route. It
is also evident that AQPs play an important role in signalling throughout
the nervous system's peripheral and sensory organs by their contribu-
tion to CVR mechanisms and K+ concentration maintenance. Under-
standing these mechanisms will be essential in developing treatments
for brain oedema following stroke, trauma and meningitis.
3.2. The renal system
3.2.1. Localisation of AQPs
The role of AQPs in the kidney is one of themost extensively studied
areas in AQP research [67]. The kidney is the major site of arginine vaso-
pressin — (AVP; also called anti-diuretic hormone or ADH) mediated
body water homeostasis; in response to osmotic stimuli, water
reabsorption occurs throughAQP channels enabling urine concentration.
AQPs in the kidney exhibit a highly-polarised and speciﬁc localisation
pattern (Fig. 1): AQP1 is expressed in proximal tubule (PT) cells; AQP2
is very prominent in the renal collecting duct (renal CD) principal cells
and is found at the apical plasma membrane [68] and in sub-apical
vesicles [1]; AQP3 and AQP4 are expressed in renal CD cells at the
basolateral membrane [69,70]. AQP1 is responsible for most water
reabsorption in the kidney [71] while AQP2 ﬁne tunes water re-
absorption; it is translocated within the sub-apical vesicles to the apical
membrane after AVP activation, increasingmembranewater permeabil-
ity [1]. Once water has entered a renal CD cell, AQP3 and AQP4 provide
exit routes to the blood [72].
3.2.2. Regulatory role of AQPs
AQP2/AVP-activated translocation is induced by a well-studied pro-
tein kinase A (PKA)-dependent pathway [73]. Upon recognition of an
osmotic stimulus, AVP is released and subsequently binds the G
protein-coupled receptor (GPCR), vasopressin V2 receptor (V2R), on
the basolateral membrane of renal CD principal cells. This results in G
protein activation of PKA and subsequent phosphorylation of AQP2 at
Ser266 within intracellular vesicles; this facilitates vesicle translocation
along the microtubule networks to the apical membrane [74] (Fig. 3A,
B). The critical role of this mechanism in the ﬁne control of water
reabsorption is exempliﬁed by its dysfunction in nephrogenic diabetes
insipidus; in this disease, mutations in the vasopressin 2 receptor or in
AQP2 itself lead to a decreased ability to concentrate urine [75].
An intracellular Ca2+ inﬂux is needed to generate the necessary RVD
response following hypotonic exposure; in the distal kidney, this only
occurs in the presence of AQP2 [76]. A functional interaction between
the Ca2+-permeable TRPV4 ion channel and AQP2 has been demon-
strated to occur under hypotonic conditions in renal CD cells and is
involved in RVD. Notably, the TRPV4 channel is only activated in cells
that express AQP2. When TRPV4 is blocked by ruthenium red, Ca2+
entry is abolished alongwith RVD. This conﬁrms AQP2 and TRPV4 as es-
sential components of the hypotonicity-induced RVD cellular response
[43]. It has also been shown that AQP2 can regulate CVR by interacting
with tropomyosin 5b (TM5b) and altering the dynamics of the cytoskel-
eton. Ser256 phosphorylation induces an AQP2-TM5b interaction lead-
ing to depolymerisation of actin ﬁlaments; this mechanism is reversible
[77].
AQP2 is also regulated independently of AVP in response to hyper-
tonic conditions. Hypertonic exposure (600 mOsM/kg) was shown to
signiﬁcantly increase activity of the AQP2 promoter, independent of
AVP, in MDCK cells expressing murine AQP2. The responsive element
was suggested to reside between−6.1 and−4.3 kb 5′ ﬂanking region
of the AQP2 gene [78]. Acute hypotonicity has also been shown to
induce translocation of AQP2 to the plasma membrane in the absence
of AVP: rapid plasmamembrane and trans-Golgi network accumulation
of AQP2 in rat renal CD cells were shown to be dependent onMAPK, P38
and ERK1/2 activity [79].
Early reports suggested that AQP1 was constitutively expressed in
PT cell membranes in the kidney [80], however recent studies have
shown that AQP1 is expressed in both the cytoplasm and in the mem-
brane of cultured cells and can be induced to undergo rapid and revers-
ible translocation to the plasmamembrane upon hypotonic stimulation
mediated by TRP channels, calcium, PKC and microtubules [57,81].
AQP1 has also been shown to undergo translocation to the plasma
membrane of cholangiocytes in response to secretin activation of specif-
ic G protein-coupled receptors [82]. Further studies have demonstrated
that the diuretic effect of acetazolamide involves triggered AQP1
translocation by promoting AQP1 and myosin heavy chain interactions
causing AQP1 localisation to proximal tubule cell membranes followed
by ubiquitin-mediated AQP1 degradation through the proteasome
[83]. AQP2 ubiquitination has also been shown to be involved in AQP2
expression and localisation [84]. Phosphorylation of AQP1 has been
shown to be involved in translocation of AQP1 to the plasmamembrane
in oocytes [85].
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3.2.3. Conclusions
Kidney AQPs form a highly-organised network that facilitates the
maintenance of water homeostasis. The speciﬁc localisation of AQPs
within renal CD cells provides a transcellular pathway for water to be
reabsorbed from the urine through AQP2 channels into renal CD cells
and back into the blood via AQP3 and AQP4 on basolateral membranes.
The regulation of AQP1 expression and translocationmediates transcel-
lular water ﬂow in PT cells [83].
3.3. Specialised secretory tissues
3.3.1. Localisation and regulatory roles of AQPs
Specialised secretory tissues rely on AQP-dependent transcellular
water ﬂow to facilitate their ﬂuid homeostasis. In the salivary gland,
AQP5 facilitates transcellular water ﬂow in both acinar and parotid sal-
ivary cells [86]; the salivary cells isolated fromAQP5−/−mice had dra-
matically reducedmembranewater permeability following exposure to
hypertonic or hypotonic conditions [3]. The localisation of AQP5 on the
luminal membrane is consistent with the membrane's high water per-
meability and its role in osmotic water transport from the acinar cells
to the lumen of the gland used in the production of saliva [87,88].
Immunohistochemistry of human salivary glands (HSG) has demon-
strated that AQP3 is present on the basolateral membranes of mucous
and serous acinar cells [89], indicating a possible role for AQP3 as well
as AQP5 in transcellular water ﬂow during saliva formation [89].
In HSG, AQP5 translocation was shown to occur in a microtubule-
dependentmanner; elevation of [Ca2+]i by stimulationwith thapsigargin
(a Ca2+-ATPase inhibitor) and a Ca2+ ionophore resulted in AQP5
localisation at the plasma membrane, which was inhibited by pre-
treatment with the microtubule inhibitors, colchicine and vinblastine
[90]. GFP-tagged human AQP5 has been shown to translocate to the
plasma membrane of HSG cells upon stimulation with carbachol
(a muscarinic type 3 receptor (M3R) agonist) [91], but little is known
about the molecular mechanisms involved.
AQP5 translocation to the apical membrane of rat parotid gland cells
has been shown to occur following stimulation of M3R with acetylcho-
line (ACh) and subsequent [Ca2+]i elevation. Furthermore, following in-
cubation with a Ca2+ ionophore translocation was activated without
ACh stimulation [92]. Increased levels of AQP5 mRNA and protein
were observed when rat submandibular acinar cell lines were exposed
to hypotonic conditions causing rapid cell swelling and more efﬁcient
RVD. EGTA chelation of intracellular and extracellular Ca2+ did not
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affect CVR in a rat acinar cell line; in fact CVRwas found to be K+- and
Cl−-dependent, with mitogen-activated ERK-activating kinase (MEK)
and the β-amino acid, taurine, playing important roles [93].
Increasing [Ca2+]i has been shown to trigger AQP5 translocation
from cytosolic compartments to the plasma membrane while the
removal of extracellular Ca2+ has been shown to inhibit translocation
of AQP1 in HEK293 cells [57]. Acinar cells from mice lacking the
TRPV4 channel or AQP5 display reduced hypotonicity-induced Ca2+
inﬂux and a suppressed RVD response suggesting an important role
for TRPV4 and AQP5 interactions in generating the Ca2+ response
required for effective RVD after hypotonic cell stress [40]. There is little
knowledge on the regulation of AQP5 in sweat glands. Eccrine sweat
glands have a high water permeability to support their role in ﬂuid
secretion; primary sweat is deposited into the lumen of the eccrine
gland before water movements allow sweat to be secreted through
the ductal region [94]. Recently, AQP5 has been shown to be expressed
in apical membranes, intracellular canaliculi of secretory coils and in
basolateral membranes of human eccrine sweat glands. Rapid apical
translocation of human AQP5 occurs in stably-transfected MDCK cells
after treatment with the Ca2+ ionophore, A23187, suggesting the
involvement of [Ca2+]i in AQP5 translocation. Rapid translocation of
AQP5 to the apical plasma membrane of cells has also been shown in
mouse sweat glands during sweating [95]. In humans, ACh activation
of muscarinic receptors raises [Ca2+]i and induces sweating [94]. It is
thought that AQP5 regulation by [Ca2+]i contributes to sweat release
by increasing apical membrane permeability, and that AQP5 may co-
localise with the Ca2+ channel, ANO1, at the plasma membrane [95].
However, the mechanisms behind AQP5 translocation within the
sweat gland, including the role of phosphorylation, still require further
elucidation.
3.3.2. Conclusions
AQP5 is involved in regulating transcellular water ﬂow in the luminal
regions of glands. This facilitates the formation of secretions at the
necessary concentrations and viscosities required to maintain water
homeostasis.
3.4. The integumentary system
3.4.1. Localisation and regulatory roles of AQPs
The integumentary system comprises the skin, hair and nails, but
nerves, certain glands and fat are often also classiﬁed as parts of the
integument. The skin plays an integral part in water homeostasis and
provides a barrier function against excessive water loss. Its water and
glycerol content is essential for normal function; this is largely under
the control of AQP3, which is expressed mainly in the plasma
membranes of the stratum basale of the epidermis, with decreasing
expression towards the stratum granulosum and none in the stratum
corneum [96]. Sugiyama and colleagues [97] ﬁrst reported expression
of AQPs 3 and 9 in human cultured keratinocytes, although AQP9 was
only observed in differentiating cells. AQP3-null mice display impaired
barrier function and reduced stratum corneum hydration, which was
not corrected by skin occlusion or exposure to high humidity. However,
topical or oral administration of glycerol has shown to correct many
defective skin functions in AQP3-null mice [98].
AQP1 has been detected in skin biopsies in a study of atopic eczema,
although its expression was no different in diseased or control skin,
whereas up-regulation of AQP3 was found [99]. Skin diseases that
show reduced stratum corneum hydration display altered expression
levels of AQP3, dependent upon the disease. In 2011, Voss and
colleagues showed that in psoriatic skin, AQP3 was preferentially
expressed in the cytoplasm rather than the plasmamembrane suggest-
ing that AQP3 may be important for transcellular water and glycerol
transport. AQP5 is also thought to be expressed at the plasma
membrane in the stratum granulosum and may play a role in trans-
cellular water homeostasis in the skin [100].
AQP7 is the primary glycerol transporter inwhite (WAT) and brown
(BAT) adipose tissues. AQP7 is abundantly expressed in the plasma
membrane of adipocytes and fasting has been shown to up-regulate
AQP7 mRNA in the adipocytes of rodents [101]. In the model mouse
adipocyte cell line, 3T3-L1, increases in AQP7 mRNA expression and
glycerol release were correlated during cell differentiation indicating
that plasmamembrane glycerol permeabilitymaymediate the accumu-
lation of fat in adipocytes [102]. AQP3 and 9 are also expressed in
human adipose tissue, with AQP3 predominantly localised in the
cytoplasm and AQP9 constitutively expressed in the plasmamembrane;
a positive correlation between the transcript levels of AQPs 3, 7 and 9
and body weight (BMI) has been suggested [103]. AQP7 gene expres-
sion is down-regulated in the WAT of obese human subjects compared
with normal controls [104,105], but unchanged in type 2 diabetes [104].
However, the link between human AQPs and obesity is contradictory; a
review by Maeda et al. [106] describes some of these studies. More
recently AQP10 has been proposed to be an alternative pathway for
glycerol efﬂux in human adipocytes [107].
3.4.2. Conclusions
AQP3, 7, 9 and 10 are aquaglyceroporins. It is therefore likely that the
roles of these AQPs in the integumentary system primarily involve
transport of glycerol, although they may also be involved in the regula-
tion of transcellular water ﬂow; this remains to be determined.
3.5. The cardiovascular system
3.5.1. Localisation and regulatory roles of AQPs
Cardiac AQPs have not been investigated to the same extent as AQPs
in the brain and kidney. In the heart, water moves from the interstitial
space, across endothelia and into blood vessels. This process is typically
attributed to paracellular water transport through the endothelium of
the heart since it is considered to be ‘leaky’ compared to the endotheli-
um of other organs [108]. Myocardial stunning is the reduced output of
the heart, often seen following cardiac surgery such as heart bypass, and
has been associated with cell swelling and oedema. The expression of
members of the AQP family in the myocardium has been poorly
characterised and their role, if any, in the pathology and resolution of
cardiomyocyte swelling, oedema and general function within the
heart has not been investigated (for a detailed review on AQPs and
myocardial water management see Egan [109]).
AQP1 has been detected in the human, rat and mouse heart tissue
[110], while AQP4 has only been detected in themouse heart [110]. Im-
munoﬂuorescence images revealed that the abundantly-expressed
AQP1 is distributed in human and murine cardiac microvasculature at
high levels only because of the dense vascularity of the heart muscle
[110]. Immunoﬂuorescence also showed that AQP4 was localised in
theplasmamembranes of the cardiomyocytes of themouse heart tissue.
Functional studies on cardiac membrane vesicles from AQP1 and AQP4
knockout mice found that only AQP1 had a role in water permeability
in the heart; vesicles from AQP1-null mice had reduced permeability
but deletion of AQP4 produced no reduction in water permeability
[110]. A study using rabbit ventricular cardiomyocytes suggested that
water movement in the heart is mediated by paracellular water ﬂow
and does not occur via AQPs [111]. On the rare occasion that an osmotic
gradient is present in the heart (e.g. during cell swelling after cardiac
surgery), endothelial AQP1 might mediate the ﬂow of water from the
expanded interstitial space into the capillaries [112]; indeed AQP1 is
the major AQP expressed in vascular endothelial cells [113].
There is controversy over the details of AQP4 expression in the
human heart; some studies have reported mRNA expression but no or
very little protein [110]. However, a recent study [114] demonstrated
the presence of AQP4 protein in the human heart using Western
blotting; it was localised to the plasma membrane with a very weak
signal in the cytosol. Immunoblot analyses of cultured mouse cardio-
myocytes also showed that AQP4 was present while immuno-gold
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electron microscopy images showed AQP4 protein on the plasma mem-
brane of the cardiomyocytes. Cardiac oedema arises when tissue with a
reduced blood supply (ischemic) becomes hypertonic, causing water to
ﬂow from the capillaries (possibly via AQP1) into cardiomyocytes; this
causes cell swelling and reduced cardiac output. Ischemic mice had a
decrease in AQP4 mRNA, as measured by RT-PCR. AQP4 knockout mice
presented with lower cardiac ischemic injury, measured as infarction,
suggesting that AQP4may be a possible target for treatment of myocar-
dial infarction.
3.5.2. Conclusions
The major AQP of the cardiovascular system is AQP1 (Fig. 1), which
probably regulates water permeability of the heart's capillary networks
by mediating the ﬂow of water through the endothelial layer into the
blood. AQP1may aid the absorption of excesswater from the interstitial
space into the capillaries, however this is controversial. Further research
is therefore required on the role of AQPs in the heart; thismight provide
evidence for AQP1 and/or AQP4 as drug targets for the treatment of
myocardial stunning oedema within the interstitium. AQP4 has only
recently been detected at the protein level within human cardio-
myocytes, which could lead to research into AQPs as transcellular
water transporters for clearance and formation of interstitial oedema
and cardiomyocyte swelling.
3.6. The airway
3.6.1. Localisation of AQPs
Airway hydration, sub-mucosal secretions and alveolar ﬂuid trans-
port all require water permeability of the epithelial and endothelial
membranes of the airway [115]. AQPs are consequently expressed in
bronchopulmonary tissues (Fig. 1) and are regulated in a way that facil-
itates transcellular water transport [116,117]. AQP1 is expressed
predominantly in the microvascular endothelia throughout the lung
and upper airways [117], while AQP3 and AQP4 are present in the
basolateral membranes of the airways' epithelial lining [88]. AQP5 is
expressed in the apical membrane of type I alveolar epithelial cells of
the distal lung and acinar sub-epithelial glandular cells, which provides
the major route (along with AQP1) for the osmotically driven ﬂow of
water within the entire airway system [118]. AQP5 is also expressed
superﬁcial epithelium of the bronchus and, as such, is ideally placed to
regulate the hydration of the airway surfaces [119]. Indeed, studies
with knockout mice have shown that AQP5 enhances ﬂuid secretion
[120]. In addition, AQP5 expression is reduced in inﬂammatory airway
conditions, such as chronic obstructive pulmonary disease (COPD),
that associate with mucus hypersecretion [119]. Modulation of AQP5
expression could therefore serve as therapy for inﬂammatory airway
conditions, alleviating symptoms such as the increase in desiccated
mucuswhich potentiates the chronic airways infections typical of cystic
ﬁbrosis [121].
3.6.2. Regulatory role of AQPs
When AQP expressionwithin the airwaywasﬁrst discovered, sever-
al murine AQP knockout studies were published that investigated the
hypothesis that water can be transported from the alveolar airspace
across the interstitial and capillary compartments via osmotically-
driven AQP transport. Initially, osmotic water permeability (Pf) of the
lungs was measured in AQP1 and AQP4 knockout mice; Pf was reduced
by 10-fold in the endothelia of AQP1 nullmice suggesting a transcellular
route. However, it was concluded that AQP1 does not provide the route
for alveolar ﬂuid absorption and little effect was observed on Pf in the
AQP4 knockout studies [122]. A year later, the same group conducted
a very similar study, this time using AQP5 knockout mice; the
airspace-capillary Pf was reduced by 10-fold in the AQP5 knockout
and a further 2–3-fold when a double knockout of AQP1/AQP5 was
used. The authors concluded that AQP5 and AQP1 are the main routes
for transcellular water ﬂow in the airway with the primary role of
AQP5 being water transport across the apical plasma membrane of
type I alveolar epithelial cells [123].
TRPV4 was subsequently shown to regulate AQP5 abundance under
hypotonic conditions in mouse lung epithelial (MLE) cells [124]. After
2 h in hypotonic medium, a decrease in AQP5 abundance in MLE cells
was observed; this result was observable after 30 min but not before
10min exposure. This decline in AQP5 was blocked in the presence of
ruthenium red, which is a TRPV4 inhibitor, and also when the cells
were cultured in Ca2+-free medium, even when the osmolality was
reduced to 127mOsM (which is hypotonic); these data support a role
for extracellular Ca2+ in the regulation of AQP5 abundance. RT-PCR
results showed that mRNA levels were not affected when protein levels
decreased. When a lysosomal inhibitor was added, a reduction in AQP5
mRNA levels was not seen suggesting that AQP5 protein is probably
undergoing degradation. The same results were observed in TRPV4-
expressing and control HEK-293 cells transfected with AQP5; an AQP5
reduction in response to hypotonicity was only seen in cells expressing
TRPV4, which was also blocked by ruthenium red. The regulation of
membrane permeability byAQP5 abundancewas concluded to be tight-
ly controlled by osmolality and mediated by TRPV4 [124].
Further evidence that osmolality regulates AQP5 expression was
provided by Hoffert and colleagues [125], who showed that hypertonic
stress induces AQP5 expression in MLE cells cultured in hypertonic
medium (500 mOsM). AQP5 protein levels increased after 8 h and
peaked 24 h post-exposure, returning to baseline after 6 h in isotonic
medium. Only relatively impermeable solutes affected AQP5 expres-
sion, suggesting that an osmotic gradient between a cell and its environ-
ment is involved in the regulation of AQP5 expression. This expression
mechanism was demonstrated to require the activation of the extra-
cellular signal-regulated kinase (ERK) pathway since several ERK
inhibitors blocked AQP5 expression; however without a hypertonic
stimulus, AQP5 expression was inhibited and ERK activators failed to
induce expression. In the same study, rats that had been given daily
intraperitoneal injections of hypertonic saline had a 2-fold increase in
AQP5 expression in the lung compared with control rats, suggesting
the physiological relevance of AQP5 regulation mechanisms in vivo
[125].
AQP5 expression has also been shown to be regulated by a cyclic
AMP/protein kinase A (cAMP/PKA)-dependent pathway. In MLE cells,
addition of the cell-permeable cAMP analogue, cpt-cAMP, caused a 4-
fold increase in AQP5 mRNA and protein levels in a dose-dependent
manner; increased protein synthesis was ablated by the addition of
the PKA inhibitor, H89. Immunoﬂuorescence studies using confocal
microscopy on MLE cells after a 24 h cpt-cAMP treatment revealed
that AQP5 was translocated to the apical plasma membrane. Increasing
endogenous cAMP levels by treatment with forskolin and the β-
adrenergic agonist, isoproterenol, also induced AQP5 protein expres-
sion. The forskolin effect was also seen to work ex vivo in murine lung
tissue suggesting that this cAMP-dependent molecular mechanism
may occur in vivo [126].
Sidhaye and colleagues [127] looked at the effects of cAMP on the
regulation of AQP5 distribution and abundance. Using AQP5-
expressing mouse lung epithelial cells, the distribution of AQP5 was
observed by immunoﬂuorescence and surface biotinylation. After
short-term treatment of cells with cAMP, AQP5 was internalised and
there was a reduced abundance of AQP5 at the membrane; long term
exposure to cAMP (approximately 8 h) resulted in higher-than-
baseline AQP5 abundance at the apical membrane indicating an up-
regulation of AQP5 membrane expression. Following short-term
exposure, AQP5 abundance was also temporarily decreased followed
by a marked increase after an 8 h exposure. When cells were treated
with theβ-adrenergic agonist, tetrabutaline,which is known to increase
intracellular levels of cAMP, identical results to those observed after
cAMP addition were seen in terms of distribution and protein abun-
dance. The same effects were observed in vivo using mice injected
subcutaneously with the agonist. When the PKA inhibitor, H89, was
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added, all cAMP-dependent effects were inhibited, additionally puriﬁed
AQP5 was phosphorylated by PKA but not PKC or casein, indicating that
PKA activation is required for AQP5 regulation in the airways.
Contrasting results were obtained from a study in which human
bronchial epithelial cells were stably transfected with wild type (WT)
AQP5 and two AQP5 mutants [128]. The ﬁrst mutant was an alanine
substitution of Ser156, the PKA substrate site for phosphorylation of
both AQP2 and AQP5, which is involved in AQP2 apical membrane
translocation. The second mutation was within the second Asn-Pro-
Ala motif, which forms the AQP pore. These experiments were designed
to examine the importance of pore formation and PKA phosphorylation
on the membrane expression of AQP5. WT-AQP5 was shown to be
expressed at the apical plasma membrane and in sub-apical vesicles,
while the Ser156Ala mutant also showed membrane expression. This
indicated that blocking the PKAbinding site did not affect AQP5 translo-
cation as in the case of AQP2. Expression of an Asn185Asp mutant was
localised throughout the cytoplasm suggesting that like AQP1, AQP5
requires the Asn-Pro-Ala motif for correct channel formation and that
it may have a role in either protein folding or oligomerisation. When
the PKA inhibitor, H89,was used, nodifference inmembrane expression
compared to the basal level was seen after 30min, which was also the
case after a 30min cAMP treatment in all three stable cell types. AQP2
translocation to the apical membrane was induced by the addition of
cAMP and this was blocked by pre-treatment with H89. Also when the
AQP2 Ser156 was mutated, AQP2 was expressed within the cytoplasm
and unable to translocate to the membrane. In WT-AQP5 and
Asn185Asp mutant cells, phosphorylation was seen before the addition
of cAMP. However, in the Ser156Ala mutant cells, AQP5 was never
phosphorylated indicating that Ser156 is the PKA substrate in AQP5,
that membrane localisation of the protein is not regulated by PKA and
that cAMP stimulation may be a separate event in contrast to the
AQP2 mechanism and the previous studies conducted by other groups
[128].
3.6.3. Conclusions
Direct evidence has been published for the involvement of AQPs in
transcellular water ﬂow across the alveolar epithelium via an apical
AQP5 route and through AQP1 in the endothelia [118]. This movement
of water between the alveolar airspace and capillary compartments is
essential for airway hydration, effective airways defences and
reabsorption of excess alveolar ﬂuid.
3.7. The reproductive system
The permeability of cell membranes to water and hormones in both
themale and female reproductive systems is essential for folliculogenesis
[2], spermatogenesis [129] and sperm osmoadaptation [41]. There are
few studies on the regulation of AQPs in the reproductive system, but
expression proﬁles have been outlined and up-to-date reviews are
available [41,129,130]. Emerging evidence suggests physiological roles
for AQPs within human reproductive systems and that water shifts are
often transcellular and AQP mediated [2]; AQPs have recently been
associated with the pathogenesis of some reproductive disorders such
as polycystic ovary syndrome (PCOS) [131] and ovarian cancer, where
AQP5 and AQP9 up-regulation were observed within the tissue of
malignant ovarian tumours [130].
3.7.1. The female reproductive system
The role of AQPs in the ovary, speciﬁcally the ovarian follicle, has
been well studied. During folliculogenesis, the antrum is expanded by
a large, rapid inﬂux of water through the granulosa cell (GC) lining; it
is unknown whether this water transport is mediated by paracellular
mechanisms or by transcellular ﬂow through AQP channels. McConnell
and colleagues [2] demonstrated that water movement into the antrum
of isolated rat follicles was 3.5-fold greater than that of C-inulin
(a complex sugar that moves through tissues via paracellular transfer),
indicating that the inﬂux of water into the antral cavity has a transcellu-
lar component. When follicles were pre-treated with HgCl2 (an AQP
inhibitor), the movement of water was reduced to that of inulin. This
suggested a role for AQPs in mediating water movement during
folliculogenesis, especially in light of the detection of AQP7, AQP8 and
AQP9 in GCs by ﬂow cytometry [2]. AQP7 and AQP9 are aquaglyceropo-
rins; their presence within the ovarian follicle suggests that the ability
of small neutral solutes to be transported rapidly across the plasma
membrane may be a requirement of folliculogenesis.
In a recent study in women with PCOS, immunoﬂuorescence was
used to conﬁrm the presence of AQP9 in the nucleus, cytoplasm and
plasma membrane of human GCs. In a study of 14 PCOS sufferers and
31 control subjects who were infertile from tubal blockage, GCs and
follicular ﬂuid were collected from the participants. Total testosterone
(TT) and luteinising hormone (LH) levels were elevated in follicular
ﬂuid from PCOS compared with samples from control women; sex
hormone binding globulin (SHBG) levels were lower in PCOS patients.
RT-PCR results indicated that AQP9 mRNA levels were decreased in
PCOS sufferers and that there was a signiﬁcant correlation between
AQP9 mRNA and TT, LH and SHBG levels in PCOS samples, but no
correlations in control samples. In vitro studies showed that the
treatment of GCs with dihydrotestosterone (DHT) had an inhibitory
effect on AQP9 mRNA expression and that the addition of LY294002, a
phosphatidylinositol 3-kinase (PIK3) inhibitor, attenuated this down-
regulation such that AQP9 mRNA levels were raised compared with
those treated with DHT alone. The addition of H89 and forskolin
did not rectify the DHT-initiated AQP9 mRNA decrease suggesting
that PKA and cAMP pathways are not involved in this mechanism.
This suggests that hyperandrogenism (excess of androgenic hor-
mones) of the follicular ﬂuid occurs in PCOS and this suppresses
AQP9 expression in GCs through a PIK3 pathway affecting follicular
development [131]. Further work into the mechanisms behind
AQP9 regulation in healthy and pathogenic ovaries may provide in-
sight into possible treatments for diseases where hyperandrogenism
is an issue.
The data discussed above suggest that transcellular water ﬂow into
the antrum of the ovarian follicle is a key aspect of folliculogenesis
and that the movement of water for expansion of the antrum is likely
to be AQP mediated.
3.7.2. The male reproductive system
There is increasing evidence that AQPs play an important role in
sperm cell RVD; this ensures maintenance of the structure and function
of sperm and thus male fertility. AQP7 cDNA was ﬁrst isolated from rat
testis and was shown to be expressed abundantly throughout the testis
and in the plasmamembrane of late stage spermatoids [132]. Aquaglyc-
eroporins, AQP3 and AQP7, have been identiﬁed within human sperm
[40,41,42,131,132,133] and their roles investigated. AQP3 has been de-
scribed as the regulator of spermosmoadaptation duringmale to female
transition, during which sperm are exposed to a hypo-osmotic environ-
ment with the potential to harm the sperm by excess swelling and re-
duced motility [41]. AQP3 is located at the plasma membrane of the
sperm ﬂagellum; AQP3mutant cells show decreasedmotility, increased
swelling and tail bending after entering the hypotonic environment of
the uterus therefore hindering the sperm's chances of reaching the ovi-
duct andmediating a fertilisation event. These defects are probably due
to ineffective RVDmechanisms and consequent swelling after hypoton-
ic stress [42]. A more recent study has outlined a relationship between
AQP7 localisation and sperm characteristics; transmission electron mi-
croscopy images showed expression of AQP7 within the pericentriolar
region of the neck, equatorial region of the acrosome and a diffuse stain-
ing along the tail. Abnormal sperm samples, characterised by malfor-
mations of the head, midpiece, or tail, displayed lower intensity and
diffuse staining in the cytoplasmic residual bodies, head and tail. A spe-
ciﬁc correlation between normal sperm AQP7 labelling and sperm
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motility and morphology suggested that AQP7 also has a role in regula-
tion of sperm cells and male fertility [134].
Severalmembers of the AQP family are expressedwithin the epidid-
ymis of the male reproductive tract [129]. They are localised to the
epithelial layer and are thought to play an important role in trans-
epithelial water transport and sperm concentration [129]. AQP9 was
the ﬁrst AQP identiﬁed in the epididymis [135] and has been labelled
the major apical AQP of the epithelium principal cells; it allows
transepithelial ﬂow of solutes such as glycerol, urea, mannitol and
sorbitol and is modulated by androgens in male adult rats [136]. AQP3
is localised exclusively to the basal cell membranes of the epididymis
and although AQP1 is absent from the epididymis epithelial cells it is
expressed within the smooth muscle and endothelium of the vascular
channels throughout the epididymis [137], together with AQP10 [138].
AQPs are important in facilitating an RVD response in sperm cells
especially upon the introduction to the hypotonic environment of the
female reproductive tract, which in AQP3-deﬁcient sperm can cause
detrimental swelling and reduced mobility. If the regulation of sperm
cells is dependent upon RVD mechanisms, future work into this ﬁeld
should concentrate on elucidating thesemechanisms. RVDmechanisms
in other tissues often involve complexes with AQPs, such as the
AQP4/TRPV4 complex in astrocytes [60] and the AQP2/TM5b interac-
tion in the kidney [77]. It is therefore feasible that AQP3 and/or AQP7
in human sperm might form molecular complexes with ion channels
such as the volume sensitive chloride channel CLC-3, which has been
identiﬁed in mammalian sperm and implicated in RVD [139,140].
3.8. The digestive system
3.8.1. Localisation and regulatory roles of AQPs
Secretion and absorption, two of the main functions of the digestive
system, both require the transfer of ﬂuid across cellular membranes.
Daily secretions in the form of saliva, gastric juices, intestinal mucous,
bile and pancreatic juice comprise a total volume of approximately
7.5 L of ﬂuid in the human digestive system; approximately 9 L of ﬂuid
is absorbed daily [141]. Several members of the AQP family are
expressed throughout the digestive system including AQP1 in the apical
and basolateral membranes and the cytoplasm of cholangiocytes, the
pancreas and throughout the endothelial cells of capillaries responsible
for transendothelial water transfer [142]; the epithelial lining of the
gastrointestinal tract contains AQP3 [143] and AQP4 [144,145]. Pancre-
atic duct cells express AQP8 in the apical plasma membrane [146] and
AQP8 [147] and AQP9 [148] are found in the hepatocytes of the liver;
in-depth reviews on the expression and localisation of AQPs in the
digestive system are available elsewhere [141,149].
In the upper digestive tract, AQP3 is expressed abundantly in strati-
ﬁed epithelia of the oral cavity to the fore-stomach. AQP3 is localised in
the basal and intermediate cell membrane becoming less abundant
towards the epithelial surface and is thought to provide a supply of
water from the sub-epithelial side of these cells which face harsh condi-
tions, such as the lowpHof the stomach, to prevent them fromdehydra-
tion [143]. Immunocytochemistry has shown strong AQP4 expression at
the basolateral membrane of the gastric parietal cells in mice and
was hypothesised to play a role in gastric acid secretion. Wang and
colleagues [144] used several secretory agonists to increase gastric
acid output in AQP4 null and control mice; no signiﬁcant differences
were seen in secretion levels suggesting that the deletion of AQP4 did
not affect the stomach's ability to secrete gastric acid [144].
In the distal colon and rectum, AQP3 is localised on the basolateral
membrane of the epithelial cells lining the lumen [143]. Inhibition of
AQP3 by HgCl2 in rats induced severe diarrhoea, suggesting a role for
AQP3 in regulating faecal water content [150], although it should be
noted that mercury is a toxic, non-speciﬁc inhibitor of AQP3 [151].
AQP3 may mediate the reabsorption of water from faeces by
transporting it from the lumen, across the endothelial layer into the
blood vessels via AQP1 [113]. The mechanism by which this is
controlled is unknown but further understanding could lead to
treatments for over- or under-active bowel problems. For example,
the temporary inhibition of AQP3 could have a laxative effect.
AQP8 may have a role in bile secretion in hepatocytes, which are
responsible for the formation of bile before it is secreted into the bile
duct and modiﬁed by cholangiocytes. AQP8 was detected in the
cytoplasm and intracellular vesicles of rat hepatocytes by confocal
microscopy. Short-term treatment with cAMP induced re-distribution
of AQP8 to the plasmamembrane and an increase inwater permeability
within 10min. Themicrotubule inhibitor, colchicine, blocked the effects
of the cAMP treatment indicating that AQP8 translocation is stimulated
by cAMP and is microtubule dependent [152].
3.8.2. Conclusions
The digestive system is a major site of ﬂuid movement and has a
wide AQP expression proﬁle within its organ network. A polarised
AQP expression pattern suggests that an organised transcellular route
for water is an essential role of AQPs in facilitating high secretion and
absorption rates.
3.9. The musculoskeletal system
3.9.1. Localisation and regulatory roles of AQPs
Articular cartilage and intervertebral disc (IVD) tissue are specialised
biomechanical structures that are under constant compressive loads
[153,154]. The cells within these avascular tissues are exposed to con-
stantly harsh conditions as the IVD is ~80% water [155] and articular
cartilage tissue is around ~70% water [156]. The IVD is composed of
three distinct regions: the gelatinous nucleus pulposus (NP), which is
encapsulated by the annulus ﬁbrosus and the cartilaginous end
plates [153]. The native cells of the NP and cartilage tissue both secrete
proteoglycans and type II collagen; the collagen meshwork traps
negatively-charged proteoglycans (such as aggrecan) which attract
cations (mainly K+, Na+ and Ca+) resulting in the inﬂux of water; this
process is responsible for the high osmotic potential of these tissues
[157,158] enabling them to resist static and dynamic biomechanical
loads [154]. Both the NP cells and the chondrocytes must regulate
their volume and water content in these rapidly changing osmotic
environments; however little is known about the mechanisms which
they employ to do this. Recently, studies have taken place to identify
which AQPs are expressed in these tissues; AQP1 and low levels of
AQP3 have also been identiﬁed within the NP cells of the human IVD
[159] while AQP1 and AQP3 have been shown to be expressed and co-
localised at the membrane of equine articular cartilage chondrocyte
cells [154] and chondrocytes of the human knee [156].
AQP1 and AQP4 are expressed in skeletal muscle and a study has
shown that cell volume changes that occur during muscle contraction
rely on rapid water inﬂux [160]. AQP1 was found in the endothelial
cells of capillaries within the muscle tissue and AQP4 on the plasma
membrane of muscle ﬁbre cells [160]. The localisation of AQP1 and
AQP4 within the muscle tissue suggests a pathway for transcellular
water ﬂow through the endothelial cell membrane and the sarcolem-
ma; these AQPs may function together as transporters for water
between the blood and myoﬁbrils during mechanical muscle activity.
3.9.2. Conclusions
It is not surprising that the native cells of the NP and articular
cartilage express AQPs and it is highly likely that AQPs are responsible
for CVR in these highly osmotic environments. More work is required
to elucidate the functional roles of aquaporins in these tissues; a
number of published studies have suggested roles for AQPs as compo-
nents of the vital cellular apparatus for maintenance of physiological
homeostasis of the musculoskeletal system.
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4. Conclusions
The constitutive distribution of AQPs is achieved by AQP gene
expression and/or AQP protein degradation on a timescale from hours
to days [161]. Further rapid spatial and temporal distribution of AQPs is
regulated by stimulated or triggered translocation of AQP-containing
vesicles to and from a particular membrane. This is particularly well
studied for V2R-mediated AQP2 translocation in kidney collecting duct
cells [74] (Fig. 3B). Similar mechanisms of triggered translocation have
been demonstrated for other AQPs [57]. We propose that the resulting
spatial and temporal distribution of AQPs is crucial for the regulation of
transcellular water ﬂow in the major systems of the human body.
For example, reabsorption of water from the lumen of the kidney
collecting duct involves transcellular water ﬂow mediated by AQP2 at
the apical membrane and AQP3 and AQP4 at the basolateral membrane.
Transcellular water ﬂow through endothelial cells of the capillary into
the blood is then mediated by AQP1 (Fig. 3A). In another example,
AQP4 knockout mice show near normal levels of intracranial pressure
and water content but reduced accumulation of water in the brain
following cytotoxic oedema caused by ischemic stroke, cerebral injury
and meningitis [162,163]. In vasogenic oedema mouse models, AQP4
null mice show greater water accumulation in the brain [61]. These
studies suggest that water homeostasis in a non-pathological state
may be independent of AQP4-mediated transcellular water ﬂow but
that AQP4 regulates transcellular water ﬂow in cerebral oedema
(Fig. 3C). In vasogenic oedema, water is eliminated from the extracellu-
lar space through AQP4 into the intact astrocytes that make up the BBB.
Water then exits the astrocyte through AQP4 in themembrane of astro-
cytic foot processes that surround the capillary. Transcellularwaterﬂow
through endothelial capillary cells into the blood is mediated by AQP1.
However, in cytotoxic oedema, transcellular water ﬂow from the
blood into astrocytes is mediated by AQP4.
In conclusion, it appears that AQPs are crucial for the regulation of
water homeostasis, providing selective pores for the rapid movement
of water, and other uncharged solutes, across diverse cell membranes
and playing regulatory roles in CVR. Gating mechanisms, which allow
conformationally distinct open and closed states, have been proposed
for human AQPs through molecular dynamic simulations [164], but
have only been speciﬁcally reported for plant and microbial AQPs
[165]. Consequently, it is likely that the distribution and abundance of
AQPs in a particular membrane are the determinants of membrane
water permeability and a regulator of transcellular water ﬂow.
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Background: The water channel protein aquaporin 4 (AQP4) controls water permeability of the blood-brain barrier.
Results: Hypotonicity induces rapid relocalization of AQP4 in a calcium-, calmodulin-, and kinase-dependent manner.
Conclusion: AQP4 can be relocalized between the cell membrane and intracellular compartments.
Significance: Pharmacological modulation of AQP4 membrane localization could provide a new approach to treating brain
edema.
The aquaporin family of integral membrane proteins is com-
posed of channels thatmediate cellular water flow. Aquaporin 4
(AQP4) is highly expressed in the glial cells of the central nerv-
ous system and facilitates the osmotically driven pathological
brain swelling associatedwith stroke and traumatic brain injury.
Here we show that AQP4 cell surface expression can be rapidly
and reversibly regulated in response to changes of tonicity in
primary cortical rat astrocytes and in transfected HEK293 cells.
The translocationmechanism involves PKAactivation, influx of
extracellular calcium, and activation of calmodulin.We identify
five putative PKA phosphorylation sites and use site-directed
mutagenesis to show that only phosphorylation at one of these
sites, serine 276, is necessary for the translocation response.We
discuss our findings in the context of the identification of new
therapeutic approaches to treating brain edema.
The aquaporins (AQPs)4 form a family of small integral
membrane proteins found in all phylogenetic kingdoms. They
act as channels for the osmotic passage of water through bio-
logical membranes and they mediate cellular water flow.
Human AQP4 is a relatively recently discovered member of
the 13-strong family ofmammalianAQPs (1). AQP4 is found in
a number of tissues including the kidney and gastrointestinal
tract but is notable for its high levels in astrocytes and its role in
brain water homeostasis (2).
AQP4 has been shown to be important for brain edema for-
mation following traumatic brain injury, stroke, andmeningitis
(3). AQP4 knock-out mice were protected from the formation
of cytotoxic edema in a stroke model (4), providing an explicit
target for managing this condition. Despite extensive research
that has built on the well understood structural biology of the
AQP family, there are no drugs available to restrict watermove-
ment throughAQP4, and in general, knownAQP inhibitors are
either cytotoxic (mercurial compounds) or nonspecific, leading
to off-target effects (5–7). Understanding the regulation of
AQP4 now provides a novel therapeutic approach for the pre-
vention of cytotoxic edema.
The most well studied system in which cellular water flow is
regulated is the translocation of AQP2 in response to vasopres-
sin (Arg-8 vasopressin (AVP); anti-diuretic hormone (ADH)) in
the cells of the collecting duct of the mammalian kidney (8).
AQP2 is shuttled between the apical cell surface and intracel-
lular vesicles to regulate water reabsorption. The mechanism
involves AVP-mediated production of cAMP resulting in the
activation of PKA and direct phosphorylation of the AQP2
C-terminal tail at serine 256 (9). Specific SNARE proteins that
facilitate the exocytosis of AQP2-containing vesicles have been
identified (10).OtherAQPshave been shown to be translocated
in response to environmental stimuli; we recently reviewed an
emerging consensus on subcellular relocalization as a regula-
tory mechanism for the AQP family (11) following our discov-
ery of the PKC-mediated translocation of threonine-phosphor-
ylated AQP1 in response to changes of tonicity (12, 13).
There is a requirement for rapid, physiological regulation of
AQP4, which could be achieved at the transcriptional level or
by short-term subcellular relocalization. Despite this, there is
no description of a mechanism of AQP4 translocation, and the
effect of stimuli on AQP4 localization is contradictory. AQP4
localization is thought to be affected by numerous intracellular
mechanisms including PKA (14), PKC (15), and actin reorgani-
zation (16). It is not clear whether there are common mecha-
nisms either within the AQP family or even for AQP4 in differ-
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ent cell types; this indicates a general lack of mechanistic
awareness of AQP regulation.
We have identified a novel regulatory pathway of endoge-
nous AQP4 translocation in primary cortical astrocytes. This
study describes this mechanism in a model HEK293 cell line
and shows how tonicity-dependent changes in the environ-
ment lead to a calcium-dependent, calmodulin-dependent, and
PKA-specific, reversible translocation of AQP4 to the cell sur-
face. We also identify a known kinase site and putative PKA
target site, serine 276, in the C-terminal tail of AQP4 that is
necessary for the translocation response. This site has been
shown to be phosphorylated in vivo, and we show that the
mechanism requires PKA activity in primary cortical astro-
cytes. Our data represent a novel mechanism that could be a
new avenue for therapeutic discovery in the treatment of cyto-
toxic brain edema.
Experimental Procedures
Materials—Cell-permeable inhibitors were purchased as fol-
lows: trifluoperazine and W7 calmodulin antagonists from
Sigma (Poole, UK); the myristoylated PKA inhibitor Myr-PKI
14-22 amide from Merck Chemicals (Nottingham, UK); and
Myr-PKC 19-27 and hypericin from Fisher Scientific (Lough-
borough, UK). FluoroDishTM dishes were from World Preci-
sion Instruments Ltd. (Stevenage, UK).Monoclonal rabbit anti-
AQP4 antibody was from Abcam (Cambridge, UK, product
code ab128906), and secondary goat anti-rabbit IgG-HRP was
from Santa Cruz Biotechnology. Gateway vectors and enzymes
were from Invitrogen (Paisley, UK). Unless otherwise specified,
all other chemicals were from Sigma or Fisher Scientific. Cell
culture reagents, including calcium-free DMEM, were from
Sigma. In each experiment, all inhibitors were analyzed using
uninhibited cells transfected with wild-type AQP4-GFP as a
positive control.
Cell Culture and Transfection—HEK293 cells were cultured
routinely in DMEM supplemented with 10% (v/v) fetal bovine
serum in humidified 5% (v/v) CO2 in air at 37 °C. Cells were
seeded into 35-mm FluoroDishTM dishes (World Precision
Instruments) and transfected after 24 h using PEI. 2!g of DNA
was added to 100 !l of pre-warmed serum-free DMEM fol-
lowed by 12 !l of 1 mg/ml PEI (pH 7.4). The mixture was incu-
bated at room temperature for 10 min. 600 !l of pre-warmed
growth media was added, and cell culture media were replaced
with the transfectionmix. 2ml of growthmediawas added after
2 h. The transfection mix was replaced by 2 ml of culture
medium after a further 22 h. Transfected cells were imaged
24–36 h after transfection. Rat primary cortical astrocytes were
isolated and cultured as described previously (12). All cells
tested negative formycoplasma using the EZ-PCRmycoplasma
test kit (Biological Industries).
Expression Constructs and Mutagenesis—Human AQP4
cDNA was a kind gift of Dr. Kristina Hedfalk (University of
Gothenburg). This was fused with C-terminal GFP in the
pDEST47 expression vector using the Gateway cloning system
(Invitrogen) as described previously (12). Site-directed mu-
tagenesis was performed using the QuikChange procedure
(Stratagene).
Confocal Microscopy—AQP4-GFP constructs were imaged
in live cells using a Zeiss LSM780 confocal microscope with a
63! 1.3 NAwater immersion objective and an incubated stage
held at 37 °C. GFP was excited using the 488-nm line of an
argon laser. FM4-64 was excited using the 514-nm line of an
argon laser. ER-Tracker Blue-White was excited using a
405-nm diode laser. Hypotonic challenges were achieved by
dilution ofmediumwith distilledH2Oon themicroscope stage.
Image Analysis—Line profiles across the cell membrane and
cytoplasm were extracted using ImageJ as described previously
(13) in a semi-automated fashion using an in-house ImageJ
macro. Line scan positions were chosen to avoid the nucleus
and perinuclear region. Relative membrane expression (RME)
was calculated from profiles using an in-houseMATLAB code.
ER-localized AQP4 affected the calculated RME by"10%. This
was confirmed by recalculating the RME after subtracting the
GFP signal that co-localized with ER-Tracker Blue-White. Cell
cross-sectional areas were calculated in ImageJ using the parti-
cle detection tool. Transfected and non-transfected cell swell-
ing was compared using the FM4-64membrane dye (see Fig. 3).
SDS-PAGE and Western Blotting—HEK293 cells were lysed
in radioimmunoprecipitation assay buffer (pH8.0). 2!g of total
cellular protein was electrophoresed on 8% polyacrylamide
gels. Blocking buffer was 20% w/v nonfat powdered milk in
PBS-Tween (0.1%). Anti-AQP4 primary antibody (Abcam,
ab128906) was diluted 1:10,000 in 0.1% PBS-Tween. Donkey
anti-rabbit IgG-HRP (Santa Cruz Biotechnology, sc2313) was
diluted 1:20,000 in 0.1% PBS-Tween.
Biotinylation—Primary astrocytes were plated in 6-well
plates 2 days before the experiments. Cell surface amines were
biotinylated using a cell-impermeable amine-reactive biotiny-
lation reagent (EZ-Link Sulfo-NHS-SS-Biotin, Thermo Scien-
tific). Cells were exposed to reductions in extracellular tonicity
by diluting culture medium with distilled H2O. Cell culture
media were washed out with PBS (with Ca2#/Mg2#) while
avoiding completely drying the cells. Cells were incubated in
600 !l of 0.5 mg/ml biotinylation reagent in PBS diluted to the
tonicitymatching the cell treatment on ice for 30min. For basal
surface expression experiments, cells were washed twice in ice-
cold PBS instead of hypotonic treatment. Unreacted reagent
was quenched in 25 mM glycine in PBS three times for 5 min.
Cells were lysed in Tris-Triton (1%) lysis buffer (pH 7.4). The
lysatewas centrifuged at 21,000! g at 4 °C for 10min to remove
insoluble material. Biotinylated proteins were pulled out by
incubation in NeutrAvidin-coated 96-well plates (Pierce) for
2 h at 4 °C. Each lysate was loaded in triplicate with the same
amount of total cellular protein (measured by BCA assay) per
lysate. Plates were blocked with 3% w/v BSA in PBS for 1 h at
room temperature. Plateswere incubated overnight at 4 °Cwith
an AQP4 antibody (Abcam, ab128906) diluted 1:2,000 in 0.05%
PBS-Tween. Plates were washed with 0.1% PBS-Tween and
incubated at room temperature for 1 h with HRP-conjugated
secondary antibody (Santa Cruz Biotechnology, sc-2313).
Plates were washed with 0.1% PBS-Tween and incubated with
o-phenylenediamine dihydrochloride (Sigma-Aldrich) for 30
min, wrapped in foil. Absorbance was measured at 450 nm
using a BioTek Synergy HT plate reader.
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Osmolality—Osmolalitiesofalltreatmentsolutionsweremea-
sured using an Osmomat 3000 freezing point depression
osmometer (Gonotec).
Statistics—For microscopy experiments in which the same
cells were imaged before and after tonicity changes, paired t
tests were used. Formultiple treatments of the same cells, anal-
ysis of variancewas used followed by paired t tests, with p values
subjected to Bonferroni’s correction. For biotinylation experi-
ments in which different cells were subject to different treat-
ments, unpaired t tests were used following analysis of variance
and p values subjected to Bonferroni’s correction. All p values
referred to in the text and figures are the post-correction values,
rounded up to 1 significant figure. p ! 0.05 was considered
statistically significant (*).
Results
AQP4Undergoes a Rapid and Reversible Subcellular Relocal-
ization in PrimaryCortical Astrocytes in Response to Changes in
the Tonicity of the Extracellular Environment—Surface expres-
sion of endogenousAQP4 in rat primary cortical astrocytes was
measured using cell surface biotinylation followedby aNeutrA-
vidin-based ELISA. Fig. 1 shows that AQP4 surface localization
increased 2.7-fold after 10 min of hypotonic challenge at 85
mosM/kg of H2O (n" 3, p" 0.006) but did not change signifi-
cantly after 10 min of hypotonic challenge at 140 mosM/kg of
H2O. It is important to confirm that this response is not due to
a general effect of hypotonicity on vesicularmembrane proteins
or changes in protein availability due to membrane unfolding
associated with cellular swelling. To discount these, we mea-
sured surface expression of the astrocytic excitatory amino acid
transporter EAAT1. Surface expression of EAAT1 did not
change significantly with either hypotonic treatment (n " 3,
p " 0.37), and there was no significant effect on cell viability
measured by trypan blue exclusion (data not shown).
Primary astrocytes suffer from poor transfection efficiencies
and slow growth. HEK293 cells were therefore used to further
investigate AQP4 subcellular relocalization because they are
much more tractable for screening cellular inhibitors and pro-
tein mutants, as demonstrated previously by our discovery of
the mechanism of tonicity-induced relocalization of human
AQP1 using GFP-tagged proteins (12, 13). The distribution of
AQP4-GFP fusion proteins transfected into HEK293 cells was
altered by changes in tonicity of the external environment.
Live-cell confocal microscopy (Fig. 2) showed a rapid translo-
cation of AQP4 to the cell surface in response to hypotonicity
(following a 30-s exposure from 340 mosM/kg of H2O to 85
mosM/kg of H2O). This effect was fully reversible. Surface
expression of AQP4-GFP in fluorescence micrographs was
quantified by calculating the RME as described previously (13).
Briefly, the difference between the average membrane fluores-
cence and the average intracellular fluorescencewas calculated,
and this was normalized to the maximum fluorescence inten-
sity (cells with protein evenly distributed between membrane
and intracellular compartments have an RME of 0, and cells
with 100%of the protein at themembrane have anRMEof 100).
Fig. 2 shows that relative membrane expression changed from
27.86 # 3.52 to 67.11 # 4.47, n " 3, p " 0.001. The change in
AQP4-GFP localization upon changing the extracellular tonic-
ity from 340mosM/kg of H2O to 85 mosM/kg of H2O happened
on a timescale of 30 s. The change in RME was not due to a
dilution effect or an artifact of theGFP tag as AQP3-GFP fusion
proteins showed a similar distribution between membrane and
cytoplasm, but no significant change in RME in response to
reduced tonicity. The translocation response was not due to a
reduction in extracellular potassium concentration as iso-
tonic reduction of [K$]o had no effect on RME (Fig. 2F, left),
whereas hypotonicity in the presence of constant [K$]o had
the same effect as hypotonicity induced by dilution of all
solutes (Fig. 2F, center). Furthermore, elevation of [K$]o to
10 mM in isotonic conditions increased AQP4 RME from
27.8 # 6.3 to 50.6 # 6.1 in agreement with published data
(17) (Fig. 2F, right). AQP4-GFP-transfected cells swelled,
leading to a 45 # 1% increase of cross-sectional area after 1
min as compared with a 5# 1% increase for non-transfected
cells in the same images (Fig. 3).
There Is a Threshold Tonicity for the Translocation Re-
sponse—AQP4 translocation in primary astrocytes was
observed following a reduction of the extracellular tonicity to
85 mosM/kg of H2O (from 340). Reduction to 170 mosM/kg of
H2O had no effect (Fig. 1). Fig. 4 shows that this phenomenon
was reproduced in HEK293 cells. RME was 25.98 # 5.32 in
control medium, 33.07# 5.24 in 170 mosM hypotonic medium
(not significantly different from control), and 63.61# 6.16 in 85
mosM hypotonic medium, p " 0.0007 as compared with 340
mosM, after Bonferroni’s correction, n" 3.
BothAQP4 IsoformsAreRelocalizedEqually—AQP4 exists in
two isoforms: a longM1 formand a shorterM23 form that lacks
the initial 22 amino acids ofM1. Both proteins can be translated
from the same full-length transcript by a “leaky scanning”
mechanism, and different cell types express different M1/M23
ratios (18) via an unknown regulatory mechanism. To deter-
mine whether both isoforms or a single isoform was expressed
FIGURE 1. Endogenous AQP4 relocalization in primary cortical astro-
cytes. Cell surface biotinylation of primary rat astrocytes subjected to hypo-
tonic stress and analysis of endogenous AQP4 surface expression is shown,
n " 3. As a negative control for translocation, membrane expression of the
glutamate transporter EAAT1 was measured under the same hypotonic con-
ditions, n" 3. All data are presented asmean# S.E. p values and significance
on the graph refer to AQP4. None of the variability in EAAT1 surface expres-
sion was statistically significant, p" 0.37. n.s., not significant.
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from the wild-type AQP4 mRNA in our HEK293 system, we
created constructs lacking either theM1 or theM23 translation
initiation sites and compared the molecular weights of the
resulting proteins with that translated from the wild-type
mRNA, using SDS-PAGE. Fig. 5 shows that only the M1 iso-
form was present in HEK293 cells transfected with the wild-
type AQP4 mRNA. M1 and M23 constructs had basal surface
expression (i.e. at 340 mosM) equivalent to the wild type, mea-
sured using cell surface biotinylation. The confocal microscopy
experiments described previously were repeated using the M1
and M23 constructs. M23 formed the punctate orthogonal
arrays of particles that have been described previously for this
isoform (19). RME for M23 changed from 24.58 ! 4.85 at 340
mosM/kg of H2O to 51.15! 5.25 at 85 mosM/kg of H2O, n" 3
FIGURE 2. AQP4-GFP relocalization in HEK293 cells. A–C, representative
fluorescence micrographs of AQP4-GFP fusion proteins in HEK293 cells fol-
lowing exposure to isotonic medium (340 mosM/kg of H2O) (A), a 30-s expo-
sure to hypotonic medium (85 mosM/kg of H2O) (B), and return to isotonic
extracellular environments (C), with fluorescence intensity profiles across the
yellow lines and cross-sectional areas calculated using ImageJ. a. u., arbitrary
units.D,meanRME in the three conditions. Three lineprofileswere calculated
per cell, and at least three cells per imagewere analyzed for each experimen-
tal repeat. n" 3. p values are from paired t tests with Bonferroni’s correction
following analysis of variance. n.s., not significant. E, RME of AQP4-GFP fusion
proteins in HEK293 cells (black curve, n " 3), measured by confocal fluores-
cencemicroscopy at a frame rate of 0.1 s#1, changed on a timescale of$30 s
in response to reduction of extracellular tonicity from 340mosM/kg of H2O to
85mosM/kg of H2O, whereasmembrane expression of AQP3-GFP fusion pro-
teins did not change (red curve, n" 3). F, translocation is not due to a reduc-
tion in extracellular potassium. Extracellular potassium reduction (left pair of
data points) and hypotonicity (central pair of data points) were applied inde-
pendently by diluting media 4-fold with either isotonic NaCl (170 mM" 340
mosM) or 5.4 mM KCl in distilled H2O. Extracellular potassium was also
increased to 10 mM in isotonic conditions (right pair of data points). All data
are presented as mean! S.E.
FIGURE 3. Cell swelling of AQP4-transfected cells. AQP4-GFP-transfected
HEK293 cellswere imagedusing theGFP tag and FM4-64, a fluorescentmem-
brane marker. A, two-color fluorescence micrograph of AQP4-GFP-trans-
fected cells (green) loaded with FM4-64 (red), before and after reduction of
extracellular osmolality from 340 mosM/kg of H2O to 85 mosM/kg of H2O. B,
representative cross-sectional areas of transfected cells before and after
hypotonic challenge, calculated using a particle detection algorithm. The
post-hypotonic challenge area as a percentage of the pre-challenge area is
shownbetweeneachpair of images.C, representative cross-sectional areasof
non-transfected cells from the same image.
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p ! 0.004. Although the hypotonic RME is lower than for the
wild type, it is not significantly so (p! 0.33). This suggested that
both isoforms are equally translocated to the surface in
response to hypotonic stimulus.
Calmodulin, Calcium, and Protein Kinase A Regulate AQP4
Relocalization—AQP surface expression is known to be regu-
lated by numerous cell signaling mechanisms. These include
kinases, calcium channels, and cytoskeletal reorganization (11).
AQP4 relocalization following hypotonic challenge was com-
pared in the presence of a number of inhibitory compounds.
These are described in Table 1. These data suggest that a com-
bination of PKA kinase activity and calcium signaling mecha-
nisms is required for AQP4 translocation. Prevention of the
translocation response by inhibitors correlated with a reduc-
tion in cell swelling, suggesting a functional increase in mem-
brane water permeability.
FIGURE 4. Tonicity dependence of AQP4 relocalization. A–C, AQP4-GFP-transfected HEK293 cells were imaged by confocal microscopy in a solution of 340
mosM/kgofH2O (A), 170mosM/kgofH2O (B), and 85mosM/kgofH2O (C). Capture of each imagewas started 30 s after the change in tonicity. For 170mosM, cells
were allowed to equilibrate for 10 min to check for a slower translocation response. No difference was observed between 30 s and 10 min images. D,
representative fluorescence profiles along the yellow lines in A, B, and C. a. u., arbitrary units. E, mean RME for the three tonicities, averaged over three
profiles/cell and at least three cells/experimental repeat, n! 3. p values are from paired t tests with Bonferroni’s correction following analysis of variance. All
data are presented as mean" S.E. n.s., not significant.
FIGURE 5. Both AQP4 isoforms are relocalized. Both the M1 and the M23 isoforms of AQP4 are translocated to the cell surface upon hypotonic stimulus. A,
membrane organization of AQP4-GFP transfected into HEK293 cells. The M1 isoform has a homogeneous membrane distribution, whereas M23 clusters into
orthogonal arrays of particles. B, SDS-PAGE of protein transcribed in HEK293 cells from the AQP4 wild-type mRNA, AQP4 M1 construct, and AQP4 M23
construct. No M23 protein was detected in the wild-type sample. C, there was no significant difference in constitutive surface expression between the three
constructs. D, both isoforms of AQP4 are relocalized in response to reduction of the extracellular osmolality to 85mosM/kg of H2O (M1: p! 0.002, n! 3. M23:
p! 0.004, n! 3. WT: p! 0.001, n! 3.). All data are presented as mean" S.E.
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Ser-276 Phosphorylation Is Required for Relocalization—The
data in Table 1 suggest a key role for PKA (but not PKC) in
mediating AQP4 translocation. Using kinase site prediction
software (NetPhosK 1.0 (20)), five serine residues were identi-
fied as PKA consensus sites. These were Ser-52, Ser-111, Ser-
180, Ser-188, and Ser-276. The locations of these residues in the
AQP4 structure are shown in Fig. 6.
The PKA consensus sites were individually mutated to ala-
nine (to block phosphorylation) and aspartate (to act as a phos-
phomimetic). The effects of these mutations on the tonicity-
induced relocalization of AQP4 are tabulated in Table 2. Only
mutations to Ser-276 had any effect on hypotonicity-induced
translocation. Substitution of Ser-276 with alanine (S276A)
blocked hypotonicity-induced translocation, whereas substitu-
tion with aspartate (S276D) had no effect, suggesting that PKA
phosphorylation at Ser-276 is necessary but not sufficient for
translocation to occur or that S276D is a poor phosphomimetic.
To determine whether this single phosphorylation event was
the only mechanistic effect of PKA, translocation of the S276D
mutant was measured in the presence of a myristoylated PKA
inhibitory peptide (Myr-PKI). Unlike the wild-type protein, for
which the translocation was inhibited by Myr-PKI, S276D still
translocated to the membrane in the presence of the PKA
inhibitor. This shows that S276D is a phosphomimetic and that
PKA phosphorylation of AQP4 at Ser-276 is a key step in the
AQP4 translocation signaling pathway. Although the S52A
mutant behaved likewild-typeAQP4, S52Ddid not translocate,
but also had greatly reduced basal surface expression in com-
parison with wild-type AQP4 and other phosphomimetic
mutants. Low surface expression prevented calculation of the
RME and measurement of cross-sectional area in confocal
micrographs. S52D appeared to be localized throughout the
cytoplasm (rather than degraded or held as inclusion bodies),
suggesting that the protein is not simply grosslymisfolded. This
may reflect a functional relevance, possibly interrupting pro-
cessing through theGolgi apparatus or post-Golgi trafficking to
the cell surface, which may be worthy of further study.
PKA Activity Is Required for Endogenous AQP4 Relocaliza-
tion in Primary Astrocytes—HEK293 cells provide a tractable
model for studying the cell signaling components required for
AQP4 translocation. However, it is possible that, despite shar-
ing the translocation response, HEK293 cells and primary
astrocytes translocate AQP4 by different mechanisms. To val-
idate the mechanistic information obtained in HEK293 cells,
we repeated the primary astrocyte cell surface biotinylation
experiments in the presence of a PKA inhibitor. Fig. 7 shows
that a 30-min pre-incubation with Myr-PKI prevented the
hypotonicity-induced relocalization of endogenous AQP4 in
rat primary cortical astrocytes. This suggests that the mecha-
nistic details elucidated using HEK293 cells are physiologically
relevant to the translocation of endogenous AQP4 in primary
astrocytes.
Discussion
AQP4-GFP fusion proteins in HEK293 cells and endogenous
AQP4 in primary rat astrocytes rapidly relocalize to the plasma
membrane in response to a reduction in local tonicity. The
relocalization response takes about 30 s in HEK293 cells and is
completely reversible upon return of the local tonicity to 340
mosM/kg of H2O. The concomitant cell swelling following
AQP4 relocalization (which was reduced by inhibitors that
blocked the translocation response) suggests that there is an
effective increase in cell membrane water permeability. The
mechanisms involved in AQP4 relocalization require PKA ac-
tivity and cytoskeletal elements. Extracellular calcium is re-
quired, presumably passing through transient receptor poten-
tial (TRP) channels, which are known to mediate a calcium
signaling response to osmotic cell swelling (21).
Calmodulin inhibition using two different calmodulin inhib-
itors (W7 and trifluoperazine) also blockedAQP4 translocation
in response to hypotonicity. Calmodulin-mediated regulation
of AQPs is well established. Calmodulin has been shown to
inhibit AQP0 water permeability by binding directly to the
C-terminal tail (22, 23), and this binding can be inhibited by
AQP0 phosphorylation (24). In rat parotid cells, AQP5was rap-
idly translocated to the apical membrane via acetylcholine sig-
naling and inhibition of signaling elements downstream of cal-
modulin (calmodulin kinase II, myosin light chain kinase, and
nitric-oxide synthase) blocked this translocation response (25).
Vasopressin-induced translocation of AQP2 in collecting duct
cells can be attenuated by extracellular calcium in a calmodu-
lin-dependentmanner (26). Calmodulin has also been shown to
bind directly to the N-terminal tail of AQP6 (27), although the
functional relevance of this interaction is unknown.We showed
previously that inhibition of calmodulin prevented hypotonic-
ity-induced relocalization of AQP1 in HEK293 cells (12). It is
not clear from our data whether calmodulin binds directly to
AQP4 or activates a third party protein tomediate AQP4 trans-
location,althoughacalmodulinbindingsitepredictiontool(Cal-
modulin Target Database (28)) does predict that themost likely
TABLE 1
Relative membrane expression of AQP4-GFP in response to hypotonic stimulus in the presence of inhibitors
Translocation of AQP4-GFP in HEK293 cells in the presence of various inhibitors, measured by confocal microscopy and subsequent image analysis, is shown. Cells were
imaged before and after reduction of the extracellular osmolality to 85 mosM/kg of H2O. Each RME value is an average over three independent experiments, with each
experiment analyzing at least 3 cells/micrograph and 3 line profiles/cell. p! 0.05 was considered statistically significant (*). Abbreviations: PKCi, PKC inhibitor; PKAi, PKA
inhibitor.
Inhibitor/control media
Isotonic RME
(! S.E.)
Hypotonic RME
(! S.E.)
Mean % of area change
(! S.E.) Translocation
Untreated control 28.77 (6.78) 78.84 (1.84)* 145.19 (1.11)* Yes
Non-specific kinase inhibitor (hypericin) 21.85 (6.80) 38.22 (5.58) 103.50 (2.05) No
PKC (Myr-PKCi) 27.27 (4.73) 55.28 (3.97)* 141.00 (2.05)* Yes
PKA (Myr-PKAi) 25.62 (5.16) 33.66 (6.62) 102.97 (5.21) No
Calcium-free media 26.69 (6.03) 32.16 (4.48) 111.60 (1.92) No
Calmodulin inhibitor (trifluoperazine) 27.23 (7.11) 31.40 (5.91) 108.61 (5.47) No
Calmodulin inhibitor (W7) 16.86 (8.43) 22.11 (8.14) 110.31 (14.21) No
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site for direct binding of calmodulin to AQP4 is the 20-residue
peptide at positions 277–296, directly upstream of the Ser-276
phosphorylation site we identified.
Kinase-dependent translocation of AQPs to the plasma
membrane from intracellular vesicles is an established regula-
tory mechanism that has been demonstrated for AQP2 in
response to vasopressin signaling via PKA (29), AQP1 in
response to hypotonicity via PKC (13), andAQP5 in response to
acetylcholine via PKG (25). Treatment with the broad-range
kinase inhibitor, hypericin, suggested a similar mechanism for
AQP4 relocalization. Using specific inhibitors identified PKA
activity as a requirement for tonicity-mediated translocation of
AQP4. There is some evidence that PKA reduced surface avail-
ability of AQP4 in human gastric cells (14). In our systems, PKA
seems to be doing the opposite.
All potential PKA sites of AQP4 were mutated, suggesting a
key requirement for serine at position 276 (Ser-276) in the
C-terminal tail of AQP4. Phosphorylation at this residue has
been detected in vivo in murine AQP4 (30) and rat AQP4 (31).
It was recently reported that phosphomimetic (S276D) or phos-
pho-blocking (S276A) mutations at this residue have no effect
on surface expression or water permeability, leaving the pur-
pose of this phosphorylated residue unclear (32). Our data pro-
vide evidence of a functional role for Ser-276 phosphorylation.
It has also been reported that phosphorylation at Ser-276 can
increase lysosomal targeting of AQP4 upon internalization
(33). This may explain the slight reduction in constitutive sur-
face expression (to 83.5 ! 5.7%) that we measured for the
S276Dmutant. PKC phosphorylation of Ser-180 in response to
AVP has been reported to cause AQP4 internalization (34); we
did not observe any change in constitutive surface expression or
translocation response for the S180D phosphomimetic mutant
in our system. This may reflect the lack of an element of this
internalization pathway in HEK293 cells or a species-specific
FIGURE 6.Phosphomimeticmutagenesis of AQP4. Locationswithin the AQP4 structure of identified putative PKA sites that weremutated (red) and the AQP
family conserved NPAmotifs (blue) are shown.
TABLE 2
Relative membrane expression of AQP4 phosphorylation mutants in response to hypotonic stimulus
Translocation of phosphomimetic and phospho-blocking mutants of AQP4-GFP in HEK293 cells, measured by confocal microscopy and subsequent image analysis, is
shown. Cells were imaged before and after reduction of the extracellular osmolality to 85 mosM/kg of H2O. Each RME value is an average over three independent
experiments, with each experiment analyzing at least 3 cells/micrograph and 3 line profiles/cell. Constitutive surface expression was measured by cell surface biotinylation
and normalized to wild-type expression. p" 0.05 was considered statistically significant (*). Abbreviation: NA, not applicable.
Mutant
Isotonic RME
(! S.E.)
Hypotonic RME
(! S.E.)
Mean % of area change
(! S.E.) Translocation
Constitutive surface expression
(% of wild-type)
S52A 34.18 (4.06) 59.34 (5.53)* 127.03 (5.99)* Yes 98.1 (5.3)
S52D NA NA NA No 17.0 (6.3)*
S111A 36.24 (9.95) 62.43 (5.42)* 130.69 (4.76)* Yes 94.8 (6.4)
S111D 31.17 (4.22) 52.99 (5.41)* 120.62 (8.40)* Yes 91.4 (4.6)
S180A 35.43 (7.78) 69.03 (6.94)* 142.65 (7.78)* Yes 109.8 (4.5)
S180D 36.86 (6.07) 53.56 (4.96)* 148.16 (16.74)* Yes 99.7 (5.0)
S188A 34.17 (7.21) 63.31 (7.00)* 137.01 (9.17)* Yes 98.6 (3.2)
S188D 31.64 (9.11) 59.18 (5.60)* 135.53 (10.47)* Yes 104.1 (4.2)
S276A 36.61 (4.64) 36.97 (5.53) 110.82 (3.85) No 96.8 (3.2)
S276D 25.72 (5.42) 57.93 (11.01)* 134.18 (15.10)* Yes 83.5 (5.7)*
S276D# PKA inhibitor 24.58 (4.85) 51.14 (5.25)* 127.12 (7.34)* Yes 86.2 (5.1)*
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effect (these experiments were done inXenopus oocytes). Phos-
phorylation of AQP4 at Ser-111 in response to elevated extra-
cellular potassium has been reported to increase membrane
water permeability in an astrocytic cell line (17). S111A and
S111Dmutations had no effect in our system, and furthermore
S276D translocated in the presence of a PKA inhibitor, suggest-
ing that the only role of PKA in our system is to phosphorylate
Ser-276. Although an isotonic increase in extracellular potas-
sium induced AQP4 translocation in our system, which agrees
with a previous study (17), the hypotonicity-induced transloca-
tion of AQP4was independent of any reduction in extracellular
potassium associatedwith the hypotonic challenge. Although it
is probable that Ser-276 is phosphorylated in our primary astro-
cyte experiments, we cannot rule out a difference in phosphor-
ylation sites between different cells or a synergistic effect of
several kinase sites in the primary cells.
Interestingly, we found that both endogenous and trans-
fected AQP4 (with and without GFP) did not relocalize in
response to any tonicity change in the U373 glioblastoma cell
line (Fig. 8). There is some evidence that a dominant-negative
splice variant of AQP4 lacking exon 4, which codes for the half-
helix containing the second NPA motif, can inhibit surface
expression of either theM1 or theM23 isoforms of AQP4when
co-expressed (35). This was reported inmuscle cells, but it may
be possible that dysregulation of this isoform inhibits surface
expression in U373 cells. People with glioblastoma have a very
poor prognosis. The cells are very invasive, and edema is a key
problem. This may be worthy of further investigation to deter-
mine whether this is a peculiarity of the U373 cell line or rep-
resentative of glioblastoma physiology.
To conclude, the data reported here provide a mechanistic
explanation for our discovery of the physiological relocalization
of AQP4 in response to changes in local tonicity. A change in
local tonicity is the key driver of cell swelling in stroke and
contributes to the effects of cytotoxic edema following trau-
matic brain injury. Modulating the surface expression of AQP4
rather than trying to directly block its pore is a novel platform
for developing therapies for these devastating conditions.
Author Contributions—PK, RED,MTC, RMB, and ACC designed all
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Figs. 1, 2, 3, 4, 5, and 8 and prepared Fig. 6. PK and LHJT performed
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ACC drafted the manuscript. RMB, MMS, RED and MTC critically
revised the manuscript. All authors approved the final version of the
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Abstract
Aquaporin membrane protein channels mediate cellular water flow. Human aquaporin 5
(AQP5) is highly expressed in the respiratory system and secretory glands where it facili-
tates the osmotically-driven generation of pulmonary secretions, saliva, sweat and tears.
Dysfunctional trafficking of AQP5 has been implicated in several human disease states,
including Sjögren’s syndrome, bronchitis and cystic fibrosis. In order to investigate how the
plasma membrane expression levels of AQP5 are regulated, we studied real-time translo-
cation of GFP-tagged AQP5 in HEK293 cells. We show that AQP5 plasma membrane
abundance in transfected HEK293 cells is rapidly and reversibly regulated by at least three
independent mechanisms involving phosphorylation at Ser156, protein kinase A activity
and extracellular tonicity. The crystal structure of a Ser156 phosphomimetic mutant indi-
cates that its involvement in regulating AQP5 membrane abundance is not mediated by a
conformational change of the carboxy-terminus. We suggest that together these pathways
regulate cellular water flow.
Introduction
The flux of water across biological membranes is facilitated by transmembrane protein chan-
nels called aquaporins (AQPs). AQPs passively transport water in response to osmotic gradi-
ents, while excluding the movement of ions and protons [1] and thus are important for cell
volume regulation [2]. In humans, thirteen members of the AQP family (AQP0-12), with sub-
tle functional differences, are expressed with different tissue-specific and time-dependent pro-
files [3].
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Eukaryotes have evolved to fine-tune water transport through AQPs by three main regula-
tory mechanisms: (i) at the transcriptional/translational level; (ii) by conformational change or
“gating” and (iii) by translocation to the membrane in response to a trigger. Regulation by
AQP gene expression and/or AQP protein degradation can be achieved over a timescale from
hours to days. However, this does not account for the dynamic control of AQPs that may be
necessary to rapidly alter membrane water permeability in response to environmental or cellu-
lar signals. Instead, this can be achieved by gating; a conformational change of the AQP protein
that alters the permeability of the pore. In addition, translocation can regulate the number of
AQP molecules present in the target membrane, altering membrane water permeability by
changing the number of pores present.
Structures of gated AQPs have revealed the molecular details of AQP gating by phosphory-
lation, pH and Ca2+ for the spinach aquaporin SoPIP2;1 [4] and mechanosensitivity for the
yeast aquaporin AQY1 [5]. Furthermore, mammalian AQP0 is suggested to be gated in a pH
and Ca2+-dependent manner, the latter being mediated by an interaction with calmodulin, as
described by a recent structural model [6]. While gating of other mammalian AQPs remains to
be conclusively shown, translocation is a common regulatory mechanism. The best-character-
ised example of this type of regulation is that of human AQP2 in the kidney: AQP2 abundance
in the apical membrane is dependent on vasopressin-activated phosphorylation of a carboxy-
terminal serine residue (Ser 256) by cAMP-dependent protein kinase A (PKA) [7]. Phosphory-
lation in response to a hormonal trigger has also been shown to mediate membrane transloca-
tion of AQP1 [8], AQP5 [9–11] and AQP8 [12], on a timescale of minutes to hours.
Translocation in response to an osmotic stimulus has been demonstrated to regulate AQP1
activity on a timescale of seconds; exposure to hypotonic conditions resulted in rapid recruit-
ment to the cell surface via a mechanism dependent on transient receptor potential channels,
extracellular calcium influx, calmodulin, and the phosphorylation of two threonine residues
(Thr 157 and Thr 239) of AQP1 [13].
AQP5 is found in tissues such as the lungs, airways and secretory glands and consequently
plays a major role in the generation of saliva, tears and pulmonary secretions [14–16]. AQP5
dysregulation has been implicated in several disease states, including bronchitis, cystic fibrosis
[17] and Sjögren’s syndrome [18]. AQP5 translocation has been shown to be affected by cAMP
in a PKA-dependent manner, with exposure to elevated intracellular cAMP levels causing a
short-term (minutes) decrease in AQP5 membrane abundance whereas long-term (8 hours)
exposure increased total AQP5 protein [15]. There are two consensus PKA sites in AQP5: Ser
156 in cytoplasmic loop D [19, 20] and Thr 259 [10] in the carboxy-terminus; the latter corre-
sponds to Ser 256 in AQP2. AQP5 can be directly phosphorylated by PKA at Ser 156 and Thr
259 [21]. Notably, Ser 156 was phosphorylated preferentially in certain tumors suggesting that
cell proliferation can be modulated by phosphorylation of this site although the constitutive
membrane abundance of an S156A mutant was not distinguishable from wild-type AQP5 [22].
Based on the crystal structure of human AQP5 it was hypothesized that phosphorylation of Ser
156 could cause structural changes in loop D that would break its interaction with the carboxy-
terminus, thereby flagging the protein for translocation to the plasma membrane [23].
In order to investigate the role of Ser 156 in the membrane translocation of AQP5, we used
real time translocation studies in living HEK293 cells; GFP-tagged full-length AQP5 mutants
were designed to either abolish or mimic phosphorylation of Ser 156. Our data show that the
phosphomimetic mutation of Ser 156 to glutamate (S156E) increased constitutive membrane
expression of AQP5. Inhibition of PKA increased constitutive membrane expression of wild-
type, S156E and S156A, suggesting that the effect of PKA on AQP5 translocation is not solely
dependent Ser 156. We further show rapid membrane translocation upon a hypotonic stimulus
independently of both Ser 156 phosphorylation and PKA activity. Finally, we have used x-ray
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crystallography to show that the phosphomimetic S156E mutation does not cause any signifi-
cant structural changes to the protein as previously suggested. We propose that three indepen-
dent mechanisms regulate the membrane abundance of AQP5, one of which involves
phosphorylation of Ser 156.
Materials and Methods
Cloning of AQP5-GFP fusion constructs for analysis in HEK293 cells
Human full-length AQP5 was fused with carboxy-terminal GFP using the Invitrogen Gateway™
cloning system according to the instructions provided by the supplier. For directional cloning
of blunt-ended PCR products into an entry vector using the Gateway™ system, four bases
(GGGG) were added to the 50-end of the forward primer followed by the 25bp attB1 attach-
ment sequence (underlined, below). This was followed by five bases (bold) to introduce a
Kozak sequence upstream and to keep the sequence in frame with the AQP coding sequence.
Finally 18-25bp of the AQP5 sequence were added to create the amino-terminal forward prim-
ers, 50-GGGG ACA AGT TTG TAC AAA AAA GCA GGC TCC ACC ATG–AQP5(18-25bp)-
30. For the reverse primer, four bases (GGGG) were added to the 50-end followed by the 25bp
attB2 attachment sequence (underlined) and then one base (bold) was added to keep the
sequence in frame with the AQP5 coding sequence. Finally 18-25bp of the AQP sequence with-
out the stop codon were added to create the carboxy-terminal forward primers 50-GGG GAC
CAC TTT GTA CAA GAA AGC TGG GTC–AQP5(18-25bp)-30. KOD polymerase was used
in PCR amplification of the AQP cDNA. Samples were heated to 94°C for 2 min, followed by
30 cycles of 94°C for 30 s, 55°C for 30 s and 68°C for 3 min and then 68°C for 7 min. Purified
PCR products were sub-cloned into the pDONR221™ entry vector (Invitrogen) using the attB1
and attB2 sites in a reaction with Gateway™ BP Clonase™ enzyme mix (Invitrogen).
pDONR221™ vectors containing the required sequences were recombined with the pcDNA-D-
EST47 Gateway™ vector using the attL and attR reaction with Gateway™ LR Clonase™ enzyme
mix (Invitrogen). This created expression vectors with the cycle 3 mutant of the GFP gene at
the carboxy-terminus of the AQP gene of interest, which were subsequently expressed as fusion
proteins. The mutant constructs S156E and S156A were amplified using the well-established,
modified QuikChange procedure (Stratagene), as previously described [13] and according to
their manual. All plasmids were handled and purified using standard molecular biological
procedures.
Cell culture and transfection
HEK 293 cells were routinely cultured in Dulbecco’s modified Eagle’s medium (DMEM) sup-
plemented with 10% (v/v) fetal bovine serum in humidified 5% (v/v) CO2 in air at 37°C. Cells
were seeded into 30 mm Fluorodish™ dishes and transfected after 24 h at 50% confluence using
the Transfast (Promega) transfection protocol with 2 μg of DNA/dish. PKA inhibition was
achieved by incubation with 3.6 μMmyristoylated PKI 14–22 amide (Enzo Life Sciences, Exe-
ter UK) for 30 minutes.
Confocal microscopy
AQP5-GFP fusion proteins were visualized in live cells enclosed in a full environmental cham-
ber by confocal laser scanning microscopy. Confocal images were acquired 24 h post-transfec-
tion with a Leica SP5 or Zeiss 780 laser scanning microscope using a 63× (1.2 NA) water
immersion objective. Images were acquired using an argon laser (excitation 488 nm; emission
band pass 505–530 nm) for GFP, UV excitation and a He-Ne laser (excitation 543nm; emission
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filter long pass (LP) 650 nm). Cells were visualized in control medium (DMEM) that had an
inorganic salt concentration of 120 mM, a glucose concentration of 25 mM and an osmolality
in the range 322–374 mosM/kg H2O. Hypotonic medium has an osmolality in the range 107–
125 mosM/kg H2O through dilution of DMEM by a factor of 3 with water.
Determination of sub-cellular localization
Protein localization was measured using a line profile (pixel density) traced on each transfected
cell. Localization data are representative of three to five cells from at least three independent
experiments. Line expression profiles were generated and analyzed with the program ImageJ
(http://rsb.info.nih.gov/ij/) and are indicated in yellow and displayed beside each confocal
image. A minimum of five line profiles were measured, distributed at regular intervals covering
the plasma membrane and the cytosol, but avoiding the nucleus of a minimum of three cells
from at least three independent experiments The fluorescence intensity over this distance was
also measured and the difference between the peak and the plateau of fluorescence was divided
by the maximum fluorescence along the line scan to calculate the percentage of fluorescence at
the membrane. This was termed the relative membrane expression (RME) [24, 25]. The overlay
of the GFP image with the bright-field image indicated integration of GFP-tagged AQP5 at the
plasma membrane as well as in the cytoplasm of HEK293 cells. In addition, correct membrane
insertion of AQP5-GFP and both S156 mutants was suggested by colocalization with the fluo-
rescent plasma membrane marker FM 4–64 as previously described for AQP4-GFP..
RME values were compared by one way ANOVA followed by either paired (for images of
the same cell before and after treatment) on unpaired (for images of different cells under differ-
ent conditions) post-hoc t-tests. The p values from the post-hoc tests were multiplied by the
number of pairwise comparisons (Bonferroni correction); p< 0.05 after correction was consid-
ered statistically significant.
Cloning of hAQP5 S156E for structural analysis
A single mutation of Ser 156 to glutamate was introduced into a vector encoding wild-type
human AQP5 using the QuikChange1 Site-Directed Mutagenesis Kit (Stratagene) according
to their protocol. In addition, a construct was made in which the carboxy-terminus was trun-
cated by introducing a stop codon after Pro 245. All mutations were confirmed by sequencing
and the construct was subsequently used to transform Pichia pastoris X-33 cells. High yielding
transformants were selected based on growth on high Zeocin concentrations as described pre-
viously [25].
Protein production and purification
Clones were grown in 3L fermentors with glycerol and methanol feed phases. Harvested cells
were resuspended in breaking buffer (50 mM phosphate buffer pH7.5, 5% glycerol) and broken
by three passages through an X-press cell (Biox AB). Cell debris was pelleted by centrifugation
at 10,000 × g for 30minutes. This centrifugation step was repeated to ensure that all debris had
been removed. Membranes were collected at 200,000 × g for 90 minutes, washed in urea buffer
(4M urea, 5 mM Tris, 2 mM EDTA 2 mM EGTA) and NaOH (20 mM) and finally resus-
pended in 7 ml resuspension buffer (20 mMHepes pH7.8, 50 mMNaCl, 10% glycerol, 2 mM
β-MeOH) per gram of membrane.
Membranes were solubilized in resuspension buffer with 6% n-nonyl-β-D-glucoside for 1h
at room temperature. Unsolubilized material was removed by centrifugation at 186,000g for
30min. The supernatant was diluted with dilution buffer (20 mMMES pH6.0, 10% glycerol,
0.4% NG and 2 mM β-MeOH) and purified using a Resource S column (GE Healthcare, 20
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mMMES pH6.0, 0.4% NG and 15 mM-1M NaCl) followed by gel filtration on Superdex 200
column (GE Healthcare, 20 mM Tris-HCl pH7.5, 100 mMNaCl, 0.4% NG). Fractions contain-
ing hAQP5 S156E was concentrated in a 10,000 MWCO concentrator (Vivaspin) to a final
concentration of 7–13 mg/ml.
Crystallization
Crystallization experiments were set up at 8°C using the hanging drop vapor diffusion tech-
nique. 7.2 μl reservoir solution (100 mM Tris-HCl pH7.8 or 7.9, 100 mM NaCl, 21% PEG400)
was mixed with 1.8 μl each of 1,6-hexanediol (30%, v/v) and 1,3-propanediol (40%, v/v) and
mixed with the protein in a 1:1 ratio. Crystals were obtained within 5–7 days and were fished
and flash frozen in liquid nitrogen without any addition of cryoprotectant.
Data collection and structure determination of AQP5 S156E
Complete X-ray diffraction data were collected on frozen crystals at cryo temperature (100
K) at the European Synchrotron Radiation Facility (ESRF) beamline ID23-2. Crystals of full-
length AQP5 S156E diffracted to 3.5 Å and belonged to space group P312 with one tetramer
in the asymmetric unit. Cell dimensions were a = b = 174.3, c = 100.9 Å, A = B = 90°, γ =
120°. Crystals of truncated AQP5 S156E crystals diffracted to 2.6Å and belonged to the space
group P63 with two tetramers in the asymmetric unit. Cell dimensions were a = b = 171 Å,
c = 171, 190 Å, A = B = γ = 90°. Images were processed and scaled using iMosflm and Scala
from the CCP4 suite [26]. The structures was solved using molecular replacement using Pha-
ser [27] with the wild-type hAQP5 structure (PDB code 3D9S [23]) as a model. Further
refinement of full-length and truncated AQP5 S156E was done in Refmac5 [28] and Phenix
[29] respectively, with iterative manual rebuilding in Coot [30]. The quality of the structure
was checked using MolProbity included in Phenix. The current model of full length AQP5
S156S contains 4 chains (A-D) with the following amino acids: A 2–245, B 5–247, C 4–245
and D 2–254. A-D as well as one phosphatidylserine. The current model of truncated
hAQP5-S156E contains 8 chains A-H with amino acids 2–245, one phosphatidyl serine and
690 waters. The two structures refined to an Rwork and Rfree of 28.0 and 31.1% for full length
AQP5 S156E and 18.7% and 23.0% for truncated AQP5 S156E. For crystallographic statistics,
see Table 1.
Results
A phosphomimetic mutation at Ser 156 increases constitutive AQP5
surface abundance
An expression vector was made in which GFP was fused to the carboxy-terminus of full-length
human AQP5 (AQP5-GFP). This expression vector was used to transfect live HEK293 cells.
Real-time localization and translocation of the corresponding fusion protein was measured
using confocal microscopy; the relative membrane expression (RME) was determined using
line intensity profiles generated from confocal images of individual live cells. An RME of 0 cor-
responds to an equal distribution of GFP signal between membrane and intracellular compart-
ments and an RME of 1 corresponds to 100% of the GFP signal at the membrane. The RME of
AQP5-GFP was increased by the introduction of the S156E mutation from 0.56 ± 0.02 to
0.67 ± 0.01 (p = 0.01), whereas the RME of AQP5-S156A was not significantly different
(p = 0.36) to wild-type AQP5-GFP (Fig 1).
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PKA inhibition increases constitutive AQP5 surface abundance
The RME of AQP5-GFP (wild-type and the two S156 mutants) was measured after a 30 minute
incubation with a cell-permeable PKA inhibitory peptide (myrPKI) or vehicle control. PKA
inhibition increased the RME of all AQP5 constructs (Fig 2) compared to non-inhibited con-
trols, suggesting a role for PKA signalling in the internalization of AQP5 as previously sug-
gested [15]. PKA inhibition further increased the membrane abundance of the S156E mutant,
indicating that this effect is independent of the phosphorylation status of Ser 156.
Hypotonicity-induced AQP5 translocation is independent of PKA activity
and phosphorylation at S156
Reduction of the extracellular osmolality to 85 mOsm/kg H2O caused rapid relocalization of
AQP5 from intracellular compartments to the plasma membrane (Fig 3). The initial
AQP5-GFP distribution profile was restored on returning to normal physiological osmolality.
The RME of AQP5-GFP increased from 0.56 ± 0.03 in control medium to 0.72 ± 0.01 in hypo-
tonic medium. This result was similar to that seen for AQP1, which translocated to and from
Table 1. Crystallographic data and refinement statistics for full-length and truncated hAQP5 S156E
structures.
Full length Truncated
Data collection
Beamline ESRF ID23-2 ESRF ID23-2
Wavelength (Å) 0.8726 0.8726
Detector distance (mm) 413 306.6
Oscillation/collection range (°) 1/100 0.4 (92)
Resolutiona (Å) 101.02–3.5 (3.69-3-5) 50.81–2.60 (2.74–2.60)
Total observationsa 142,487 (20,652) 375,143 (54,612)
Unique reﬂectionsa 21,914 (3,193) 94,885 (13,925)
Completenessa 98.9 (99.8) 98.8 (99.4)
Redundancya 6.5 (6.5) 4.0 (3.9)
I/σa 13 (1.9) 7.0 (2.1)
Rsym
a,b (%) 0.095 (0.799) 0.180 (0.778)
Reﬁnement
Resolutiona (Å) 100–3.5 48.2–2.60
Space group (α, β, γ) P312 (90, 90, 120) P63 (90, 90, 120)
Cell dimensions (a, b, c) 174, 174, 101 171, 171, 190
Molecules in the asymmetric unit 4 8
Rwork
c/Rfree
d (%) 28.0/31.1 18.7/23.0
Average B valules, entire model (Å2) 161.6 31.4
Average B values, protein/waters (Å2) 163.4/- 31.1/35.6
Root-mean-square deviations from ideal values
Bond lengths (Å) 0.007 0.008
Bond angles (°) 1.084 1.058
PDB accession code 5DYE 5C5X
a Values in brackets are for the highest resolution shell
b Rsym = ΣhΣi|Ii(h)-<I(h)>|/ ΣhΣiI(h), where Ii(h) is the ith measurement.
c Rwork = Σh||F(h)obs|-|F(h)calc||/Σh|F(h)obs|
d Rfree was calculated for 5% of reﬂections randomly excluded from the reﬁnement
doi:10.1371/journal.pone.0143027.t001
Regulation of Human AQP5 Membrane Abundance
PLOS ONE | DOI:10.1371/journal.pone.0143027 November 16, 2015 6 / 17
the membrane in response to altered tonicity in the surrounding media [24]. Similarly, the
RME increased from 0.55 ± 0.02 to 0.71 ± 0.02 for the S156A mutant and from 0.67 ± 0.02 to
0.81 ± 0.01 for the S156E mutant. Despite an increased level of constitutive surface expression,
the change in RME for the S156E mutant (ΔRME = 0.14 ± 0.01) was similar to that for AQP5
or the S156A mutant (ΔRME = 0.15 ± 0.03 and 0.13 ± 0.02 respectively). Inhibition of PKA,
despite increasing constitutive surface expression of all constructs, did not inhibit the hypoto-
nicity-induced relocalization of AQP5. Taken together, these results suggest that hypotonicity-
Fig 1. Surface expression of AQP5 S156mutants.Representative fluorescence confocal micrographs of
HEK293 cells transfected with GFP-tagged (A) AQP5 wild-type, (B) AQP5-S156A and (C) AQP5-S156E; the
fluorescence intensity profiles along each yellow line are shown. (D) Relative membrane expression
calculated from fluorescence intensity profiles: 5 profiles were taken per cell and at least 3 cells per
micrograph, repeated in 3 independent experiments. Asterisks denote p < 0.05 using Student’s t-test followed
by Bonferroni correction for multiple comparisons.
doi:10.1371/journal.pone.0143027.g001
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induced relocalization of AQP5 is not mediated by either PKA activity or phosphorylation at
Ser 156.
The crystal structure of AQP5 S156E suggests phosphorylation is not
accompanied by a conformational change
We previously solved the structure of wild-type human AQP5 expressed in P. pastoris to 2.0 Å
resolution [23]. To determine whether phosphorylation of Ser 156 confers any structural
changes that could be important for membrane translocation, we crystallized and solved the
Fig 2. Effect of PKA inhibition on surface expression of AQP5.Representative fluorescence confocal
micrographs of HEK293 cells transfected with GFP-tagged (A) AQP5 wild-type, (B) AQP5-S156A and (C)
AQP5-S156E that were treated with a PKA inhibitory peptide for 30 minutes. (D) Relative membrane
expression of the 3 AQP5 constructs with and without PKA inhibition. Asterisks denote p < 0.05 using
Student’s t-test followed by Bonferroni correction for multiple comparisons.
doi:10.1371/journal.pone.0143027.g002
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structure of a single phosphomimetic mutant (S156E) of full-length AQP5 at 3.5 Å resolution
(PDB code 5DYE). Since at this resolution, information about side-chain positions and interac-
tions is limited, we truncated AQP5 S156E at Pro 245, the last visible residue in the high-reso-
lution wild-type structure AQP5. The truncated AQP5 S156E construct crystallized in a
different space group and diffracted to significantly higher resolution, allowing us to solve the
structure at 2.6 Å resolution (PDB code 5CX6). Both full-length and truncated AQP5 S156E
crystallized in space groups lacking the four-fold symmetry otherwise commonly associated
with AQP crystals (P312 with one tetramer in the asymmetric unit for full-length AQP5 S156E
and P63 with two tetramers in the asymmetric unit for truncated AQP5 S156E), thereby allow-
ing for structural differences between monomers in the tetramer to be examined. Crystallo-
graphic data and refinement statistics are summarized in Table 1.
Both structures of AQP5 S156E are very similar to that of wild-type AQP5; overlaying with
a root-mean-square deviation of 0.51 Å for 970 Cα-atoms for full-length AQP5 S156E and of
0.37Å for 975 Cα-atoms for truncated AQP5 S156E (Fig 4A & 4B). For full-length AQP5
S156E, additional electron density could be seen beyond Pro 245 in one of the monomers
(monomer D), allowing us to build nine more residues (Fig 4C). However, this region does not
interact with any other residues within the tetramer. Instead, it forms crystal contacts with
symmetry-related AQP5 molecules in the crystal packing, explaining why this region is ordered
in this particular monomer of the full-length structure.
In the truncated AQP5 S156E structure, seven water molecules were observed in the water-
conducting channel of all monomers with one exception, monomer F, which contained six
water molecules. For full-length AQP5 S156E, the limited resolution prevented the identifica-
tion of water molecules in the channel. In both structures, a lipid molecule could be observed
Fig 3. Hypotonicity-induced translocation of AQP5.Relative membrane expression of AQP5 and mutants
was measured in the same cells before and 1 minute after reduction of the extracellular osmolality to 85
mOsm/kg H2O by fourfold dilution of the culture medium with dH2O. PKA inhibition was achieved by a 30
minute incubation with a PKA inhibitory peptide. Asterisks denote p < 0.05 by paired t-tests followed by
Bonferroni correction for multiple comparisons.
doi:10.1371/journal.pone.0143027.g003
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in the central channel formed between monomers in the tetramer, albeit at slightly different
positions. Similarly to wild-type AQP5, this lipid was modelled as phosphatidyl serine
(Fig 4D).
Loop D and the carboxy-terminus retain their native conformations in
AQP5 S156E
In the wild-type AQP5 structure, an interaction between loop D and the carboxy-terminal
region was observed [23]. This interaction anchored at the carboxy-terminal helix in a manner
that was well conserved in other mammalian AQP structures and involved hydrogen bonds
between the sidechain of Arg 153 and the backbone atoms of Pro 226 and Phe 227 (Fig 5A). It
Fig 4. Overall structure of AQP5 S156E. (A) The structure of full length (green, PDB code 4DYE) and truncated S156E AQP5 (orange, PDB code 5CX6)
overlaid on the wild-type structure of AQP5 in blue (PDB code 3D9S). Water molecules in the water-conducting channel of truncated S156E AQP5 are shown
as red spheres. (B) Same as in (A), viewed from the cytoplasmic side. (C) Structure of the carboxy-terminus of full-length S156E monomer D, showing its
interactions with a symmetry-related molecule (grey). 2Fobs-Fcalc electron density is displayed at 1.0 σ. Loop D and Glu 156 in monomers A and D are
highlighted in yellow. (D) Lipid molecule in the tetrameric channel of full-length and truncated AQP5 S156E.
doi:10.1371/journal.pone.0143027.g004
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was hypothesized that phosphorylation of Ser 156 may cause structural changes within loop D
that breaks these interactions, allowing for a conformational change of the carboxy-terminus.
Since there were no significant differences between the strucutres of full-length and trun-
cated AQP5 S156E, we used the higher-resolution truncated AQP5 S156E structure to examine
the finer structural details (from hereon denoted as AQP5 S156E). No structural change of
loop D was observed in any of the eight monomers when compared to wild-type hAQP5 (Fig
5B) and the interactions between loop D and the carboxy-terminus were conserved (Fig 5A).
The carboxy-terminus retained the same conformation as in the wild-type AQP5 structure (Fig
5C). In two of the monomers in each tetramer, there was a 1–2 Å shift in the position of the
small carboxy-terminal helix when compared to wild-type AQP5. Comparison between the 8
monomers of AQP5 S156E shows that the carboxy-terminal helices overlap perfectly, suggest-
ing that the shift in position arises from minor structural differences between monomers in
wild-type AQP5. As is apparent from the electron density map in Fig 5D, serine was success-
fully replaced by glutamate at position 156.
Fig 5. Structure of loop D and its interaction with the carboxy-terminus.Wild-type AQP5 and AQP5
S156E are coloured blue and orange respectively. (A) Zoomed in view of the boxed area in Fig 4A showing
that the interactions between loop D and the carboxy-terminus are maintained in the S156E mutant structure.
Hydrogen bonds are shown as dashed lines. Structural comparison of (B) loop D and (C) the carboxy-
terminus shows that there are no structural differences between wild-type AQP5 and AQP5 S156E. In (D),
the four monomers from the crystal structure of human AQP2 are overlaid, showing a significant
conformational variability of the carboxy-terminal helix within the tetramer. The four AQP2 monomers are
colored in different shades of grey. (D) Structure of the S156E mutation site showing 2Fobs-Fcalc electron
density contoured at 1.0 σ. The structure of wild-type AQP5 is shown in blue for comparison.
doi:10.1371/journal.pone.0143027.g005
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Discussion
The regulation of protein abundance in a particular membrane requires a delicate balance
between two opposing processes: Translocation to and internalization from the membrane.
This is achieved through multiple sorting signals, often consisting of post-translational modifi-
cations in the cytoplasmic regions of the protein. One of the best-characterized examples is
AQP2, for which phosphorylation of multiple sites in the carboxy-terminus governs its translo-
cation to the apical membrane [31]. Internalization of AQP2 is triggered by ubiquitination of
the carboxy-terminus [32] and the internalization rate is also influenced by the phosphoryla-
tion status of AQP2 in the membrane [33].
Emerging evidence suggests that the regulation of AQP5 cell surface abundance is equally
complex. It is known that AQP5 translocation between intracellular storage vesicles and the
apical membrane can occur upon agonist stimulation of the muscarinic (M3) receptor [34] or
α-1 adrenergic receptor [35]. Furthermore, intracellular cAMP levels have been shown to reg-
ulate AQP5 abundance at the transcriptional level as well as affect the long-term (! 24 hours)
sub-cellular distribution of the protein in a PKA-dependent manner [11]. Interestingly,
increased cAMP levels have been shown to have a biphasic effect on the sub-cellular distribu-
tion of AQP5 with decreased expression in the apical membrane in the short term due to
increased internalization, followed by an increase in membrane abundance in the long-term
[15]. While inhibition of PKA had an effect on both components of this biphasic response, an
increase in levels of phosphorylated AQP5 could only be seen for the long-term effect, sug-
gesting that the target for PKA-phosphorylation in the short-term response is not AQP5
itself. This dual response to increased levels of cAMP on the trafficking of AQP5 could help
explain why increased as well decreased expression in the apical membrane have been
reported [14, 16].
AQP5 contains two consensus PKA-sites but unlike AQP2, their roles in AQP5 transloca-
tion have not been determined. PKA-mediated phosphorylation of AQP5 has been demon-
strated at both Ser 156 [21] and Thr 259 [36]. However, removal of these phosphorylation sites
by mutation to alanine resulted in constructs with the same membrane abundance as wild-type
AQP5. Additional phosphorylation sites are predicted to be present in AQP5, for example a
PKC site at Ser 152 that overlaps with the PKA site at Ser 156. Furthermore, Thr 259 is also
part of a PKG consensus site. These are additional components that may affect the overall
translocation of AQP5 in a cell-dependent manner.
Our data suggest that membrane-localization of AQP5 is regulated by at least three inde-
pendent pathways (Fig 6). We show that membrane expression of AQP5 is affected by phos-
phorylation of Ser 156, either by increased targeting or decreased internalization or both. To
our knowledge this is the first time a phosphorylation site has been directly linked to a differ-
ence in membrane expression. The fact that the S156A mutant behaves like wild-type AQP5
indicates that phosphorylation of Ser 156 may not occur under basal conditions. In this respect
it is intriguing that Ser 156 has been shown to be preferentially phosphorylated in tumour cells
[21]. It has been suggested that in tumours, PKA-dependent phosphorylation of Ser 156
increases cell proliferation by activating the Ras-pathway [37]. A number of studies have
shown that upregulation of AQPs promotes cell proliferation and migration [38] Our data hint
at a mechanism whereby phosphorylation of Ser 156 in AQP5 increases its membrane localiza-
tion, thereby enhancing cancer cell proliferation.
It was previously suggested that phosphorylation of Ser156 would break interactions
between loop D and the carboxy-terminus, thereby triggering a conformational change [23].
Significant conformational variability of the carboxy-terminus was seen in the structure of
human AQP2, where the carboxy-terminal helix of each monomer adopted a unique
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conformation that had not been observed in any previous mammalian AQP structure (Fig 5C)
[39]. As the carboxy-terminal region is known to be important for membrane translocation of
both AQP2 [31] and AQP5 [10, 40], such conformational changes may be recognized as a
structural sorting signal by the cellular trafficking machinery. However, our structure of the
AQP5 S156E mutant did not reveal any structural differences within loop D or the carboxy-ter-
minus (Fig 5B and 5C). We therefore suggest that it is the presence of a phosphate group at Ser
156 rather than a conformational change of the carboxy-terminus that is recognized as a sort-
ing signal, resulting in increased AQP5 membrane abundance.
Our data further show that, independent of Ser 156, basal levels of PKA activity (i.e. in the
absence of a cAMP-stimulating agonist) decrease the membrane abundance of AQP5 (Fig 2).
This fits well with the short-term effect of cAMP and PKA that has been seen previously and
for which PKA has been suggested to be involved in AQP5 internalization [15]. Since PKA-
inhibition further increased membrane expression of the S156E mutant, this indicates that
phosphorylation of Ser 156 is not responsible for this short-term effect. Instead, we suggest
that Ser 156 phosphorylation may be involved in the long-term cAMP and PKA-dependent
effect whereby an increase in AQP5 membrane abundance is seen after several hours. This is in
agreement with the observation that the long-term effect of cAMP and PKA involves direct
phosphorylation of AQP5 while the short-term effect does not [15].
Finally, we show that AQP5-GFP is rapidly translocated to the target membrane of HEK293
cells in response to hypotonic conditions, but that this translocation is independent of Ser 156
in loop D and also independent of PKA (Fig 3).
Fig 6. A proposedmodel of the equilibrium between vesicular and surface-localized AQP5. Panel A shows wild-type AQP5 under isotonic conditions.
The large arrows represent an increase in AQP5 translocation (and the small arrows are a decrease). This is regulated by three independent factors:
Phosphorylation of AQP5 at position S156 (orange cylinders in panel B; shown by a phosphomimetic glutamate substitution (S156E) of AQP5; the effect of
PKA (green cylinders in panel C) and the effect of decreasing the relative tonicity of the environment (panel D). We speculate that these three pathways
control the surface abundance of AQP5.
doi:10.1371/journal.pone.0143027.g006
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The hypotonicity-induced membrane translocation of AQP5 described here is consistent
with that of AQP1 where the phosphorylation of Thr157 and/or Thr239 by PKC results in
rapid accumulation in the cell-surface membrane [13]. Whether direct phosphorylation of
AQP5 by PKC or another kinase mediates hypotonicity-induced membrane translocation in a
similar manner remains to be shown. AQP5 is found in tissues that are subject to rapid changes
in osmolarity and has been shown to play an important role in cell volume regulation [14–16].
Upon exposure to hypotonic conditions, cells undergo a rapid cellular volume decrease (RVD)
to avoid rupture. This happens within a couple of minutes and involves the release of cellular
water. RVD is often followed by a regulatory volume increase (RVI) whereby the osmotically
shrunken cell approaches its original volume [2]. The rapid response to hypotonicity reported
here supports the involvement of AQP5 in RVD as previously suggested [14]. On a longer time
scale, hypotonic exposure has been shown to cause a decrease in AQP5 membrane abundance
[16], most likely corresponding to the RVI response. Taken together, regulation of AQP5
membrane abundance seems to be important for both the RVD and RVI components of cell
volume regulation.
We previously showed that hypotonicity-induced calcium influx through TRPC1 was vital
for translocation of AQP1 [13] and others have shown that calcium influx through TRPV4
mediates the AQP5-dependent regulatory volume decrease in acinar cells [14]. We therefore
speculate that the sensor of extracellular osmolality that leads to AQP5 translocation is a mem-
ber of the TRP family of gated cation channels.
Conclusion
Due to its importance for fluid secretion in airways submucosal glands, AQP5 has been sug-
gested to be a pharmacological target to treat the hyper-viscous and excessive gland secretions
in cystic fibrosis and bronchitis/rhinitis, respectively. Our data provide the first link between a
specific AQP5 phosphorylation site, Ser 156, and changes in its sub-cellular localization. We
further show that the Ser 156-mediated change in localization does not require a substantial
protein conformational change. We show that, independent of Ser 156, PKA is further involved
in basal recycling of AQP5 between the plasma membrane and intracellular compartments.
Finally, we provide evidence of tonicity-regulated changes in AQP5 localization that are not
mediated by phosphorylation of Ser 156 or PKA. This will now enable us to elucidate the
detailed mechanism by which these post-translational modifications govern translocation of
the protein from intracellular storage vesicles to the target membrane in response to protein
kinase activity and osmotic triggers, thus providing key information for drug design targeting
AQP5.
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ABSTRACT: The aquaporins (AQPs) make up a family
of integral membrane proteins that control cellular water
ﬂow. Gating of the water channel by conformational
changes induced by phosphorylation or protein−protein
interactions is an established regulatory mechanism for
AQPs. Recent in silico and crystallographic analyses of the
structural biology of AQPs suggest that the rate of water
ﬂow can also be controlled by small movements of single-
amino acid side chains lining the water pore. Here we use
measurements of the membrane water permeability of
mammalian cells expressing AQP4 mutants to provide the
ﬁrst in vitro evidence in support of this hypothesis.
Rapid modulation of aquaporin (AQP)-mediated cellmembrane water permeability in response to external
stimuli is a vital regulatory mechanism that underlies a variety
of physiological processes in mammals and plants.1,2 There are
two ways in which this could be achieved: by changing the
number of AQP molecules in the membrane via exo- or
endocytosis or by directly blocking or activating AQP
molecules via a conformational change that opens or closes
the pore. There are examples of each of these approaches to
AQP regulation being taken in nature, the best-studied
examples of which are the arginine-8 vasopressin (AVP)-
mediated traﬃcking of AQP2 to the apical membrane of kidney
collecting duct cells3 and the phosphorylation-mediated gating
of spinach AQP SoPIP2, involving a large scale motion of an
intracellular loop that stabilizes a closed conformation of the
aqueous pore.4
A conceptual model of AQP gating in which the channel is
either open or closed and can be “switched oﬀ” by stimuli is
probably overly simplistic, and indeed, researchers in the ﬁeld
of G protein-coupled receptor (GPCR) structural biology have
long since abandoned conceptual models in which receptors are
thought to be “on” or “oﬀ” in favor of models in which
receptors are thought to be continually visiting various
conformations, each with unique ligand aﬃnities and signaling
capacities. In this framework, rather than “switching on” a
receptor, ligands are thought to stabilize (increasing the
probability to visit) a particular conformation with a particular
signaling capacity. In silico work on the bacterial AQPZ,5 human
AQP5,6 AQP1,7 and human AQP1 and -48 suggests that a
similar model may be appropriate for AQPs and that
particularly important local conformational changes may
involve the pore-lining residues within the aromatic/arginine
(ar/R) selectivity ﬁlter region.
Here we show that speciﬁc site-directed mutations to the
selectivity ﬁlter region of human AQP4 can quantitatively alter
the permeability of the channel in a manner independent of
surface expression. We made alanine substitution mutants of
the three AQP4 residues whose side chains form the ar/R
selectivity ﬁlter, F77A, H201A, and R216A. The histidine is
typically replaced by a glycine in the GLP subfamily, so we also
made a H201G mutant. After ﬁnding that the H201A and F77A
mutations had no eﬀect, we combined them into the H201A/
F77A and H201G/F77A double mutants. Finally, we made the
H201E mutant to try to form a salt bridge between the
glutamate residue and R216. Mutants were generated by site-
directed mutagenesis as previously described.9 The M1 isoform
of AQP4 with a C-terminal GFP tag and all selectivity ﬁlter
mutants of this construct were stably transfected into type I
MDCK cells (ATCC CRL-2935) to measure water perme-
ability using a plate reader-based calcein ﬂuorescence
quenching method adapted from ref 10. Expression of AQP4
mutants in stable clones was checked visually using the GFP tag
and sodium dodecyl sulfate−polyacrylamide gel electropho-
resis/Western blotting against AQP4. Endogenous AQP4 was
not detected in MDCK cells in Western blots. After 5 s of
reading at 50 ms intervals in isotonic culture medium, an equal
volume of 600 mM mannitol in culture medium was injected to
give a ﬁnal mannitol concentration of 300 mM and an osmotic
gradient of 300 mOsm/kg of H2O, and ﬂuorescence was
measured for a further 50 s. Normalized ﬂuorescence time
series were converted to volume time series. Cell shrinkage
rates were background-subtracted (using an untransfected
MDCK control to correct for any basal water permeability of
the cells) and normalized to surface expression (measured
using a cell surface biotinylation-based enzyme-linked immu-
nosorbent assay as previously described9) to give relative single-
channel water permeability. For most mutants, the variations in
the shrinkage rates of individual clones (Figure 1B) were
consistent with the variation in surface expression (Figure 2A).
After normalization, none of the mutants except H201E and
R216A had water permeability signiﬁcantly diﬀerent from that
of wild-type AQP4. The water permeability of H201E was
reduced to 63 ± 8% of that of the wild type (n = 4; p = 0.002),
and the water permeability of R216A was increased to 147 ±
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3% of that of the wild type (n = 4; p = 0.005); this is shown in
Figures 1 and 2.
Hub et al. previously reported that, in molecular dynamics
simulations, ﬂuctuations of R216 of AQP4 could switch the
channel between an open and a closed state with an open
probability of ∼0.45 using the OPLS force ﬁeld8 (with open
deﬁned as a distance of >0.57 nm between the arginine Cζ atom
and the closest histidine heavy atom). We performed molecular
dynamics simulations of an AQP4 tetramer embedded in a
POPC bilayer using the GROMOS 53A6 force ﬁeld, based on
the AQP4 crystal structure,11 to attempt to qualitatively validate
this result and to address the possibility of quantitative
diﬀerences in the open probability between diﬀerent protein
force ﬁelds. We also found that a two-state model is appropriate
for describing the simulation data, with the average R216−
H201 distances of the open and closed states being 6.5 and 4.3
Å, respectively (Figure 3). Using the same deﬁnition of open,
we ﬁnd an open probability of 0.52 ± 0.12 (with the
uncertainty estimated as the standard error over the four
monomers). This is consistent with the work of Hub et al.,
suggesting that this probability is reasonably robust when
measured using diﬀerent force ﬁelds.
Assuming this simple two-state model, our in vitro results
allow us to estimate the open probability of the wild-type
AQP4 channel, based on the idea that the R216A mutation
forces the channel to permanently occupy the open state.
Previous molecular dynamics simulations suggested an
approximately 40-fold diﬀerence in permeability between the
open and closed states of AQP4.8 Using the following equation
=
+ −
+ −
P
P
P p P p
P p P p
(1 )
(1 )
R216A
WT
o o,R216A c o,R216A
o o,WT c o,WT
where PR216A and PWT are the permeabilities measured in our
experiments, Po and Pc are the permeabilities of the open and
closed states, respectively, and po is the channel open
probability. Setting po,R216A equal to 1 and Po equal to 40Pc
gives a wild-type open probability of 0.67 ± 0.02 (which is
slightly higher than the value of 0.52 ± 0.12 that we estimated
from simulations, but in reasonable agreement).
Crystallographic analysis12 and simulations5 of AQPZ have
also suggested that the selectivity ﬁlter arginine residue may
undergo ﬂuctuations between “up” and “down” conformations,
with the down conformation associated with a closed state of
the channel and reduced channel permeability. Similar results
were reported for ﬂuctuations of the selectivity ﬁlter histidine
residue in human AQP5.6 In silico mutation of the AQPZ
arginine to serine (R189S) increased the average water
permeability by 26% in molecular dynamics simulations.5
Although this result was not validated in vitro, it is qualitatively
similar to our in vitro result for AQP4 R216A.
To further test the idea of the R216 side chain dynamics
controlling the average channel permeability, the selectivity
ﬁlter histidine residue (H201), which is directly opposite R216
in the AQP4 ar/R selectivity ﬁlter region, was replaced with the
similarly sized glutamate (H201E) to attempt to stabilize the
closed conformation of the arginine residue by formation of a
salt bridge between the arginine and glutamate residues. Initial
mutation of this histidine to both alanine and glycine did not
aﬀect water permeability, showing that the histidine side chain
is not a crucial factor for the permeability in AQP4. The water
permeability of the H201E mutant was reduced to 63 ± 8% of
that of wild-type AQP4; we hypothesize that this mutation
reduces the average permeability by stabilizing the closed
conformation of the arginine residue. Although we have
interpreted our in vitro data in terms of changes in the ar/R
selectivity ﬁlter open probability, it remains a possibility that
Figure 1. (A) Representative calcein ﬂuorescence quenching curves of
control MDCK cells and our stable MDCK-AQP4 cell line upon
addition of 300 mM mannitol. (B) Cell shrinkage rates of MDCK cells
stably transfected with AQP4 mutants. Relative ﬂuorescence data were
converted to relative volume, and exponential decay functions were
ﬁtted.
Figure 2. (A) Surface expression of AQP4 mutants in stable MDCK
clones, normalized to wild-type AQP4. (B) Normalized single-channel
permeability calculated by subtracting the untransfected MDCK
background (see Figure 1B) and normalizing to surface expression.
An asterisk represents p < 0.01.
Figure 3. Representative molecular dynamics simulation snapshots of
wild-type AQP4 with R216 and H201 and channel water molecules
highlighted as sticks of (A) the open state of the selectivity ﬁlter and
(B) the closed state of the selectivity ﬁlter. (C) Histogram of the
R216−H201 distance distribution in simulations, showing two clearly
distinct states. Fitted Gaussians (red, sum in green) are centered at
0.43 and 0.65 nm.
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the H201E mutation decreases the open state permeability
rather than the open probability and the R216A mutation
increases the permeability of the open state rather than the
open probability. We think it would be an unlikely coincidence
if both of these mutations had exactly the eﬀect that would be
predicted on the basis of published in silico data, but mediated
in a diﬀerent way, but it cannot be excluded on the basis of our
data alone. It is also possible that the eﬀect of our mutations is
to reposition the peptide backbone rather than a direct eﬀect of
the side chains per se. We think that the fact that our data agree
with published predictions based on atomic-resolution
molecular dynamics simulations makes this unlikely, but again
this cannot be excluded.
Taken together, our results support predictions previously
made in the literature, based on molecular dynamics
simulations, that the dynamics of the ar/R selectivity ﬁlter
arginine residue are important for determining the quantitative
water permeability of AQPs.
Interestingly, a study of the selectivity ﬁlter of AQP1 found
that the R195A mutant (analogous to R216A in AQP4) did not
have water permeability signiﬁcantly diﬀerent from that of wild-
type AQP1 expressed in Xenopus oocytes.13 The volumetric
data were not normalized to AQP1 surface expression, so it is
possible that a subtle diﬀerence in membrane expression
masked a diﬀerence in water permeability in this study.
Simulations suggest that the balance of open and closed
probabilities for AQP1 is very similar to that of AQP4,8 but it is
also possible that the closed probability is close to zero in
AQP1, making any measurement of the diﬀerence between the
wild type and a constitutively open channel very diﬃcult.
Control of the balance of open and closed probabilities by,
e.g., protein post-translational modiﬁcation or protein−protein
interactions may represent an unexplored mechanism by which
AQP water permeability could be regulated by physiological
stimuli.
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The aquaporin (AQP) family of integral membrane protein
channelsmediate cellular water and solute flow. Although qual-
itative and quantitative differences in channel permeability,
selectivity, subcellular localization, and trafficking responses
have been observed for different members of the AQP family,
the signature homotetrameric quaternary structure is con-
served. Using a variety of biophysical techniques, we show that
mutations to an intracellular loop (loop D) of human AQP4
reduce oligomerization. Non-tetrameric AQP4 mutants are
unable to relocalize to the plasma membrane in response to
changes in extracellular tonicity, despite equivalent constitutive
surface expression levels and water permeability to wild-type
AQP4. A network of AQP4 loop D hydrogen bonding interac-
tions, identified using molecular dynamics simulations and
based on a comparative mutagenic analysis of AQPs 1, 3, and 4,
suggest that loop D interactions may provide a general struc-
tural framework for tetrameric assemblywithin theAQP family.
The aquaporin (AQP)3 family of integral membrane proteins
facilitate both osmosis and diffusion of small polar molecules
through biological membranes. A wealth of medium-to-high
resolution structural data for various familymembers (there are
48AQP structures in the ProteinData Bank) all suggest that the
AQP homotetrameric quaternary structure is highly conserved
despite diversity in solute permeability, subcellular localization,
and trafficking responses of individualAQPs. Early biochemical
work, using carboxyl-amine fusion dimers (consisting of 1wild-
type unit and 1 unit lacking the cysteine residue required for
mercurial inhibition), showed that monomers are the func-
tionalAQPunits (1); numerousmolecular dynamics simulation
studies support this (2). Recentwork has suggested that isolated
AQP monomers are equally capable of facilitating water trans-
port as those incorporated into a tetramer (3). Therefore it is
not clear whyAQPs retain this tetrameric structure. Regulation
of AQP function by the formation of heterotetramers has been
suggested for some plant AQPs (4). The fifth, central pore
formed at the 4-fold axis of the tetramer has also been suggested
to transport carbon dioxide (5) and cations (6), at least inmam-
malian AQP1. Trigger-induced relocalization of AQP-contain-
ing vesicles to the plasma membrane is a well established regu-
latory mechanism for AQPs; the best studied example of this is
relocalization ofAQP2 to the apicalmembrane of the collecting
duct in the mammalian kidney in response to arginine vaso-
pressin (also called anti-diuretic hormone). There is also evi-
dence for similar mechanisms for other AQPs including AQP1
(7), AQP5 (8), and AQP7 (9). A naturally occurring AQP2
mutant (R187C) has also been reported that is unable to relo-
calize in response to arginine vasopressin or to form tetramers
(10).Given the ubiquity of these regulatory responses across the
AQP family and the conservation of the tetrameric quaternary
structure, it may be that these trigger-induced relocalization
responses involve interaction with proteins that only recognize
the tetrameric form of AQPs.
Here we demonstrate that intracellular loop D of AQP4
forms vital homomeric interactions between AQP subunits
that stabilize the tetrameric quaternary structure. We also
show that loss of tetramerization does not affect single channel
water permeability.Our data suggest that tetramerization is not
required for AQP4 to be trafficked through the endoplasmic
reticulum and Golgi to the plasma membrane, but that unlike
wild-type AQP4, the non-tetrameric mutants are unable to
relocalize to the plasma membrane in response to changes in
local osmolality. Finally, based on loss and gain of oligomeriza-
tion mutants of AQP1 and AQP3, we suggest that loop D-me-
diated inter-monomer interactions may control formation of
the signature quaternary structure of the family.
Experimental Procedures
Expression Constructs and Mutagenesis—Human AQP4
cDNA cloned into pDEST47 (Life Technologies) was used as
previously described (11). An untagged AQP4 construct was
created from this by mutagenesis of the first two codons of the
GFP linker peptide to stop codons. These were used as tem-
plates for mutagenesis following the QuikChange protocol
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(Stratagene). Mutagenic primers were synthesized by Sigma.
Mutant plasmids were amplified in TOP10 Escherichia coli
with 100 ng/ml of ampicillin selection. Plasmid DNAwas puri-
fied using a Wizard Maxiprep kit (Promega) and diluted to 1
mg/ml for transfection.
Cell Culture and Transfection—HEK293 cells were cultured
routinely in DMEM with L-glutamine (Sigma) supplemented
with 10% (v/v) fetal bovine serum (Sigma) and without antibi-
otics in humidified 5% (v/v) CO2 in air at 37 °C. Cells were
seeded into either tissue culture treated 6-well plates (Falcon)
for Blue Native (BN)-PAGE and biotinylation or 35-mm
FluoroDishesTM (World Precision Instruments) for confocal
microscopy. Cells were transfected (at 50% confluence) using
polyethyleneimine (branched, average Mr !25,000, Sigma) as
previously described (11). MDCK cells were cultured in the
same conditions as HEK293 cells. Stable transfections were
done using the neomycin resistance gene on the pDEST47 vec-
tor. Cells were transiently transfected as described above, then
trypsinized and serially diluted into tissue culture plates after
24 h. Cells were treated with 700!g/ml of G418 antibiotic for 2
weeks, with medium replaced every third day. GFP-expressing
resistant colonies were picked using cloning cylinders (Sigma)
and serially diluted. The lowest dilution that grew to confluence
was used to generate a stable cell line. Cellular protein was
subjected to SDS-PAGE and Western blotting as previously
described (11), and the highest expressing clone was chosen for
experiments. No endogenous AQP4 was detected in Western
blots. Reduced G418 pressure (300 !g/ml) was used to main-
tain the stable cell lines after colony isolation. All cells were
routinely tested formycoplasmausing the EZ-PCR test kit (Bio-
logical Industries), and all data reported are from cells that
tested negative. HEK293 and MDCK cells both expressed
only the M1 isoform of AQP4 from the wild-type AQP4 con-
struct. This was confirmed byWestern blotting comparing the
wild-type construct to AQP4 constructs in which either theM1
or M23 translation initiation sites were removed, as previously
described (11).
Confocal Microscopy—AQP4-GFP constructs were imaged
in liveHEK293 cells using aZeiss LSM780 confocalmicroscope
with a "63 1.4 NA oil immersion objective. GFP was excited
using the 488-nm line of an argon laser, Venus using the
514-nm line and mTurquoise2 using a 405-nm diode laser.
Hypotonic exposurewas performedby adding 3ml of ddH2O to
cells in 1 ml of growth medium (280 to 70 mosmol/kg of H2O).
Line profiles across the cell membrane and cytoplasm were
extracted using ImageJ as previously described (7). Relative
membrane expression was calculated from these profiles (3
profiles per cell and at least 3 cells per image) using in-house
Matlab code. Fluorescence recovery after photobleaching
(FRAP) was done using a circular bleaching 1-!m area of
radius. Recovery curves were fitted to a single phase exponen-
tial recovery function and diffusion coefficients were calculated
using the approach and equations of Kang et al. (12). Recovery
curves were collected from 5 different cells on the same plate
per experiment. FRET experiments were done using the sensi-
tized emissionmethodology with the FRET signal corrected for
donor emission in the acceptor channel and direct excitation of
the acceptor, following van Rheenen et al. (13) and normalized
to the acceptor emission to give an apparent FRET efficiency.
The contrast of some images in the figures was adjusted man-
ually using ImageJ to aid the eye. All analysis was performed on
raw, unadjusted images.
Cell Surface Biotinylation—Cell surface amineswere biotiny-
lated using an amine-reactive biotinylation reagent that is not
cell permeable (Thermo number 21328, EZ-Link Sulfo-NHS-
SS-Biotin), and surface AQPs were detected using a neutravi-
din-based ELISA as previously described (11).
BN-PAGE—Transfected cells were lysed in ice-cold BN lysis
buffer (1% (v/v) Triton X-100, 10% (v/v) glycerol, 20 mM bis-
tris, 500mMaminohexanoic acid, 20mMNaCl, 2mMEDTA, pH
7.0, 250 !l/well). The lysate was centrifuged at 21,000 " g at
4 °C for 10 min to remove insoluble material. The supernatant
was collected and diluted 10-fold in Triton lysis buffer. 8% bis-
tris-buffered polyacrylamide gels (0.75 mm) at pH 7.0 contain-
ing 66 mM aminohexanoic acid were used. Wells were topped
up with cathode buffer (50 mM Tricine, 15 mM bis-tris, 0.02%
(w/v) Coomassie G-250, pH 7.0). 10 !g of BSA was used as a
molecular mass marker, giving bands at 66 and 132 kDa. Gels
were run on ice at 100 V until samples entered the gel, then at
180 V until the Coomassie dye front reached the end of the gel.
Immunoblotting—BN-PAGE gels were destained with 40%
(v/v) methanol, 10% (v/v) glacial acetic acid for 30min, refresh-
ing the destaining solution every 10 min. Gels were soaked for
30 min in 1% SDS in Tris-buffered saline, pH 7.4, at room tem-
perature. Proteins were blotted onto PVDF membrane by wet
transfer at 100 V for 1 h. Coomassie-stained BSAmarker bands
weremarked onto themembrane using a felt-tipped pen.Mem-
branes were blocked in 20% (w/v) Marvel-skimmed milk pow-
der in 0.1% PBS-Tween for 1 h. Membranes were incubated
overnight at 4 °C on a roller in rabbit anti-AQP4 antibody
(Abcam, ab128906) diluted 1:5,000 or rabbit anti-GFP (Abcam,
ab6556) diluted 1:10,000, both in 5 ml of 0.1% PBS-Tween.
Membranes were washed in 0.1% PBS-Tween and incubated
with donkey anti-rabbit HRP (Santa Cruz, sc-2313) diluted
1:10,000 in 20 ml of 0.1% PBS-Tween at room temperature for
1 h. HRP was detected on x-ray film using ECL reagent (Amer-
sham Biosciences).
Statistics—For multiple comparisons, one-way ANOVA was
used, followed by post hoc t-tests with the p values subjected to
Bonferroni correction for multiple comparisons. All data are
presented as mean# S.E.
Simulations—Simulations were done using the GROMOS
53A6 forcefield (14) extended to include lipid parameters (15)
in Gromacs version 4.5.5 (16). An AQP4 tetramer was gener-
ated according to the biological assembly entry in the AQP4
Protein Data Bank file 3GD8 (17). N and C termini of the pro-
tein were truncated in the structure so proteins were simulated
with neutral termini. The AQP4 tetramer was embedded into 5
pre-equilibrated 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-
choline bilayers using inflateGRO (18) and hydrated usingGro-
macs. Na$ and Cl% were added to a final concentration of 100
mM. Equilibration was achieved by steepest gradient energy
minimization, 100-ps NPT simulation with 1,000 kJmol%1
nm%1 restraints on protein heavy atoms followed by three 1-ns
NVT simulations with 1000, 100, and 10 kJmol%1 nm%1
restraints on protein heavy atoms followed by 30-ns unre-
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FIGURE 1. Residues at the AQP4 tetrameric interface. A, we identified hydrophobic residues (orange) in TMs 1, 2, 4, and 5 that formed inter-monomer
contacts in the crystal structure and B, polar residues (green) at the bottom of TM2 and in the intracellular loop D. C, ball diagram showing the position of the
identified residues in the primary sequences and secondary structuralmotifs of AQP4. Two regions of loopDwere selected for compoundmutation, whichwe
denote loop D1 (179DSKRT183) and loop D2 (184DVTGS188). Blue lines represent the approximate position ofmembrane lipid headgroups. All residues are listed
in Table 1.
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strained simulation. A Nosé-Hoover thermostat (0.5 ps, 310 K)
was used to maintain constant temperature and 2 Parinello-
Rahmann barostats (2 ps, 1 atm) were used to maintain con-
stant pressure with zero surface tension. 1.4-nm cut-offs were
applied for dispersion and short-range electrostatic interac-
tions. Long-range electrostatics were treated using particle
mesh Ewald. Hydrogen bonds were identified using the
H-bonds plugin of visual molecular dynamics (19) using 3 Å
and 20° cut-offs. Hydrogen bond occupancy was calculated
according to these cut-offs at 100-ps intervals along the 100-ns
trajectories and averaged over the 4 monomers and 5
trajectories.
Calcein Fluorescence Quenching—Plate reader-based calcein
fluorescence quenching was done following Fenton et al. (20).
MDCK cells were plated into black-walled, clear-bottomed tis-
sue culture treated 96-well plates (Greiner) at 50% confluence
24 h before the experiment. Cells were loaded with 5 !M cal-
cein-AM in growth medium supplemented with 1 mM probe-
necid (to inhibit dye leakage) for 90 min. Cells were washed
twice with HEPES-buffered growth medium supplemented
with 1 mM probenecid, then covered with 75 !l of probenecid-
supplemented HEPES-buffered medium. Fluorescence was
read on a BioTek synergy HT plate reader with injector system.
Each well was read continuously (dt! 50 ms) for 5 s, followed
by injection of 75 !l of HEPES-buffered medium containing
400mMmannitol to give a final concentration of 200mMand an
osmotic gradient of 200 mosmol. Fluorescence was read for a
further 50 s. Normalized fluorescence values were converted to
normalized volumes using a Coulter counter generated stan-
dard curve. Single-phase exponential decay functions were fit-
ted and rate constants were taken as proportional to the mem-
brane water permeability.
Results
Mutation of Loop D of AQP4 Reduces Tetrameric Assembly
Using the crystal structure of AQP4 (17), residues likely to
form the tetrameric interface were identified, based on the
physical distance between residues on adjacent monomers.
Alanine substitution mutagenesis was used to investigate the
contribution of these residues to oligomeric assembly. The
identified residues were clustered into two regions. The first
cluster comprises a patch of hydrophobic residues at the inter-
faces of TM1 and TM2 of onemonomer with TM4 and TM5 of
the adjacent monomer (Fig. 1A); the second cluster comprises
12 predominantly polar and charged residues forming intracel-
lular loop D and the bottom of TM2 (Fig. 1B). 24 single point
alanine-substitution mutants were made and six compound
mutants were used to investigate the possibility of synergistic
effects of several residues. There are two protein kinase A/C
consensus sites in loop D (Ser180 and Ser188) so phosphomi-
metic mutations were also made (S180D and S188D). All
mutants are listed in the left-hand column of Table 1.
BN-PAGE followed by immunoblotting was used to assess the
oligomeric state of all mutants expressed in HEK293 cells. Rep-
resentative BN blots are shown in Fig. 2A and the effect of all
mutations on oligomeric assembly and surface expression sum-
marized in Table 1 and Fig. 2B. None of the hydrophobic resi-
dues in the hydrophobic patches had any effect on tetramer
formation, either in isolation or in compound mutants. TM
compound mutants consisted of simultaneous mutations of all
residues identified within that transmembrane segment (e.g.
TM1 denotes the simultaneous mutations I43A/I47A/L50A/
L51A/I57A). Of the loop D single alanine mutants, only D179A
had an effect on oligomeric assembly in isolation, and this effect
was only minimal, with 95 " 2% of the protein still assembled
into tetramers. Unlike the hydrophobic cluster, the compound
mutants of loop D had a clear effect on the ability of AQP4 to
tetramerize. The two compound mutants, loop D1 (D179A/
S180A/K181A/R182A/T183A) and loop D2 (D184A/V185A/
T186A/G187A/S188A), caused reductions in oligomeric
assembly: only 19" 4% of the loop D1 protein assembled into
tetramerswith both dimers (27" 5%) andmonomers (53" 4%)
being present, whereas the loop D2 protein predominantly
formed dimers (67" 7%) with 33" 7% assembled into tetram-
ers (n! 3).
Surface Expression of Non-tetrameric Mutants
There was no significant difference in the surface expres-
sion of the loop D mutants compared with wild-type AQP4.
Surface expression was assessed qualitatively by live cell con-
focal microscopy using GFP-tagged AQP4 mutant con-
structs and quantitatively by cell surface biotinylation. Fig.
TABLE 1
Oligomerization state and surface expression of AQP4mutants
Oligomerization state of all AQP4 mutants analyzed. Compound mutations are
represented by a solid slash between the relevant point mutations, e.g. L72A/L79A.
T ! tetramer, D ! dimer, M ! monomer. All data are reported as mean " S.E.,
n! 3.
Mutant
Oligomerization
state
Surface
expression
% of WT
I43A T 113.9" 5.1
I47A T 95.8" 3.2
L50A T 102.5" 4.1
L51A T 96.1" 13.0
I57A T 104.1" 4.1
TM1 (I43A/I47A/L50A/L51A/I57A) T 86.9" 3.1
L72A T 121.1" 25.6
L79A T 88.9" 13.3
TM2 (L72A/L79A) T 97.7" 5.6
L161A T 91.9" 18.4
I165A T 87.9" 3.6
TM4 (L161A/I165A) T 85.4" 11.2
I189A T 97.7" 5.9
I199A T 96.2" 8.5
F203A T 112.4" 13.3
TM5 (I189A/I199A/F203A) T 93.3" 9.0
Q86A T 118" 4.4
H90A T 113.5" 4.1
D179A T (95" 2%) 87.6" 19.4
D (5" 2%)
S180A T 109.8" 4.5
S180D T 99.7" 4.9
K181A T 103.2" 4.5
R182A T 96.1" 22.1
T183 T 105.6" 3.6
Loop D1 (D179A/S180A/K181A/
R182A/T183A)
T (19" 4%) 88.5" 6.1
D (27" 5%)
M (53" 4%)
D184A T 97.7" 8.8
V185A T 102.2" 5.4
T186A T 95.1" 7.5
G187A T 106.7" 5.1
S188A T 98.6" 3.2
S188D T 104.1" 4.2
Loop D2 (D184A/V185A/T186A/
G187A/S188A)
T (33" 7%) 83.1" 11.0
D (67" 7%)
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3A shows representative confocal micrographs of HEK293
cells transfected with GFP fusion proteins of AQP4 wild-
type, and the loop D1 and loop D2 mutants. Surface expres-
sion in transiently transfected HEK293 cells measured by cell
surface biotinylation was not significantly different (p !
0.53, one-way ANOVA, n ! 3) for either of the loop D com-
pound mutants (D1 and D2) or the single alanine mutants
(Fig. 3B). This suggests that the trafficking machinery is able
to interact with non-tetrameric aquaporins. The cell surface
biotinylation data are summarized for all mutants in the
third column of Table 1.
Mutants in the PlasmaMembrane Exhibit Reduced
Tetramerization
It was important to confirm the reduction in tetramerization
of AQP4 molecules that had been constitutively trafficked to
the cell surface and to rule out intracellular retention of
dimeric/monomeric species or changes in detergent sensitivity
caused by loop D substitutions. Several complementary bio-
physical techniques were used to address this.
Fluorescence Recovery after Photobleaching (FRAP)—Recov-
ery curves were collected from 5 different cells per experimen-
tal repeat (n! 6). Representative fluorescence recovery curves
are shown in Fig. 3D, along with the average recovery half-
times. From these, diffusion coefficients were calculated: 5.2"
0.3 # 10$3 !m2 s$1 (AQP4 WT), 5.9 " 0.3 # 10$3 !m2 s$1
(loopD1), and 5.8" 0.2# 10$3!m2 s$1 (loopD2). Both loopD
mutant diffusion coefficients were significantly different
from the wild-type (D1 p! 0.01 and D2 p! 0.02 by Student’s
t test following ANOVA, with p values subjected to Bonfer-
roni correction). The FRAP data suggest reduced tetramer-
ization for the surface-localized loop D mutants, although
the increased diffusion coefficient could also be explained by
the inability of these mutants to form a complex with a third
party protein.
BN-PAGE of Biotinylated Cell Surface Protein—To comple-
ment these FRAP experiments, biotinylated cell surface pro-
teins were isolated using neutravidin-coated plates, eluted by
reducing the S-S bond incorporated into the biotinylation re-
agent (using 1%"-mercaptoethanol in BN lysis buffer) and sub-
jected to BN-PAGE (representative blots are shown in Fig. 3C).
Surface-localized mutant AQP4 molecules subjected to BN-
PAGE had the same changes in tetramerization seen in whole
cell lysates (n! 3).
Forster Resonant Energy Transfer (FRET)—To complement
the above analyses, AQP4 constructs tagged with Venus (a yel-
low fluorescent protein (YFP) derivative) and mTurquoise2 (a
cyan fluorescent protein (CFP) derivative) were generated and
co-transfected into HEK293 cells to form a FRET biosensor for
homo-oligomerization in living cells. Thewild-typeAQP4 con-
structs gave a robust FRET signal with an average apparent
efficiency of 44.2 " 3.6% (Fig. 4). We were unable to measure
any FRET in cells co-transfected with AQP1-Venus andAQP4-
FIGURE 2. BN-PAGE andWestern blotting of AQP4mutants. A, representativeWestern blots following BN-PAGE of Triton X-100-solubilized AQP4mutants,
showing the effect of the loop D1 and loop D2 compoundmutations, and a lack of effect of mutations on the transmembrane hydrophobic patch. 66 and 132
denote the positions of BSAmolecular weightmarker bands. The AQP4-GFP construct, including linker peptide, has a predictedmolecularmass of 63.1 kDa. B,
percentage of protein assembled into tetramers calculated using densitometry following BN-PAGE andWestern blotting. Effectivemutations are highlighted
withwhite bars. Data are presented as mean" S.E. from 3 experimental repeats.
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Turquoise despite high co-localization (data not shown), sug-
gesting that the FRET interactions occur primarily within the
AQP4 tetramers and not between tetramers that are transiently
close together in the plane of themembrane. The probability of
a particular donor molecule taking part in FRET is dependent
on the number of acceptors within the Forster radius and vice
versa. For CFP-YFP, the Forster radius is!5 nm (21). Based on
the AQP4 crystal structure, the monomer-monomer center of
mass separations are 2.8 (adjacent monomers) and 3.9 nm
(diagonal monomers), respectively, so both would be expected
to contribute to the FRET signal (assuming that the average
separation of the C-terminal tails is similar). The average num-
ber of FRETpairings in a sample of co-transfected cells is there-
fore dependent on the level of AQP4 oligomerization. Both D1
and D2 compound mutants had a slightly larger than 2-fold
reduction in FRET efficiency (to 17 " 6 and 20 " 4%, respec-
tively, p # 0.003 and p # 0.005, n # 4) compared with the
wild-type (Fig. 5A), suggesting that these constructs have a
reduced propensity to oligomerize in live cells, further confirm-
ing that the changes seen in the BN-PAGE were not mediated
by changes in detergent sensitivity. Furthermore, for the
mutants, there was no difference in FRET efficiency between
plasma membrane and intracellular membranes (Figs. 5, B and
C), suggesting that the oligomerization state of thesemutants is
the same in all membrane compartments (e.g. Golgi, vesicles,
plasmamembrane). Taken together, these data suggest reduced
tetramerization for the AQP4 loop D mutants in the plasma
membrane of living cells.
FIGURE 3. Plasmamembrane localization of non-tetrameric mutants. A, representative fluorescence micrographs of HEK293 cells transfected with C-ter-
minal GFP fusions of AQP4WT and loop Dmutants. B, surface expression of AQP4mutants in HEK293 cells measured by cell surface biotinylation followed by
a neutravidin-based ELISA. LoopD compoundmutants are highlighted in red. The S52Dmutant was used as a negative control for surface expression. n.s., not
significant. C, reprsentative blots of AQP4mutants subjected to BN-PAGE.WC, whole cell lysate; S, surface protein only, isolated by cell surface biotinylation.D,
representative FRAP curves from photobleaching AQP4-GFP fusion proteins in HEK293 cells. E, average half-times of fluorescence recovery averaged over fits
to 5 curves per experiment and 6 experimental repeats. All data are presented as mean" S.E.
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Loop D Mutants Have Wild-type Water Permeability—Both
loop D compound mutants (D1 and D2) and wild-type AQP4
were stably transfected into MDCK cells to measure water
channel function. Membrane water permeability of MDCK
cells, measured by calcein fluorescence quenching (Fig. 6A),
was increased 7-fold by stable expression of AQP4. Water per-
meability due to the transfected AQP was calculated by sub-
tracting the permeability of untransfected cells (Fig. 6B); the
resulting permeability was normalized to the surface expres-
sion measured by cell surface biotinylation to allow for differ-
ences in cellular expression due to differences in the position of
chromosomal integration of the stably transfected gene (Fig. 6,
C and D). After normalization to surface expression, no signif-
icant difference in permeability was observed between the loop
D mutants and wild-type AQP4 (one-way ANOVA, p ! 0.17,
n! 4), suggesting that tetramerization of AQP4 is not required
for full water channel activity.
Loop DMutants Do Not Relocalize to the PlasmaMembrane
in Response to Hypotonicity—We recently reported that AQP4
rapidly relocalizes to the plasma membrane from intracellular
membranes in response to reduced extracellular tonicity (11)
and that this phenomenon is true for other mammalian AQPs
(7, 22). Despite wild-type water permeability and constitutive
surface expression of the loop D mutants, D1 and D2, this
response to hypotonicity was not observed for either. Relative
membrane expression of wild-type AQP4-GFP imaged in live
HEK293 cells increased from 27.9 " 3.5 to 67.1 " 4.5 (p !
0.003, n! 3) upon reduction of the extracellular tonicity to 85
mosmol, whereas the distribution of both the D1 and D2
mutants did not change significantly (p ! 0.29 and p ! 0.34
respectively, n! 3; Fig. 7).
Molecular Dynamics Simulations Suggest a Dynamic Net-
work of LoopD Interactions—To investigate the contribution of
loop D to AQP4 oligomerization we did five independent
100-ns molecular dynamics simulations of a hydrated AQP4
tetramer embedded in a 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine bilayer. We found a dynamic network of
hydrogen bonds between loop D residues on adjacent mono-
mers and also between loop D residues and both a glutamine
(Gln86) and histidine (His90) residue at the bottom of TM2. On
average, eachmonomerwas involved in 3.8" 1.4 (mean" S.D.)
loop D hydrogen bonds with its two neighboring molecules at
any given time, which is equivalent to 7.6" 2.8 loop D hydro-
gen bonds per tetramer. Every loop D residue apart from Ser180
was able to act as a hydrogen bond donor or acceptor with
another loopD residue on one of the two adjacentmonomers; 7
residues (Arg182, Thr183, Asp184, Val185, Thr186, Gly187, and
Ser188) were found to have at least 3 different possible hydrogen
bonding interactions. This network of interactions is repre-
sented as a heat map in Fig. 8A. Interactions involving Val185
and Gly187 were backbone hydrogen bonds. Both of these resi-
dues were able to act as hydrogen bond donors from the back-
bone amine group (Val185 to an adjacent Val185, and Gly187 to
Asp184, Val185 and Thr186) and acceptors at the backbone car-
bonyl group (Val185 from an adjacent Val185 as well as Thr183,
Thr186, Gly187, and Ser188, and Gly187 from Thr186, Ser188, and
Gln86). Loop D (as well as loop A) showed relatively large struc-
tural fluctuations (Fig. 8, B and C) despite maintaining an aver-
age of 3.8" 1.4 inter-monomer hydrogen bonding interactions.
Representative snapshots showing the most highly occupied
hydrogen bonds, His90-Asp179, Ser188-Gly187, Ser188-Ser188,
Gln86-Asp184, Gln86-Ser188, and Thr183-Asp184 are shown in
Fig. 8F. LoopD could potentially stabilize theAQP4 tetramer in
one of two ways: by preventing monomers from drifting apart
during rapid association/dissociation of the inter-monomeric
TM interfaces, or by providing inter-monomer interactions
that stabilize the tetramer in amore permanentway, preventing
dissociation in the first place. In simulations we found that the
FIGURE 4. A FRET biosensor for AQP4 oligomerization. A, fluorescence confocal microscopy of live HEK293 cells transiently transfected with AQP4-Venus
alone, AQP4-mTurquoise2 alone, and the two co-transfected. Excitation (Ex) at 405 nm is for Turquoise and 514 is for Venus. The contrast of these images has
been manually optimized to aid the eye. All analysis was performed on raw, unadjusted images. Em, emission.
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average monomer-monomer center of mass separation was
stable with a root mean square fluctuation of only 0.53 Å (c.f.
typical carbon-carbon bond length of !1.5 Å) about a mean
of 28.67 Å, and the inter-monomer buried (solvent-inacces-
sible) area was also stable, with a root mean square fluctua-
tion of 230 Å2 about amean of 2960 Å2. Representative traces
are shown in Fig. 8, D and E. This suggests that there is no
spontaneous dissociation/reassociation of the inter-mono-
mer interfaces, at least on the time scale of these simulations
(100 ns).
Loop D May Represent a Common Motif for Oligomeric
Assembly Across the AQP Family—To investigate whether our
AQP4 data could be more widely applicable to other members
of the AQP family, we performed a sequence alignment of the
loop in all human AQPs, as well as the E. coliAQPs as compar-
ison (Fig. 9A) using the Clustal Omega software (23). AQP1
contains a similar acidic-X-basic-basic motif to AQP4 in the
first half of the loop (DRRRR versus DSKRT), so we made the
D1 mutant in AQP1 (D158A/K159A/K160A/K161A/K162A).
This motif is lacking in AQP3, therefore we introduced it via 2
different mutations, P181S/Y182K/N183R and P181E/Y182K/
N183R (to give DSKRN and DEKRN versus the wild-type
DPYNN). The D1 compound mutation in AQP1 caused a sim-
ilar loss of oligomerization to that observed for AQP4. Both
AQP3 mutations caused the protein to migrate primarily as a
bandwith amolecular weight consistent with a dimeric species,
whereas wild-type AQP3 appeared to migrate primarily as a
monomer (Fig. 9B), consistentwithprevious studies on theolig-
omerization state of this AQP. Both AQP1 and AQP3migrated
as diffuse bands, consistent with glycosylation. PNGase F treat-
ment was used to attempt deglycosylation. This appeared to be
incompatible with the BN-PAGE experiments, because 1-h
treatments with PNGase F at 37 °C caused AQP1 and"3 wild-
type and mutants to form aggregates that did not migrate
beyond the interface between the stacking and separating gels
(data not shown). This may be due to increased temperature
sensitivity of Triton X-100-solubilized AQPs. Finally, to inves-
tigate whether loss of AQP oligomerization is a general feature
of the glyceroporin subfamily, we transfected HEK293 cells
with AQPs 9 and 10 and subjected Triton X-100-extracted pro-
tein to BN-PAGE. Unlike AQP3, we found that AQPs 9 and 10
migrated exclusively as tetramers (Fig. 9B).
FIGURE 5. Reduced FRET from AQP4 mutants. A, average apparent FRET efficiencies for AQP4 wild-type and loop D1 and D2 mutants, calculated by
normalizing the corrected FRET intensity to YFP intensity for each pixel. Five different areas on each plate were imaged per experimental repeat, n # 4. B,
representative line scan across a cell, passing throughmembrane and cytoplasm and avoiding the nucleus. Whereas the YFP signal (red) shows clear peaks at
the plasma membrane, the FRET efficiency (blue) does not. C, representative processed FRET efficiency images compared with unprocessed FRET and YFP.
Whereas both YFP and the raw FRET show clear membrane signals, the FRET efficiency does not.
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Discussion
Our data show that the plasma membrane abundance of
AQP4 in HEK293 cells is unaffected by the oligomeric state of
the protein. This strongly suggests that tetrameric assembly is
not required for AQP4 to be correctly trafficked through the
endoplasmic reticulumandGolgi to the plasmamembrane. It is
possible that our mutants are trafficked as tetramers and then
dissociate once inserted into the plasma membrane; the FRET
data suggest that this is unlikely to be the case, although we
cannot differentiate between particular intracellular compart-
ments on the basis of this data, leaving open the possibility of
differences in oligomerization state between different intracel-
lular compartments. Our diffusion coefficients calculated from
the FRAP data compare reasonably with other reports of diffu-
sion of AQP-GFP constructs in mammalian cells (e.g. 5.7 !
10"3 !m2 s"1 for AQP2 (24), 3.1 ! 10"3 !m2 s"1 for AQP1
(25)). We found a small, but statistically significant increase in
diffusion coefficient for the mutants that were non-tetrameric
in BN-PAGE. Although we have not estimated hydrodynamic
radii for our constructs, the relationship D# ln(1/R) derived by
Saffman and Delbruck (26) suggests a hydrodynamic radius of
1.2$ 1.0 nm for our non-tetrameric constructs (assuming r%
4 nm for a freely diffusing AQP4 tetramer), which is at least
consistent with a loss of tetrameric assembly. We found no
difference in the mobile fraction between the wild-type and D1
or D2 mutants (90$ 6, 89$ 4, and 92$ 7%, respectively, n.s.
p% 0.28), suggesting that there is no difference in the propor-
tion of the protein involved in membrane anchoring interac-
tions. Although we cannot rule out loss of an AQP4 binding
partner as an alternative explanation of these datawith absolute
certainty, in combination with the cell surface BN-PAGE and
FRET data it is highly suggestive of non-tetrameric mutant
AQP4 molecules in the plasma membrane. Human AQP3 was
reported to exist in all four possible oligomeric states (mono-
mer, dimer, trimer, and tetramer) in the plasma membrane of
erythrocytes (27). It may be that some or all members of the
AQP family can be trafficked to the plasmamembrane indepen-
dently of their oligomerization state.
Our molecular dynamics simulations suggest a dynamic net-
work of transient hydrogen bonds between the residues of loop
D of adjacent monomers and also with two residues at the bot-
tom of TM2. The fact that almost every residue involved in this
network has several hydrogen bonding options may explain
why none of the single alanine substitution mutations had an
effect on tetrameric assembly. For example, the most highly
occupied hydrogen bond that we found was His90-Asp179,
which had 66.5% occupancy averaged over the four monomers
and five trajectories. When this bond was not occupied, the
Asp184 side chain was able to act as a hydrogen bond acceptor
from the histidine imidazole NH group, and the Thr186 side
chain hydroxyl group was able to act as a hydrogen bond donor
to Asp179. These alternative interactions may be able to par-
FIGURE 6. Water permeability of non-tetrameric mutants. A, representative calcein fluorescence quenching curves from stably transfected MDCK cells
subjected to a 200mosmol of mannitol osmotic gradient. B,water permeability of MDCK cells normalized to AQP4WT-transfected MDCK cells. C, normalized
surface expression of AQP4 constructs in the stably expressing MDCK clones used for water permeability measurements, measured by cell surface biotinyla-
tion. D, MDCK membrane water permeability normalized to surface expression, to give normalized single channel permeability. All data are presented as
mean$ S.E., n% 4.
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tially compensate for the loss of the Asp179-His90 interaction in
the D179A and H90A single mutations. Asp179 had only one
alternative interaction, whereas His90 had three. This may
explain why the D179A mutation had a slight effect on oligo-
merization, whereas the H90A mutant did not. Interestingly,
MD simulations have suggested that a histidine residue just
beyond the bottom of TM2 in the intracellular loop B (H95)
could modulate the channel open probability via spontaneous
formation and dissociation of a hydrogen bond with a cysteine
residue at the interface between TM4 and loop D (Cys178) (28).
In our simulations, we did not observe this hydrogen bond. A
recent study combining in silico and in vitro evidence also did
not observe this hydrogen bond in simulations and suggested
that His95 may indeed act as a channel gating residue, but by
formation of a histidine protonation state-dependent salt
bridge with a glutamate residue (Glu41), independent of Cys178
(29).
S-Nitrosylation of AQP11 at a cysteine residue in the extra-
cellular loop E (Cys227) has been suggested to be required for
AQP11 oligomeric assembly, with the C227S mutant showing
reduced oligomeric assembly in mouse kidney (30). This sup-
ports the idea of a role for post-translational modification in
AQP oligomerization. Loop D of AQP4 contains two sites pre-
dicted to be targets for post-translational modification. These
are protein kinase sites at Ser180 and Ser188. Phosphorylation at
Ser180 was suggested to reduce AQP4 water permeability via a
gating effect in LLC-PK1 cells (31), but this was not supported
by molecular dynamics simulations of AQP4-Ser(P)180 (32),
and structural studies showed no difference between wild-type
AQP4 and a phosphomimetic S180Dmutant (33, 34). We used
phosphomimetic (S180D, S188D) and phospho-blocking
(S180A, S188A) mutations to investigate a potential role for
post-translationalmodification in the AQP4 oligomeric assem-
bly. We found that all four phosphorylation mutants were able
FIGURE 7. Tonicity-induced translocation of non-tetrameric mutants. A, representative fluorescence micrographs of HEK293 cells transfected with AQP4-
GFP fusionproteins, before and after 30 s of exposure to hypotonic (85mosmol)medium.B, relativemembrane expressionof AQP4-GFP fusionproteins before
and after exposure to hypotonic medium. At least 4 cells per image were analyzed for each experimental repeat, n! 3. Data are presented as mean" S.E.
Oligomerization of Aquaporin-4
MARCH 25, 2016•VOLUME 291•NUMBER 13 JOURNAL OF BIOLOGICAL CHEMISTRY 6867
 at ASTON UNIVERSITY on M
ay 16, 2016
http://www.jbc.org/
Downloaded from 
Oligomerization of Aquaporin-4
6868 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 13•MARCH 25, 2016
 at ASTON UNIVERSITY on M
ay 16, 2016
http://www.jbc.org/
Downloaded from 
to assemble into tetramers, suggesting that phosphorylation of
loop D is not involved in tetrameric assembly of AQP4.
We recently reported that AQP4 in primary rat astrocytes
and HEK293 cells rapidly relocalizes to the plasma membrane
upon reduction of extracellular tonicity (11); this may involve
changes in interactions between AQP4-containing vesicles and
cytoskeletal elements as described by others (35, 36). Interest-
ingly, neither of themutants with reduced ability to tetramerize
were able to relocalize in response to a hypotonic extracellular
stimulus. It is possible that a binding partner of AQP4 involved
in the translocation response recognizes an epitope formed by
the interface of several AQP molecules within a tetramer, and
that disrupting tetrameric assembly disrupts this epitope.
Although the C-terminal PKA phosphorylation site (Ser276),
which controls this response is!100 residues away in the pri-
mary sequence, it may be that phosphorylation of this residue
causes a conformational change in the large (!70 residue)
C-terminal tail of AQP4, which allows an AQP4-binding pro-
tein to bind to the intracellular face of AQP4 including loop D.
Structural data for AQPs are routinely collected after cleaving
the C terminus at the bottom of TM6 to aid crystallization and
high-resolution structure determination (37). This is true for
AQP4 and in the structure that we used to identify mutagenic
targets and as input for our simulations, the protein was trun-
cated at the bottom of TM6, at residue 254 of 323 (17). This
makes it difficult for us tomake any concrete predictions about
interactions of the AQP4 C terminus, especially given its large
size.
Based on a sequence alignment of loop D, we made mutants
of human AQPs 1 and 3.Wild-type AQP1 existed as a tetramer
when extracted fromHEK293 membranes using Triton X-100,
whereas AQP3 existed primarily as a monomer, both of which
are in agreement with previous reports (27, 38). Mutating the
first five residues of AQP1 loop D to alanine (which rendered
AQP4 primarilymonomeric) caused the protein tomigrate pri-
marily as a monomer in BN-PAGE. Introducing the conserved
acid-X-base-base motif (present in loop D of both AQPs 1 and
4) into AQP3 caused it to migrate primarily as a dimer. It has
been suggested that lack of oligomerization may have a role in
controlling substrate selectivity of the glyceroporin subfamily
(39), which consists of AQPs 3, 7, 9, and 10 in humans. How-
ever, we find that, unlike AQP3, both AQPs 9 and 10 both exist
exclusively as tetramers when extracted from HEK293 mem-
branes. This suggests that solute permeability of AQPs is not
correlated with the oligomeric state.
Previous mutational analysis of AQP1 found an extracellular
motif consisting of an aspartate residue (Asp185) at the top of
TM5 that can interact with a lysine residue (Lys51) at the top
of TM2 to increase tetramer stability in detergent (40).
Whether this had an effect on native protein in live cells was not
clear. The S205Dmutant of an insectAQP (AQPcic)was shown
to exist in a primarily monomeric state when extracted from
yeast and Xenopus oocyte membranes, whereas the wild-type
was tetrameric (41, 42). This mutant had a complete loss of
water channel function, and it is not clear whether this was due
to subtle changes in structure leading to a gating effect, gross
misfolding, loss of surface expression, or a direct result of the
loss of oligomerization through loss of monomer-monomer
interactions that stabilize the open state of the pore. Thismakes
interpretation of this result very difficult.
In summary, we show that loop D of AQP4 forms a hub for a
dynamic network of interactions that stabilize the AQP4
tetramer, both when solubilized using non-ionic detergent and
in living mammalian cells. Tetrameric assembly is not required
for either endoplasmic reticulum-to-Golgi-to-plasma mem-
brane trafficking or water channel activity. Mutants with
reduced tetrameric assembly are unable to relocalize in
response to tonicity changes, which may reflect a requirement
for tetramerization in the regulation of AQP relocalization or
key protein-protein interactions mediated by loop D of AQP4.
FIGURE 8.A dynamic network of loop D hydrogen bonds in simulations of AQP4. A, heat map showing percentage occupancy of loop D hydrogen bonds
averaged over 4 monomers comprising a tetramer and over 5 independent 100-ns simulations. B, backbone heavy atom root mean square deviation (RMSD)
of AQP4 residues, demonstrating the structural flexibility of loops A andD. RMSDswere calculated independently for each trajectory and averaged.C, close-up
view of loop D RMSD. D, representative inter-monomer center of mass distance for a single interface (red) and averaged over the four interfaces of a tetramer
(blue). E, representative inter-monomer buried area for a single interface (red) and averaged over the four interfaces of a tetramer (blue). F, snapshots of
molecular dynamics trajectories in which the six most highly occupied inter-monomer hydrogen bonds involving loop D residues are occupied.
FIGURE 9. Comparison of loop D between different human AQPs. A, all 13 human AQPs as well as AQPZ and GlpF (both from E. coli) were aligned using
Clustal Omega (EMBL-EBI). Acidic residues are colored red; basic, blue; and neutral residues able to form sidechain hydrogen bonds, green. B, BN-PAGE and
Western blotting of wild-type and mutant AQPs 1 and 3 and wild-type AQPs 9 and 10. 66 and 132 represent BSA molecular weight markers.
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We conclude that loop D interactions may represent a con-
served mechanism for controlling oligomerization across the
AQP family.
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